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1. General introduction: sulfoximine chemistry  
 
During the last decades sulfoximines have gained considerable attention as chiral auxilaries 
and ligands.[1] Their facile synthesis providing an access to both enantiomers, combined with 
variable steric and electronic features (due to an influence of substituent R at the nitrogen atom) 
makes them very useful for asymmetric synthesis. The sulfoximido group possess an unique 
combination of properties, namely chirality, carbanion stabilization, nucleofugacity, basicity, 
nucleophilicity and a low redox potential (Scheme 1). Recently, several of these characteristics 
have been exploited in the asymmetric synthesis of natural products and their analoges. 
 
Scheme 1 Properties of sulfoximine group 
H3C
S
O NR
free electron pair which can coordinate 
Lewis- and Brönstedt acids
the bulky phenyl ring can direct 
stereoselective reactions
S-Stereocenter
acidic protons which can be 
abstracted by strong bases
easily cleavable 
C-S bond
1
 
The bond between S atom and O atom, presented in Scheme 1, does not possess the structure of 
double bond (according to the molecular calculations), and is rather a single bond with a 
disconnected charge, similar to those which could be found in ylides.[1c] However, it will be 
presented as a double bond in order to simplify this thesis. 
 
 Isocarbacycline 9 displays high activity with myocardial infarction, cerebrovascular 
disorder and chronical arterial obstruction.[2]  An asymmetric synthesis was achieved from readily 
available ketone 2 by the olefination-isomerization-cross-coupling strategy with chiral 
sulfoximines (Scheme 2).[3]  Thus, the alkenyl sulfoximine 5 (98% de) was prepared from 2 and 
the lithiated sulfoximine 3 by an asymmetric olefination via an addition-elimination protocol (for 
details see page 17). Sulfoximine 5 was subsequently treated with lithium methanolate furnishing 
the allylic sulfoximine 6. Upon treatment with a corresponding cuprate the allylic sulfoximine 6 
underwent a cross-coupling reaction giving the key intermediate 8 in 95% yield with an excellent 
regioselectivity.  
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Scheme 2 Sulfoximine-mediated synthesis of isocarbocycline 9 
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The structural motif of azaspirocycle has been found in a number of highly interesting 
natural products. [4] The efficient and stereoselective synthesis of azospirocyclic compounds via 
the sulfoximine-mediated strategy has been recently published (Scheme 3). [5] The sulfoximine-
substituted homoallylic alcohol 11 obtained through γ-hydroxyalkylation of allylic sulfoximine 
10 was converted into carbamate 12, which subsequently underwent a highly diastereoselective 
intramolecular aza-Michael addition creating azabicycle 13. Subsequent n-BuLi-mediated double 
lithiation followed by the trapping of lithiated intermediate in situ with corresponding ditosylate 
provided an access to tricyclic azaspirocycle 14. Finally, the substitution of sulfoximine moiety 
by chloride via a reaction with the corresponding chloroformate gave the target azaspirocycle 16 
in 74% yield. 
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Scheme 3 Sulfoximine-mediated synthesis of azospirocycle 16 
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 The asymmetric synthesis of γ-amino acids is a subject of current interest. [6]  An effective 
synthesis has recently been achieved starting from sulfoximine-substituted homoallylic alcohol 
18, which was obtained from allylic sulfoximine 17 (Scheme 4). [7]  Its conversion into carbamate 
19 followed by a highly diastereoselective intramolecular aza-Michael reaction gave the cyclic 
carbamate 20. Subsequently, the sulfoximine moiety was converted into the chloride and then 
into cyanide that resulted in the formation of nitrile 21. The latter was submitted to acid-catalyzed 
hydrolysis followed by protection of an amine group and lactonization giving lactone 23. Finally, 
the furan moiety was oxidized to give a carboxylic group of the amino acid 25 and corresponding 
lactone 24. 
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Scheme 4 Sulfoximine-mediated synthesis of γ-amino acid 25 
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2. Asymmetric synthesis of functionalised carbocycles via Ring-
Closing Metathesis of sulfoximine-substituted trienes. 
 
 
 
 
 
2.1 Introduction: RCM 
 
 
The importance of medium- and large-size rings in organic chemistry is exemplified by being 
the structural core of a large number of biologically important natural products. [8]  Synthetic 
approaches to five- and six-membered rings via cyclization and cycloaddition reactions are well 
established. [9]  Seven-, eight-membered and larger rings are not as abundant. Furthermore, 
cyclization strategies to medium-sized rings are often limited by the entropic factors and 
transannular interactions. [10]  In general, the number of methods for preparing medium-sized 
carbocycles by cyclization or cycloaddition reactions from acyclic substrates is relatively limited. 
Thus, research in this field is still a subject of continuous interests. Ring-closing metathesis [11] 
has been frequently reported as a very efficient method providing access to cyclic systems. The 
catalytic cycle of RCM (Scheme 5) consists of an initiation stage (generation of an active 
complex) and a propagation phase (the active complex promotes additional cycles). [12] Diene I 
reacts with a catalyst forming the metallacyclobutane II. Liberation of volatile ethylene III (or 
other small molecular system) is the driving force in an annulation of this intermediate. The new 
metylidene complex IV undergoes [2+2] cycloaddition yielding bicycle V which finally 
rearranges via annulation to the cyclic olefin VI and new active carbene VII. In the propagation 
cycle a similar sequence of reactions is postulated. In contrast to the initiation cycle, the whole 
process is being started by the ruthenium complex VII and not by the catalyst. 
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Scheme 5 Mechanism of Ring–closing metathesis 
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Catalysts most frequently used in the ring-closing metathesis are the alkylidene 
complexes of ruthenium 28−31, molybdenum 26 and tungsten 27 (Scheme 6). [13] Catalysts based 
on molybdenum have been introduced to the organic synthesis by Schrock et al. They are 
believed to be very active and were reported to catalyze reactions involving very demanding 
alkenes. However they are also very unstable and their use requires strictly inert conditions 
including Glove-box techniques and use of degassed solvents. [14] On the other hand, complexes 
based on ruthenium developed by Grubbs et al. are very stable and have proved to be compatible 
in the presence of many sensitive functional groups including esters, amides, ammonium salts, 
silyl ethers and acetals. [15] 
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Scheme 6 Catalysts frequently used in Ring-closing metathesis 
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Recently, various total syntheses of natural products utilizing ring-closing metathesis as a 
key step have been published. [16] Martin et al. synthesized azacycle 33, an advanced precursor in 
the synthesis of manzamine A, [17] via the ring-closing reaction of tricyclic amide 32 (Scheme 7). 
The RCM was accomplished via treatment of the amide 32 with an equimolar amount of 
molybdenum catalyst 26 in degassed benzene. 
 
 
Scheme 7 Synthesis of manzamine A 33 
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The synthesis of the tetracyclic lactone 35, an intermediate in the total synthesis of australine 
36 has recently been published by White et al (Scheme 8). [18] The ring-closing metathesis of 
diene 34 with Grubbs’ catalyst 30 was exploited as the crucial step of the presented synthesis to 
afford the corresponding azacycle 35 in 97%. 
 
Scheme 8 Synthesis of australine 36 
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Rawal et al. utilized Grubbs’ ruthenium complex 30 in the ring-closing metathesis of diene 
37 to produce tetracycle 38 (Scheme 9). [19] Tetracycle 38 was subsequently converted into 
pentacyclic amide 39 in a stereoselective manner via intramolecular Heck palladium-catalyzed 
cyclization. This strategy represents a general, stereocontrolled synthetic pathway to the 
geissoschizine and akagerine alkaloid family of natural products. 
 
Scheme 9 Synthesis of tetracycle 38 
N
N
Br Me
O N
N
Br Me
O
N
N
Me
O
30 (3-6%)
CH2Cl2, 25 pC
94%
Pd(OAc)2 (5 mol%)
PPh3 (20 mol%)
Proton Sponge
K2CO3, toluol
110 oC, 82%
3837
39
N
N
Br Me
O
38 H
H
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A recent synthesis of (-)-centrolobine 43 (for an alternative synthesis see Chapter 3) reported 
by Blechert et al. demonstrates, how powerful metathesis reactions can be if it is combined with 
other organometallic transformations (Scheme 10). [20] Diastereoselective ring-closing-ring-
opening metathesis of 40 was achieved through treatment of 40 with the second-generation 
Grubbs catalyst 30. Migration of double bonds is usually an undesired side-process in RCM, 
frequently reported to be affected by the contamination of commercially available catalyst with 
[Ru-H] species. [21] In the synthesis of (-)-centrolobine Blechert et al. utilized this phenomenon in 
order to shift the terminal double bond of the dihydrofuran 41. This reaction was accomplished 
by [Ru-H] species, which were formed via the NaBH4-mediated reduction of the second-
generation Grubbs catalyst 30. Cross-metathesis of the dihydrofuran 42 with parahydroxy styrene 
in the presence of the second-generation Hoveyda 31 catalyst, followed by hydrogenation 
afforded (-)-centrolobine 43. 
Scheme 10 Synthesis of (-)-centrolobine 43 
CH2
O
O
CH2
O
Me
MeO
MeO
MeO
O
MeO
OH
c)
Reagents and conditions: a) 30, benzene/CH2CH2,  50 oC, 90%, b) 30, NaBH4, benzene 
50 oC, 90% c) 31, parahydroxystyren, toluene, RT,  d)  5% Pd/C H2 (1 atm), 50%
40 41 42 43
a) b) c), d)
 
Ring-closing dienyne metathesis (Scheme 11) is an interesting modification of a typical 
alkene RCM, which provides access to bicyclic systems. [22] This interesting reaction constitutes 
a cascade of cycloadditions mediated frequently by ruthenium alkenyl complexes. The first 
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cycloadditon occurs between an alkenyl ruthenium species and a triple bond of VIII. The cyclic 
intermediate IX generated in this step is converted through elimination of ethylene into triene X, 
which cyclizes to bicycle XI. Eventually, bicycle XI split into carbine XIII and cyclic system 
XII possessing terminal double bond conjugated with a double bond of cyclic alkene. 
Subsequently, the double bond in the acyclic chain can undergo RCM to give the desired bicyclic 
system XIV. 
Scheme 11 Mechanism of Ring-closing enyne metathesis 
C1 C2
C3 C4
(catalyst) C1 C2
C3 C4
C1 [M]
C3 C4
[M] CH2
C2
CH2
[M]
C4
+
C1 [M]
C3 C4
C1
C3
VIII IX XI XII
XIII
[M] CH2
C2 C2 C2
C5 C5 C5 C5 C5
X
[M]
C4
+
C1
C3
XII XIII XIV
C2
C5
C1
C3
C2
C5
 
 
The dienyne ring-closing metathesis (RCEYM) was the key step of the novel route to the 
anti-cancer agent (-)-irofulven 46 which has recently been described by Movassaghi et al. 
(Scheme 12).[23] Thus, the dienyne 44 was converted upon treatment with ruthenium complex 30 
into bicyclic intermediate 45 with 74-79% yield.  
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Scheme 12 Synthesis of (-)-irofulven 46 
OSi
O
Me3SiO Ph
OSi
O
Me3SiO
Ph
HO
O
OH
30 (10 mol%)
C6H6, reflux
44 45 46
 
 
The synthesis of medium-size rings via RCM is often limited by the unselective formation 
of a new double bond. An interesting solution for this problem has recently been presented by 
Fürstner et al. in the synthesis of the actin cytoskeleton disrupting agent latrunculin A 49 
(Scheme 13). [24] The key step of this synthetic pathway was a RCM between two terminal triple 
bonds of 47 mediated by molybdenum complex formed in situ. The cyclic alkyne 48 was 
subsequently submitted to selective reduction which converted it into the desired Z-configured 
alkene which was further converted into latrunculin A 49 
 
Scheme 13 Synthesis of latrunculin A 49 
a) [Mo{N(tBu)(Ar)}3] (10 mol%), CH2Cl2/toluene, 80 oC, 70%
O
O
O
Me
MeMe
OCH3N
S
Teoc
O
O
O
O
Me
OCH3N
S
Teoc
O
Me
O
O
O
Me
OHN
S
H
O
Me
47 48 49
a)
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2.2 Project objectives 
 
One of the most important issues in RCM is a Z/E-selectivity, with which the new double 
bond is formed. [25] This thesis is based on the assumption that the desired selectivity could be 
provided by the sulfoximine-substituted double bond present in the starting material for RCM 
(Scheme 14). Such a rigid structural motif should influence a conformation of a transition state 
and lead to a selective formation of Z-izomerized alkene XVIII Moreover, a sulfoximine-
mediated synthetic pathway would enable modular synthesis and access to the whole spectrum of 
ring sizes and possible substituents.  
The synthesis was planned to be started by the conversion of N,S-dimethyl sulfoximine 50 
into allylic sulfoximine XV. Since this reaction is well developed, an introduction of the whole 
spectrum of substituents R1 should be possible. The allylic sulfoximine XV should be 
subsequently converted via γ-hydroxyalkylation into sulfoximine-substituted homoallylic 
alcohols XVI. This methodology, which has been used in our research group for several years, 
proofed to be compatible with several allylic sulfoximines and to enable diastereoselective 
formation of two stereocenters. Although the introduction of an unsaturated chain, which would 
be necessary for following RCM, has never been investigated, the formation of series of alcohols 
varying in the length of spacer (variable number n of CH2 groups) should be possible.  
 
Scheme 14 Synthesis of medium-sized carbocycles via RCM of sulfoximine-substituted trienes -
retrosynthetic analysis. 
S
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R2
R1Et3SiO
( )
( )
n
m
R1
OH
R1
S
Et3SiO
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R3
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R2
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( )
( )
n
m
(  )n
m(  )
(  )n
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O NMe
Me
Ph
O NMe
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O NMe
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Subsequently, sulfoximine-substituted homoallylic alcohols XVI should be converted via 
α-functionalization into the corresponding trienes XVII. Possible functionalization, the α-
alkylation and α-hydroxyalkylation, which were reported before this work started, could be used 
to introduce double bond. Moreover, this method would either lead to the formation of the 
corresponding alkenes (α-alkylation) or alcohols (α-hydroxyalkylation) with variable length of 
the spacer (variable number m of CH2 groups). The RCM of sulfoximine-substituted trienes 
should result in the formation of desired carbocycles XVIII, thereby formation of the whole 
spectrum of ring sizes should be possible as well the introduction of several substituents R1, R2 
and R3. Finally, the substitution of sulfoximine-group with new group R4 should be carried out to 
give the desired carbocycles XIX. 
Since the synthesis of medium-sized carbocycles is such a popular topic, many interesting 
reports were recently published. The synthesis of highly substituted cycloheptadienes reported by 
Davies et al. presents an interesting combination of metathesis with ruthenium catalysed 
cyclization (Scheme 15).[26] Thus, the alkins 51a and 51b reacted under exposure to ruthenium 
complex 30 with the vinyl ether 52 to give the corresponding dienes 53a and 53b. Subsequently, 
dienes 53a and 53b reacted under the influence of chiral ruthenium complex 56 with carbines 54a 
and 54b. The desired cycloheptadienes 55a and  55b were obtained in good yields, with good 
diastereoselectivity and with excellent enantioselectivity. 
 
Scheme 15 Synthesis of medium-sized carbocycles 55a, 55b via combination of metathesis with 
ruthenium catalysed cyclization 
 
 
R1 E/Z carbocycle yield de ee
iPr 3:1 55a 75% 90% 92%
CH2OBz 2:1 55b 69% 82% 87%
R1
CO2Me
Ph
N2
CO2MeR1
EtO Ph
OEt
R1
CH2
EtO
30, 5 mol%
CH2Cl2, reflux
Rh2 (S-DOSP)4
hexane, rt
+
+
N
SO2(p-C12H25)C6H4
O
O Rh
Rh
H
R1
CH2
EtO
51a, 51b 53a, 53b52
54a, 54b 53a, 53b 55a, 55b
56
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Intramolecular silicon-assisted cross-coupling reaction presents a very useful method for 
the synthesis of medium-sized carbocycles (Scheme 16).[27] The iodides 57a−57e gave the 
corresponding carbocycles 58a−58e in good yields upon treatment with allylpalladium chloride 
dimer (APC). The modularity of this methodology was demonstrated in the synthesis cyclic ether 
60, which also worked very efficiently (72% yield). Noteworthy is that in this case the palladium 
catalyzed cyclization did not destroy the stereocenters present in iodide 59. 
 
Scheme 16 Synthesis of medium-sized carbocycles 58a−58e via the intramolecular silicon-
assisted cross-coupling reaction 
 
Iodide m n carbocycle Yield
57a 2 1 58a 70%
57b 3 1 58b 63%
57c 4 1 58c 55%
57d 5 1 58d 72%
57e 2 2 58e 71%
I O Si
Me Me APC (7.5 mol%)
TBAF (10 equiv)
THF, rt( )m ( )n HO
( )n
( )m
I
O
O Si
Me
Me Me
APC (7.5 mol%)
TBAF (10 equiv)
THF, rt OMe
HO
57a-57e 58a-58e
59 60, 72%
 
 
The synthesis of medium sized carbocycles is justified by being a structural core of many 
natural compounds which possess interesting biological activity.[28] The hydroxydietyldial 61, an 
antimicrobial metabolite of Dictyota spinulasa, inhibits feeding in the omnivorous fish Tilapia 
mossambica (Scheme 17). This interesting carbocycle contains a nine-membered ring with 
several substituents. In contrast, the obscuratin 62, a metabolite of Xenia Obscurata, possess a 
ten-membered carbocyclic system. 
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Scheme 17 Medium-sized carbocycles: Hydroxydietyldial 61 and Obscuratin 62 
 
OHC
OHC
Me
MeMe
MeOH
Me
OHMe
Me
H
61 62
 
 
Medium sized carbocycles occur frequently fused with smaller rings.[28] The dolbellane-
class diterpenes isolated from Dilophus fasciola from the North Adriatic Sea, contain an 
interesting system of eleven-membered ring fused with a five-membered ring. Representing this 
class of terpenes, the carbocycle 63 presented in Scheme 18 exhibits significant toxicity. 
 
Scheme 18 Medium-sized carbocycles: dolbellane-class diterpene 63 
 
MeH
AcO CH2OH
Me
63
  
A number of sesquiterpenes characterized by an eight-membered ring fused with a five-
membered ring has been isolated from marine sources.[29] The most significant representatives of 
this class are precapnelliadiene 64, dactylol 65 and poitediol 66 (Scheme 19) 
 
Scheme 19 Medium-sized carbocycles: precapnelliadiene 64, dactylol 65 and poitediol 66 
 
MeMe
Me Me Me
Me MeMe
H H
OH OHH
Me Me Me
HO
64 65 66
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Dibenzocyclooctadieno lignans containing eight-membered carbocycle fused with three 
side rings were reported to possess significant antileukemic activity.[29] Interesting members of 
this class are steganones such as steganone 67, staganacin 68 and staganagin 69 (Scheme 20). 
 
 
 
 
Scheme 20 Medium-sized carbocycles: steganone 67, staganacin 68 and staganagin 69 
 
O
O
O
O
OH
H
MeO
MeO
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Presumably the most biologically interesting family of cyclooctanoid diterpenoids are the 
taxanes.[30] The unique bridged tricyclic ring skeletons are found in several species of the yew 
tree. taxol 70, the most important member of this class, is an object of current interest because of 
its unique antimimotic properties and its role in treatment of ovarian and other types of cancers 
(Scheme 21). 
 
Scheme 21 Medium-sized carbocycles: taxol 70 
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2.3 Synthesis of allylic sulfoximines via AEI route 
 
The addition-elimination-izomerization (AEI) route to N-methylallylsulfoximines starting 
from N,S-dimethylsulfoximine 50 is well established. [31] The enantiomerically pure sulfoximine 
50 can be easily obtained starting from thioanisol by a four step-synthesis, including a racemate 
separation with campher-10-sulfonic acid. [32] The N,S-dimethylsulfoximine 50 is subsequently 
converted via treatment with n-BuLi into the corresponding lithated intermediate Li-50 which is 
then trapped with an aldehyde (Scheme 22). The epimeric mixture of the thus generated 
alcoholates XX is in situ converted into carbonates XXI via treatment with methylchloroformate, 
which subsequently undergo a DBU-mediated elimination to afford the alkenyl sulfoximine 
XXII. Finally, upon treatment of the alkenyl sulfoximine XXII with sodium methanolate in THF 
for 5 days, it undergoes izomerization into the allylic sulfoximines XXIII in very good yield and 
with high selectivity. Recent investigations carried out in our reaserch group revealed that the 
aforementioned izomerization leads originally to Z-configured allylic sulfoximines. [33] The E-
configured allylic sulfoximine, which is the thermodynamically favored product of this 
izomerization, is generated only after a prolonged reaction time. 
 
Scheme 22 Synthesis of allylic sulfoximines – the mechanism 
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Using this procedure, N,S-dimethylsulfoximine 50, isovaleric aldehyde and 
cyclohexanone were converted into the corresponding allylic sulfoximines 17 and 71 in 78% and 
72% yield respectively (Scheme 23). [31]  In the case of allylic sulfoximine 17, the Z- and E-
isomers were obtained in a ratio of 93:7 and separated via flash chromatography. Since only the 
E-configured allylic sulfoximine is reactive in the following γ-hydroxyalkylation, [33] the Z-
configured minor product was submitted after separation to a sodium methanolate-mediated E/Z-
isomerization. 
 
Scheme 23 Synthesis of allylic sulfoximines 17 and 71 
iPr S
a) 1. 1.1eq n-BuLi; 2. 1.1 eq isovaleric aldehyde; 3. 1.3 eq ClCO2Me; 4. 3 eq DBU;  
5. 3 eq MeONa; THF, −78 oC to rt
Ph
O NMe
17, 78%
Me
S
O NMe
b) 1. 1.1eq n-BuLi; 2. 1.1 eq cyclohexanone; 3. 1.3 eq ClCO2Me; 4. 3 eq DBU;  
5.  3 eq MeONa; THF, −78 oC to rt
Me
S
O NMe
S
Ph
O NMe
71,  72 %
a)
b)
50
50
 
2.4. Synthesis of sulfoximine-substituted homoallylic alcohols  
 
Depending on the titanium group, titanated N-methylallylsulfoximines react with 
aldehydes regio- and diastereoselectively in α- or γ-position. [33] The γ-hydroxyalkylation was 
intensively investigated over last few years in our research group. Thus, allylic sulfoximines 17, 
72a−72c were reacted with the corresponding aldehydes to give the desired homoallylic alcohols 
73a−73i (Scheme 24). Noteworthy is that all desired alcohols were obtained as single 
diastereoisomer. However, for a long time this reaction was limited since alcohols were obtained 
with yields lower than 50%. First, the application of the second equivalent of 
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triisopropoxytitanium chloride, which activates sulfoximine group via formation of 
corresponding complex (see mechanism of the γ-hydroxyalkylation, Scheme 25), enabled an 
improvement of the yield.  
 
Scheme 24 Synthesis of homoallylic alcohols 73a−73i through γ-hydroxyalkylation of allylic 
sulfoximines 17, 72a−72c 
Allylic 
Sulfoximine Aldehyde
Homoallylic
alcohol R
1 R2 Yield (%)a Yield (%)b
72a MeCHO 73a Me Me 31 -
72a EtCHO 73b Me Et 32 -
72a iPrCHO 73c Me iPr 36 -
72b MeCHO 73d Et Me 44 74
17 MeCHO 73e iPr Me 32 -
17 iPrCHO 73f iPr iPr 44 82
17 PhCHO 73g iPr Ph 43 -
72c EtCHO 73h C6H11 Et 69 -
72c iPrCHO 73i C6H11 iPr 52 72
a
 yield for the reaction carried out with 1.1 eq of ClTi(OiPr)3
b
 yield for the reaction carried out with 2.1 eq of ClTi(OiPr)3
R1 S Ph
O NMe
R2
R1
OH
1.1 eq n-BuLi
ClTi(OiPr)3 
R2CHO
THF, -78 oC to r.t.
17, 72a-72c 73a-73i
S
Ph
O
NMe
 
 
The γ-hydroxyalkylation of allylic sulfoximines XV with unsaturated aldehydes was of 
special interest for the synthesis of sulfoximine-substituted trienes XVII (Scheme 14, page12). 
This well established protocol should enable introduction of a double bond required for RCM. 
Hainz, Decker and Muller reported that the reactivity of E-configured allylic sulfoximines in γ-
hydroxyalkylation is outstandingly higher than that of Z-configured ones. [33] In light of these 
observations both the mixture of E- and Z-configured allylic sulfoximines as well as the pure a E-
configured compounds could be submitted to γ-hydroxyalkylation without any influence on 
reaction outcome. On the other hand the Z-configured allylic sulfoximines could be isomerized 
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into valuable E-configured one via treatment with NaOMe in THF for prolonged time. 
Interestingly, during this work better overall yield of the whole process were obtained if a 
mixture of the Z- and E-allylic sulfoximine 17 was separated prior to γ-hydroxyalkylaton and 
only the E-configured compound was submitted to this reaction.  
The mechanism of the γ-hydroxyalkylation of allylic sulfoximine 17 is presented in 
Scheme 25. [33] The sequence of reactions starts with the selective lithiation of allylic sulfoximine 
17 at the α-position upon treatment with n-BuLi in THF at −78 oC to give Li-17. The subsequent 
transmetallation with triisopropoxytitanium chloride affords the titanium diallylsulfoximine 
complex Ti-17 which finally reacts with the corresponding aldehyde via transition state 17M. 
The two new stereocenters of the thus obtained homoallylic alcohol are formed 
diastereoselectively. The presence of the second equivalent of triisopropoxytitanium chloride 
enhances the reactivity of titanium intermediate Ti-17 in the reaction with the aldehyde leading to 
much better yield. Presumably, the titanium reagent is coordinated as a Lewis acid by the basic 
nitrogen atom of the sulfoximine group of Ti-17 that results in enhanced reactivity in γ-
hydroxyalkylation. Noteworthy is that in reactions carried out without the second equivalent of 
triisopropoxytitanium chloride, the desired alcohols 73a−73i were obtained in maximally 50 % 
yield (see Scheme 24). 
 
Scheme 25 Synthesis of sulfoximine-substituted homoallylic alcohols – the mechanism 
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 N-Methylallylsulfoximine 17 was successively treated with n-BuLi and 2 equiv. of 
ClTi(OiPr)3 in THF at −78 oC to generate the corresponding titanium complex Ti-17, which gave 
in the reaction with either 2-butenal or 4-pentenal the homoallylic alcohols 74 and 75 in 70% and 
75% yield, respectively (Scheme 26). Alcohols 74 and 75 were obtained exclusively as Z-
configured isomers with very high diastereoselectivity. In the case of the cyclic N-
methylallylsulfoximine 71 the 1H NMR spectrum of the crude reaction mixture revealed the 
formation of two diastereomeric homoallylic alcohols in a 5:1 ratio. However, only diastereomer 
76 could be isolated after flash chromatography in 60% yield. In the case of the homoallylic 
alcohols 74 and 76 the γ-hydroxyalkylaton proceeded with the yield given only when 2-butenal 
was slowly added as a solution in THF. When neat 2-butenal was added yields were lower. In 
this case because of the local high concentration 2-butenal presumably underwent an aldol 
reaction in the presence of triisopropoxytitanium chloride.[34] .Moreover, since the commercially 
available 2-butenal contained a small amount of Z-configured minor isomer (varying between 5 
and 12%), the homoallylic alcohols 74 and 76 were slightly contaminated with corresponding Z-
isomers (NMR). However, such mixtures were used for further reactions since the configuration 
of the discussed bond did not influence the RCM which was a goal of this synthetic route (see 
Scheme 14, page 12). 
The allylic sulfoximine 17 which served as a starting material for the synthesis of 
homoallylic alcohols 74 and 75 was chosen for several reasons. First of all, 17 could be obtained 
in very good yield on a multi-gram scale. Moreover corresponding derivatives would bear an 
isopropyl group which was frequently found to be a substituent in natural products. Additionally, 
an isopropyl group gives unique signals in an 1H NMR spectrum which would enable easier 
analysis of corresponding derivatives. 
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Scheme 26 Synthesis of homoallylic alcohols 74−76 
 
Entry Aldehyde R1 Alcohol
1
Me
O a
Me 74
b
, 70%, >96 % de
2
O
75, 75%, >96 % de
3
Me
O a
Me 76
b
, 60 %, 78 % d.e.
S
R1
HO
Ph
O NMe
SPh
O NMe
Reagents and conditions :a) 1. 1.1 eq n-BuLi  2. 2.1 eq ClTi(OiPr)3  
3. 1.5 eq Aldehyde ; THF, − 78 0C to r.t. 4. (NH4)2CO3
iPr S
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O NMe
R1
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OH
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17 74; 75
71 76
a 2-butenal was used as a mixture of E- and Z-izomer 
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S
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2.4.1 Synthesis of sulfoximine-substituted silyl ethers   
 
The sulfoximine-substituted homoallylic alcohols were supposed to be used as parent 
compounds for synthesis of the corresponding trienes XVII (Scheme 14, page12), which would 
be subjected to RCM. Since the introduction of side chains containing a new double bond was 
planned to be completed via lithiation followed by condensation with the corresponding 
electrophile, the hydroxyl groups present in alcohols 74−76 had to be protected. The triethylsilyl 
protecting group was chosen due to its easy introduction and stability under reaction conditions. 
Furthermore, the triethylsilyl group could be easily cleaved under mild acidic conditions. [35] 
Conversion of sulfoximine-substituted homoallylic alcohols 74−76 into the corresponding 
silyl ethers 77−79 was achieved via the imidazole-mediated reaction with triethylsilylchloride in 
water-free DMF (Scheme 27). Subsequent aqueous work-up and purification via flash 
chromatography yielded the silyl ethers 77−79 in 96% yield. 
 
Scheme 27 Synthesis of silyl ethers 77−79 
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1 74 Me 77, 96 %.
2 75 78, 96%.
3 76 Me 79, 96 %
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2.5 Synthesis of sulfoximine-substituted trienes 
 
2.5.1 Introduction 
 
For the key step of our synthetic approach to medium-sized carbocycles, the RCM 
reaction, the synthesis of sulfoximine-substituted trienes XVII (Scheme 14, page12), was 
required. Previous works of Wang-Woo and Loo have shown alkenyl sulfoximines to be 
selectively lithiated in the α-position upon treatment with alkyllithium reagents. [36] The Z-
configured α-lithiated derivatives undergo isomerisation to the corresponding E-configured ones 
at increased temperature. The E-configured lithiated intermediates can then be trapped with 
suitable nucleophiles. This methodology enabled introduction of a methyl substituent in the α-
position of 59 via methyllithium-mediated lithiation followed by the assembling with MeI 
(Scheme 28). The corresponding α-methylated alkenyl sulfoximine 81 was obtained in a very 
good yield and selectivity. 
 
Scheme 28 Alkylation of alkenyl sulfoximine 81 
1. MeLi
Et2O, −78 oC
1. 2 h, −35 oC
2.  MeI
Et2O
Ph
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OSiEt3
S
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O NMe
Ph
iPr
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O
NMe
Ph
iPr
OSiEt3
S
Ph
O
NMe
Li
Me
80 Li- 80 81
 
 
Since the structural motif of allylic alcohol is ubiquitous in organic chemistry, an 
interesting continuation of this strategy was a trapping of lithiated alkenyl sulfoximine with 
aldehydes. The α-hydroxyalkylation of alkenyl sulfoximines has already been reported to be a 
very effective reaction, which, however, leads to the unselective formation of the new 
stereocenter. [37] The formation of an equimolar mixture of epimeric allylic alcohols is surprising 
since the proximity of chiral sulfoximine moiety could be expected to provide asymmetric 
induction. Thus, several additives were used in model reaction of the alkenyl sulfoximine Li-82 
with propanal in order to improve the diastereoselectivity with witch the corresponding allylic 
alcohols 83 (Scheme 29) was formed. The whole range of Lewis acids (entry 2-6) was used in 
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order to provide complexes with the basic sulfoximine group. Moreover, the additives are known 
to activate aldehydes in the desired addition. The results were rather unsatisfactory and alcohol 
83 was obtained with only 11 to 22% de. Another possible solution was provided by the use of a 
chiral base (entry 7), which directs the addition of lithated derivative Li-82 to aldehyde. 
Unfortunately, the additon of (−)-sparteine did not provide significant improvement of 
diastereoselectivity. In this case α-hydroxyalkylation afforded the corresponding allylic alcohol 
83 with 16% de. 
 
Scheme 29 Attempted diastereoselective synthesis of sulfuximine-substituted allylic alcohols 
Entry additive Yield de
1 - 86% 4%
2 ZnCl2 12% 11%
3 BF3/Et2O 27% 11%
4 TiCl4 47% 14%
5 ZnCl2/TiCl4 86% 22%
6 Ti(OiPr)4 58% 14%
7 (-)-sparteine 58% 16%
1. n-BuLi
Et2O, −78 °C
1. 
additive
Et2O,  −78 °C
Et
S
Ph
O NMe
Et
S
Ph
O NMe
Li
Et
S
Ph
O NMe
Et OH
Et
O
82 Li-82 83
 
 
Since all aforementioned attemts to perform α-hydroxyalklytion of alkenyl sulfoximines 
with high diastereoselectivity failed, the development of an alternative synthetic route was 
considered. An assumption was made that α-sulfoximido aldehydes XXV could serve as parent 
compounds for requested allylic alcohols XXVI (Scheme 30). In this case the nitrogen atom in 
the sulfoximido group could form a chelate-like complex with an organometallic reagent and 
direct a diastereoselective attack. Related reactions with chiral amine or imine attached to sp3 
carbon are well described and frequently used in asymmetric synthesis [38]. However, 
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diastereoselective additions of organometallic reagents to carbonyl groups of enones, which is 
enabled here by the sulfoximido group, are scarce. 
 
Scheme 30 Diastereoselective addition of organometallic reagents to sulfoximine-substituted 
enones – retrosynthetic analysis 
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2.5.2 Synthesis of trienes via α -alkylation of alkenyl sulfoximines 
 
According to the previous section, α-alkylation of alkenyl sulfoximines is a selective and 
efficient reaction. For the aims of this project, α-alkylation constitutes an interesting opportunity 
for the introduction of a double bond. The mechanism of this interesting reaction is depicted in 
Scheme 31. [36] The first stage of this process is accomplished by the reaction of the protected δ-
hydroxy alkenyl sulfoximine XXVII with n-BuLi in THF at –78 °C. The Z-configured lithiated 
derivative XXVIII undergoes isomerisation to the E-configured isomer XXIX at elevated 
temperature. Presumably, the Z-configured lithiated intermediate exists in equilibrium with the 
N-lithiated ylide XXIX which can be attacked by a lithium counterion from both sides of the 
double bond. Since the E-configured lithiated alkenyl sulfoximine XXX is thermodynamically 
more stable, the reaction follows an observed pathway. Finally, the lithiated derivative XXX 
reacts with an alkenyl halide yielding the triene XXXI. 
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Scheme 31 Alkylation of alkenyl sulfoximines – the mechanism 
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 The reactions of the alkenyl sulfoximines 77 and 78 with alkenyl halides were performed 
using the α-alkylation strategy mentioned above (Scheme 32). Thus, the reaction of Li-77 and Li-
78 with allyl bromide gave trienes 84 and 85 in 90 and 75% yield respectively (entries 1 and 2). 
The E-configuration of the double bond bearing sulfoximido group was determined via formation 
of cyclic derivatives 131 and 133 (Chapter 2.6.2, page 45). The analogues reactions of Li-77 with 
4-pentyl bromide (entry 4) and 3-butyl bromide (entry 3) failed, probably due to the lower 
reactivity of these electrophiles. Having this hypothesis in mind, the much more reactive 4-pentyl 
triflate was used (entry 5). Unfortunately, this reaction also failed due to a decomposition of the 
alkenyl sulfoximine 78. Interestingly, no signals corresponding to the protons of the N-Me group 
were observed in the NMR spectrum of the mixture obtained after the reaction. This observation 
implies that the triflate reacted with the nitrogen of sulfoximido group in 78, leading to the 
formation of the corresponding sulfinamide and decomposition of the alkenyl rest. Since isolation 
of products was impossible, this theory could not be corroborated. 
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Scheme 32 Alkylation of alkenyl sulfoximines 77 and 78 
 
Entry AlkenylSulfoximine R1 X(  )
n Triene Yield
Recovery
of alkenyl
Sulfoximine
1 77 Me Br 84 90% -
2 78 Br 85 75% -
3 77 Me Br 86 - 96%
4 77 Me Br 87 - 96%
5 78 Me OTf 88 - -
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iPr
OSiEt3
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O NMe
Li
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OSiEt3
S
Ph
O NMe2. 
-45 oC
THF
X(  )
n
(  )n
1. n-BuLi, -78 oC
2. 3 h 0 °C
THF
77, 78 Li-77, Li-78 84−88
 
 
 
2.5.3 Synthesis of trienes via α-hydroxyalkylation of alkenyl sulfoximines. 
 
The α-hydroxyalkylation of protected δ-hydroxy alkenyl sulfoximines with aldehydes 
provides an interesting possibility for the synthesis of sulfoximine-substituted trienes (Scheme 
33). According to the examples mentioned in the introduction this reaction proceeds efficiently, 
but the new stereocenter is formed almost non-stereoselectively. In the first step of this protocol 
δ-hydroxy alkenyl sulfoximine XXXVII is converted into Z-configured lithiated derivative 
XXXVIII in a reaction with n-BuLi. Secondly, the lithiated intermediate rearranges at higher 
temperature to E-configured lithiated compound XXX which subsequently reacts with the 
corresponding aldehyde to give mixture of epimeric alcohols XXXII after hydrolysis with NH4Cl 
solution.  
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Scheme 33 a-Hydroxyalkylation  of alkenyl sulfoximines – the mechanism 
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 The δ-hydroxy alkenyl sulfoximines 77 and 78 were submitted to the α-hydroxyalkylation 
described above (Scheme 33). Their successive treatment with n-BuLi and unsaturated aldehydes 
in THF at −78 oC (Scheme 34) afforded the allylic alcohols 89−92 as equimolar mixtures of 
epimers. Noteworthy is that the homoallylic alcohols 89−92 were only obtained in such good 
yields if the final hydrolysis with NH4Cl solution was performed at −78 oC. If the mixture of 
alcoholates was allowed to raise to ambient temperature, decomposition was observed, 
presumably via retro α-hydroxyalkylation. The epimers were separated by flash chromatography 
on silica gel. The configuration of the newly-formed stereocenter in allylic alcohols 90 and 92 
was determined via NOE-experiments of their cyclic derivatives 139−R, Z-140 (Chapter 2.6.3, 
page 57). Moreover, the chemical shift of the olefinic proton placed close to a sulfoximido group 
was significantly higher in the case of R-isomers. This observation allowed a tentative estimation 
of the absolute configuration of the allylic alcohols 89 and 91. 
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Scheme 34 α-Hydroxyalkylation of alkenyl sulfoximines 77 and 78 
 
Entry AlkenylSulfoximine R
1 R3CHO Allylic 
alcohol
R-epimer S-epimer
1 77 Me Me CHO 89 40% 44%
2 77 Me CHO 90 38% 36%
3 77 Me CHO 91 45% 39%
4 78 CHO 92 40% 32%
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In the case of the cyclic δ-hydroxy alkenyl sulfoximine 79 better yields were achieved 
when a two-step procedure was used (Scheme 35). In first stage of this protocol, the Z-configured 
alkenyl sulfoximine 79 was isomerized through successive treatment with n-BuLi and steering 
for 3 h at an elevated temperature to E-configured 93. The E-configured alkenyl sulfoximine 93, 
which was obtained almost quantitatively, was subsequently successively treated with n-BuLi 
and 2-butenal to give the corresponding allylic alcohols epi-94 and 94 in a ratio of 7:3 (as 
revealed by 1H NMR sprectrum of the crude mixture). The major diastereomer 94 was isolated in 
65% yield while separation of the minor epimer epi-94 failed. 
 
Scheme 35 Synthesis of allylic alcohol 94 
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2.5.4 Synthesis of trienes via addition of Grignard reagents to the α-
sulfoximido aldehydes 
 
The α-hydroxylation described in chapter 2.5.3 is a very effective method for a synthesis 
of sulfoximine-substituted trienes. The unselective formation of the new stereocenter, however, 
limits this method. In order to overcome this selectivity problem an alternative approach was 
developed. We envisioned that the allylic alcohols XXXV could be obtained via addition of 
Grignard reagents to α-sulfoximido aldehydes XXXIV (Scheme 36).  
 
Scheme 36 Synthesis of allylic alcohol via addition of Grignard reagents to the α -sulfoximido 
aldehydes retrosynthetic analysis 
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This synthetic approach was started with the formylation of the protected δ-hydroxy 
alkenyl sulfoximine 77. The introduction of a formyl moiety is a well established reaction in 
organic chemistry and many protocols are available. [39] For the aims of this project, several of 
them were examined. Thus, the alkenyl sulfoximine 77 was reacted with n-BuLi to generate the 
E-configured lithiated intermediate Li-77, which was subsequently treated with the corresponding 
formylating agent (Scheme 37). In the case of DMF (96)[40] and N-formylcarbazole (97)[41] only 
the E-isomer E-77 was isolated (entry 1 and 2). Upon treatment of 77 with Weinreb amide-like 
reagent [42]  98 (entry 3) aldehyde 95 was obtained.  
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Scheme 37 Synthesis of the α -sulfoximido aldehyde 95  
Entry Reagent T Yield
1 H
Me
N
Me
O
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−78 °C
   0 °C
a
a
2
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   0 °C
a
a
3 H
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   0 °C
a
46%-84%
4 NO
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   0 °C
a
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MeMe Me
77 Li-77 95
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However, the results were irreproducible and yields varied from 84% to 46%, presumably 
due to contamination of the reagent 98 with products of its decomposition. Purification of 98 
failed, since it was found that during its destillation partial decomposition occurred. Thus, the 
mixture had to be used, which led to unreproductive results. Finally, N-formylmorpholine [43] (99) 
was investigated as a formylating agent. In this case the aldehyde 95 was synthesized in 86% 
yield. The proper purification of 99 was found to be essential for such a good yield. 
Commercially available N-formylmorpholine was dried over P2O5 and further purified by passing 
through basic alumina. After these operations the reagent was stored under argon for circa one 
month without a noticeable loss of reactivity. 
Having the substituted formyl sulfoximine 95 in hand, the addition of organometallic 
reagents was investigated. Grignard reagents were chosen because of their easy synthesis and 
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higher complexation tendency of magnesium and nitrogen atoms in comparison to those of 
lithium. [44] It was assumed, therefore, that the complexation of magnesium with the nitrogen 
atom in the sulfoximine group of 95 would provide a chelated transition state. Such chelate 
complexes are known to direct additions to neighbouring carbonyl groups. 
In order to synthesize trienes required for following RCM, aldehyde 95 was treated with 3 
equivalents of the alkenylmagnesium halide in THF at −78 oC (Scheme 38). The corresponding 
allylic alcohols S-89, S-90, 100 and 101 were obtained with excellent yields and good to very 
good selectivity. The configuration of the new stereocenter was determined via NOE-experiments 
of corresponding cyclic derivatives (for details see Chapter 2.6.3). 
 
Scheme 38 Synthesis of the allylic alcohols 89, 90, 100 and 101 
RMgX R Alcohol(yield) de
Me MgBr Me S-89 (90%) 96%
MgBr 100 (84%) 80%
MgCl 96%
MgBr 96%
1. 3 eq RMgX 
THF, −78 oC
iPr
S
Et3SiO
Me Ph
O NMe
OH
iPr
S
Et3SiO
Ph
O NMe
OH R
Me
101 (94%)
95 S-89, S- 90, 100, 101
S-90 (92%)
 
 
The transition state depicted in Scheme 39 is believed to be responsible for the 
diastereoselective addition. Since the bulky phenyl ring is shielding the Re-side of the carbonyl 
group, attack on the Si-side of the carbonyl moiety is favoured. As a result RMgX attacks from 
the Si-side which leads to the observed S-configuration of obtained alcohols S-89, S-90, 100 and 
101. The lower selectivity of an addition of allylmagnesium bromide could be explained by the 
higher reactivity of this reagent.  
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Scheme 39 Transition state of diastereoselective addition of organometallic reagents to  
aldehyde 95 
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2.5.5 Synthesis of trienes via addition of Grignard reagents to the α-
sulfoximido ketones 
 
 Efficient and diastereoselective synthesis of secondary allylic alcohols via addition of 
Grignard reagents to sulfoximine-substituted aldehydes encouraged us to study the analogues 
synthesis of tertiary allylic alcohols XXXVIII (Scheme 40). Noteworthy is that this approach 
would enable the synthesis of both epimers depending on the order in which substituents R2 and 
R3 are introduced.  
 
Scheme 40 Synthesis of trienes via addition of Grignard reagents to the α-sulfoximido ketones – 
retrosynthetic analysis 
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Synthesis of α-sulfoximido ketones of type XXXVII required for the envisioned synthesis 
of allylic alcohols XXXVIII could be achieved via reaction of δ-hydroxy alkenyl sulfoximines 
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with the corresponding Weinreb amides. The use of Weinreb amides in modern organic synthesis 
is well established and provides one of the most efficient methods for the synthesis of ketones. [45]  
However, the reports concerning conversions of substituted alkenyllithiums, similar to the 
intermediates used in this project, are scarce. Thus, the intermediate Li-77, which was obtained 
via n-BuLi-mediated lithiation of the δ-hydroxy alkenyl sulfoximine 77, was further treated with 
amide 102 at –78 oC to give the desired ketone 103 in 40% yield and E-configured alkenyl 
sulfoximine E-77 in 55% yield. (Scheme 41, entry 1). In order to improve the conversion, this 
reaction was carried out at –45 oC and finally at 0 oC (entries 2 and 3). Disappointingly, no 
significant improvement of the yield was observed.  
 
Scheme 41 Synthesis of the α-sulfoximido ketone 103 
 
Entry t
Yield of 
aldehyde
103
E-77
1
−78 oC 40% 55%
2
−45 oC 40% 55%
3 0 oC 50% 40%
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2.5.5.1. Oxidation of sulfoximine-substituted allylic alcohols 
 
Since the synthesis of the α-sulfoximido ketones from the corresponding Weinreb amides 
gave unsatisfactory yields, another approach was developed. According to a retrosynthetic 
analysis α-sulfoximido ketones XXXXI could be synthesized via the well established α-
hydroxyalkylation of alkenyl sulfoximines XXXX followed by an oxidation of corresponding 
alcohols XXXIX (Scheme 42).  
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Scheme 42 Synthesis of α-sulfoximido ketones – retrosynthetic analysis 
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 A synthetic route similar to this presented in Scheme 42 was previously investigated in 
our research group. [46]  Thus, the oxidation of allylic alcohol 104 with the whole spectrum of 
reagents was examined (Scheme 43). Reactions with pyridiniumdichromat, MnO2 and Jones 
reagent did not lead to any conversion of the alcohol 104 (entry 2, 3, 5). Upon treatment with 
Dess-Martin periodinane (DMP), activated MnO2 and Swern reagent formation of a mixture of 
undefined products was observed (entries 1, 4 and 6). The NMR analysis of the crude mixture 
allowed us to speculate that in the case of reaction with DMP ketone 105 was formed. However, 
ketone 105 was unstable and decomposed during work-up.  
 
Scheme 43 Attempted synthesis of ketone 105 
Entry Reagent Observation
1 Swern 
reagent decomposition
2 PDC no conversion
3 MnO2 no conversion
4 Dess-MartinPeriodinane decomposition
5 Jones 
reagent no conversion
6 ActivatedMnO2 decomposition
Me S Ph
O NMe
Ph OH
Me S Ph
O NMe
Ph O
104 105
 
THEORETICAL PART 
 
37
 Because of the successful oxidation of 104 with Dess-Martin periodinane (DMP), the 
allylic alcohols 89−92 were treated with the same reagent. Surprisingly, the corresponding 
enones 106–109 were obtained in excellent yields (Scheme 44). Noteworthy is the simplicity of 
this reaction. A solution of the allylic alcohol in CH2Cl2 was treated at ambient temperature with 
a commercially available 15% wg solution of Dess-Martin periodinane (DMP) in the same 
solvent. TLC revealed that the reaction was complete after 0.5 h. In order to deactivate the excess 
of DMP, the reaction mixture was subsequently treated with Na2S2O3. Finally, aqueous NaHCO3 
was added to neutralize the acetic acid formed during the reaction. The residue, which was 
obtained after work-up procedure, consisted predominately the desired enone, which was finally 
purified by flash chromatography. 
 
Scheme 44 DMP-mediated oxidation of sulfoximine-substituted allylic alcohols 89−92 
Allylic
alcohol R1 R3
Ketone 
(Yield)
89 Me Me 106 (80%)
90 Me 107 (96%)
91 Me 108 (96%)
92 109 (96%)
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R3 O
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S
Ph
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According to the retrosynthetic analysis, a double bond, which is required for RCM, can 
be introduced in the reaction of a sulfoximido ketone of type XXVII (Scheme 40) with the 
corresponding Grignard reagent. Thus, the α-sulfoximido enone 111 bearing a saturated 
substituent R3 was also suitable for the synthesis of a corresponding tertiary allylic alcohol 113 
(Scheme 45). The synthesis of its parent compounds, α-sulfoximido allylic alcohols 110, was 
accomplished via the established α-hydroxylation of δ-hydroxy alkenyl sulfoximines 77 (Scheme 
45). Thus, alkenyl sulfoximine 77 was successively treated with n-BuLi and propanal in THF at − 
78 oC to afford a mixture of allylic alcohols 110 and epi-110 in 90% yield. The mixture was 
oxidized with the aid of DMP in a similar way as described above to give enone 111 in 96% 
yield. 
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Scheme 45 Synthesis of a sulfoximine-substituted ketone 90 
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Finally the DMP-mediated oxidation of the cyclic allylic alcohol 94 was performed, 
which gave the cyclic enone 112 in 96% yield after purification by flash chromatography 
(Scheme 46). 
 
Scheme 46 DMP-mediated oxidation of sulfoximine-substituted allylic alcohol 94 
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2.5.5.2. Addition of Grignard reagents to α-sulfoximido ketones 
 
With the sulfoximine-substituted ketones 106−109 and 111 at hand the addition of Grignard 
reagents was investigated. In this case it was postulated that, the chelated transition state depicted 
in Scheme 47 would allow diastereoselective addition to carbonyl moiety. 
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Scheme 47 Transition state of diastereoselective addition of organometallic reagents to 
sulfoximine-substituted ketones 
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Thus, solutions of the sulfoximine-substituted ketones 107 and 111 in THF were treated at –
78 °C with an excess (3 equiv) of Grignard reagent (Scheme 48). The reaction was followed by 
TLC which revealed complete conversion of the enones 107 and 111 after ca. 15 min. After this 
time, saturated solution of NH4Cl was added in order to hydrolyse the excess of Grignard regent. 
The residues which were obtained after evaporation of a solvent consisted predominately of the 
desired allylic alcohols, which were finally purified by flash chromatography. In the case of the 
reaction with MeMgBr, formation of two diastereomers was observed (entry 3). Because of its 
size, MeMgBr was presumably capable to attack the Re-side of carbonyl moiety as well, despite 
the shielding provided by the phenyl ring in the sulfoximine group. The configuration of the 
newly-formed stereocenters was tentatively assigned via NOE experiment of cyclic derivatives 
(Chapter 2.6.3, page 57). 
Scheme 48 Addition of Grignard reagents to α-sulfoximido ketones 107 and 111 
 
Entry Ketone R1 R2MgX Alcohol(Yield) de
1 111 Et MgBr 113 (90%) 96%
2 107 PhMgCl 114 (86%) 96%
3 107 MeMgBr 115 (60%) 70%
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2.6. RCM of sulfoximine-substituted trienes 
 
2.6.1 Introduction  
 
RCM is one of most important tools of modern organic synthesis. Thanks to recent 
progress in this field many interesting cyclic systems could be synthesized. However, reports 
concerning the use of sulfoximine-substituted compounds, similar to trienes obtained within this 
work, are scarce. Until now, only sulfoximines bearing unsaturated substituents on nitrogen atom 
and sulphur atom have been successfully submitted to RCM (Scheme 49)[47] Thus, dienyl 
sulfoximines 116a−116d, 118a, 118b and 120 were converted upon treatment with ruthenium 
complex 30 into corresponding cyclic sulfoximines 117a−117d, 119a, 119b and 121. In contrast 
to the project presented here, RCM was used for the synthesis of heterocyclic sulfoximines and 
not carbocycles bearing a sulfoximine group as a substituent. 
 
Scheme 49 Synthesis of cyclic sulfoximines via RCM 
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Recently, an intensive research concerning RCM of alkenyl sulfoximines has been carried 
out in our research group. Günter tried to synthesize the pipecolinic acid derivatives 123 via 
RCM of the corresponding δ-amino sulfoximines (Scheme 50). [48]  Thus, α-amino acid 122 was 
treated with the ruthenium complex 29 in CH2Cl2 at reflux temperature. However, this treatment 
only yielded the parent alkenyl sulfoximine 122 after 16 h. 
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Scheme 50 Attempted RCM of alkenyl sulfoximine 122 
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Since the aforementioned reaction failed, the compatibility of sulfoximine moiety with the 
ruthenium complexes used in RCM was questioned. In order to verify this hypothesis, alkenyl 
sulfoximine 124 possessing an unsubstituted alkyl rest was submitted to RCM (Scheme 51).[49] 
The absence of other functional groups excludes interaction which could lead to deactivation of 
catalyst.  
 
Scheme 51 Attempted RCM of alkenyl sulfoximine 124 
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Unfortunately, treatment of 124 with the ruthenium complex 30, returned unreacted 
alkenyl sulfoximine 124. In the light of these negative results, the success of the project presented 
here could be questioned. Thus, an analysis of RCM of the alkenyl sulfoximine 124 and triene 84 
is required. In the first step the alkenyl sulfoximine 124 reacts with the ruthenium complex 30 at 
the terminal double bond to give intermediate 124a (Scheme 52). This assumption is based on the 
fact that unsubstituted double bonds are favored in cycloadditions of ruthenium complexes. [11] 
Subsequently, styrene is liberated and ruthenium intermediate 124b is formed. 
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Scheme 52 RCM of alkenyl sulfoximine 124 - the mechanism 
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The next step is the formation of the bicyclic derivative 124c, which could be difficult 
because of electronic and steric effects. First of all, the sulfoximine moiety reduces the electron 
density of the neighbouring double bond. Moreover, the double bond attached to the sulfoximine 
group is sterically hindered. However, successful cross metathesis of alkenyl sulfone 126 with 
protected 5-pentenol 127, reported recently by Grela et al., throws a new light on this problem 
(Scheme 53). [50] Since double bond attached to a sulfoximine moiety is believed to possess 
similar properties to those of a double bond attached to a sulfonyl group, formation of the 
intermediate 124c could be possible. The next step is an annulation of bicyclic system 124c 
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Scheme 53 RCM of vinylic sulfone 126 – the mechanism 
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which leads to a formation of cyclohexene and ruthenium species 125a. Subsequently, the 
ruthenium species 125a should initiate the next turn-over of the catalytic cycle. However, if 125a 
is unstable or not able to undergo cycloaddition, the reaction will stop at this stage. Thereby, the 
aforementioned mechanism of RCM with alkenyl sulfones does not involve sulfone derived 
carbene analogues to 125a. In this case, further cycles are catalysed by active and stable 
intermediate 130. To sum up, in the mechanism of RCM of alkenyl sulfoximines, two steps could 
cause significant problem and can lead to negative results which were observed. 
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In the case of RCM with sulfoximine-substituted triene 84, the first step consist of the 
ruthenium complex 30 reacting with the terminal unsubstituted double bond yielding the cyclic 
intermediate 84a (Scheme 54). This rearranges further to ruthenium species 84b which 
subsequently cyclizes to bicyclic intermediate 131a. In marked contrast to the already discussed 
RCM of alkenyl sulfoximine 124, the crucial cycloaddition occurs at the electron-rich and easy 
accessible double bond. 
 
Scheme 54 RCM of sulfoximine substituted triene 84 – the mechanism 
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Finally 131a resolves into carbocycle 131 and ruthenium species 132. Noteworthy is that 
ruthenium complex 132 represents a typical intermediate of RCM, which is known to be capable 
of catalyzing this reaction. [11] To sum up this mechanistic deliberation the following conclusion 
can be drawn. There are no apparent electronic or steric hindrances which could inhibit RCM of 
sulfoximine trienes. On the other hand, RCM of alkenyl sulfoximines can be considered as a very 
ambitious and difficult task. 
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2.6.2 Results and discussion 
 
The RCM reaction of the trienes 84 and 85 obtained via α-functionalization of δ-hydroxy 
alkenyl sulfoximines was investigated. In order to avoid a competing cross-metathesis, the 
reaction was carried out in a highly diluted solution at 0.005 M. Thus, triene 84 gave the seven-
membered carbocycle 131 in only 40% yield with 50% recovery of 84 upon treatment with 
ruthenium complex 30 for 16 h in refluxing CH2Cl2 (Scheme 55, entry 1). To accelerate the 
conversion, a similar RCM of triene 84 was carried out in higher boiling toluene.  
 
Scheme 55 RCM of sulfoximine-substituted triene 84 and 85 
Entry triene Solvent Carbocycle recovery of triene
1 84 CH2Cl2 131 (40%) 50%
2 84 toluene 131 (96%) -
3 85 toluene 133 (90%) -
iPr
S
Et3SiO
Ph
O NMe 30 5%
c = 0,005 M
solvent, reflux
iPr
Et3SiO
S
Ph
O NMe
84 131
iPr
S
Et3SiO
Ph
O NMe iPr
Et3SiO
S
Ph
O NMe
30 5%
c = 0,005 M
solvent, reflux
85 133
 
This reaction led to formation of carbocycle 131 in 96% yield (entry 2). The similar RCM 
of triene 85, which was performed under the optimized conditions, yielded, after purification by 
flash chromatography, the nine-membered carbocycle 133 in 90% yield (entry 3). Interestingly, 
the NMR spectrum of the crude mixture revealed that the Z-configured isomer 133 was formed 
exclusively. 
THEORETICAL PART 
 
46
 The aforementioned RCM of triene 85 led to an exclusive formation of the nine-
membered carbocycle 133. As it was previously assumed, a double bond bearing a sulfoximine 
moiety was inactive in an RCM reaction. Thus, formation of the theoretically possible six-
membered carbocycle 85a was not observed (Scheme 56). 
 
Scheme 56 RCM of sulfoximine-substituted triene 85 
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 Ruthenium catalyst 30 is also known to cause a migration of a double bond. [21] Thus, the 
RCM reactions described above could be expected to generate side products 84b and 131b or 
85b and 133b (Scheme 57). Moreover, hypothetic products 84b, 131b, 85b and 133b would 
possess a system of conjugated double bonds, which is known to be thermodynamically favored. 
However, the RCM reactions carried out with the sulfoximine-substituted trienes 84 and 85 
selectively gave the desired carbocycles 131 and 133. Thereby, the formation of the 
aforementioned side products 84b, 131b, 85b and 133b was not observed. Presumably, the 
sulfoximine moiety connected to the double bond prevented undesired rearrangements. 
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Scheme 57 RCM of sulfoximine-substituted trienes 84 and 85 - migration of double bond 
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Next the RCM of sulfoximine-substituted allylic alcohols was investigated (Scheme 58). 
Thus, solutions of allylic alcohols R-90, S-90, R-92, S-92 and 113 were treated at room 
temperature with the ruthenium complex 30 in CH2Cl2. Since the reactions carried out for 16 h 
did not lead to any conversion of alcohols R-90, S-90, R-92, S-92 and 113, as it was revealed by 
TLC, mixtures were heated to reflux for another 4 h.  
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Scheme 58 RCM of sulfoximine-substituted trienes R-90, S-90, R-92, S-92 and 113 
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 The NMR spectra of mixtures, obtained from the aforementioned reactions, revealed that 
the tertiary allylic alcohol 113 was completely converted into carbocycle 136. In contrast, RCM 
of secondary allylic alcohols R-90, S-90, R-92 and S-92 resulted in a decomposition of the allylic 
alcohols. The eight-membered carbocycle 136 was subsequently purified via flash 
chromatography and isolated in 90% yield. 
 Since the interference of a hydroxy group contained in the dienes, with the Grubbs 
catalyst is known, [51] it was assumed that they were responsible for the aforementioned 
decomposition. The tertiary allylic alcohol 113 successfully underwent metathesis because, in 
this case, access to the hydroxy group is sterically hindered. In order to prevent this interaction in 
the case of secondary allylic alcohols R-90, S-90, R-92 and S-92, their hydroxy groups were 
protected as silyl ether (Scheme 59). The protection was accomplished via imidazole-mediated 
reaction with tBuMe2SiCl in a water-free DMF. Silyl ethers R-137, S-137 and R-138, S-138 were 
obtained in very good yields after aqueous work-up followed by flash chromatography on silica 
gel. 
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Scheme 59 Protection of sulfoximine-substituted alcohols R-90, S-90, R-92 and S-92 and 113 
 
Alcohol R1 R2 R3 Silylether R
1 R2 R3 Yield
R-90 Me OH H R-137 Me H OSitBuMe2 96%
S-90 Me H OH S-137 Me OSitBuMe2 H 96%
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O NMe
R2
1. 4 eq Imidazole 
2. 4 eq tBuMe2SiCl 
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R-90, S-90, R-92, S-92 R-137, S-137, R-138, S-138
 
 
 The silyl ethers R-137, S-137 and R-138, S-138 were subsequently subjected to a RCM 
catalyzed by the ruthenium complex 30 in refluxing CH2Cl2 (Scheme 60). TLC revealed that the 
reaction was completed after 16 h. Carbocycles R-139, S-139 were obtained after purification by 
flash chromatography on silica gel in 80% and 90% yield, respectively. Interestingly, the nine-
memebered carbocycles R-139 and S-139 were obtained exclusively as Z-isomer. The RCM 
reaction of the triene R-138 afforded after separation by flash chromatography a mixture of R, Z-
140 and R, E-140 in 70% and 4 % yield, respectively.  
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Scheme 60 RCM of sulfoximine-substituted trienes R-137, S-137 and R-138 
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Surprisingly, the RCM of the S-configure silyl ether S-138 carried out in refluxing 
CH2Cl2 in the presence of 30 (5 mol% in regard to S-138) led to the C2-symmetric 22-membered 
carbocycle S-141 and the corresponding asymmetric carbocycle S-142, which were isolated after 
flash chromatography in 32% and 38% yield, respectively (Scheme 61). The expected 11-
membered carbocycle S-140 was isolated only in 4% yield. The structures of carbocycles S-141 
and S-142 were determined via NMR- and MS-experiments (EI and CI). Thus, due to C2-
symmetrie of 142 its 1H NMR spectrum revealed only signals corresponding to one part of the 
molecule. Moreover, a unique signal, corresponding to the proton at the double bond formed in 
the cross-metathesis reaction, was observed. Analysis of this signal revealed only coupling with 
aliphatic protons. The coupling with the other olefinic proton (at the same double bond) was not 
observed. Finally, the CI-MS and EI-MS spectra revealed signals corresponding to the fragments 
derived from the structure 141 which are not possible for the hypothetic RCM product. Although 
the carbocycles 142 is not C2-symmetric, its 1H NMR spectrum possess features which are 
unique for C2-symmetric compounds (see description above). This phenomenon is justified by 
the very similar surrounding of the corresponding protons in both parts of 142. 
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Scheme 61 RCM of sulfoximine-substituted trienes S-138 
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This result can be rationalized by the following mechanism. In the first step the ruthenium 
complex 30 reacts with the sulfoximine-substituted triene S-138 (Scheme 62). Thereby, a 
cycloaddition of a ruthenium species can occur to both double bonds with the same probability, 
since both of them posses the same substitution pattern. Thus, the ruthenium species S-138a and 
S-138b could be generated in an almost equimolar amount. The ruthenium complexes S-138c and 
S-138d can subsequently rearrange to bicyclic S-140a and S-140b via intramolecular 
cycloaddition. Annulation of bicyclic intermediates S-140a and S-140b led then to carbocycle S-
140 and ruthenium species 143. Formation of carbocycle S-140 in only 4% yield indicates that 
this synthetic pathway is disfavored. Presumably, intermediates S-138c and S-138d underwent 
cross-metathesis with a second molecule of the triene S-138 to generate either adduct S-141a 
(Scheme 63) or S-142 (Scheme 64). 
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Scheme 62 Formation of the sulfoximine-substituted carbocycle S-140 
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The cross-metathesis intermediate S-141a (Scheme 63) decomposes next to give acyclic 
pentaen S-141b. The latter one under exposure to the ruthenium complex 143 afforded bicyclic 
S-141c, which finally decomposes to give the carbocycle S-141. 
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Scheme 63 Formation of the sulfoximine-substituted carbocycle S-141 
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A similar sequence of reactions leads to the carbocycle S-142 (Scheme 64). In this case, 
however, two alternative scenarios are possible. According to the first one, a double bond 
between two TBDMS protected hydroxyl groups is formed in a cross-metathesis reaction to give 
intermediate S-142a. In the next step, S-142a undergoes RCM mediated by one of the ruthenium 
species present in the reaction mixture to give bicyclic S-142c. Annulation of S-142c leads 
finally to the 22-membered carbocycle S-142. Alternatively, cross-metathesis reaction could form 
the double bond placed between two TES protected hydroxyl groups to afford the intermediate S-
142d. This is subsequently converted via following RCM into bicyclic S-142f, which finally 
gives the carbocycle S-142 and corresponding active species. 
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Scheme 64 Formation of the sulfoximine substituted carbocycle S-142 
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The formation of the mixture of 22-membered carbocycles S-141 and S-142 through 
metathesis of triene S-138 was very surprising. This phenomenon, however, could be explained 
in terms of conformation of the parent trienes S-138, R-138, S-137 and R-137. The most stable 
conformers (calculated by ChemDraw 3D, MM2 molecular mechanic and dynamic) are presented 
below (Scheme 65). In order to make the structures easier to analyze, only the most significant 
protons are depicted (H3, H4 and H5) as well as dihedral angles between then. The analysis of 
the conformers reveals that in the case of triene R-138, the parent compound of carbocycle R,Z-
140 and R,E-140, the double bonds are placed at the same side of the axe crossing carbons C4, 
C3 and C2. In contrast, the terminal double bonds in triene S-138, the parent compound of cross-
metathesis-ring-closing-metathesis products S-141 and S-142, double bonds are placed at the 
opposite sides of the aforementioned axe. Thus, the triene S-138 underwent cross-metathesis in 
stead of ring-closing-metathesis.  
 
Scheme 65 Conformation of the sulfoximine substituted trienes S-138 and R-138 
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The analogues conformers were calculated (ChemDraw 3D, MM2 molecular mechanic 
and dynamic) for trienes S-137 and R-137 (Scheme 66). The double bonds of triene R-137 are 
placed at the same side of the C4−C3−C2 axe while in the triene S-137 they are placed at the 
opposite sides. However, in the case of triene S-137 the distance between double bonds which 
undergo metathesis, is much shorter than in triene S-138 that can explain different results of their 
treatment with ruthenium complex 30 (RCM product obtained from R-137 and cross-metathesis-
ring-closing-metathesis products obtained from S-137). Noteworthy is that the conformation of 
atoms surrounding sulfoximine-substituted double bond (C3, C4 and C5 as well as protons 
attached to then) remains unchanged for the aforementioned conformers. (Coupling constant 3J 
(H3-H4) of aprox. 11 Hz which corresponds to the dihedral angle of aprox. 1600 as well as 
coupling constant 3J (H4-H5) of aprox. 4.6 Hz which corresponds to the dihedral angle of aprox. 
500). 
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Scheme 66 Conformation of the sulfoximine-substituted trienes S-137 and R-137 
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A similar combination of cross-metathesis and ring-closing metathesis was reported by 
Amos Smith III et al. as key step in a synthesis of (-)-cylindrocyclophane A 146 (Scheme 67). [52] 
The RCM of diene 144 was performed under several conditions. Carbocycle 145 was obtained in  
 
Scheme 67 Synthesis of (-)-cylindrocyclophane A 146  
Entry Catalyst CatalystLoad Solvent Time Temperature Yield
1 26 30% C6H6 2h 20 0C 72%
2 26 34% C6H6 1h 20 0C 77%
3 30 15% CH2Cl2 4h 40 0C 48%
4 30 15% CH2Cl2 27h 40 0C 58%
5 29 15% CH2Cl2 25h 20 0C 55%
6 29 20% CH2Cl2 72h 20 0C 61%
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the best yield when a solution of diene 144 in refluxing benzene was treated with a Mo-based 
catalyst 26 (entry 2). Interestingly, formation of the head-to-tail adduct was observed exclusively. 
The MM2 calculations revealed that the head-to-head cross-metathesis product formation is 
energetically disfavored. Authors speculated that reversible cross-metathesis could lead to 
formation of both possible adducts; however, only one of them underwent ring-closing 
metathesis after prolonged reaction time to give 145. 
The spontaneous cascade or cross- and ring-closing metathesis could be very useful for 
the synthesis of macrocyclic systems, whose substructure is present in number of biologically 
active natural products. However, the spontaneous formation of 22-membered carbocycles S-141 
and S-142 could hardly be applied for a target-oriented synthesis due to obvious lack of 
selectivity. Thus, an alternative approach was envisioned, which could lead to the selective 
formation of C2-symetric carbocycles from corresponding intermediate obtained via selective 
head-to-head cross-metathesis (Scheme 68). Thus, enone 107 was subjected to treatment with 
catalyst 30 in refluxing CH2Cl2, which selectively gave the cross-metathesis product 147 (no 
formation of corresponding RCM product was observed) in 84% yield. The structure of 147 was 
determined through 1H NMR spectroscopy and mass-spectroscopy. Thus, due to C2-symmetrie of 
147 its 1H NMR spectrum revealed only signals corresponding to one part of the molecule. 
Moreover, a unique signal, corresponding to the proton at the double bond formed in the cross-
metathesis reaction, was observed. Analysis of this signal revealed only coupling with aliphatic 
protons. The coupling with the other olefinic proton (at the same double bond) was not observed. 
Finally, the CI-MS and EI-MS spectra revealed signals corresponding to the fragments derived 
from the structure 147 which are not possible for the hypothetic RCM product. The selective 
formation of cross-metathesis product 147 was assumed to be affected by two factors. Firstly, the 
carbonyl group presents in the structure of ketone 107 hinders free rotation of the molecule and 
disables conformation which is necessary for RCM. Secondly, the methyl substituted double 
bonds are known to be disfavoured in the cycloaddition of ruthenium carbenes. The C2-
symmetric enone 147 would subsequently react with a Grignard reagent (for details see Chapter 
2.5.5.2) that should lead to to diastereoselective formation of the corresponding alcohol 148. 
Presumably, diketone 148 would undergo RCM upon treatment with suitable catalyst to give 
desired macrocycle 149. 
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Scheme 68 Synthesis of macrocycle 149  
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2.6.3 Determination of configuration of cyclic allylic alcohols S-139, R-139 and 
R,Z-140 
 
Since all carbocycles, which were produced via RCM of sulfoximine trienes, were 
obtained as viscous liquids and all attempts at their crystallisation failed, NOE experiments 
constitute the only possibility for determination of their configuration. The determination was 
started with the nine-membered carbocycles S-139 and R-139. In the case of R-139 the most 
significant for assignment of configuration was the one between H-4 and H-1 (Scheme 69). In 
the epimeric alcohol S-139 the evidence for the configuration was provided by NOE-effect 
between H-12 (methyl moiety of isopropyl group) and the methyl moiety of the TBDMS 
protecting group. Moreover, a NOE-effect between H-8 and H-5 indicates conformation of 
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carbon skeleton of S-139 (Scheme 70). Finally, the configuration of the eleven-membered 
carbocycle R,Z-140 could be determined (Scheme 71), since an NOE-effect between H-4 and H-
1 was observed. 
 
Scheme 69 Configuration of eleven-membered carbocycle R-139, significant NOE-effect  
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Scheme 70 Configuration of eleven-membered carbocycle S-139, significant NOE-effect  
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Scheme 71 Configuration of eleven-membered carbocycle R,Z-140, significant NOE-effect  
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2.7. Transformations of sulfoximine-substituted carbocycles. 
 
2.7.1 Selective desilylation–oxidation of sulfoximine-substituted cyclic allylic 
alcohols  
As described in Chapter 2.5.3, α-hydroxyalkylation of the δ-hydroxy alkenyl sulfoximine 
XLII provides an access to the corresponding trienes XLIII (Scheme 72). However, since the 
new stereocenter is formed unstereoselectively, this methodology is less attractive for the 
synthesis of cyclic allylic alcohols XLV and epi-XLV due to the separation of the epimeric 
allylic alcohols XLIV and epi- XLIV. However, if α-hydroxyalkylation is followed by the 
oxidation of alcohols XLVII and epi- XLVII to corresponding enones XLVIII, the problem of 
stereoselectivity can be overcome. Moreover, cyclic enones XLVIII represent attractive building 
blocks that make their synthesis from corresponding mixtures of epimeric cylic allylic alcohols 
XLVII particularly interesting.  
Scheme 72 Synthesis of sulfoximine-substituted cyclic allylic alcohols and enones 
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Thus, carbocycle R,Z-140 was treated with a mixture of acetic acid in THF in order to 
deprotect the hydroxyl group, which was planned to be oxidized (Scheme 73). Gratefully, the 
more bulky TBDMS group was hydrolyzed exclusively under these conditions which gave 
alcohol 150 in 90% yield. According to the postulated mechanism in the first step of this reaction 
the basic nitrogen is selectively protonated to generate the intermediate R,Z-140a. Because of an 
activation provided by the hydrogen bond, a chloride anion attacks the silicon atom of the 
TBDMS group that resulted in the selective deprotection and formation of 150.  
 
Scheme 73 Selective desilylation of sulfoximine-substituted cyclic allylic alcohol R,Z-140 
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Allylic alcohol 150, which was synthesized via the aforementioned selective desilylation, 
was subsequently treated with DMP, according to the procedure which was already established 
(page 37). The desired enone 151 was obtained after purification by flash chromatography in 
92% yield (Scheme 74) 
Scheme 74 Oxidation of sulfoximine-substituted cyclic allylic alcohol 150 
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2.8 Replacement of the sulfoximine group 
 
 One of the most important properties of a good chiral auxiliary is its easy removal after a 
reaction which it mediates. The removal of the sulfoximine moiety could be performed using one 
of the several well established protocols. Moreover, some of them enable simultaneous 
introduction of a new substituent. In general, the removal techniques can be divided into two 
groups: techniques which are suitable for sulfoximine moiety attached to a sp3 hybridized carbon 
and those which are suitable for sulfoximine moiety attached to sp2 carbon atom.  
In the case of alkyl sulfoximines, reactions with chloroformates are especially attractive, 
since the enable the substitution of the sufloximine moiety by a chlorine atom. Furthermore, the 
use of iodoformate renders an access to corresponding iodines. Reactions of this type have been 
reported to work very efficiently and selectively. [53] Moreover, sulfonimides, which are obtained 
as a second product of this reaction, are enantiomerically pure and can be subsequently converted 
into N,S-dimethylsulfoximine.  
 The cross-coupling reaction of alkenyl sulfoximines constitutes the most useful cleavage 
strategy for a sulfoximine group attached to a sp2 hybridized carbon. [54] Reactions of this type are 
very efficient and allow the synthesis of the corresponding alkenes with a good E/Z selectivity. 
Cross coupling of alkenyl sulfoximines could be performed either as a Ni-catalyzed reaction [55] 
or as a stoichiometric reaction with the corresponding cuprates. [56] 
The cross coupling reaction of alkenyl sulfoximines bearing H-atom at the α-position 
with cuprates has recently been investigated in our research group by Loo (Scheme 75). [56] 
Interestingly, only Z-configured alkenyl sulfoximines underwent this conversion, whilst E-
configured ones gave Michael-addition products under similar conditions. In the representative 
experiment alkenyl, sulfoximine 152 was treated with the corresponding cuprate in Et2O at –40°C 
to afford alkenes 153-155 in yields ranging from 50 to 85%. 
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Scheme 75 Cross coupling reaction of alkenyl sulfoximine 152 with cuprates 
Entry R Conditions Alken Yield E/Z AlkenylSulfoximine
1 n-Bu -40°C/1h 150 - - 82%
2 n-Bu -40°C to 0°C/4h 150 51% 98:2 26%
3 Me -40°C to RT/18h 151 80% 30:1 -
4 Ph -40°C to RT/18h 152 85% 35:1 -
152
1. R2CuLi
2. H+ 
-CH3(H)N-SOPh
Et2O
Me
iPr
OSiEt3
S
Ph
O
NMe
Me
iPr
OSiEt3
R
153-155
 
 
 The Ni-catalyzed cross-coupling of alkenyl sulfoximines has been intensively 
investigated in our group for the last two decades. [55] One of the most interesting reports in this 
field concerns the successful use of this strategy in the synthesis of prostacyclines and their 
analogues (page 2). However, there are only a few reports concerning Ni-catalyzed cross 
coupling of alkenyl suloximines bearing substituent at the α-position.  
Bülow investigated the cross-coupling reactions of the α-methylated alkenyl sulfoximine 
156. [57] Thus, reactions of alkenyl sulfoximine 156 with organozink reagents catalyzed by several 
NiCl2 complexes were performed (Scheme 76). Moreover, the influence of MgBr2 on the reaction 
outcome was examined. In the case of reactions with the bis-((trimethylsilyl)methyl))-zinc (entry 
1-3), conversion of alkenyl sulfoximine 156 was found to be very slow. As expected, reactions 
with diphenyl zinc (entry 4-7) gave better results due to the well established higher reactivity of 
this compound in cross coupling reactions. [58] Thus, upon treatment with diphenyl zinc in the 
presence of a catalytic amount of NiCl2(dppp) alkene 158 was prepared in 82% yield and 93% ee 
In the case of the similar experiment performed in the presence of MgBr2 (entry 5 and 7), 
conversion of alkenyl sulfoximine 156 was found to be slower and the alkene 158 was isolated in 
only 66% yield. 
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Scheme 76 Nickel-catalysed cross coupling reaction of the α-methylated alkenyl sulfoximine 156 
Entry ZnR2 NiCl2L Time
 (d)
MgBr2
equiv. Alken Yield
Alkenyl
Sulfoximine e.e
1 Zn(CH2SiMe3)2 NiCl2(dppp) 3 0 157 40 50 59
2 Zn(CH2SiMe3)2 NiCl2(dppp) 3 3 157 55 35 23
3 Zn(CH2SiMe3)2 NiCl2(PPh3)2 4 3 157 32 45 37
4 ZnPh2 NiCl2(dppp) 1 0 158 82 0 93
5 ZnPh2 NiCl2(dppp) 1 3 158 66 0 89
6 ZnPh2 NiCl2(PPh3)2 3 o 158 62 18 94
7 ZnPh2 NiCl2(PPh3)2 1 3 158 21 73 74
1. ZnR2
NiCl2L
MgBr2
Et2O
SMe
Ph
O NMe
RMe
156 157, 158
 
 
 Voswinkel investigated the nickel-catalysed cross-couping of the β-hydroxy alkenyl 
sulfoximines 159 and 160, which were synthesized via α-hydroxyalkylation (see chapter 2.5.3). 
[59] First, sulfoximine substituted allylic alcohol 159 protected as silyl ether was submitted to the 
cross coupling reaction with MeMgCl in the presence of the corresponding nickel complexes 
(Scheme 77, entry 1-3), which led to multicomponent mixtures. Thereby, the isolation of both 
product and starting material failed. The bulky TBDMS-protecting group was anticipated to 
hinder cross-coupling reaction. In order to verify this hypothesis, several reactions with the less 
sterically demanding methyl ether 160 were carried out (entry 4-7), but in this case only 
decomposition products were observed, as well.  
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Scheme 77 Nickel-catalysed cross-coupling of β-hydroxy alkenyl sulfoximines 159 and 160 
Entry Alkenylsulfoximine R
1 R2MgCl NiCl2L Time
 (h) t Alcohol Yield
1 159 SiMe2tBu MeMgCl NiCl2(PPh3)2 18 RT 161 -
2 159 SiMe2tBu MeMgCl NiCl2(PPh3)2 11 0°C 161 -
3 159 SiMe2tBu MeMgCl NiCl2(dppp) 24 RT 161 -
4 160 Me PhMgBr NiCl2(PPh3)2 18 RT 162 -
5 160 Me PhMgBr NiCl2(PPh3)2 15 0°C 162 -
6 160 Me MeMgCl NiCl2(PPh3)2 15 RT 163 -
7 160 Me BuMgBr NiCl2(PPhMe2)2 0 RT 164 -
1. NiCl2L
R2MgCl
Et2O
S
Ph
O NMeOR1
R2
OR1
159, 160 161−164
 
 
 Reductive cleavage provides a useful methodology for the removal of a sulfoximine 
moiety. This strategy can be applied in the case of a sulfoximine moiety attached to both sp2 and 
sp3 hybridized carbon atom. [60] The well-established protocol involves either treatment with the 
Raney-nickel or with aluminium amalgam. In the first variant of this reaction, a sulfoximine 
substituted compound is treated with an excess of Raney-nickel slurry to liberate corresponding 
alkanes or alkenes. Noteworthy is that this method is much frequently exploited in the case of 
saturated sulfoximines, since alkenyl ones are often further reduced which makes those reactions 
unselective. Moreover, sulfoximine moiety is reduced under applied conditions to the thiophene. 
This phenomenon depreciates this methodology since the chiral auxiliary is irrevocably lost.  
Reductive cleavage by the aluminum amalgam-mediated is frequently the reaction of 
choice for alkenyl sulfoximines since double bonds present in the molecule are inert under this 
conditions.[60] Moreover, sulfoximine moiety is converted into the corresponding sulfinamide 165 
with a complete retention of configuration. The enantiopure sulfinamide 165 can be subsequently 
converted into N,S-dimethyl sulfoximine 50 using well established two - step protocol (Scheme 
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78). [60]  Thus, treatment of sulfinamide 165 with tBuOCl results in the formation of intermediate 
166 which can be subsequently reacted with MeMgBr to give desired  N,S-dimethyl sulfoximine 
50. 
Scheme 78 Conversion of sulfinamide 165 into N,S-dimethylsulfoximine 50 
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 2.8.1 Copper-mediated Cross-coupling reactions 
 
The aforementioned copper-mediated cross-coupling enables a cleavage of a sulfoximine 
moiety combined with an introduction of a new substituent. This interesting reaction was applied 
in this project for the first time to α-substituted alkenyl sulfoximines.  
Thus, a slurry of copper iodide in diethylether was treated with methyl lithium to generate 
the corresponding methyl cuprate (Scheme 79). Subsequently, the solution of methylcuprate was 
treated with the seven-membered carbocycle 113 (entry 1). Although the mixture was kept for 12 
h (first at −78 oC, then the mixture was allowed to warm to ambient temperature), conversion of 
carbocycle 131 was not observed. In order to improve the reactivity of sulfoximine moiety in 
cross coupling, the reaction was carried out in the presence of ClSiMe3 (entry 2).[61] The 
experiment performed with this modification afforded the methylated carbocycle 164 in 60% 
yield with a recovery of 35% of 131. Treatment of carbocycle 131 with a larger excess of methyl 
cuprate gave similar result (entry 3). 
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Scheme 79 Copper-mediated cross-coupling of cyclic sulfoximine 131 
Entry MeLi CuI Me3SiCl 167
Yield
131
1 5 eq 3 eq - - 96%
2 5 eq 3 eq 5 eq 60% 35%
3 10 eq 6 eq 10 eq 60% 35%
S
iPr
Et3SiO
Me
iPr
Et3SiO
1. Me2CuLi 
2. Me3SiCl 
3.  NH4Cl/NH3
Et2O, -78°C to RT
Ph
O NMe
131 167
 
2.8.2. Reductive cleavage 
 
The reductive cleavage reaction described in the introduction was found to enable 
successful removal of a sulfoximine moiety. Particularly interesting for the purposes of this 
project was the conversion of the β-hydroxy alkenyl sulfoximines 168 into the corresponding 
allylic alcohols, which was reported by Voswinkel to work efficiently (Scheme 80). [59] 
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Scheme 80 Reductive cleavage of β-hydroxy alkenyl sulfoxines 168−170 
Entry alkenylsuomine R de Alcohol Yield de
1 168 Et 96% 171 78% 92%
2 169 iPr 98% 172 90% 95%
3 170 Ph 27% 173 41% 95%
Al/Hg
THF/H2O
S
Ph
O NMeOH
R H
OH
R
168−170 171−173
 
 
Since the copper-mediated cross coupling reaction of the sulfoximine-substituted 
carbocycle 131 gave the corresponding methylated derivative in only medium yield, application 
of a reductive cleavage for removal of the sulfoximine moiety from those compounds was 
examined. Thus, the nine-membered carbocycle 133 was subjected to the aluminum amalgam-
mediated reduction (Scheme 81). The sulfoximine-substituted carbocycle 133 was dissolved in 
wet THF and freshly prepared aluminum amalgam was added. The reaction was found to be 
exothermic with evolution of hydrogen. The progress of the reaction was followed by TLC, 
which revealed complete consumption of 133 after 4 h. The NMR spectra of the crude mixture, 
as well as TLC, revealed formation of at least three compounds. Flash chromatography of this 
mixture gave the expected carbocycle 174 and sulfinamide 175 (single diastereomer) in 50% and 
30% yield, respectively. Interestingly, when this reaction was carried out for a longer time, only 
formation of 174 and 165 was observed. Subsequent purification by flash chromatography 
afforded 174 and 165 in 78% and 42% yield, respectively 
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Scheme 81 Reductive cleavage of carbocycle 133 
Entry Time
 (h) 174 175 165
1 4 50% 30% -
2 12 76% - 42%
iPr
Et3SiO
S
iPr
Et3SiO
Ph
S
O
NHMe
Al/Hg
THF/H2O, r.t.
HPh
O NMe
iPr
Et3SiO
S
O
NHMe
+ +
133 174 175 165
 
This result throws a new light on the mechanism of the reductive cleavage of S-phenyl 
sulfoximines.[60] Presumably, the reactions can follow two pathways, leading either to the desired 
carbocycle 174 and sulfinamide 165 (Scheme 82, pathway A) or to the cyclic sulfinamide 175 
and benzene (pathway B). Consumption of the cyclic sulfinamide 175 after a prolonged reaction 
time indicates that this compound is unstable under applied conditions and is presumably further 
reduced to the carbocycle 174. Moreover, pathway B provides a good explanation for the low 
yield in which sulfinamide 165 was isolated (42%). 
 
Scheme 82 Reductive cleavage of carbocycle 133 – the mechanism 
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2.9 Summary 
 
The synthesis of substituted chiral medium-sized carbocycles is an important goal of organic 
synthesis. Ring-closing metathesis of acyclic dienes is a very effective method for the synthesis 
of medium-sized rings. In this project, sulfoximine-substituted trienes were proven to be 
excellent parent compounds for the selective synthesis of Z-configured medium sized carbocycles 
(Scheme 83). Presumably, the rigid structural motif of the sulfoximine-substituted double bond 
influenced a conformation of a transition state and provided desired selectivity. Moreover, the 
sulfoximine-mediated strategy enabled modular synthesis and gave access to the whole spectrum 
of ring sizes and substituents. The formation of sulfoximine-substituted trienes XVII, key 
intermediates of the described synthesis, was accomplished via α-functionalisation of 
sulfoximine-substituted homoallylic alcohols XVI, whereby several protocols were developed. 
The synthesis of homoallylic alcohols XVI and their precursors, allylic sulfoximines XV, was 
already known and was only applied for this project. 
 
Scheme 83 Synthetic route towards medium-sized carbocycles 
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 The δ-hydroxy alkenyl sulfoximines could be selectively lithiated in the α-position. Their 
Z-configured lithiated derivatives underwent izomerization at ambient temperature to the 
corresponding E-configured ones, which can be subsequently condensed with nucleophiles. Thus, 
the sulfoximine-substituted trienes required for the RCM were synthesized via n-BuLi-mediated 
lithiation of δ-hydroxy alkenyl sulfoximines 77 and 78 followed by the reaction with allyl 
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bromide (trienes 84 and 85) or with unsaturated aldehydes (trienes 89−92 and epi-89−epi-92) 
(Scheme 84) 
 
Scheme 84 Synthesis of sulfoximine-substituted trienes 84, 85, R-89−R-92, S-89−S-92 
 
S-89, R2=H, R3= -OH, R4= -CH=CHCH3 (44%)
R-89, R3= -OH, R2=H, R4= -CH=CHCH3 (40%)
S-90, R2=H, R3= -OH, R4= -CH2CH2CH=CH2 (36%)
R-90, R3= -OH, R2=H, R4= -CH2CH2CH=CH2 (38%)
S-91, R2=H, R3= -OH, 
            R4= -CH2CH2CH2CH2CH=CH2 (39%)
R-91, R3= -OH, R2=H, 
            R4= -CH2CH2CH2CH2CH=CH2 (45%)
S-92, R2=H, R3= -OH, R4= -CH2CH2CH=CH2 (32%)
R-92, R3= -OH, R2=H, R4= -CH2CH2CH=CH2 40%)
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 Since the aforementioned α-hydroxyalkylation gives mixtures of epimeric allylic alcohols 
an alternative approach was developed. Thus, δ-hydroxy alkenyl sulfoximine 77 was converted 
into the corresponding aldehyde 95 via α-lithiation mediated by n-BuLi followed by treatment 
with N-formylomorpholine (99, Scheme 85). The aldehyde 95 was subsequently treated with 
Grignard reagents to give corresponding allylic alcohols R-89, R-90, 100 and 101 in very good 
yields and with good to very good diastereoselectivity.  
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Scheme 85 Diastereoselective synthesis of sulfoximine-substituted allylic alcohols 
Entry RMgX Alcohol de
1 89 (90%) 96%
2 MgCl 100 (84%) 80%
3 MgBr 90 (92%) 96%
4 MgBr 101 (94%) 96%
1. 1.1 eq n-BuLi 
2. 3 h 0 oC 
THF, −78 oC
N
O
HO
1. 1.1 eq
 
2. NH4Cl (aq)
THF,  0 oC
iPr
S
Et3SiO
Ph
O NMe
O
95, 78%
1. 3 eq RMgX 
THF, −78 oC iPr
S
Et3SiO
Ph
O NMe
OHR
89, 90, 100, 101
77 Li-77 99
MgBr
 
 
 The positive results of this strategy encouraged us to extend this approach to the synthesis 
of tertiary allylic alcohols (Scheme 86). The sulfoximine-substituted ketones 107 and 111 
required for this strategy were synthetized via DMP-mediated oxidation of allylic alcohols 90 and 
111 which were previously obtained via α-hydroxyalylation of δ-hydroxy alkenyl sulfoximines. 
Finally, the sulfoximine-substituted ketones 107 and 111 were treated with Grignard reagents to 
give corresponding tertiary allylic alcohols 113−115 in very good yields and with good to very 
good diastereoselectivity. 
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Scheme 86 Diastereoselective synthesis of sulfoximine-substituted tertiary allylic alcohols 
113−115 
Ketone Yield R1 R2 Alcohol(Yield) de
111 96% Et 113 (90%) 96%
107 96% Ph 114 (86%) 96%
107 96% Me 115 (75%) 70%
iPr
S
Et3SiO
Me Ph
O NMe
O
1. 3 eq R2MgX 
2. NH4Cl (aq)       
 
 THF, −78 oC iPr
S
Et3SiO
Ph
O NMe
R2
OH
R1
Me
R1
107; 111 113−115
 DMP
DCM, r.t.iPr
OSiEt3
S
Ph
O NMe
R3 OH
Me
90; 111
 
 
 With the spectrum of sulfoximine-substituted trienes at hand, we investigated their RCM. 
Thus, the products of α-functionalisations described above (the hydroxyl groups of secondary 
allylic alcohols R-90, S-90 and R-92 were previously converted into corresponding silyl ethers R-
137, S-137 and R-138) were treated with Grubbs second generation catalyst to give the desired 
carbocycles 131, 133, 136, R-139, S-139 and R,Z-140 in very good yields (Scheme 87). 
Interestingly, all carbocycles were obtained exclusively as Z-configured isomers, but only in the 
case of the 11-membered carbocycle formation of a small amount of E-configured isomer R,E-
140 was observed. Finally, sulfoximine moiety was removed from carbocycles 131 and 133. In 
the case of seven-membered carbocycle 131 methyl group was introduced via cross-coupling 
reaction with corresponding methyl cuprate. The nine membered carbocycle 133 was treated with 
aluminium amalgam to give corresponding carbocycle 174. Interestingly, the second product of 
this synthetic transformation, enantiopure sulfinamide 165 could be easily converted into N,S,-
dimethylsulfoximine 
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Scheme 87 Ring-closing metathesis of sulfoximine-substituted trienes 84, 85, S-137, R-137, 138 
and 113 
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3. Asymmetric synthesis of functionalised oxabicycles, spiroethers and  
spiroketals using Ring-Closing Metathesis protocol and Prins reaction of 
sulfoximine-substituted pyran derivatives 
 
3.1 Introduction: Pyrans, oxabicycles, spiroethers and spiroketals 
 
Tetrahydropyrans, spiroethers, and spiroketals are important subunits in a plethora of 
biologically active natural products.[62] Furthermore, they are attractive buildings block since they 
can be subjected to versatile synthetic transformations. [63] Although the synthesis of these 
subunits has been intensively investigated over the last years, most available methodologies are 
limited either due to lengthy sequence of steps and/or due to poor overall yields. [64] 
The spiroketal moiety is found in many natural products ranging from uncomplicated 
insect pheromones to stereochemically complex systems like those of okadaic acid and the 
milbemycin family of antibiotics. [65] The stereocontolled synthesis of spiroketals still presents a 
challenging task in target- and diversity-oriented synthesis. [64] The conventional synthetic 
approaches to spiroketals involve an acid-promoted intramolecular spiro-cyclization of acyclic 
dihydroxy ketones or their equivalents. The stereochemistry of the spiro-center results either from 
stereocenters included in peripheral of the molecule or from thermodynamic reasons. [67] Thus, 
spiroketals are frequently synthesized as mixtures of diastereomers due to a balance between 
anomeric stabilization and preference of substituents for equatorial orientation. Recently, several 
interesting synthesis of natural products possessing spiroketal subsystem have been reported. 
Panek et al. have reported an asymmetric synthesis of the marine metabolite bistramide A 
178 (Scheme 88). [68] This compound has been found to exhibit numerous biological properties, 
including antiproliferative, antiparasitic, immunomodulatory, neurotoxic and cytotoxic activities. 
One of the key steps of this synthesis, the formation of spiroketal substructure 177, was 
accomplished via the formation of oxocarbenium ion from hemiacetal 176 followed by its 
trapping with the liberated homoallylic alcohol.  
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Scheme 88 Synthesis of bistramide A 178 
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The reveromycins A and B are members of a family of compounds isolated from the 
Streptomyces genus. [69] Reveromycin A and B were found to display antiproliferative activity 
against human tumor cells. The synthesis of revormycin A 182 has been recently published by 
Rizzacasa et al. (Scheme 89). [70] The spiroketal substructure 181 was synthesized in 40% yield 
via the Hetero-Diels-Alder reaction promoted by Eu(fod)3 between hetero-dienophile 179 and 
diene 180. 
 
Scheme 89 Synthesis of reveromycin A 182 by Rizzacasa  
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Synthesis of reveromycin A 182 has been also performed by Nakata et al. (Scheme 90). [71] 
The crucial formation of the spiroketal system 184 was accomplished via deprotection-
spirocyclization of the corresponding protected dihydroxy ketone 183. Disappointingly, this 
reaction preceded only with a moderate selectivity to give desired spiroketal 184 and its 
diastereomers 185 in 54% and 27% yield respectively. 
 
Scheme 90 Synthesis of reveromycin A 182 by Nakata 
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Okadaic acid 190 is a marine natural product, originally isolated from the Pacific sponge 
Halichondria okadai in the 70s as a potential anticancer agent. [72] Further studies of this 
compound revealed its potent activity as an inhibitor of protein serine/threonine phosphatases 1 
and 2A (PP1 and PP2A, respectively) that made it a valuable tool in biomedical research. 
Moreover, okadaic acid 190 also became a subject of synthetic interest due to its unique and 
challenging polyether structure. Forsyth et al. have published a whole series of contributions 
concerning synthetic endeavors towards this interesting compound. [73] Strategies, which were 
exploited in the synthesis of the spiroketal substructures 187 and 189 of okadaic acid, are 
presented in Scheme 91. The assembly of fragment 187 was accomplished via treatment of the 
parent protected dihydroxy ketone 186 with p-TsOH/H2O in benzene. Unfortunately, the 
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spiroketal 187 was synthesized in only poor yield. In contrast, the formation of spiroketal 189 
proceeded very effectively. The protocol, which was exploited in this case, involved hydrogen-
promoted removal of the protecting benzyl groups followed by spirocyclization. Authors 
anticipated that the commercially available Pd/C, which was used in this sequence of reactions, 
delivered a source of acid that catalyzed the aforementioned spirocyclization. 
Scheme 91 Synthesis of okadaic acid 190  
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Milbemycins have attracted significant interest due to their biological activity. [74] Thus, 
members of this class have shown antibiotic activity and were found to be active against various 
agricultural pests. Furthermore, they proved to display minimal cytotoxicity to plants and 
animals. De novo synthesis of milbemycin β3 194 has been recently reported by O’Doherty et al. 
(Scheme 92). [75] This 22-step long synthetic pathway involved very efficient formation of 
spiroketal moiety 193 via a one-pot hydrogenation/ hydrogenolysis/spiroketalization procedure of 
hydroxyketons 191 and 192.  
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Scheme 92 Synthesis of milbemycin β3 194 
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Hsung et al. have recently reported an interesting synthesis of (+)-aigialospirol 199 
(Scheme 93).[76] The key step of this synthetic pathway was accomplished via RCM of α,α’-
dialkenyl dihydropyran 197 catalyzed by the ruthenium complex 29. The corresponding 
spiroketal 198 was obtained in 86% yield and was further converted (+)-aigialospirol 199. The 
stereocenter of spiroketal 197 was created in the spiroketalization of hemiacetal 195. Thus, 195 
under catalytic influence of Tf2NH, which was proven here to be an excellent Lewis acid, was 
treated with the corresponding alcohol 196 giving the desired 197 in 76% yield as single 
diastereomer. 
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Scheme 93 Synthesis of (+)-aigialospirol 199 
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The same research group has recently reported the use of the aforementioned strategy 
(spiroketalization followed by RCM) for the synthesis of C11−C23 fragment of spirastrellolide A 
203.[77] Thus, hemiacetal 200 gave in reaction with alcohol 201, which was atalyzed by Tf2NH, 
the desired ketal 202. Ketal 202 was subsequently treated with ruthenium complex 29 to give the 
desired 203 (Scheme 94). 
 
Scheme 94 Synthesis of the C11−C23 fragment of Spirastrellolide A 203 
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Oscillatoxin D 207, which is a natural product derived from β-polyketides, was found to 
display antileukemic activity. [78] Since this compound has received interest as attractive synthetic 
target, several studies concerning its synthesis have been reported. An interesting synthetic 
approach to oscillatoxin D 207 has been presented by Ichihara et al. (Scheme 95). [79] The crucial 
spiroether substructure 205 was assembled via an intramolecular Micheal-additon. Thus, 
homoallylic alcohol derivative 204 underwent upon treatment with tBuOK addition to an α,β-
unsaturated ketone substructure yielding the desired spiroketal 205 and its diastereomer 206 in 
43% and 19% yield, respectively. Interestingly, under acidic conditions dihydroxy ketone 204 
gave all four possible diastereomers. 
 
Scheme 95 Synthesis of oscillatoxin D 207 
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Oxabicyclic compounds are interesting building blocks in organic synthesis, since they 
can be stereoselectively manipulated in a variety of ways. [80] However, their use is limited, 
because general methods for their efficient synthesis are still missing. Mascarenas et al. have 
recently published results of synthetic investigations concerning the use of oxabicycles as parent 
compounds of embedded cyclic ketones (Scheme 96). [81] The first step of this synthetic pathway 
was accomplished via thermal cycloaddition (3+5) of cycloprane derivative 209, which 
participates in this reaction as a three-carbon component, with highly activated alkene 208. 
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Subsequently, rearrangement mediated by Lewis acid delivered oxabicycle 211 Disappointingly, 
authors did not attempt to unmask the embedded cyclic ketone. 
 
Scheme 96 Synthesis of oxabicycle 211 
 
208
O
O
O O
O
O
O
RO H
H
AcO
O
OAc
OR
+
Et3N
CH2Cl2
NaBH4/
CaCl2
CH2Cl2
Ac2O
TMSOTf
209 210 211
 
 
In addition, bridged oxabicycles constitute a central and common substructural motif of 
several natural products. [82] Cembranoids, a pharmacologically important family of marine 
metabolites with a wide spectrum of biological activity, have been a subject of considerable 
interest. [83] A bridged oxabicycle motif was also found in the hexacyclic polyketide natural 
product hexacyclinic acid 214, which has been proven to have antitumor activity. [84] Ebden et al. 
have recently reported synthetic endeavours towards the bicyclic subsystem of hexacyclinic acid 
214 (Scheme 97). [85] The key step of this approach involved a iodination-hemiacetalization, 
which was performed via treatment of the nine-membered ketone 212 with iodide-silver acetate 
mixture (in situ formation of AcOI) to give oxabicyclic product 213. 
 
Scheme 97 Synthesis of hexacyclinic acid 214  
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Tadano et al. have recently reported synthesis of (+)-mycoepoxydiene 218, in which the 
crucial bicyclic structure was synthesized via RCM.[86] Thus, oxabridged bicycle 217 was 
produced via treatment of dialkenylo tetrahydropyran 216 with ruthenium complex 30. The 
desired bicyclic 217 was obtained in 86% yield (Scheme 98).  
 
Scheme 98 Synthesis of (+)-mycoepoxydiene 218 
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3.2 Project objectives 
The advantages of the sulfoximine-mediated modular approach were extensively exemplified 
in the synthesis of carbocycles described in the first part of this work.[87] Thus, we have decided 
to apply this interesting strategy for a synthesis of spirocyclic and oxabicyclic compounds 
(Scheme 99). The key compounds of our synthesis were the sulfoximine-substituted pyrans LI, 
which served as parent compounds for spiroketals LVI, spiroethers LVII and oxabicycles LV. It 
was planned to synthesize the latter compounds via introduction of a suitable substituent in the α-
position of pyrans LI followed by RCM. The synthesis of the pyrans LI could be accomplished 
via deprotection-cyclization of the corresponding α-sulfoximido ketones L. The synthesis of 
these compounds via successive α-hydroxyalkylation-DMP-mediated oxidation should pose no 
problems, since suitable strategy was already developed.  
Scheme 99 Retrosynthetic analysis of spiroketals LVI, spiroethers LVII and oxabicycles LV 
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3.3 Synthesis of sulfoximine-substituted pyran derivatives 
 
The δ-hydroxy ketones with three contiguous stereogenic centers are very attractive as starting 
materials for the synthesis of dihydropyrans. Moreover, possible variations of R1 to R3 could 
enable a synthesis of the whole spectrum of compounds. Asymmetric synthesis of sulfoximine-
substituted acyclic ketones bearing hydroxy groups at their δ-positions had been previously 
optimized (Chapter 2.5.5.1, page 37 and 38). Thus, the δ-hydroxy alkenyl sulfoximines 77−79, 
219, 222 were converted via α-hydroxyalkylation into the corresponding allylic alcohols 89−92, 
94, 110, 220 and 223. The synthesis of allylic alcohols 89−92, 94 and 110 was already described 
(see page 30 and 38) and was only adopted for the aims of this project. The synthesis of allylic 
alcohol 220 and 223 were accomplished via treatment of either alkenyl sulfoximine 219 or 222 
with n-BuLi at −78 oC in THF followed by addition of 5-hexenal. The desired alcohols 220 and 
223 were both obtained as equimolar mixtures of epimers after flash chromatography on silica 
gel in 90% and 76% yield (combined yield of both epimers), respectively. The synthesis of δ-
hydroxy ketones 106−109, 111 and 112 via DMP-mediated oxidation was already described (see 
page 37 and 38) and was only adopted for the aims of this project. The DMP-mediated oxidation 
of alcohols 220 and 223 gave the corresponding enones 221 and 224 after purification by flash 
chromatography both in 96% yield (Scheme 100). 
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Scheme 100 Synthesis of allylic alcohols 89−92, 94, 110, 220 and 223 and enones 106-109, 111, 
112, 221 and 224 
Entry AlkenylSulfoximine R
1 R2 R3 Alcohol(Yield)
Enone
(Yield)
1 77 Me iPr Me 89 (90%) 106 (80%)
2 77 Me iPr 90 (85%) 107 (96%)
3 77 Me iPr 91 (90%) 108 (96%)
4 78 iPr 92 (90%) 109 (96%)
5 79 Me - 94 (65%) 112 (96%)
6 77 Me iPr Et 110 (90%) 111 (96%)
7 219 iPr iPr 220 (92%) 221 (96%)
8 222 iPr - 223 (90%) 224 (96%)
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 Having the enantio- and diastereopure ketones at hand, their deprotection-cyclization was 
investigated (Scheme 101). The outcome of the reaction was first explored using the enone 109, 
which gave the corresponding pyran 225 in ca. 65% yield upon treatment with nBu4NF at room 
temperature in THF (entry 1). The 1H NMR spectrum of the crude reaction mixture also revealed 
signals corresponding to sulfinamide 165. Treatment of 109 with acetic acid in THF or with 
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PPTS in methanol did not lead to a conversion of 109 (entry 3 and 4). Enone 109 also remained 
unreactive in the presence of p-TsOH in dry CH2Cl2 (entry 5). Finally, the desired pyran 225 was 
obtained as a single diastereomer in 90% yield, after treatment of 109 with a mixture of AcOH, 
THF, H2O and HCl in the ratio of 8:8:1:0.2 (entry 6). The configuration of the new formed 
stereocenter depicted in Scheme 101 was determined for the comparable dihydropyran 229 (see 
page 92). 
Scheme 101 Deprotection-Cyclization of hydroxyketone 109 – screening of reaction conditions 
Entry Conditions t solvent t (h) 222 162
1 (n-Bu)4NF r.t. THF 1 65% b
2 (n-Bu)4NF 0°C THF 1 70% b
3 AcOH r.t., THF 3 a a
4 PPTS r.t. MeOH 3 a a
5 p-TsOH r.t., DCM 3 a a
6
AcOH:THF:H2O:
HCl:
8:8:1:0.2
r.t., - 3 90% -
109
iPr
Et3SiO
O O
iPr
OH
conditions
225
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The optimized protocol was subsequently utilized for the conversion of ketones 106-109, 
111, 112, 221 and 224 into the corresponding pyrans (Scheme 100). In the case of ketones 107-
109, 111 and 221 the corresponding cyclic derivatives 225, 227-229 and 231 were obtained as 
single diastereomers in 80-90% yield. Similar reactions of ketones 106, 112 and 224 gave only 
the decomposition products which forced us to revisit the conditions. The configuration of the 
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newly-formed stereocenters was determined by NOE experiment of dihydropyran 229 (see page 
92). Since dihydropyrans 225, 227, 228 and 231 were produced in comparable manner as 
dihydropyran 229, their configuration was assumed to be the same as those of 229.  
Scheme 102 Synthesis of sulfoximine-substituted dihydropyrans 225, 227−229 and 231 
Entry Startingmaterial R
1 R2 R3 Product Yield
1 106 Me iPr Me 226 a
2 107 Me iPr 227 92%
3 108 Me iPr 228 84%
4 109 iPr 225 90%
5 111 Me iPr Et 229 90%
6 112 Me - 230 a
7 221 iPr iPr 231 80%
8 224 iPr - 232 a
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Thus, ketones 106, 112 and 224 were dissolved in THF and treated with (nBu)4NF at 
room temperature (Scheme 103). In the case of ketone 224, the desired pyran 232 was obtained 
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after purification by flash chromatography in 94% yield. In contrast, reactions of 106 and 112 
only led to decomposition products. 
Scheme 103 Synthesis of sulfoximine-substituted dihydropyrans 226, 230 and 232 
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In order to rationalize the negative outcome of the reaction of enones 106 and 112, 
containing the substructure element of a triethylsilyl-protected allylic alcohol, the following 
assumption was made. In contrast to 224, the allylic alcoholates 106a and 112a, which were 
generated via desilylation by fluoride ion, could undergo a retro γ-hydroxyalkylation (Scheme 
104). Presumably, this process is capable to start a cascade of reactions leading to the observed 
decomposition. 
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Scheme 104 Decomposition of ketones 106, 112  
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The configuration of the sulfoximine-substituted pyrans 225, 227, 228, 231 and 229 were 
determined via NOE experiment of dihydropyran 229 (Scheme 105). The most important NOE 
effect was observed between proton H-6 and proton H-8. Moreover, the values of the observed 
coupling constants revealed details concerning the conformation of the dihydropyran ring. Since 
the coupling constant between protons H-4 and H-5 is 1.2 Hz the dihedral angle between both 
substituents must be aprox. 180o. The coupling constant of 10.2 Hz between protons H-5 and H-6 
indicates their trans position in respect to each other. This information leads to conclusion that 
the isopropyl- and 2-propenyl-substituents are in pseudoequatorial position in regard to the 
dihydropyran ring. 
Scheme 105 Configuration of dihydropyran 229 – significant NOE effect 
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Our rationale for the highly stereoselective formation of dihydropyrans 225−231 is 
depicted in Scheme 106. The assumption that the configuration of dihydropyrans, which was 
observed, is thermodynamically favored one, is justified by the fact that the deprotection-
cyclization of hydroxyketons 106-109, 111, 112, 221 and 224 reactions were carried out at 
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room temperature for 3 h under conditions, where an equilibrium of the corresponding 
epimers LIa and LIb could occur. Structures of dihydropyrans LIa and LIb, which could be 
formed in the aforementioned reactions, are characterized by different position of the 
hydroxyl group. The axially placed hydroxyl group in the structure LIa, which in fact 
corresponds to the observed configuration and conformation of dihydropyrans 225, 227−229, 
231 and 232 enables stereoelectronic-effect (known as anomeric-effect) decreasing energy of 
this structure.[88] Anomeric effect can be described as a stabilizing interaction 
(hyperconjugation) between an unshared electron pair on the heteroatom (oxygen in this case) 
and the σ* orbital of the axial C–O bond which is marked on the structure LIa. 
 
Scheme 106 Diastereoselective formation of sulfoximine-substituted dihydropyrans of type 
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3.4 Synthesis of sulfoximine-substituted oxabicycles 
 
Bridged oxabicyclic compounds are not only a synthetic target due to their presence in 
several natural products, but also due to their use as templates and building blocks in organic 
chemistry.[80] However, due to the lack of a general and effective method of their asymmetric 
synthesis their application was restricted. The synthetic route envisioned in our group could 
provide oxabicycles with various substitution pattern (Scheme 107). Moreover, variations of ring 
sizes combined in the bicyclic system should also be possible. 
 
Scheme 107 Retrosynthetic analysis of sulfoximine-substituted oxabicycles 
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 Hence, the sulfoximine-substituted dihydropyrans bearing unsaturated substituents at C-2 
and C-6 were subjected to the RCM. Solutions of 225, 227, and 228 in CH2Cl2 were treated with 
the ruthenium complex 30 at room temperature (Scheme 108). Since TLC revealed only the 
presence of 225, 227, and 228 after stirring for 4 h, the mixture was heated at reflux. Under these 
conditions RCM of the hemiacetal 227 proceeded smoothly and gave oxabicycle 233 in 90% 
yield after purification via flash chromatography (entry 1). In contrast, hemiacetals 227 and 228 
were recovered unreacted after being submitted to similar protocol (entry 2 and 3). The outcome 
of the reaction was also negative when the higher boiling toluene was used as a solvent (entry 4 
and 5). Moreover, in the case of hemiacetal 225 and 228, the use of toluene led only to the 
formation of decomposition products. 
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Scheme 108 RCM of dialkenylo dihydropyrans 225, 227 and 228 
Entry Startingmaterial n m R
1 Solvent Product Yield
1 227 0 2 CH3 CH2Cl2 233 90%
2 225 2 2 H CH2Cl2 234 a
3 228 0 4 CH3 CH2Cl2 235 a
4 225 2 2 H toluene 234 b
5 228 0 4 CH3 toluene 235 b
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c = 0,005 M
CH2Cl2, RT to reflux
ano conversion of starting material, bdecomposition
225, 227, 228 233, 234, 235
 
At this moment no explanation for the observed results can be proposed. Analysis of the 
reaction mechanism does not point out any electronic hindrances in the case of failed reactions. 
Thus, steric factors seem to be responsible for the different reactivity. Synthesis of a nine-
membered oxabicycle, similar to that attempted in our project, has recently been reported to fail 
by Pontilo and Jung. [89] The authors anticipated that formation of the nine-membered subsystem 
of oxabicycle is unlikely due to the increasing strain in the transition state (enthalpic factors), and 
the low probability of the chain ends meeting (entropic factors). 
The oxabicycles obtained via RCM were planned to serve as building blocks because of 
their high synthetic utility. Hence, the synthesis exploiting their ability to form the corresponding 
oxonium ion, which could be subsequently trapped with various electrophiles, was proposed. The 
Sakurai reaction[90] with the corresponding keten acetal[91] 236 was applied since this reaction 
enables simultaneous formation of the new C-C bond and introduction of an ester moiety. 
However, to the best of our knowledge reactions of this type have never been carried out with a 
trisubstituted hemiacetal. Aside from the steric hinderence there are several side reactions 
possible in this protocol, which morphs the attempted synthesis into a challenging task (Scheme 
109). [92]  
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Scheme 109 Sakurai reaction of hemiacetal 233 – possible side reactions 
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Thus, oxonium ion 233b can rearrange to give chloro ketone 233d, which would 
presumably decompose under reaction conditions.  
Having all these doubts in mind, the synthesis of ester 237 was attempted (Scheme 110). 
The solution of oxabicycle 233 in CH2Cl2 was treated with a TiCl4 (2 equiv) at –78 °C in order to 
generate the required oxonium ion. Subsequently, the ketene acetal 236 admixed with 236b (side 
product obtained during synthesis of 236, which could not be separated) was added in order to 
trap the intermediate. The mixture was then allowed to warm gradually to ambient temperature 
and submitted to aqueous work up, which gave back oxabicycle 233 in quantitative yield. 
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Scheme 110 Attempted synthesis of bicyclic ester 237 
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It was assumed that the aforementioned reaction did not work because the formation of 
oxonium ion 233a failed. This hypothesis seems to be reasonable, since difficulties in formation 
of carbocations in the bridge position of a bicyclic system are known. [93] Thus, an alternative 
synthetic pathway to ester 237 was developed, involving RCM of diene 238 which was 
synthesized through Sakurai reaction of hemiacetal 227 (Scheme 111). 
 
Scheme 111 Retrosynthetic analysis of bicyclic ester 237 
O
iPr S Ph
O NMe
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O
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Ph
O NMe
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The first step of this synthetic pathway was accomplished via treatment of a CH2Cl2-
solution of hemiacetal 227 with 2 equiv. of TiCl4 at –78 °C followed by addition of the mixture 
of ketene diacetal 236 admixed with ethyl acetate 236b (Scheme 112). In order to overcome a 
loss of reagents in the aforementioned side reactions, the same protocol was applied twice in 20 
min. interval. Aqueous work up of the mixture followed by flash chromatography gave the 
desired ester 238 as a single diastereomer in 63% yield. The configuration of the new 
stereocenter was determined via an NOE experiment. The most important NOE-effect was 
observed between protons H-10b and H-6 and indicated the configuration depicted in scheme 
112. Moreover, the coupling constant of 10.2 Hz between protons H-5 and H-6 indicates their 
trans position in respect to each other. This information leads to conclusion that the isopropyl- 
and 2-propenyl-substituents are in pseudoequatorial position in regard to the dihydropyran ring. 
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Scheme 112 Synthesis of ester 238 
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The rationalization of highly diastereoselective formation of ester 238 is depicted in Scheme 
113. The allyloxy-carbenium 238a ion could be regarded as the most stable and reactive 
conformer. In this case an attack anti to the bulky propenyl group is favored. A comparable 
directing effect of the substituent was already reported. Thus, the C-glycosidation of glycals with 
alkynylsilanes, catalyzed by indium tribromide, was found to proceed with high 
diastereoselectivity due to directing effect of substituents at the pyran ring. [94] 
 
Scheme 113 Diastereoselective formation of ester 238  
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Subsequently, triene 238 was subjected to the RCM catalyzed by the ruthenium complex 
30 in refluxing CH2Cl2 (Scheme 114). TLC control revealed complete consumption of 238 within 
16 h. The oxabicyclic ester 237 was obtained after purification via flash chromatography in 90% 
yield. 
 
Scheme 114 RCM of ester 238 
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Having oxabicycles 233 and 237 at hand, the removal of the sulfoximine moiety was studied. 
The reaction of choice was the aluminum amalgam-mediated reductive cleavage, since this 
reaction was proven to be compatible with a free hydroxyl group present in the molecule (see 
page 67).[59] Thus, a solution of oxabicycle 233 in wet THF was treated with high excess of 
aluminum amalgam freshly prepared from aluminum foil and solution of HgCl2 (2 wg%). The 
reaction, which was strongly exothermic in its primal stage, was followed by TLC which 
revealed complete conversion of 233 after 14 h. The crude mixture was passed through short 
layer of celite in order to separate the remains of alumina. The residue was purified via flash 
chromatography to give oxabicycle 239 and sulfinamide 165 in 59% yield (77% in regard to the 
formation of 239). Subsequent determination of the optical rotation of 165 confirmed its optical 
purity and configuration. 
 
Scheme 115 Reductive cleavage of sulfoximine 233 
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3.5 Synthesis of sulfoximine-substituted spiroethers 
 
 The synthesis of spiroether motif is justified by its presence in a number of natural 
products. In our retrosynthetic analysis, it was envisioned that the sulfoximine-substituted pyrans 
LXI could be converted into ethers LXI via introduction of an unsaturated substituent at the α-
position. Subsequent RCM should convert LXII into spiroether LXIII (Scheme 116). 
 
Scheme 116 Retrosynthetic analysis of sulfoximine-substituted spiroethers LXIII 
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Banarjee of our research group recently reported an interesting approach to sulfoximine-
substituted spiroether via TiCl4-mediated Sakurai reaction followed by RCM (Scheme 117).[95] 
Thus, solutions of pyran 240, 241 in CH2Cl2 were treated with excess of TiCl4 to generate 
corresponding oxonium ion, which was subsequently trapped with allyltrimethylsilane. Aqueous 
work-up and purification by flash chromatography gave ketals 242 and 243 in 90% and 85 % 
yield respectively. Moreover, ethers 242 and 243 were obtained as single diastereomers. The 
dienyl dihypyrans gave eventually upon treated with Grubbs catalyst 30 the desired spiroethers 
244 and 245 in 87% and 92% yield, respectively.  
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Scheme 117 Sakurai reaction of dihydropyrans 240, 241 and 231 
Entry Dihydro-pyran R
1 R2 Product Yield de Spiroether Yield
1 240 iPr H 242 90% 95% 244 87%
2 241 -(CH2)4- 243 94% 95% 245 92%
3 231 iPr H 246
a
 + 247a
248b 92%
c
- - -
OiPr
S Ph
O NMe
OH
R2
R1
O
R1
iPr
S Ph
O NMe
SiMe31.
2.TiCl4
 CH2Cl2
−78 oC to −40 oC
R2
( )n
OiPr
S Ph
O NMe
OH
iPr
O
iPr
iPr
S Ph
O NMe
SiMe31.
2.TiCl4
CH2Cl2
-78 oC to -40 oC
O
iPr
iPr
S Ph
O NMe
Cl
Cl
a
 product of the Prins Reaction, b not observed in the crude mixture
c combined yield
240, 241 242, 243
231 246 247
O
R1
iPr
S Ph
O NMeR2
( )n
244, 245
30, 10%
c = 0,005 M
CH2Cl2, reflux
O
iPr
iPr
S Ph
O NMe
( )n
248
+ +
 
In a light of the aforementioned results it was interesting to investigate similar reaction of 
dihydropyrans bearing a 1-pentenyl substituent at C-2. Surprisingly, the dihydropyran 231 did not 
undergo the Sakurai reaction and formation of the desired spiroethers 248 was not observed. 
Instaed of this, successive treatment of 231 with excess of TiCl4 and allyltrimethylsilane in 
CH2Cl2 resulted in the formation of chlorides 246 and 247. The Prins cyclisation[96] , which will 
be discussed in the next section, was proposed to rationalize this interesting observation.  
 
3.5.1. The Prins reaction – introduction 
 
The acid-promoted Prins-type reaction is a useful tool for the stereoselective synthesis of 
tetrahydropyrans.[97] This strategy involves cyclization of an oxycarbenium ion generated in situ 
either from reaction of the parent homoallylic alcohol with an aldehyde [98] or from a homoallylic 
acetal [99] or -acetoxy ether. [100]  
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The Prins reaction could be applied to the stereoselective construction of trisubstituted 
tetrahydropyrans, as it was recently reported by Rychnovsky. [101] According to this report 
homoallylic alcohol 249 was treated with corresponding aldehyde in the presence of the 
corresponding Lewis acid (TfOH or SnBr4, Scheme 118). The Prins reaction followed by pinacol 
rearrangement delivered desired tetrahydropyran 251a−251g in good to very good yield and with 
good to excellent selectivity. 
 
Scheme 118 Synthesis of tetrahydropyran 251a−251g 
Product RCHO acid stereosel Yield of 251 a-g
251a PhCH2CH2CHO TfOHSnCl4
18:1
10:1
81
65
251b MeCHO TfOHSnCl4
11:1
10:1
73
66
251c PhCH2CHO TfOHSnCl4
6:1
8:1
61
56
251d iPrCHO TfOHSnCl4
14:1
12:1
65
68
251e tBuCHO TfOHSnCl4
9:1
10:1
76
50
251f (E)-PhCH=CHCHO TfOHSnCl4
6:1
8:1
68
59
251g PhCHO TfOHSnCl4
8:1
6:1
61
76
OH
Me
OHPh
OHMe
Br
a) t-BuLi
b) CuCN
c) Ph
O
Aldehyde ( 2equiv)
SnCl4 (0.5 equiv)
MeNO2, -25oC OPh
OMe
R
249 250 251a−251g
 
 
Methodology based on the Prins reaction has recently extended to the synthesis of the 
pentasubstituted tetrahydropyran fragment of phorboxazole A (Scheme 119). [102] Thus, -acetoxy 
ether 252 was submitted to BF3/Et2O-mediated Prins reaction with AcOH to generate the desired 
product 253 in 52% yield as a single diastereoisomer. [103] 
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Scheme 119 Synthesis of pentasubstituted tetrahydropyran 253 
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The straightforward synthesis (for alternative synthesis see page 12) of optically pure (-)-
centrolobine 43, an antibiotic isolated originally from the heartwood of Centrolobium robustum, 
highlights the utility of the Prins cyclizations (Scheme 120). [104] Thus, the hemiacetal 254 was 
treated with SnBr4 to afford trisubstituted tetrahydropyran 255 in 84% yield. Further synthetic 
steps involving reductive elimination of bromide yielded desired centrolobine 43. 
 
Scheme 120 Synthesis of (-)-centrolobine 43 via the Prins cyclization 
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Reagents and conditions: (a)  SnBr4,CH2Cl2,− 78 °C, 84%. (b) K 2CO3, MeOH, 
reflux. (c) MeI, K2CO3, acetone, 85% (d) Bu3SnH, AIBN (cat.) PhCH3, reflux,
86%. (e) H2, 10% Pd/C, 72%.
O
MeO
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a b-e
255 43
 
The intramolecular Sakurai reaction was recently reported by Paquete et al. to be a very 
useful methodology for the synthesis of spirocyclic ethers.[105] Thus, sulfones 256, 258, 260 and 
262 were subjected to treatment with t-BuLi in THF at –78 oC followed by reaction with iodide 
264. The instable intermediates, which were formed via this addition cyclized immediately to 
give corresponding spiroethers 257, 259, 261, 263 and their regioisomers 257a, 259a, 261a, 
263a. The stereoselectivity in which desired spiroethers 257, 259, 261 and 263 were obtained, 
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varied depending on substitution pattern from 98:2 to 3.7:1. The stereoselectivity was 
rationalized in terms of the favoured nucleophilic capture of the corresponding to 
tetrahydropyrans 257, 259, 261 and 263 oxonium ions via a chair-like or twist-boat transition 
state. 
 
Scheme 121 Synthesis of spiroethers 257, 259, 261, 263 via intramolecular Sakurai reaction 
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The modularity of the method developed by Paquette et al. was demonstrated in the 
diastereoselective synthesis of spiroether 269a. In the first step of the reactions sequence chiral 
epoxide 265 was selectively open to give substituted alcohol 266. Alcohol 266 was subsequently 
converted via ozonolisysis of the terminal double bond into the corresponding hydroxy aldehyde, 
which served as parent compound for hemiacetal 267. Hemiacetal 267 was converted via 
successive treatment with corresponding sulfone and iodide into mixture of spiroethers 269 and 
269a in a ratio of 25:1. Finally, the mixture of spiroethers 269 and 269a was treated with p-
TosOH in CH2Cl2 to give 269 and 269a in a ratio of 1:99. 
THEORETICAL PART 
 
105
Scheme 122 Synthesis of spiroethers 269a via intramolecular Sakurai reaction 
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The surprising outcome of the Sakurai reaction of dihydropyrans, can be regard as a 
prelude to a target-oriented synthesis of spirocyclic chlorides (Scheme 117, page 101). 
Instaed of expected ethers, formation of 246 and 247 in a 8:1 ratio was observed. Extensive 
analysis of their NMR- and MS spectra allowed determining their structures. Rationalization 
of this phenomenon could be as follows (Scheme 123). Presumably, upon treatment with 
TiCl4 hemiacetal 231 was converted into oxonium ion 231a. Formation of the carbocations 
231c could be explained as a result of an intramolecular trapping of carbocations 231a by the 
terminal double bond. Subsequently, spirocyclic carbocations 231c were trapped by the 
chloride ion to generate chloride 246. Formation of the minor chloride 247 can be explained 
by trapping of 231d by the chloride ion. Thereby, a 1,2-hydride shift was anticipated to be 
responsible for the conversion of 231c into 231d. 
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Scheme 123 Synthesis of chlorides 246 and 247 – the mechanism 
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The mechanistic analysis reveals that observed phenomenon is closely related to the Prins 
reaction. However, comparison of the proposed mechanism with that of Prins reactions unveils 
the novelty of the process (Scheme 124). Thus, the oxonium ion LXVI, which is formed in the 
first step of the Prins reaction, is then trapped by terminal double bond to form heterocyclic 
carbocation LXVII. This intermediate reacts subsequently with corresponding nucleophile to 
yield tetrahydropyran LXVIII. In contrast, the approach developed in our laboratory enables 
formation of the carbocyclic ring of spiroether via analogues trapping of carbocation 231c 
(Scheme 123). Thus, the methodology developed by us, could be regarded as an extension of the 
classic Prins reaction. 
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Scheme 124 Mechanism of Prins cyclization 
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Having the proposed mechanism in mind, a target oriented synthesis was attempted. An 
additional goal was also to develop methodology, which would provide exclusively spiroether 
with a chloride substituent attached to C-8. In order to examine this reaction pyran 232 was 
reacted with TiCl4 in various chlorinated solvents at various temperatures (Scheme 125). The 
mixtures in each case were treated with with (NH4)2CO3 to hydrolyze the excess of a Lewis acid. 
The desired chloride 270 was obtained with the highest selectivity of 8:1 (as revealed by NMR 
spectroscopy of the crude mixture), if a solution of parent compound 232 in CH2Cl2 was treated 
with 3 equiv. of TiCl4 (entry 1 and 2). Similar reaction mediated by 3 equiv. of TiCl4 in CHCl3 at 
−60 oC gave chlorides 270 and 271 in a ratio of 6:1, while treatment of 232 with 3 equiv. of TiCl4 
in (CH2Cl)2 at −35oC resulted in ratio of 3:2 (entry 5 and 6). The use of SnCl4 as a Lewis acid led 
only to partial conversion of 232 into unknown product (entry 3).  
 
Scheme 125 Synthesis of chlorides 270 and 271 
Entry Solvent t Lewis Acid 270:271
1 CH2Cl2 − 78 0C TiCl4 3 eq a 8 : 1
2 CH2Cl2 − 90 0C TiCl4 6 eq 8 : 1
4 CH2Cl2 − 78 0C SnCl4 3 eqa a
5 ClCH2CH2Cl − 35  0C TiCl4 3 eqa 3 : 2
6 CHCl3 − 60 0C TiCl4 3 eqa 6 : 1
OiPr
S Ph
O NMe
OH
OiPr
S Ph
O NMe
OiPr
S Ph
O NMe
Cl
Cl232 270 271
a compound was added as solution in corresponding solvent
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Finally, hemiacetal 231 was treated with 3 equiv. of TiCl4 at −78 oC in CH2Cl2 to yield the 
mixture of spirocyclic chlorides 246 and 247 in a ratio of 8:1, which were isolated via flash 
chromatography in 70% and 7% yield, respectively (Scheme 126). 
 
Scheme 126 Synthesis of chlorides 246 and 247 
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These results led to following conclusion. The anticipated 1,2 hydride shift, which is 
responsible for the formation of the minor chlorides 247 and 271, can be suppressed by low 
temperature or quick trapping of the spirocyclic carbocations with the chloride ion. The latter 
effect can be achieved when excess of TiCl4 is used to give high concentration of chloride anions. 
The configuration of the spirocyclic chlorides S-246 and S-247 was determined via NOE 
experiments. Possible diastereomers of chlorides S-246 and S-247 are depicted in Scheme 127. In 
the case of chloride S-246 proton H-8 posses coupling constants 3J of 10.2, 4.1 and 3.1 Hz, which 
indicates its equatorial position. Due to this observation only structures S-246 and R-246a could 
be discussed. The information deciding for the determination of configuration is provided by 
NOE effects. The NOE effect between equatorial protons H7 and proton H2 is theoretically 
possible for both structures. In contrast, the NOE effect between axial proton H11 and one of the 
ortho-protons of phenyl ring in sulfoximine group is possible only in the case of structure. S-246. 
Thus, structure S-246 could be accepted. In the case of chloride S-247 proton H-9 has coupling 
constants of 3.5 and 4.3 Hz, which indicates its axial position. This fact enables to concentrate the 
discussion on structures S-247 and R-247a. Additional information are provided by NOE effects. 
The NOE effect between equatorial proton H7 and proton H2 is theoretically possible for both 
structures. In contrast, the NOE effect between the axial proton H11 and one of the ortho-protons 
of the phenyl ring of the sulfoximine group is possible only in the case of structure S-247. Thus, 
structure S-247 could be accepted. 
 
 
THEORETICAL PART 
 
109
Scheme 127 Configuration of chlorides 246 and 247, significant NOE effect 
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The diastereoselective formation of chlorides 246 and 247 was assumed to be affected by 
the directing effect of chiral sulfoximine group (Scheme 128). It was also assumed that the 
addition of chloride ion occurred within conformers 246b and 247b. Presumably, in the first step 
TiCl4 (Lewis acid) is coordinated to the basic nitrogen atom of the sulfoximine group. The 
nitrogen atom is also capable to accelerate the cleavage of the Ti-Cl bond. The further transfer of 
the chloride ion is thus directed either in axial position of carbocation 246b or equatorial position 
of carbocation 247b. Finally, conformers 246c and 247c morphs into presumably energetically 
more stable conformers 246 and 247. In the case of chloride 246 the formation of observed 
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conformer is due to the steric repulsion between the chloride atom and sulfoximine group. In the 
case of chloride 247 the steric repulsion between chlorinated ring and sulfoximine group can be 
regarded as a reason for the adopted conformation. 
Scheme 128 Diastereoselective formation of chlorides 246 and 247 – the mechanism 
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3.6 Synthesis of sulfoximine-substituted spiroketals 
 
The modular approach, enabled by the sulfoximine-based strategy, has been recently applied 
by Banarjee in our research group to the synthesis of spiroketals (Scheme 129).[95] Thus, the 
sulfoximine-substituted pyran 240 was treated with an unsaturated alcohol in the presence of 
BF3/Et2O in order to generate the corresponding acetals 273-275. Unfortunately, only the 
reactions with allylic alcohol gave the desired ketal 273, similar reactions with less reactive 
alcohols failed.  
Scheme 129 Synthesis of spiroketals 273−275 
Entry startingmaterial ROH Product Yield d.e.
1 240 HO 273 90% 95%
2 240 HO 274 - -
3 240
HO
275 - -
O
iPr
iPr
S Ph
O NMe
O
ROH
BF3/Et2O
CH2Cl2, 0 oC to r.t.
O
iPr
iPr
S Ph
O NMe
OH
R
240 273−275
 
 
The ketal 273 was subsequently submitted to RCM mediated by Grubbs second 
generation catalyst 30 in CH2Cl2 at room temperature (Scheme 130). The corresponding 
spiroketal 276 was obtained in 90% yield.  
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Scheme 130 RCM of ketal 273 
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Since the strategy described above showed significant limitation and gave only access to 
the 1.8-dioxaspiro[6.5]dodecane system, development of another synthetic pathway was required. 
The strategy of choice was a deprotection-spiroketalisation route which has been frequently 
exploited in synthesis of natural products containing spiroketal substructure. According to the 
retrosynthesis, spiroketal LXXI was planned to be synthesized via deprotection-spiroketalisation 
of sulfoximine-substituted dihydroxy ketone LXX obtained from corresponding δ-hydroxy 
alkenyl sulfoximine LXIX (Scheme 131). 
 
Scheme 131 Retrosynthetic analysis of sulfoximine-substituted spiroketals LXXI 
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The first step of this synthestic pathway was accomplished by treatment of the δ-hydroxy 
alkenyl sulfoximines 77 and 219 with n-BuLi followed by trapping of generated α-lithiated 
derivative Li-77 and Li-219 at −78 oC in THF with valerolactone (Scheme 132). Thereby, the 
corresponding dihydroxy ketones 277 and 278 were obtained in 96% and 94% yield respectively. 
In the case of cyclic alkenyl sulfoximine 93, with the same protocol applied, no conversion was 
observed. This could serve as an indication for the lower reactivity of corresponding lithiated 
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derivative Li-79. This assumption is in agreement with our previous observations concerning α-
hydroxyalkylation of cyclic alkenyl sulfoximines (chapter 2.5.3, page 30). In this case the yield 
of α-hydroxyalkylation was significant lower than in the case of acyclic alkenyl sulfoximines 77 
and 78. 
 
Scheme 132 Synthesis of hydroxyketons 277−279 
 
Entry AlkenylSulfoximine R
1 R2 R3 Hydroxy-keton Yield
1 77 Me iPr H 277 96%
2 219 iPr iPr H 278 94%
3 79 iPr -(CH2)4- 279 a
R1
R2
S
Et3SiO
R1
R2 O
S
Et3SiO1. n-BuLi
THF, −78 oC
OH
Ph
O NMe
Ph
O NMeR3 R3
R1
R2
S
Et3SiO
Ph
O NMeR3
Li
O
2.
3. NH4Cl (aq)
THF,  −78 oC
O
a
 no conversion
77, 79, 219 Li-77, Li-79, Li-219 277−279
 
 
The hydroxyketones 277 and 278 were subsequently submitted to an acid-catalyzed 
deprotection-spirocyclisation. Several protocols were tested during exploration of this method 
(Scheme 133). p-TsOH proven to be the most suitable acid for this reaction since its use led to 
complete conversion of the hydroxyketones and spiroketal 280 was obtained with quite good 
diastereoselectivity (85:15, entry 1)). In comparison, the reactions catalyzed by CSA or PPTS 
gave an equimolar mixture of diastereomeric spiroketals 280 and epi-280 (entry 4-6). Reaction 
performed with a solution of HCl in THF or with a mixture of HCl, acetic acid and THF gave a 
mixture of diastereomeric spiroketals (entry 2 and 3). Moreover, the NMR spectrum of a crude 
mixture revealed signals that point out to the formation of hemiacetal 281, which could be 
regarded as an intermediate in this synthesis. Unfortunately, the isolation of 281 failed. Thus, its 
formation could not be proved unequivocally.  
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Scheme 133 Synthesis of spiroketals 280 and 282 
 
entry hydroxy-ketone R
1 solvent reagent Spiroketal
ratio of 
spiroketals 
 (1H NMR)
Yeld
1 277 Me TsOH 3 eq 280 and epi-280 85:15 80%a
2 277 Me
CH3COOH:
THF:
H2O:HCl  
8:8:1:0.2
280, epi-280 and 
281 30:30:40 50%
b
3 277 Me THF HCl (1N) 280, epi-280 and 281 30:30:40 46%b
4 277 Me CH2Cl2 PPTS 2 eq 280 and epi-280 50:50 70%a
5 277 Me CH2Cl2 CSA (+), 3 eq 280 and epi-280 50:50 75%a
6 277 Me CH2Cl2 CSA (-), 3 eq 280 and epi-280 50:50 85%a
7 277 Me HFIP p-TsOH 3 eq 280 96:4
c 82%
8 278 iPr HFIP p-TsOH 3 eq 282 96:4c 84%
R1
iPr O
S
Et3SiO
OH
O
SiPr
R1
O Ph
O NMe
Ph
O NMe
reagent
r.t 3h
solvent
O
SiPr
R1
O Ph
O NMe
O
SiPr
R1
OH Ph
O NMe
+ + OH
a
 combined yield of 222 and epi-222 b combined yield of 222 and epi-222,  235 was not isolated 
c
 only signals corresponding to major diastereomer observed in 1H NMR of the mixture
280, 282277, 278 epi-280 281
CH2Cl2
 
 
Finally, solutions of the sulfoximine-substituted ketodiols 177 and 178 in hexafluoro 
isopropanol (HFIP) gave upon treatment with p-TsOH the desired spiroketals 280 and 282 as 
single diastereomers. The subsequent purification by flash chromatography afforded the desired 
spiroketals 280 and 282 in 82% and 84% yield, respectively The fluorinated solvent was selected 
based on the consideration of the reaction mechanism. It was anticipated that the step 
determinating diastereoselectivity of this reaction is the trapping of the oxonium ion (Scheme 
134). Thus, the stereoselectivity should be higher, if a solvent capable to stabilize the key 
intermediates 277a and 278a is used. It was envisioned that hexafluoroisopropanol would be able 
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to stabilize carbocations 277a and 278a, since this solvent has been proven to posses required 
abilities in diastereomeric epoxidations. [103] 
 
Scheme 134 Synthesis of spiroketals 280 and 282 – the mechanism 
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O NMe
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O
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O NMe
O
SiPr
R1
Ph
O NMe
+OH
- H+
280, 282277, 278
epi-280, epi-282
277a, 278a
277, R1 =
278, R1 = iPr
 
The configuration of the new-formed stereocenter of spiroketal 280 was determined via 
NOE experiment. The possible diastereomers and conformers 280a, 280b, 280c and 280d are 
depicted in scheme 135. The most significant NOE effect, was between the axial proton H-8 and 
proton H-2. This is only possible in the case of structures 280a and 280c. This observation allows 
excluding structures 280b and 280d from the discussion. Additional information concerning 
conformation of the spiroketal structure was provided by NOE effect between axial proton H-11 
and one of ortho-protons of the phenyl ring of the sulfoximine group. This NOE effect is possible 
only in the case of structure 280a. 
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Scheme 135 Configuration of spiroketal 280 – significant NOE effects. 
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The rationalization of highly diastereoselective formation of ester 280 is depicted in Scheme 
136. The allyloxy-carbenium 280e ion could be regarded as the most stable and reactive 
conformer. In this case an attack anti to the bulky propenyl group is favored. A comparable 
directing effect of the substituent was already observed. Thus, the C-glycosidation of glycals with 
alkynylsilanes, catalyzed by indium tribromide, was found to proceed with high 
diastereoselectivity due to a directing effect of substituents at the pyran ring. [94] 
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Scheme 136 Diastereoselective formation of spiroketal 280 
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3.7 Replacement of the sulfoximine moiety 
 
The deprotection-spiroketalisation route, described in the last chapter, enabled an efficient 
and diastereoselective synthesis of sulfoximine-substituted spiroketals. The next step was the 
replacement of the sulfoximine moiety via a cross-coupling reaction with cuprates. This 
interesting reaction allowed the formation of methylated carbocycle 167 (Chapter 2.8.1, page 66). 
Thus, spiroketal 280 was treated with methyl cuprate in diethyl ether at –78°C (Scheme 137, 
entry 1). Unfortunately, no conversion of spiroketal 280 was observed. Similar reaction 
performed in the presence of CH3SiCl, which proved to activate the sulfoximine moiety in cross 
coupling reactions, also did not afford the desired spiroketal 283 (entry 2).  
 
Scheme 137 Attempted synthesis of spiroketal 283 
 
Entry MeLi CuI Me3SiCl Time (h) t Product
Starting
material
recovery
1 3 eq 5 eq - 16 −78 °C - 96%
2 3 eq 5 eq 5 eq 16 0°C - 96%
280
O
SiPr
O Ph
O NMe
O
iPr
O
Me Me
Me
1. Me2CuLi 
2. Me3SiCl 
3.  NH4Cl/NH3
Et2O
283
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Since the cross-coupling with cuprates did not lead to the desired conversion, the nickel 
catalyzed reaction was examined. Thus, the spiroketal 280 was treated with diphenyl zink in the 
presence of suitable nickel complex (Scheme 138, entry 1). The assigment of signals in the NMR 
spectrum of the crude mixture was difficult due to a huge excess of diphenyl formed during 
reaction. Purification by flash chromatography gave, besides the already mentioned diphenyl, 
only 63% of the spiroketal 280. Moreover, traces of an unknown, unpolar product were isolated. 
The reaction was repeated with slight modifications. However, neither the use of a nickel catalyst 
bearing different ligands (entry 4), nor variations of reaction media (entry 2 and 3) and 
organozinc reagent (entry 5 and 6) led to the formation of the desired spiroketals 284 or 285.  
 
Scheme 138 Attempted synthesis of spiroketals 284 and 285 
 
 
Entry R2Zn NiCl2L Solvent Time (h) t Product Startingmaterial
1 Ph2Zn NiCl2(dppp) Et2O 18 RT 284 -
2 Ph2Zn NiCl2(dppp) THF 11 0°C 284 -
3 Ph2Zn NiCl2(dppp) Et2O (degassed) 24 RT 284 -
4 Ph2Zn NiCl2(PPh3)2 Et2O (degassed) 18 RT 284 -
5 Et2Zn NiCl2(dppp) Et2O (degassed) 15 0°C 285 -
6 Et2Zn NiCl2(PPh3)2 Et2O (degassed) 15 RT 285 -
1. NiCl2L
R2Zn
Solvent
O
SiPr
O Ph
O NMe
O
iPr
O
Me Me
R
280 284, 285
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The scope of nickel-catalysed reactions, which did not lead to formation of the desird 
spiroketals 284 or 285, justifies the assumption that the sulfoximine-substituted spiroketals 
cannot undergo nickel-catalysed cross-coupling reactions. Presumably, insertion of the bulky 
nickel complex into the sulphur alkenyl carbon bond is hampered by sterical factors. It is also 
possible that trisubstituted double bond does not form a π-complex with nickel. On the other 
hand, the observed consumption of spiroketal 280 indicates that some reaction took place. The 
lack of analytical date, however, hampers further speculations concerning reaction mechanism. 
Finally, removal of the sulfoximine moiety of 280 via reductive cleavage was applied 
(Scheme 139). A solution of spiroketal 280 in wet THF was treated with freshly prepared 
aluminum amalgam. Evolution of dihydrogen combined with a boiling of the mixture was 
observed. After approximately 1 h the temperature of the mixture became ambient. TLC revealed 
complete conversion of 280 after stirring for 16 h. The mixture was filtered through short plague 
of celite to separate the aluminum foil and the residue was washed several times with CH2Cl2. 
The filtrate was washed with water, dried and evaporated in vacuum. The residue was 
subsequently purified by flash chromatography on silica gel. Interestingly, the NMR spectra of 
crude mixture revealed formation of the desired spiroketal 286 and a small amount of its 
diastereomer epi-286. It was anticipated that procedure which was applied for the synthesis of 
spiroketal 286 provided an acid at some stage. It was assumed that acidic impurities from CH2Cl2 
and silica gel, which was used for chromatography, provided protons responsible for ring-
opening of 286. The ring-opening of 286 generated intermediate 286a, which subsequently 
cyclized again to give the mixture of diastereomers 286 and epi-286. Presumably, spiroketal 286 
is much more sensitive to acid than its parent compound 280 since the basic sulfoximine moiety 
present in 280 is able to trap protons and prevented in this way an acid catalyzed opening of the 
spiroketal. 
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Scheme 139 Reductive cleavage of sulfoximine 280 – the mechanism 
 
 
In order to avoid the formation of the diastereomer epi-286 CH2Cl2 was ommited and 
silica gel was neutralized. Thus, the washing of celite after aforementioned filtration was 
accomplished with ethyl acetate instead of CH2Cl2 and the following purification via flash 
chromatography was performed with the additive NEt3 in the previously used eluant. 
Moreover, during addition of aluminum amalgam suspension to solution of spiroketal 280 in 
wet THF was cooled to ambient temperature. The reaction performed under such modified 
conditions led to selective formation of the ketal 286 in 72% yield (Scheme 140). 
Additionally, enantiopure sufinamide 165 was isolated in 50% yield.  
 
Scheme 140 Reductive cleavage of sulfoximine 280 
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3.8 Summary 
 
 The increasing pharmacological importance of compounds containing pyran substructure 
makes their efficient synthesis an important challenge of organic synthesis. We envisioned that 
sulfoximine-substituted chiral pyran derivatives LI could serve as parent compounds for 
spiroketals LVI, spiroethers LVII and bicyclic hemiacetals LV (Scheme 141). The chiral pyran 
derivatives L1 were synthesized from sulfoximine-substituted δ-hydroxy enones L obtained via 
DMP oxidation of corresponding alcohols IL.  
 
Scheme 141 Retrosynthetic analysis of spiroketals LVI, spiroethers LVII and oxabicycles LV 
 
O
SR2
R1
n(  )
Ph
O NMeR3
O
SR2
R(  )n
Ph
O NMe
m(  )
R3
O
SR2
R4
OH
R1
Ph
O NMeR3
R1
R2
S
Et3SiO
Ph
O NMe
O
R1
R2
S
Et3SiO
Ph
O NMe
OHR3
R3
R3
O
SR2
O
R1
n(  )
Ph
O NMeR3
R4
IL
L
LV
LI LVII
LVI
 
 The synthesis of sulfoximine-substituted pyran derivatives was achieved via deprotection-
cyclisation of the corresponding enones (Scheme 142). In the case of acyclic enones 107−109, 
111 and 221 acidic conditions provided desired dihydropyrans 225, 227−229 and 231 in very 
good yields. In contrast, cyclic enone 224 was converted into corresponding bicyclic 
dihydropyran derivative 232 in better yields upon treatment with (n-Bu)4NF. 
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Scheme 142 Synthesis of dihydropyrans 225, 227−229, 231 and 232 
 
Enone R1 R2 R3 R4 Dihydro-pyran
107 Me iPr H 227 (92%)a
108 Me iPr H 228 (84%)a
109 iPr H 225 (90%)a
111 Me iPr H Et 229 (90%)a
221 iPr iPr H 231 (80%)a
224 iPr - (CH2)4 - 232 (90%)b
107−109, 111, 221, 224
O
R2
R1 R4
OH
R1
R2
S
Et3SiO
OR4
R3
S
Ph
O NMe
Ph
O NMe
Conditions: a)  AcOH:THF:H2O:HCl, 3 h; b) (n-Bu)4NF, THF, 2 h
a) or b)
R3
225, 227−229, 231, 232
 
 
 With the sulfoximine-substituted pyrans in hand we exploited their synthetic utility. Thus, 
the pyran derivative 227 upon treatment with the Grubbs second generation catalyst underwent 
RCM giving oxabicyclic hemiacetal 233 (Scheme 143). Subsequently, oxabicycle 233 was 
treated with aluminum-amalgam to yield corresponding 239 and sulfinamide 165. Moreover, the 
TiCl4-mediated Sakurai reaction was applied for conversion of 227 into corresponding ester 238, 
which subsequently underwent RCM giving oxabicyclic ester 237. 
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Scheme 143. Synthesis of oxabicycles 233, 237 and 239 
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 The synthetic methodology recently developed in our research group enables synthesis of 
chiral substituted spiroketals. However, this strategy does not provide access to the substucture of 
1.7-dioxaspiro[5.5]undecane, which is very common in natural products. Thus, we decided to 
synthesize products containing this structural motif via deprotection-spirocyclization of 
corresponding dihydroxy ketones, which were synthesized from corresponding δ-hydroxy 
alkenyl sulfoximines 77 and 219 via n-BuLi-mediated lithiation followed by condensation with 
valeric lactone (Scheme 144). Deprotection-cyclization of dihydroxy ketones 277 and 278 was 
used for synthesis of spiroketals 280 and 282. Screening of several solvents revealed that this 
reaction proceeded stereoselectively only if hexafluoroisopropanol was used as reaction medium. 
Finally, the spiroketal 286 was synthesized from 280 via treatment with aluminum-amalgam. 
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Scheme 144. Synthesis of spiroketals 280, 282 and 286 
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The strategy recently developed in our research group, which provided access to spiroethers 
via the Sakurai reaction followed by RCM, was extended to spiroethers bearing a substituent at 
the new-formed ring. It was envisioned that a synthetic transformation similar to the Prins 
reaction could enable synthesis of spiroethers containing a cyclohexane ring substituted with 
chloride. Thus, sulfoximine-substituted pyran derivatives bearing 1-pentenyl substituent at C-2 
231 and 232 (Scheme 145) were treated with TiCl4 to give the desired chlorides 246 and 270 in 
good yields and with very high diastereoselectivity. However, the formation of two regioisomers 
247 and 271 was observed, which was assumed to be the result of 1.2-hydride shift. Interestingly, 
whilst the typical Prins reaction provides access to substituted pyran derivatives, our 
methodology enables high-yield synthesis of substituted carbocyclic substractures. 
 
Scheme 145. Synthesis of chlorides 246, 247, 270 and 271 
 
O
SiPr
iPr OH
Ph
O NMe
O
SiPr
iPr
Cl
O
SiPr
iPr
Cl
+
Ph
O NMe
Ph
O NMe
O
S
iPr OH O
S
iPr
Cl
O
S
iPr
Cl
+
Ph
O NMe
Ph
O NMe
Ph
O NMe
 TiCl4 3eq
DCM, -78 oC
 TiCl4 3eq
DCM, -78 oC
231 246 (70%) 247 (8%)
232 270 (68%) 271 (5%)
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
 
 
 
 
 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
 
126
4.1 General Remarks 
 
All reactions involving air- or moisture-sensitive compounds were carried out under argon using 
standard Schlenk and vacuum line techniques. Glassware were heated under vacuum with a heat 
gun and flushed with argon. Addition of all reagents as well as solvents was carried out with glass 
or polypropylene syringes equipped with steel needles under argon steam.  
 
4.2 Determination of the Physical Data 
 
1H NMR Spectroscopy 
 
1H NMR spectra were recorded at room temperature on a VarianGemini 300 (300 MHz), Inova 
400 (400 MHz) or Varian Unity 500 spectrometer. The chemical shifts are given in ppm using 
tetramethylsilane (δ = 0.00 ppm) as internal standard. The coupling constants J are given in 
Hertz. The following abbreviations are used in order to describe the signals observed in the 1H 
NMR-spectra: s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), m (multiplet), bs 
(broad signal). The diastereomeric ratio (dr) was determined by analysis of the 1H NMR-spectra 
of the crude mixture. Chemical shifts of protons in 1H NMR were assigned via comparison of 
gcosy and ghmqc spectra, as well as ATP and DEPT puls sequence. 
 
13C NMR Spectra 
 
13C NMR spectra were measured with a Varian Gemini 300 (75 MHz) and Inova 400 (100 MHz) 
spectrometer. The chemical shifts are given in ppm using tetramethylsilane (δ = 0.00 ppm) as 
internal standard. Peaks in the 13C NMR spectra are denoted as “u” for carbons with zero or two 
attached protons or as “d” for carbons with one or three attached protons, as determinated from 
the APT puls sequence. 
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Mass spectrometry 
 
Mass spectra were recorded on a Varian MAT 212 and a Finnigan MAT 95 spectrometer. All 
values are given in atomic units of mass per elemental charge (m/z). The intensity is given as a 
percentage of the base peak. 
 
IR-spectroscopy 
 
Infrared spectra were recorded on a Perkin-Elmer PE-1760 FT apparatus. All adsorptions are 
given in cm−1. Only peaks of ν ≥ 750 cm−1 are listed, s = strong, m = medium, w = weak.  
 
Optical rotation 
 
Optical rotations were determined on a Perkin Elmer PE-241 instrument at room temperature 
(approx. 20 ◦C) using solvents of Merck UVASOL-quality. The measurements were carried out 
using a wave lenght of 589 nm (D-line of a sodium vapour lamp) in a cuvette (length d = 10 cm; 
concentration c is given in g/100 mL). 
 
Elemental analysis 
 
All microanalyses were conducted on a Heraeus CHN RAPID instrument. All values are given in 
mass percentages. 
 
Chromatography 
 
Thin layer chromatography (TLC): 
TLC was performed using precoated aluminium sheets (Merck silica gel 60 F254). Detection was 
performed by using UV radiation (254 nm). 
 
 
 
 
EXPERIMENTAL PART 
 
 
128
Column chromatography 
 
Separations by column chromatography were conducted according to the literature.[106] Silica gel 
60 (Merk, mesh 40-63 µm) was employed as stationary phase. All solvents were distilled prior to 
use. 
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4.3 Reagents and solvents 
 
1. Solvents 
The solvents were dried and distilled under argon according to standard procedures. CH2Cl2 was 
distilled from CaH2 under N2. Diethyl ether: was predried over KOH distilled from sodium 
benzophenone ketyl radical under N2. DMF: was purchased from Merck and used as received. 
THF: was predried over KOH and distilled from sodium benzophenone ketyl radical under N2. 
Toluene: was distilled from sodium benzophenone ketyl radical under argon and stored over 4 ˚ 
A molecular sieves. 
 
 
n-BuLi was obtained from commercially sources and standarized by titration with diphenylacetic 
acid.  
 
ClTi(OiPr)3 was obtained from commercially sources as 1M solution in hexanes and was used 
without further purification. 
 
(S)-S-Methyl-S-phenylsulfoximine of ≥99% ee, which is commercially available, was 
synthesized as described previously. [33] 
 
(+)-(E,S)-N-Methyl-S-(4-methyl-2-pentenyl)-S-phenylsulfoximine (17) of ≥99% ee was 
synthetized from (S)-S-methyl-S-phenylsulfoximine and 3-methyl-butanal by the one-pot 
procedure according to the literature. [33] 
 
(+)-(E,S)-N-Methyl-S-(cyclohexenylmethyl)-S-phenylsulfoximine (71) of ≥99% ee was 
synthetized from (S)-S-methyl-S-phenylsulfoximine and cyclohexanon by the one-pot procedure 
according to the literature. [33] 
 
Pent-4-enyl trifluoromethanesulfonate was synthetized from 5-bromopent-1-ene and silber 
trifluoromethanesulfonate according to the literature. [107] 
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Hex-5-enal was synthetized from hex-5-enol via Swern oxidation according to the literature. [108] 
 
Hept-6-enal was synthetized from octa-1,7-dien via two-step procedure (formation of 
monoepoxide followed by its HIO4-mediated cleavage) according to the literature. [109] 
 
N-formylo carbazole (97) was synthetized form carbazole and formic acid according to the 
literature. [41] 
 
N-methoxy-N-methyl formamide (98) was synthetized from O,N-Dimethylhydroxylamine 
hydrochloride and methyl formate according to the literature. [42] Unfortunately, its separation 
(through destilation) from unknown decomposition products failed and a equimolar mixture was 
used. 
 
N-formylmorpholine (99) obtained from commercially sources was dried over P2O5 and further 
purified by passing through basic alumina. 
 
(Z)-triethyl(4-isopropyl-2-methyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]hex-5-en-3-
yloxy)silane (219) was synthetized from allylic sulfoximine 17 and isobutyraldehyde according 
to the literature.[33] 
 
(Z)-triethyl(2-methyl-1-(2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]methylene 
cyclohexyl)propoxy)silane (222) was synthetized from allylic sulfoximine 71 and 
isobutyraldehyde according to the literature. [33] 
 
(1-ethoxyvinyloxy)trimethylsilane (236) was synthetized from ethyl acetate, LDA and Me3SiCl 
according to the literature. Unfortunately, its separation (through destilation) from regioisomeric 
ethyl acetate 236b failed and an equimolar mixture of 236/236b was used. [91] 
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4.4. Synthesis of Sulfoximine-Substituted Homoallylic Alcohols  
 
 
4.4.1 General Procedure for the Synthesis of Homoallylic Alcohols 74, 75 and 76 (GP1). 
  
To a solution of sulfoximine 17 or 71 (1 mmol) in THF (40 mL) was added at −78 0C n-BuLi (1.1 
mmol, 0.69 ml of 1.6 M in n-hexanes) and the mixture was stirred at −78 0C for 1 h. Then a 
solution of ClTi(OiPr)3 (2.1 mmol) in THF (3 mL) was added and the resulting mixture was 
stirred first at −78 0C for 1 h and then at ambient temperatures for 1 h. Subsequently the mixture 
was cooled to −78 0C and a solution of the aldehyde (2 mmol) in THF (5 mL) was added within 
45 min. After the mixture was stirred at −78 0C for 2 h, saturated aqueous (NH4)2CO3 (10 mL) 
was added and the mixture was stirred at ambient temperature for 30 min. Then the mixture was 
extracted with EtOAc and the combined organic phases were dried (Na2SO4) and concentrated in 
vacuum. Purification by flash chromatography gave alcohols 74-76. 
 
4.4.2 Synthesis of (1Z,3R,4S,5E)-3-Isopropyl-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
hepta-1,5-dien-4-ol (74). 
 
iPr
OH
S
Ph
O
NMe 74 
 
 
Following GP1, reaction of sulfoximine 17 (1.80 g, 7.59 mmol) with buten-2-al (1.26 ml, 1.06 g, 
15.18 mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane, 3:1) 
alcohol 74 (1.63 g, 70%, ≥98:2 dr) as a colorless solid and sulfoximine 17 (360 mg, 20%).  
 
Rf = 0.36 (EtOAc/cyclohexane, 3:1)  
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[α]D = −104.3 (c 1.00, CH2Cl2) 
 
1H NMR (300 MHz, CDCl3, TMS)  δ 0.67 (d, J = 6.9 Hz, 3 H, CH3) , 0.78 (d, J = 6.7 Hz, 3 H, 
CH3), 1.75 (dd, J = 6.4, J = 1.5 Hz, 3 H, CH3), 1.77−1.88 (m, J = 6.9, J = 6.7, J = 4.0 Hz, 1 H, CH-
(CH3)2 ), 2.64 (s, 3 H, N-CH3), 3.40−3.49 (m, J =11.9, J = 9.2, J = 4.0, 1 H, CH=CH-CH ), 3.93 (dd, 
J = 9.2, J = 7.7 Hz, 1 H, CH-OH), 5.49−5.58 (m, J = 15.3, J = 7.7 Hz, 1 H, CHOH-CH=CH
 
), 
5.66−5.78 (m, J = 15.3, J = 6.4 Hz, 1 H, -CH=CH-CH3), 6.29 (dd, J = 11.9, J = 10.8 Hz, 1 H, CH-
CH=CH), 6.61 (d, J = 10.8 Hz, 1 H, CH-CH=CH), 7.53−7.61 (m, 3 H, Ph) 7.89−7.92 (m, 2 H, Ph) 
 
13C NMR (75 MHz, CDCl3, TMS)  δ 15.9 (d), 17.8 (d), 21.5 (d), 28.0 (d), 29.1 (d), 49.9 (d), 
73.5 (d), 127.8 (d), 129.1 (d), 129.4 (d), 133.0 (d), 133.4 (d), 134.7 (d), 139.3 (u), 144.3 (d) 
 
IR (KBr) ; 3243 (s), 3026 (w), 2962 (s), 2916 (m), 2873 (m), 2806 (w), 1617 (m), 1450 (m), 
1381 (w), 1301 (w), 1245 (s), 1207 (s), 1148 (s), 1113 (s), 1034 (w), 971 (s), 862 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 308 (3) (M++1), 306 (1), 237 (35), 236 (24), 222 (41), 
182 (14), 156 (59), 152 (12), 137 (18), 125 (100), 109 (49), 107 (18), 81 (17) 
 
Anal. Calcd for C17H25NO2S (307.16): C, 66.41; H, 8.20; N, 4.56. Found: C, 66.04, H, 8.06; N, 
4.41 
 
4.4.3 Synthesis of (Z,3R,4S)-3-Isopropyl-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]octa-1,7-
dien-4-ol (75).  
 
S
Ph
O
NMe
iPr
OH
75 
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Following GP1, reaction of sulfoximine 17 (1.35 g, 5.69 mmol) with pent-4-enal (0.716 mg, 8.53 
mmol) afforded after purification by chromatography (EtOAc/cyclohexane, 3:1) alcohol 75 (1.37 
g, 75%, ≥98:2 dr) as a colorless solid and sulfoximine 17 (243 mg, 18%).  
 
Rf = 0.32 (EtOAc/cyclohexane, 3:1) 
 
[α]D = −126.0 (c 1.00, CH2Cl2 ) 
 
1H NMR (400 MHz, CDCl3, TMS) δ 0.69 (d, J = 6.9 Hz, 6 H, CH3), 1.47−1.57 (m, J = 6.9, J = 6.7, 
J = 4.0 Hz, 1 H, CHOH-CHH), 1.75−1.86 (m, J = 6.9, J = 6.7, J = 4.0 Hz, 2 H, CHOH-CHH, CH-
(CH3)2 ), 2.19−2.37 (m, J = 6.9, J = 6.7, J = 4.0 Hz, 2 H, CH2-CH2), 2.64 (s, 3 H, N-CH3), 3.28−3.36 
(ddd, J =11.8, J = 7.2, J = 5.5 Hz, 1 H, CH=CH-CH
 
), 3.66 (dd, J = 12.3, J = 7.1 Hz, 1 H, CH-OH), 
4.99 (dd, J = 10.2, J = 1.6 Hz, 1H, CH=CH2 ), 5.09 (dd, J = 17.0, J = 1.6 Hz, 1 H, CH=CH2 ), 
5.83−5.93 (m, J = 17.2, J = 10.2, J = 7.1, J = 3.4 Hz, 1 H, -CH=CH2), 6.33 (dd, J = 11.8, J = 10.7 
Hz, 1 H, CH-CH=CH), 6.66 (d, J = 10.7 Hz, 1 H, CH-CH=CH), 7.53−7.64 (m, 3 H,Ph), 7.89−7.94 
(m, 2 H, Ph) 
 
13C NMR (100 MHz, CDCl3, TMS)  δ 17.0 (d), 21.3 (d), 28.0 (d), 28.9 (d), 29.6 (u), 35.0 (u), 
49.0 (d), 70.7 (d), 114.8 (u), 129.1 (d), 129.4 (d), 133.0 (d), 133.4 (d), 138.7 (d), 139.0 (u), 145.9 
(d) 
 
IR (KBr) ν 3217 (s), 3079 (m), 3029 (m), 2961 (s), 2925 (s), 2870 (s), 2800 (w), 1640 (w), 1618 
(m), 1467 (m), 1447 (m), 1384 (w), 1326 (w), 1245 (s), 1207 (s), 1152 (s), 1113 (m), 1052 (m), 
995 (m), 912 (m), 859 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 321 (M+) (0.5), 306 (5), 305 (2), 304 (8), 266 (11), 237 
(16), 236 (21), 222 (19), 195 (24), 156 (66), 126 (11), 125 (100), 109 (10), 107 (31), 81 (16)  
 
Anal. Calcd for C23H39NO2SSi (321.18): C, 67.25; H, 8.47; N, 4.36. Found: C, 66.96; H, 8.14; 
N, 4.27 
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4.4.4 Synthesis of (S,E)-1-((R,Z)-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-cyclohexyl)but-2-
en-1 (76).  
 
S
OH
Ph
O NMe
76 
 
 
Following GP1, reaction of sulfoximine 71 (1.00 g, 4.22 mmol) with 2-butenal (0.591 mg, 8.44 
mmol) afforded after purification by chromatography (EtOAc/cyclohexane, 3:1) alcohol 76 (0.81 
g, 60 %, dr ≥ 96%) as an oil and sulfoximine 71 (150 mg, 15%). Purifacation of minor 
diastereomers observed in the 1H NMR of the crude mixture failed. 
 
Rf = 0.30 (EtOAc/cyclohexane, 3:1) 
 
[α]D = − 110.2 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, CDCl3, TMS)  δ 1.37 (m, 3 H, CH2-CH2-CH2-CH2-C=CH), 1.69 (d, J = 6.4 
Hz, 3 H, CH=CH-CH3), 1.80 (m, 2 H, CH2-CH2-C=CH), 2.06 (d, J = 14.1 Hz, 1 H, CHH-C=CH), 
2.38 (m, 1 H, CHH-C=CH), 2.64 (s, 3 H, N-CH3), 3.74 (dd, J = 10.5, J = 3.5 Hz, 1 H, CH2-CH2-
CHOH-CH-C=CH), 4.07 (dd, J = 10.0, J = 8.4 Hz, 1 H, CH-OH), 4.46 (bs, 1 H, CHOH), 5.40 (ddd, 
J = 15.4, J = 7.9, J = 1.4 Hz, 1 H, CHOSi-CH=CH-CH3), 5.65 (m, J = 15.4, J = 6.4 Hz, 1 H, CHOSi-
CH=CH-CH3), 6.10 (s, 1 H, CH2-C=CH-S), 7.45−7.54 (m, 3 H, Ph), 7.76−7.83 (m, 2 H, Ph)  
 
13C NMR (100 MHz, CDCl3, TMS)  δ 17.8 (d), 20.3 (d), 27.6 (u), 28.3 (u), 29.4 (d), 33.4 (d), 
43.0 (u), 72.3 (d), 126.0 (d), 128.3 (d), 128.9 (d), 132.6 (d), 133.5 (d), 140.2 (d), 160.6 (d) 
 
IR (CHCl3) ν 2934 (s), 2862 (m), 1675 (w), 1619 (m), 1446 (s), 1229 (s), 1143 (s), 1104 (w), 
1079 (m), 1029 (w), 967 (m), 923 (w), 856 (m), 818 (w), 754 (s) 
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MS (EI, 70 eV) (relative intensity, %) m/z 320 (42) (M+), 249 (22), 203 (12), 201 (24), 170 (30), 
169 (47), 164 (44), 163 (17), 155 (53), 149 (64), 142 (10), 141 (18), 135 (29), 129 (11), 126 (11), 
124 (100), 121 (31), 109 (13), 108 (10), 107 (32), 105 (14), 95 (14) 
 
HRMS (EI) Calcd for C18H25NO2S: calcd. 319,160602; Found: 319,160131 
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4.5. Synthesis of Sulfoximine-Substituted Silyl Ethers  
 
 
4.5.1 General Procedure for the Synthesis of the Silyl Ethers 77−79 (GP2)  
 
To a solution of alcohol 74−76 (1 mmol) in DMF (5 mL) was added at 0 0C imidazole (273 mg, 4 
mmol). After the mixture was stirred for 1 h, ClSiEt3 (4 mmol) was added dropwise. Then the 
mixture was stirred for 20 h at ambient temperatures, half saturated aqueous NaHCO3 was added 
and the resulting mixture was extracted with ether. The combined organic phases were dried 
(Na2SO4) and concentrated in vacuum. Purification by chromatography (EtOAc/cyclohexane, 
1:3) gave the silyl ethers 77-79 
 
4.5.2 Synthesis of triethyl-((1Z,3R,4S,5E)-3-isopropyl-1-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-hepta-1,5-dien-4-yloxy)silane (77). 
 
S
Ph
O
NMe
iPr
Et3SiO
77 
 
Following GP2, reaction of alcohol 74 (1.18 g, 3.85 mmol) afforded after purification by flash 
chromatography (cyclohexan/EtOAc, 3:1) the silyl ether 77 (1.56 g, 95%) as a viscous liquid.  
 
Rf = 0,28 (EtOAc/cyclohexane, 1:3)  
 
[α]D  = −197.1 (c 1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.62 (d, J = 6.9 Hz, 3 H, CH3) , 0.66 (q, J = 8.0 Hz, 6 H, Si-
CH2), 0.97 (d, J = 6.6 Hz, 3 H, CH3), 1.03 (t, J = 8.0 Hz, 9 H, Si-CH3), 1.63 (dd, J = 6.3, J = 1.4 Hz, 
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3 H, CH3), 1.77−1.87 (m, J = 8.3, J = 6.6, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.86 (s, 3 H, N-CH3), 
3.52−3.59 (m, J = 11.5, J = 8.3, J = 3.0 Hz, 1 H, CH-CH=CH), 4.43 (dd, J = 7.4, J = 3.0 Hz, 1 H, 
CH-OSi), 5.49−5.58 (m, J = 15.4, J = 6.3 Hz, 1 H, CHOSi-CH=CH
 
), 5.62−5.72 (m, J = 15.4, J = 7.4 
Hz, 1 H, -CH=CH-CH3), 6.07 (dd, J = 11.5, J = 11.3 Hz, 1 H, CH-CH=CH), 6.28 (d, J = 11.3 Hz, 1 
H, CH-CH=CH), 7.03−7.07 (m, 3 H, Ph), 7.95−7.98 (m, 2 H, Ph) 
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.6 (u), 7.2 (d), 17.6 (d), 20.5 (d), 21.3 (d), 28.7 (d), 29.6 
(d), 49.7 (d), 74.7 (d), 126.2 (d), 128.8 (d), 129.1 (d), 131.9 (d), 132.5 (d), 133.9 (d), 141.71 (u), 
145.5 (d) 
 
IR (capillar) ν 2956 (s), 2878 (s), 2801 (w), 1621 (w), 1453 (m), 1379 (w), 1250 (s), 1151 (s), 
1110 (m), 1071 (s), 1010 (m), 968 (m), 861 (s), 823 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 422 (4) (M++1), 393 (11), 392 (41), 267 (16), 266 (45), 
251 (21), 240 (15), 239 (14), 237 (15), 236 (22), 224 (21), 223 (100), 222 (11), 193 (10), 191 
(11), 186 (15), 185 (92), 182 (23), 156 (14), 125 (32), 115 (71), 109 (13), 103 (19), 87 (50) 
 
Anal. Calcd for C23H39NO2SSi (421.25): C, 65.51; H, 9.32; N, 3.32, Found: C, 65.51, H, 9.27; 
N, 3.68 
 
 
4.5.3 Synthesis of ((Z,3R,4S)-3-Isopropyl-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]octa-1,7-
dien-4-yloxy)triethylsilane (78).  
 
S
Ph
O
NMe
iPr
Et3SiO
78 
 
Following GP2, reaction of alcohol 75 (1.37 g, 4.26 mmol) with ClSiEt3 (2.56 g, 17.04 mmol) 
afforded the silyl ether 78 (1.78 g, 96 %) as a viscous liquid.  
 
EXPERIMENTAL PART 
 
 
138
Rf = 0.30 (EtOAc/cyclohexane, 1:3) 
 
[α]D = − 158.7 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.62 (q, J = 8.0 Hz, 6 H, Si-CH2), 0.65 (d, J = 6.9 Hz, 3 H, 
CH3), 0.95 (d, J = 6.9 Hz, 3 H, CH3), 1.00 (t, J = 8.0 Hz, 9 H, Si-CH2-CH3), 1.60−1.80 (m, 2 H, 
CHOH-CHH; CH-(CH3)2 ), 1.94−2.07 (m, 1 H, CHOH-CHH), 2.25−2.38 (m, 1 H, CH2-CHH), 
2.41−2.54 (m, 1 H, CH2-CHH), 2.81 (s, 3 H, N-CH3), 3.51−3.60 (ddd, J =11.2, J = 8.6, J = 1.8 Hz, 1 
H, CH-CH=CH-S), 4.02 (dd, J = 8.6, J = 4.9, J = 1.8 Hz, 1 H, CH-OH), 5.04 (dd, J = 10.2, J = 1.0 
Hz, 1 H, CH=CHH), 5.23 (dd, J = 17.2, J = 1.8 Hz, 1 H, CH=CHH), 5.87−6.02 (m, J = 17.2, J = 
10.2, J = 7.1 Hz, 1 H, -CH=CH2), 6.16 (dd, J = 11.2, J = 11.2, 1 H, CH-CH=CH-S), 6.33 (d, J = 11.2 
Hz, 1 H, CH-CH=CH-S), 7.06−7.13 (m, 3 H, Ph), 7.88−7.96 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ  5.8 (u), 7.3 (d), 21.1 (d), 21.3 (d), 28.8 (d), 29.5 (d), 30.6 
(u), 36.0 (u), 47.2 (d), 72.7 (d), 115.0 (u), 129.1 (d), 129.4 (d), 132.1 (d), 133.0 (d), 138.9 (d), 
141.7 (u), 145.7 (d) 
 
IR (capillar) ν 3067 (w), 2956 (s), 2879 (s), 2802 (w), 1634 (w), 1457 (m), 1378 (w), 1249 (s), 
1150 (s), 1078 (s), 1009 (m), 909 (w), 860 (s), 814 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 435 (0.5, M+), 408 (5), 407 (13), 406 (46), 392 (15), 
381 (16), 380 (63), 280 (11), 270 (34), 265 (19), 251 (13), 238 (13), 237 (59),236 (42), 226 (22), 
225 (13), 222 (17), 199 (12), 195 (69), 191 (14), 182 (15), 168 (16), 156 (43), 148 (16), 125 (32), 
115 (100), 109 (11), 107 (17), 105 (12), 103 (33), 87 (75), 81 (13),  
 
HRMS (EI) Calcd for C24H41NO2SSi: calcd. 435,262731; Found: 435,262719 
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4.5.4 Synthesis of triethyl-((S,E)-1-((R,Z)-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]cyclohexyl)but-2-enyloxy)silane (79).  
 
S
Et3SiO
Ph
O NMe
79 
 
Following GP3, reaction of alcohol 76 (0.8 g, 2.49 mmol) with ClSiEt3 (1.5 g, 9.96 mmol) 
afforded the silyl ether 79 (1.04 g, 96 %) as a viscous liquid.  
 
Rf = 0.35 (EtOAc/cyclohexane, 1:3) 
 
[α]D  = − 124.6 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.66 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.99−1.09 (m, 1 H, CHH-
CH2-CHH-CH2-CH=CH), 1.05 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 1.10−1.20 (m, 1 H, CHH-CH2-
CH2-CH=CH), 1.22−1.43 (m, 1 H, CHH-CH2-CH2-CH=CH), 1.52 (dd, J = 6.4 Hz, 3 H, CH=CH-
CH3), 1.49−1.61 (m, 1 H, CH2-CHH-CH2-CH=CH), 1.73 (t, J = 13.6 Hz, 1 H, CHH-CH2-CH2-CHH-
C=CH-S), 2.26 (m, J = 13.6, J = 4.5, J = 1.4 Hz, 1 H, CHH-C=CH-S), 2.97 (s, 3 H, N-CH3), 4.07 (m, 
J = 7.9, J = 4.8 Hz, 1 H, CHOSi-CH-C=CH-S), 4.39 (t, J = 7.9 Hz, 1 H, CH-OSi), 5.37−5.56 (m, 2 
H, CHOSi-CH=CH), 6.35 (d, J = 1.3 Hz, 1 H, CH2-C=CH-S), 6.98−7.11 (m, 3 H, Ph), 8.06−8.12 (m, 
2 H, Ph) 
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.6 (u), 7.3 (d), 17.6 (d), 21.3 (d), 27.9 (u), 29.1 (u), 29.8 
(d), 34.2 (d), 42.2 (u), 74.6 (d), 127.0 (d), 127.3 (d), 128.8 (d), 129.0 (d), 131.6 (d), 134.7 (d), 
143.3 (d), 159.9 (u) 
 
IR (CHCl3) ν 2937 (s), 2871 (s), 2802 (m), 1619 (m), 1447 (s), 1231 (s), 1143 (s), 1105 (s), 1080 
(s), 1024 (m), 967 (s), 923 (w), 856 (s) 
EXPERIMENTAL PART 
 
 
140
MS (EI, 70 eV) (relative intensity, %) m/z 404 (1) (M+-C2H5), 319 (12), 249 (11), 248 (24), 202 
(15), 200 (24), 169 (34), 168 (52), 163 (45), 162 (13), 155 (52), 148 (65), 141 (11), 140 (20), 134 
(28), 128 (11), 125 (14), 124 (100), 121 (27), 120 (28), 108 (17), 107 (13), 106 (29), 104 (11), 96 
(11), 94 (14), 92 (100), 91 (26), 79 (17) 
 
HRMS (EI) Calcd for C24H39NO2SSi−C2H5: calcd. 404.207956; Found: 404.208615 
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4.6 Synthesis of Sulfoximine-Substituted Trienes 
 
 
4.6.1 General Procedure for the Synthesis of Trienes 84 and 85 (GP3) 
 
To a solution of sulfoximine 77 or 78 (1 mmol) in THF (40 mL) was added at −78 OC n-BuLi 
(0.69 ml of 1.6 M in hexane, 1.1 mmol) and the mixture was stirred at 0 OC for 3 h. Then solution 
of corresponding alkenyl halide (3 mmol) in THF (3 mL) was added at –45 OC and the mixture 
was stirred first at −45 OC for 2 h and then at ambient temperature for 1 h. Subsequently, half 
saturated aqueous NaCl (10 mL) was added and the mixture was extracted with EtOAc. The 
combined organic phases were dried (Na2SO4) and concentrated in vacuum. 
 
 
4.6.2 Synthesis of triethyl((2E,4S,5R,6E)-5-isopropyl-7-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-deca-2,6,9-trien-4-yloxy)silane (84) 
 
iPr
OSiEt3
S
Ph
O NMe
84 
 
Following GP3, reaction of sulfoximine 77 (262 mg, 0.62 mmol) with allyl bromide (223 mg, 
1.86 mmol) afforded after purification by chromatography (EtOAc/cyclohexane, 1:3) triene 84 
(258 mg, 90%) as a viscous liquid.   
 
Rf = 0.60 (EtOAc/cyclohexane, 1:3) 
 
[α]D = + 37.1 (c 1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.57 (q, J = 8.0 Hz, 6 H, Si-CH2), 0.83 (d, J = 6.9 Hz, 3 H, 
CH3), 0.92 (d, J = 6.6 Hz, 3 H, CH3), 1.00 (t, J = 8.0 Hz, 9 H, Si-CH2-CH3), 1.41 (dd, J = 6.0, J = 1.1 
Hz, 3 H, CH3), 1.89−1.96 (m, J = 11.3, J = 6.9, J = 4.7 Hz, 1 H, CH=CH-CH), 2.15−2.22 (m, J = 6.9, 
J = 6.9, J = 6.6 Hz, 1 H, CH-(CH3)2), 2.99 (s, 3 H, N-CH3), 3.16−3.22 (m, 1 H, CH2-CH=CH2), 
3.23−3.30 (m, 1 H, CH2-CH=CH2), 4.22 (dd, J = 7.7, J = 4.7 Hz, 1 H, CH-OSi), 4.82 (ddd, J = 9.9 
Hz, J = 1.4 Hz, 1 H, CH2-CH=CH2), 4.93 (ddd, J = 17.0, J = 1.7 Hz, 1 H, CH2-CH=CH2), 5.21−5.28 
(dd, J = 15.4, J = 7.7, J = 1.1 Hz, 1 H, CH=CH-CH3), 5.28−5.36 (m, J = 15.4, J = 6.0 Hz, 1 H, 
CHOSi-CH=CH), 5.71−5.83 (m, J = 17.0, J = 9.9, J = 6.05 Hz, 1 H, CH2-CH=CH2), 6.93−7.08 (m, 3 
H, Ph), 7.25 (d, J = 11.3, 1 H, CH-CH=C), 8.03−8.07 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  5.6 (u), 7.2 (d), 17.4 (d), 19.7 (d), 21.5 (d), 28.8 (d), 29.7 (d), 
31.9 (u), 52.6 (d), 74.8 (d), 115.8 (u), 126.3 (d), 128.6 (d), 129.4 (d), 131.7 (d), 134.1 (d), 135.7 
(d), 140.7 (u), 142.6 (d) 
 
IR (capillar) ν 3063 (w), 2956 (s), 2877 (s), 2803 (w), 1638 (w), 1449 (m), 1380 (w), 1246 (s), 
1152 (s), 1109 (w), 1079 (s), 1008 (m), 972 (m), 916 (w), 861 (m), 812 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 461 (1) (M+), 432 (7), 418 (9), 336 (13), 293 (13), 277 
(26), 276 (47), 228 (14), 186 (16), 185 (100), 182 (20), 133 (13), 125 (20), 115 (53), 103 (11), 87 
(34) 
 
HRMS (EI) Calcd. for C26H43NO2SSi−C3H7: 418.223606; Found: 418.223674  
 
4.6.3 (Synthesis of (E,5S,6R)-6-Isopropyl-8-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]undeca-
1,7,10-trien-5-yloxy)triethylsilane (85) 
 
iPr
OSiEt3
S
Ph
O NMe
85 
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Following GP3, reaction of sulfoximine 78 (360 mg, 0.83 mmol) with allyl bromide (298 mg, 
2.49 mmol) afforded after purification by chromatography (EtOAc/cyclohexane, 1:3) triene 85 
(295 mg, 75 %) as a viscous liquid.  
 
Rf = 0.52 (EtOAc/cyclohexane, 1:3) 
 
[α]D  = −42.0 (c 1.00, CH2Cl2 ) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.59 (q, J = 7.4 Hz, 6 H, Si-CH2), 0.82 (d, J = 7.4 Hz, 3 H, 
CH3), 0.90 (d, J = 7.4 Hz, 3 H, CH3), 1.00 (t, J = 7.4 Hz, 9 H, Si-CH2-CH3), 1.42−1.52 (m, 2 H, 
CHOH-CH2), 1.83−1.93 (m, J = 7.4 Hz, 1 H, CH-(CH3)2), 1.93-2.01 (m, 2 H, CH2-CH2), 2.13-2.20 
(m, J = 11.1, J = 7.8, J = 3.3 Hz, 1 H, CH-CH=CH), 2.98 (s, 3 H, N-CH3), 3.24 (dd, J = 6.6, J = 1.4 
Hz, 1 H, CH-CH=CH2 ), 3.88−3.93 (ddd, J =6.4, J = 3.3 Hz, 1 H, CH-OH ), 4.86 (dd, J = 10.6, J = 
1.7 Hz, 1 H, CH=CH2 ), 4.92 (dd, J = 17.2, J = 6.6 Hz, 1 H, CH=CH2), 4.94 (dd, J = 10.2, J = 1.7 Hz, 
1 H, CH=CH2), 4.98 (dd, J = 17.0, J = 6.6 Hz, 1 H, CH=CH2 ), 5.62−5.74 (m, J = 17.2, J = 10.6, 
J=6.3 Hz, 1 H, -CH=CH2), 5.75−5.86 (m, J = 17.2, J = 10.6, J = 6.3 Hz, 1 H, -CH=CH2), 6.97−7.06 
(m, 3 H, Ph), 7.25 (d, J = 11.1 Hz, 1 H, CH-CH=CH), 7.96−8.03 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.7 (u), 7.3 (d), 20.6 (d), 21.7 (d), 28.9 (d), 29.7 (d), 29.8 
(u), 32.2 (u), 35.5 (u), 50.0 (d), 72.4 (d), 114.8 (u), 116.1 (u), 128.6 (d), 129.3 (d), 131.7 (d), 
135.8 (d), 138.1 (d), 140.9 (u), 142.6 (d) 
 
IR (capillar) ν 3071 (w), 2955 (s), 2878 (s), 2802 (w), 1639 (w), 1454 (m), 1418 (w), 1246 (s), 
1149 (s), 1083 (s), 1007 (m), 912 (m), 861 (m), 803 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 475 (5) (M+), 446 (25), 432 (22), 350 (26), 307 (16), 
277 (39), 276 (80), 240 (15), 235 (24), 231 (11), 228 (42), 218 (21), 199 (34), 182 (40), 168 (25), 
155 (24), 152 (15), 151 (10), 143 (15), 134 (10), 133 (68), 125 (50), 116 (14), 115 (100), 109 
(15), 106 (18), 105 (15), 104 (11), 103 (30), 91 (16), 87 (76) 
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Anal. Calcd for C27H45NO2SSi (475.29): C, 68.16; H, 9.53; N, 2.94; Found: C, 67.95; H, 9.46; N, 
3.27 
 
4.6.4 Attempted synthesis of triethyl-((2E,4S,5R,6E)-5-isopropyl-7-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]undeca-2,6,10-trien-4-yloxy)silane (86) 
 
iPr
OSiEt3
S
Ph
O NMe
86 
 
Following GP3, reaction of sulfoximine 77 (100 mg, 0.23 mmol) with homoallyl bromide (92 
mg, 0.69 mmol). The desired triene 86 was not observed, instead sulfoximine E-77 was isolated 
quantitatively.  
 
iPr
OSiEt3
S
Ph
O NMe
 E-77 
 
Rf  = 0,33 (EtOAc/cyclohexane, 1:3) 
 
[α]D  = −175.3 (c 1.00, CH2Cl2) 
 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.48 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.74 (d, J = 6.8 Hz, 3 H, 
CH3), 0.85 (d, J = 6.8 Hz, 3 H, CH3), 0.91 (t, J = 7.9 Hz, 9 H, Si-CH3), 1.39 (dd, J = 6.3, J = 1.4 Hz, 
3 H, CH3), 1.75−1.85 (m, 2 H, CH-(CH3)2, CH-CH=CH), 2.90 (s, 3 H, N-CH3), 4.12 (dd, J = 7.7, J = 
4.9 Hz, 1 H, CH-OSi), 5.13 (ddd, J = 15.4, J = 7.9, J = 1.6 Hz, 1 H, CHOSi-CH=CH), 5.28 (m, J = 
15.4, J = 6.3 Hz, 1 H, CH=CH-CH3), 6.33 (dd, J = 15.1 Hz, 1 H, CH-CH=CH), 7.00 (dd, J = 15.1, 
10.2 Hz, 1 H, CH-CH=CH), 7.05−7.13 (m, 3 H, Ph), 7.98−8.03 (m, 2 H, Ph) 
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13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.4 (d), 19.2 (d), 21.4 (d), 28.2 (d), 29.5 
(d), 56.3 (d), 74.5 (d), 126.7 (d), 128.8 (d), 128.9 (d), 131.8 (d), 133.3 (d), 133.7 (d), 141.2 (u), 
145.9 (d) 
 
IR (capillar) ν 2957 (s), 2878 (s), 2803 (w), 1451 (m), 1248 (s), 1152 (s), 1079 (s), 1008 (m), 971 
(m), 867 (m), 822 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 422 (1) (M++1), 393 (3), 392 (9), 267 (6), 266 (8), 251 
(8), 240 (11), 239 (8), 237 (21), 236 (20), 224 (6), 223 (7), 222 (6), 193 (1), 191 (12), 186 (17), 
185 (100), 182 (5), 156 (12), 125 (10), 115 (46), 109 (4), 103 (10), 87 (30) 
 
HRMS (EI) Calcd. for C23H39NO2SSi−C2H5: 392.207956; Found: 392.207887 
 
4.6.5 Attempted synthesis of triethyl-((2E,4S,5R,6E)-5-isopropyl-7-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]dodeca-2,6,11-trien-4-yloxy)silane (87) 
 
iPr
OSiEt3
S
Ph
O NMe
87 
 
Following GP3, reaction of sulfoximine 77 (100 mg, 0.23 mmol) with 5-bromopent-1-ene (102 
mg, 0.69 mmol). Formation of the desired triene 87 was not observed, instead unreacted E-77 
was isolated quantitatively. 
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4.6.6 Attempt to synthesis of triethyl((5S,6R,E)-6-isopropyl-8-[(S)-N-methyl-S-phenyl-
sulfon-imidoyl)]trideca-1,7,12-trien-5-yloxy)silane (88) 
 
iPr
OSiEt3
S
Ph
O NMe
88 
 
To a solution of sulfoximine 57 (100 mg, 0.23 mmol) in THF (10 mL) was added at −78 OC n-
BuLi (0.16 ml of 1.6 M in hexane, 0.26 mmol) and the mixture was stirred at 0 OC for 3 h. Then 
solution of pent-4-enyl trifluoromethanesulfonate (60 mg, 0.28 mmol) in THF (3 mL) was added 
at –45 OC and the mixture was stirred first at −45 OC for 2 h and then at ambient temperature for 
1 h. Subsequently, half saturated aqueous NaCl (10 mL) was added and the mixture was extracted 
with EtOAc. The combined organic phases were dried (Na2SO4) and concentrated in vacuum. 
Formation of the desired triene 88 was not observed, instead a mixture of undefined products was 
isolated. 
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4.7. Synthesis of Trienes via α-Hydroxyalkylation of Alkenyl Sulfoximines 
 
 
4.7.1 General Procedure for the Synthesis of Allylic Alcohols (GP 4)  
 
To a solution of sulfoximine 77, 78 or 79 (1 mmol) in THF (10 mL) was added at –78 °C BuLi 
(1.1 mmol, 0.69 ml of 1.6 M in hexane) and the mixture was stirred at 0 °C for 3 h. Then a 
solution of the corresponding aldehyde (2 mmol) in THF (3 mL) was added at –78 °C and the 
resulting mixture was stirred for 2 h. Subsequently half saturated aqueous NaCl (10 mL) was 
added and the resulting mixture was extracted with EtOAc. The combined organic phases were 
dried (Na2SO4) and concentrated in vacuum. The purifcation by flash chromatograph and 
subsequently by HPLC (Chromasil Si 100, 30 mm, EtOAc/cyclohexane, 5:95) gave alcohols 
89−92 
 
4.7.2 Synthesis of (2E,4S,5E,7R,8S,9E)- and (2E,4S,5E,7R,8S,9E)-7-isopropyl-5-[(S)-N-methyl-
S-phenyl-sulfonimidoyl)]8-(triethylsilyloxy)undeca-2,5,9-trien-4-ol (R-89) and (S-89) 
 
iPr
OSiEt3
S
Ph
O NMe
OH
R-89
iPr
OSiEt3
S
Ph
O NMe
OH
S-89 
 
Following GP4, reaction of sulfoximine 77 (300 mg, 0.71 mmol) with but-2-enal (100 mg, 1.42 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:5) alcohols R-
89 (140 mg, 40 %) and S-89 (150 mg, 44 %) as viscous liquids.  
 
S-89  
 
Rf  = 0.38 (EtOAc/cyclohexane, 1:5) 
 
[α]D = − 29.4 (c = 1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.48 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.81 (d, J = 6.8 Hz, 3 H, 
CH3), 0.91 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 0.92 (d, J = 6.8 Hz, 3 H, CH3), 1.52−1.56 (m, 6 H, 
CHOSi-CH=CH-CH3, CHOH-CH=CH-CH3), 1.91 (dd, J = 8.2, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.25 
(ddd, J = 11.4, J = 8.3, J = 3.2 Hz, 1 H, C=CH-CH-CHOSi), 2.76 (s, 3 H, N-CH3), 4.19 (td, J = 5.4, J 
= 2.9 Hz, 1 H, CH-OSi), 5.24 (m, 3 H, CHOSi-CH=CH-CH3, CHOH-CH=CH), 5.79 (ddd, J = 15.3, 
J = 6.5, J = 1.6 Hz, 1 H, CHOH-CH=CH-CH3), 6.07 (ddq, J = 15.3, J = 6.3, J = 1.6 Hz, 1 H, CHOH-
CH=CH-CH3), 6.80 (d, J = 11.3 Hz, 1 H, CH-CH=C-S), 6.96−7.07 (m, 3 H, Ph), 8.00-8.05 (m, 2 H, 
Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 17.6 (d), 20.9 (d), 21.2 (d), 29.1 
(d), 29.3 (d), 52.4 (d), 70.5 (d), 74.3 (d), 126.4 (u), 126.6 (d), 128.9 (d), 129.4 (d), 131.9 (d), 
133.8 (u), 134.0 (u), 141.7 (d), 144.1 (d), 145.0 (u) 
 
IR (CHCl3) ν 3390 (w), 2956 (s), 2809 (w), 1453 (m), 1380 (w), 1243 (s), 1151 (m), 1080 (s), 
1007 (m), 973 (m), 860 (w), 752 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 492 (6) (M+), 491 (8), 462 (26), 307 (11), 306 (27), 
279 (14), 196 (41), 195 (28), 186 (16), 185 (100), 155 (11), 147 (35), 125 (40), 115 (49), 103 
(13), 87 (48) 
 
HRMS (EI) Calcd for C27H45NO3SSi: calcd. 491,288946; Found: 491,288807 
 
R-89  
 
Rf = 0.34 (EtOAc/cyclohexane, 1:5) 
 
[α]D = − 7.9 (c, 1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.50 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.91 (d, J = 6.8 Hz, 3 H, 
CH3), 0.94 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 0.92 (d, J = 6.8 Hz, 3 H, CH3), 1.28 (dd, J = 6.5, J = 1.5 
Hz, 3 H, CHOSi-CH=CH-CH3), 1.53 (dt, J = 6.5, J = 1.7 Hz, 3 H, CHOH-CH=CH-CH3), 1.86 (dd, J 
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= 7.8, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.32 (ddd, J = 11.5, J = 7.1, J = 4.8 Hz, 1 H, C=CH-CH-
CHOSi), 2.78 (s, 3 H, N-CH3), 4.14 (td, J = 7.8, J = 4.8 Hz, 1 H, CH-OSi), 4.98 (ddd, J = 15.3, J = 
7.8, J = 1.6 Hz, 1 H, CHOSi-CH=CH-CH3), 5.18 (dq, J = 15.3, J = 6.6, J = 1.9 Hz, 1 H, CHOSi-
CH=CH-CH3), 5.38−5.48 (m, 2 H, CHOH-CH=CH-CH3), 5.94 (ddq, J = 15.3, J = 6.6, J = 1.9 Hz, 1 
H, CHOH-CH=CH-CH3), 6.97−7.10 (m, 3 H, Ph), 7.26 (d, J = 11.5 Hz, 1 H, CH-CH=C-S), 
7.93−7.96 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.4 (d), 17.6 (d), 19.4 (d), 21.2 (d), 28.6 
(d), 29.3 (d), 52.0 (d), 69.1 (d), 74.5 (d), 124.8 (u), 126.4 (d), 128.5 (d), 129.9 (d), 131.8 (d), 
133.7 (u), 134.0 (u), 141.3 (d), 143.4 (d), 143.6 (u) 
 
IR (CHCl3) ν 2956 (s), 1451 (s), 1380 (w), 1239 (s), 1146 (s), 1079 (s), 1009 (m), 971 (s), 860 
(m), 751 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 494 (1), 493 (4), 492 (10) (M+), 491 (13), 462 (10), 
306 (29), 279 (13), 196 (51), 195 (39), 186 (16), 185 (100), 181 (11), 155 (10), 147 (41), 126 
(12), 124 (45), 115 (49), 103 (14), 87 (47) 
 
HRMS (EI) Calcd for C27H45NO3SSi: calcd. 491,288946; Found: 491,288819 
 
4.7.3 Synthesis of (5R,6E,8R,9S,10E)- and (5S,6E,8R,9S,10E)-8-isopropyl-6-[(S)-N-methyl-S-
phenyl-sulfonimidoyl)]-9-(triethylsilyloxy)dodeca-1,6,10-trien-5-ol (R-90) and (S-90). 
 
iPr
OSiEt3
S
Ph
O NMe
OH
R-90
iPr
OSiEt3
S
Ph
O NMe
OH
S-90 
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Following GP4, reaction of sulfoximine 77 (870 mg, 2.06 mmol) with 4-pentenal (347 mg, 4.12 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:5) alcohols R-
90 (396 mg, 38 %) and S-90 (375 mg, 36 %) as viscous liquids.  
 
R-90:  
 
Rf  = 0.36 (cyclohexane/EtOAc, 1:5)  
 
[α]D = −3.5 (c 1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.51 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.92 (d, J = 6.9 Hz, 3 H, 
CH3), 0.94 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 0.95 (d, J = 6.9 Hz, 3 H, CH3), 1.32 (dd, J = 6.4 Hz 3 H, 
CH=CH-CH3), 1.77−1.83 (m, J = 13.7, J = 6.9 Hz, 1 H, CHOH-CHH’-CHH), 1.83−1.92 (m, J = 6.9, 
J = 6.7 Hz, 1 H, CH-(CH3)2), 2.00−2.08 (m, 1 H, CHOH-CHH’-CHH’), 2.10−2.21 (m, J = 8.9, J = 
4.5 Hz, 1 H, CHOH-CHH’-CHH’), 2.26−2.35 (m, 1 H, CHOH-CHH’-CHH’), 2.33−2.40 (m, J = 
11.5, J = 6.7, J = 5.0 Hz, 1 H, CH-CH=C-S), 2.80 (s, 3 H, N-CH3), 4.15 (dd, J = 8.0, J = 5.0 Hz, 1 H, 
CH-OSi), 4.83 (dd, J = 8.9, J = 4.7 Hz, 1 H, CH-OH), 4.97 (ddd, J = 17.0, J = 1.7, 2 H, CH2-
CH=CH2), 5.03 (ddd, J = 15.4, J = 8.0 Hz, 1 H, CH=CH-CH3), 5.19 (m, J = 15.4, J = 6.4 Hz, 1 H, 
CHOSi-CH=CH), 5.78 (m, J = 17.0,  J = 10.4, J = 6.2, J = 7.1 Hz, 1 H, -CH2-CH=CH2), 6.93−7.08 
(m, 3 H, Ph), 7.22 (d, J = 11.5 Hz, 1 H, CH-CH=C), 8.03−8.07 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 19.2 (d), 21.3 (d), 28.8 (d), 29.4 
(d), 31.1 (u), 37.2 (u), 52.0 (d), 69.4 (d), 74.7 (d), 114.7 (u), 126.4 (d), 128.9 (d), 129.3 (d), 131.9 
(d), 133.8 (d), 138.3 (d), 141.0 (u), 143.2 (d), 145.8 (u) 
 
IR (capillar) ν 3428 (w), 3070 (w), 2951 (s), 2354 (w), 1643 (w), 1452 (s), 1242 (s), 1155 (m), 
1074 (m), 1004 (m), 916 (w), 859 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 505 (2) (M+), 476 (4), 435 (5), 380 (7), 307 (6), 266 
(10), 240 (6), 223 (7), 186 (16), 185 (100), 175 (9), 157 (8), 156 (36), 125 (21), 115 (29), 103 (9), 
87 (23) 
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HRMS (EI) Calcd. for C28H47NO3SSi: 505.304596; Found: 505.304483 
 
S-90: 
 
Rf = 0,30 (cyclohexane/EtOAc, 1:5) 
 
[α]D = +19.9  (c 1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.48 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.82 (d, J = 6.8 Hz, 3 H, 
CH3), 0.89 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 0.92 (d, J = 6.6 Hz, 3 H, CH3), 1.56 (dd, J = 4.9, J = 1.0 
Hz, 3 H, CH=CH-CH3), 1.83−1.93 (m, J = 8.5, J = 6.8 Hz, 1 H, CH-(CH3)2), 1.93−2.06 (m, J = 11.3 
Hz, 1 H, CHOH-CHH’-CHH), 2.15−2.21 (m, J = 11.4, J = 8.5, J = 2.3 Hz, 1 H, CH-CH=C-S), 
2.22−2.45 (m, J = 9.0, J = 5.0 Hz, 2 H, CHOH-CHH’-CH2), 2.52−2.61 (m, J = 9.7, J = 8.4, J = 5.3 
Hz, 1 H, CHOH-CHH’-CHH’), 2.71 (s, 3 H, N-CH3), 4.19 (dd, J = 6.5, J = 3.0 Hz, 1 H, CH-OSi), 
4.77 (dd, J = 9.9 , J = 4.1 Hz, 1H, CH-OH), 4.97 (ddd, J = 10.3, J = 2.2, J = 1.3 Hz, 1 H, CH2-
CH=CHH), 5.08 (ddd, J = 17.2, J = 3.4, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.28 (m, J = 15.3, J = 6.3 
Hz, 2 H, CHOSi-CH=CH), 5.81 (m, J = 17.2,  J = 10.3, J = 6.8 Hz, 1 H, CH2-CH=CH2), 6.60 (d, J = 
11.4 Hz, 1 H, CH-CH=C), 6.99−7.08 (m, 3 H, Ph), 8.03−8.07 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 21.1 (d), 21.2 (d), 29.0 (d), 29.3 
(d), 31.0 (u), 37.8 (u), 52.5 (d), 69.6 (d), 74.4 (d), 115.2 (u), 126.6 (d), 129.0 (d), 129.5 (d), 132.1 
(d), 134.0 (d), 138.6 (d), 141.1 (u), 143.4 (d), 146.0 (u) 
 
IR (capillar) ν 3067 (m), 2957 (s), 2805 (m), 1639 (m), 1448 (s), 1417 (m), 1380 (w), 1239 (s), 
1149 (s), 1113 (s), 1079 (s), 1009 (m), 972 (s), 914 (m), 861 (s), 814 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z z 505 (4) (M+),476 (4), 435 (8), 380 (7), 307 (6), 266 
(10), 240 (5), 223 (13), 186 (16), 185 (100), 175 (5), 157 (6), 156 (28), 125 (18), 115 (33), 103 
(8), 87 (27) 
 
EXPERIMENTAL PART 
 
 
152
HRMS (EI) Calcd. for C28H47NO3SSi: 505.304596. Found: 505.304540 
 
4.7.4 Synthesis of (7R,8E,10R,11S,12E)- and (7S,8E,10R,11S,12E)-10-isopropyl-8-[(S)-N-
methyl-S-phenyl-sulfonimidoyl)]-11-(triethylsilyloxy)tetradeca-1,8,12-trien-7-ol (R-91) and 
(S-91) 
 
iPr
OSiEt3
S
Ph
O NMe
OH
R-91
iPr
OSiEt3
S
Ph
O NMe
OH
 S-91 
 
Following GP4, reaction of sulfoximine 77 (400 mg, 0.95 mmol) with 6-heptenal (160 mg, 1.90 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:5) alcohols R-
91 (230 mg, 45 %) and S-91 (200 mg, 39 %) as viscous liquids 
 
R-91: 
 
Rf  = 0.35 (cyclohexane/EtOAc, 5:1) 
 
[α]D  = + 5.3 (c 1.00, CH2Cl2) 
 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.52 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.93 (d, J = 6.9 Hz, 3 H, 
CH3), 0.94 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 0.95 (d, J = 6.9 Hz, 3 H, CH3), 1.35 (dd, J = 6.4 Hz 3 H, 
CH=CH-CH3), 1.24−1.41 (m, 1 H, CHOH-CH2-CHH’), 1.61−1.77 (m, 3 H, CHOH-CHH’-CHH’-
CHH’), 1.88 (m, J = 6.9, 1 H, CH-(CH3)2), 1.94−2.11 (m, 4 H, CHOH-CHH’-CH2-CHH’-CH2), 2.45 
(m, J = 11.5, J = 6.5, J = 5.4 Hz, 1 H, CH-CH=CH-S), 2.84 (s, 3 H, N-CH3), 4.15 (dd, J = 7.9, J = 
5.2 Hz, 1 H, CH-OSi), 4.85 (dd, J = 9.4, J = 3.9 Hz, 1 H, CH-OH), 4.99 (ddd, J = 10.2, J = 1.5 Hz, 1 
H, CH2-CH=CH2), 5.04 (ddd, J = 17.0, J = 1.7 Hz, 1 H, CH2-CH=CH2), 5.06 (m, J = 15.4, 1 H, 
CH=CH-CH3), 5.25 (m, J = 15.4, J = 6.4 Hz, 1 H, CHOSi-CH=CH), 5.78 (dd, J = 17.0,  J = 10.1, J = 
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6.7 Hz, 1 H, CH2-CH=CH2), 6.97−7.08 (m, 3 H, Ph), 7.23 (d, J = 11.5 Hz, 1 H, CH-CH=C), 8.00-
8.03 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 19.0 (d), 21.5 (d), 26.5 (u), 28.8 
(d), 29.3 (u), 29.5 (d), 34.1 (u), 38.1 (u), 51.8 (d), 69.9 (d), 74.8 (d), 114.4 (u), 126.6 (d), 128.9 
(d), 129.3 (d), 131.8 (d), 133.9 (d), 138.9 (d), 141.9 (u), 142.6 (d), 145.5 (u) 
 
IR (CHCl3) ν 3404 (w), 3339 (w), 3296 (w), 3068 (w), 2956 (s), 2877 (s), 2805 (w), 1639 (w), 
1449 (s), 1416 (w), 1243 (s), 1164 (m), 1111 (w), 1078 (s), 1006 (m), 972 (w), 910 (w), 860 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 534 (2) (M+), 505 (2), 504 (5), 492 (1), 450 (7), 380 
(11), 270 (11), 186 (17), 185 (100), 156 (46), 125 (18), 115 (31), 87 (26) 
 
HRMS (EI) Calcd for C30H51NO3SSi−CH3N: calcd. 504,309347; Found: 504,307157 
 
S-91 
 
Rf  = 0.34 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = + 17.4  (c, 1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.48 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.84 (d, J = 6.9 Hz, 3 H, 
CH3), 0.88 (d, J = 6.9 Hz, 3 H, CH3), 0.97 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 1.27−1.52 (m, 4 H, 
CHOH-CHH-CH2-CHH), 1.60 (dd, J = 6.4 Hz 3 H, CH=CH-CH3), 1.62−1.70 (m, 1 H, CHOH-
CHH’-CHH), 1.89 (m, J = 6.9 Hz, 1 H, CH-(CH3)2), 1.93−2.05 (m, 3 H, CHOH-CHH’-CHH’-CHH-
CHH’), 2.17 (m, J = 11.5, J = 8.7, J = 2.8 Hz, 1 H, CH-CH=CH-S), 2.43 (dtd, J = 14.1, J = 9.7, J = 
4.8 Hz, 1 H, CHOH-CH2-CH2-CH2-CHH’), 2.74 (s, 3 H, N-CH3), 4.20 (dd, J = 7.4, J = 2.7 Hz, 1 H, 
CH-OSi), 4.74 (dd, J = 9.3, J = 4.9 Hz, 1 H, CH-OH), 4.95 (dd, J = 10.1, J = 1.5, 1 H, CH2-
CH=CHH), 4.99 (dd, J = 17.1, J = 1.7, 1H, CH2-CH=CH), 5.24−5.39 (m, 2 H, CHOSi-CH=CH), 
5.74 (ddd, J = 17.1, J = 10.3, J = 6.8 Hz, 1 H, -CH2-CH=CH2), 6.58 (d, J = 11.5 Hz, 1 H, CH-
CH=C), 6.98−7.07 (m, 3 H, Ph), 8.02−8.06 (m, 2 H, Ph) 
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13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 21.1 (d), 21.4 (d), 26.5 (u), 29.0 (u), 
29.1 (d), 29.3 (u), 30.1 (d), 34.1 (u), 38.4 (u), 52.5 (d), 70.4 (d), 74.4 (d), 114.4 (u), 126.5 (d), 128.8 
(d), 129.3 (d), 131.9 (d), 133.8 (d), 138.9 (d), 140.9 (u), 143.1 (d), 145.9 (u) 
 
IR (CHCl3) ν 2956 (s), 2876 (s), 1461 (m), 1380 (w), 1151 (m), 1111 (w), 1078 (s), 1009 (m), 
972 (m), 910 (w), 860 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 534 (0.5) (M+), 504 (3), 504 (5), 492 (2), 450 (6), 380 
(9), 270 (17), 223 (13), 186 (17), 185 (100), 156 (27), 125 (16), 115 (31), 87 (25) 
 
HRMS (EI) Calcd for C30H51NO3SSi−CH3N: calcd. 504,309347; Found: 504,307330 
 
4.7.5 Synthesis of (5R,8R,9S,E)- and (5S,8R,9S,E)-8-Isopropyl-6-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-9-(triethylsilyloxy)trideca-1,6,12-trien-5-ol (R-92) and (S-92). 
 
iPr
OSiEt3
S
Ph
O NMe
OH
R-92
iPr
OSiEt3
S
Ph
O NMe
OH
S-92 
 
Following GP4, reaction of sulfoximine 78 (700 mg, 1.60 mmol) with 4-pentenal (270 mg , 3.2 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:7) alcohols R-
92 (334 mg, 40%) and S-92 (267 mg, 32%) as viscous liquids.  
 
S-92: 
 
Rf = 0.35 (EtOAc/cyclohexane, 1:7) 
 
[α]D = +47.3 (c  1.00, CH2Cl2) 
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1H NMR (300 MHz, C6D6, TMS)  δ 0.44 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.79 (d, J = 6.6 Hz, 3 H, 
CH3), 0.85 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 0.86 (d, J = 6.6 Hz, 3 H, CH3), 1.34−1.42 (m, 2 H, 
CHOSi-CH2), 1.71−1.84 (m, J = 6.6, J = 2.6 Hz, 1 H, CH-(CH3)2), 1.88−2.02 (m, J = 7.5, J = 1.2 Hz, 
1 H, CHOSi-CH2-CHH), 2.04−2.20 (m, J = 9.2, J = 1.8 Hz, 3 H, CHOSi-CH2-CHH, CHOH-CHH, 
CH-CH=C-S), 2.38−2.47 (m, J = 7.3, J = 1.6 Hz, 2 H, CHOH-CH2-CH2), 2.66 (s, 3 H, N-CH3), 
2.69−2.76 (m, J = 9.9, J = 5.5, J = 2.4 Hz, 1 H, CHOH-CHH), 3.81 (ddd, J = 7.0, J = 3.8, J = 1.7 Hz, 
1 H, CH-OSi), 4.79 (dd, J = 9.9, J = 3.7 Hz, 1 H, CH-OH), 4.99 (ddd, J = 10.1, J = 2.2, J = 1.4 Hz, 2 
H, CHOSi-CH2-CH2-CH=CHH, CHOH-CH2-CH2-CH=CHH), 5.14 (ddd, J = 17.3, J = 1.6 Hz, 2 H, 
CHOSi-CH2-CH2-CH=CHH, CHOH-CH2-CH2-CH=CHH), 5.72 –5.92 (m, J = 17.3, J = 10.2, J = 6.8 
Hz, 2 H, CHOH-CH2-CH2-CH=CH2 , CHOSi-CH2-CH2-CH=CH2), 6.36 (d, J = 11.4 Hz, 1 H, CH-
CH=C-S), 6.99−7.10 (m, 3 H, Ph), 7.92−7.96 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.6 (u), 7.2 (d), 21.2 (d), 22.0 (d), 28.8 (d), 29.3 (d), 30.2 
(u), 31.0 (u), 35.8 (u), 37.0 (u), 49.4 (d), 69.5 (d), 72.1 (d), 115.3 (u), 115.4 (u), 129.1 (d), 129.7 
(d), 132.3 (d), 138.3 (d), 138.6 (d), 140.3 (u), 142.6 (d), 146.4 (u) 
 
IR (capillar) ν 3279 (m), 3074 (m), 2956 (s), 2805 (m), 1640 (m), 1450 (s), 1417 (m), 1373 (w), 
1238 (s), 1147 (s), 1083 (s), 1008 (m), 913 (s), 860 (s), 809 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 520 (6), 519 (17) (M+), 490 (13), 464 (28), 435 (10), 
364 (13), 321 (20), 320 (30), 271 (10), 270 (52), 267 (16), 266 (39), 240 (11), 239 (9), 237 (13), 
200 (9), 199 (50), 189 (10), 178 (24), 167 (23), 157 (12), 155 (100), 148 (17), 139 (10), 135 (14), 
133 (17), 124 (70), 116 (13), 115 (91), 109 (12), 106 (21), 105 (12), 103 (36), 91 (12), 87 (83).  
 
HRMS (EI) Calcd. for C29H49NO3SSi: 519.320246. Found: 519.320508 
 
R-92:  
 
Rf = 0,30 (EtOAc/cyclohexane, 1:7) 
 
[α]D = −23.8 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.54 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.92 (d, J = 6.9 Hz, 3 H, 
CH3), 0.96 (d, J = 6.6 Hz, 3 H, CH3), 0.97 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 1.17−1.28 (m, 1 H, 
CHOSi-CHH), 1.32−1.40 (m, J = 4.7, J = 1.9 Hz, 1 H, CHOSi-CHH), 1.57−1.67 (m, 1 H, CHOH-
CHH), 1.81−1.89 (m, 2 H, CHOSi-CH2-CHH, CH-(CH3)2), 2.06−2.17 (m, J = 6.2, J = 2.4 Hz, 1 H, 
CHOH-CH2-CHH-CH=CH2), 2.22−2.31 (m, J = 9.2, J = 4.6 Hz, 1 H, CHOH-CHH), 2.31−2.37 (m, J 
= 10.7, J = 7.7, J = 4.6 Hz, 1 H, CH-CH=C-S), 2.31−2.47 (m, J = 6.2, J = 2.4 Hz, 1 H, CHOH-CH2-
CHH), 2.79 (s, 3 H, N-CH3), 3.87 (ddd, J = 7.5, J = 4.7, J = 3.2 Hz, 1 H, CH-OSi), 4.82 (dd, J = 9.9, 
J = 3.7 Hz, 1 H, CH-OH), 4.89 (ddd, J = 17.6, J = 10.3, J = 2.0 Hz, 2 H, CHOH-CH2-CH2-CH=CH2), 
5.04 (ddd, J = 17.2, J = 10.6, J = 1.6 Hz, 2 H, CHOSi-CH2-CH2-CH=CH2), 5.55–5.65 (m, J = 17.2, J 
= 10.1, J = 7.5 Hz, 1 H, CHOSi-CH2-CH2-CH=CH2), 5.75–5.86 (m, J = 17.6, J = 10.3, J = 6.5 Hz, 1 
H, CHOH-CH2-CH2-CH=CH2), 6.97−7.06 (m, 3 H, Ph), 7.23 (d, J = 10.7 Hz, 1 H, CH-CH=C-S), 
7.92−7.97 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.6 (u), 7.2 (d), 20.4 (d), 21.4 (d), 28.8 (d), 29.3 (d), 29.4 (u), 
31.1 (u), 35.5 (u), 37.2 (u), 49.3 (d), 69.3 (d), 72.2 (d), 114.8 (u), 115.0 (u), 127 (3), 128.9 (d), 129.1 
(d), 131.9 (d), 137.7 (u), 138.2 (d), 143 (d), 144.9 (u) 
 
IR (capillar) ν 3315 (m), 3075 (m), 2956 (s), 2808 (m), 1640 (m), 1448 (s), 1417 (w), 1376 (w), 
1243 (s), 1147 (s), 1080 (s), 1007 (m), 912 (m), 859 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 519 (6) (M+), 490 (16), 464 (21), 364 (27), 321 (18), 
320 (13), 270 (38), 267 (11), 266 (32), 240 (10), 239 (8), 237 (12), 200 (10), 199 (52), 189 (14), 
167 (28), 157 (11), 156 (100), 148 (11), 135 (17), 132 (14), 125 (63), 116 (11), 115 (82), 106 
(18), 105 (10), 103 (35), 91 (11), 87 (71) 
 
HRMS (EI) Calcd for C29H49NO3SSi: 519.320246. Found: 519.320274 
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4.7.6 Synthesis of triethyl-((S,E)-1-((R,E)-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]cyclohexyl)but-2-enyloxy)silane (93) 
 
To a solution of sulfoximine 79 (500 mg, 1.15 mmol) in THF (30 mL) was added at −78 OC BuLi 
(0.79 ml of 1.6 M in hexane, 1.26 mmol) and the mixture was stirred at 0 OC for 3 h. 
Subsequently, half saturated aqueous NaCl (20 mL) was added and the mixture was extracted 
with EtOAc. The combined organic phases were dried (Na2SO4) and concentrated in vacuum to 
give 93 (500 mg, 100%) as viscous oil. 
 
Et3SiO
S
Ph
O NMe
93 
 
 
Rf  = 0.38 (EtOAc/cyclohexane, 1:3) 
 
[α]D = − 30.5 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.47 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.92 (t, J = 7.1 Hz, 9 H, Si-
CH2-CH3), 1.08−1.31 (m, 3 H, CH2-CHH-CH2-CH=CH), 1.31−1.53 (m, 3 H, CH2-CH2-CHH-CH2-
CH=CH), 1.46 (dd, J = 6.4 Hz, 3 H, CH=CH-CH3), 1.99 (dt, J = 8.5, J = 4.6 Hz, 1 H, CHOSi-CH-
C=CH-S), 2.28 (m, J = 13.5, J = 7.8 Hz, 1 H, CHH-C=CH-S), 2.93 (s, 3 H, N-CH3), 3.34 (dt, J = 
13.5, J = 4.8 Hz, 1 H, CH2-CH2-CHH), 4.10 (t, J = 7.9 Hz, 1 H, CH-OSi), 5.21 (m, J = 15.2, J = 7.9, 
J = 1.4 Hz, 1 H, CHOSi-CH=CH-CH3), 5.34 (m, J = 15.2, J = 6.2 Hz, 1 H, CHOSi-CH=CH-CH3), 
6.56 (s, 1 H, CH2-C=CH-S), 6.98−7.11 (m, 3 H, Ph), 8.05−8.10 (m, 2 H, Ph)   
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 17.5 (d), 22.5 (d), 27.0 (u), 27.8 (u), 29.6 
(d), 30.5 (d), 52.3 (u), 74.5 (d), 127.2 (d), 129.0 (d), 129.2 (d), 131.6 (d), 133.7 (d), 142.9 (d), 
158.6 (d) 
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IR (CHCl3) ν 2937 (s), 2876 (s), 1622 (w), 1448 (m), 1241 (s), 1148 (s), 1084 (s), 1059 (m), 
1008 (m), 970 (m), 855 (s), 825 (w), 750 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 278 (2), 249 (16), 203 (10), 201 (17), 170 (23), 169 
(38), 164 (40), 163 (11), 156 (44), 149 (56), 141 (15), 135 (27), 129 (11), 126 (11), 125 (100), 
122 (25), 121 (30), 109 (18), 107 (36), 105 (14), 95 (18) 
 
HRMS (EI) Calcd for C24H39NO2SSi: 404.207956. Found: 404.207717 
 
 
 
4.7.7 Synthesis of (2S,E)-1-(phenylsulfonyl)-1-(2-((S,E)-1-(triethylsilyloxy)but-2-
enyl)cyclohexylidene)hex-5-en-2-ol (94) 
 
Et3SiO
S
Ph
O NMeHO
94 
 
Following GP4, reaction of sulfoximine 93 (450 mg, 1.03 mmol) with 4-pentenal (173 mg, 2.06 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:5) alcohol 94 
(355 mg, 65 %) as viscous liquids. The minor epimer could not be isolated. 
 
Rf  = 0,34 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 42.5 (c 1.00, CH2Cl2) 
 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.51 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.95 (t, J = 7.1 Hz, 9 H, Si-
CH2-CH3), 1.13−1.23 (m, 2 H, C=C-CH2-CH2-CHH-CHH), 1.25−1.40 (m, 1 H, C=C-CH2-CH2-CH2-
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CHH), 1.47 (d, J = 5.4 Hz, 3 H, CH=CH-CH3), 1.58−1.73 (m, 4 H, C=C-CHH-CH2-CHH), 1.99 
(dddd, J = 13.6, J = 8.6, J = 7.5, J = 3.8 Hz, 1 H, CHOH-CHH), 2.41−2.60 (m, 2 H, CHOH-CH2-
CH2), 2.63 (s, 3 H, N-CH3), 2.76−2.90 (m, 2 H, CHOH-CHH, CH-C=C-S), 3.52−3.60 (m, 1 H, C=C-
CHH), 4.18 (t, J = 9.1, J = 7.6 Hz, 1 H, CH-OSi), 5.05 (ddt, J = 10.2, J = 2.2, J = 1.2 Hz, 1 H, CH2-
CH=CHH), 5.17 (dd, J = 17.2, J = 3.7 Hz, 1 H, CH2-CH=CHH), 5.22−5.40 (m, 3 H, CHOH, CHOSi-
CH=CH-CH3), 5.94 (ddd, J = 17.2, J = 10.2 Hz, J = 7.3 Hz, 1 H, CH2-CH=CH2), 6.91 (d, J = 10.1 
Hz, 1 H, CHOH), 6.97−7.12 (m, 3 H, Ph), 8.20−8.24 (m, 2 H, Ph) 
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 17.5 (d), 21.0 (d), 27.9 (u), 28.1 (u), 28.4 
(d), 29.7 (u), 31.2 (d), 39.1 (d), 46.5 (u), 70.1 (d), 74.9 (d), 115.2 (u), 128.2 (d), 128.8 (d), 131.5 
(d), 133.8 (d), 138.9 (d), 139.9 (d), 143.4 (d), 156.0 (d) 
 
IR (CHCl3) ν 3007 (w), 2940 (s), 2876 (m), 1448 (m), 1222 (s), 1143 (s), 1087 (s), 1061 (m), 
1008 (w), 858 (w), 757 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 518 (4) (M+), 517 (3), 487 (3), 462 (6), 391 (12), 277 
(12), 276 (13), 187 (10), 186 (26), 185 (100), 160 (17), 156 (11), 155 (16), 144 (11), 130 (11), 
124 (20), 115 (43), 102 (17), 87 (30) 
 
HRMS (EI) Calcd for C29H47NO3SSi: calcd. 517,304596; Found: 517,304865 
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4.8. Synthesis of α -Sulfoximido Aldehyde (2E,4R,5S,6E)-4-isopropyl-2--[(S)-N-
methyl-S-phenyl-sulfonimidoyl)]-5-(triethylsilyloxy)octa-2,6-dienal (95) 
 
 
4.8.1 General Procedure for the Synthesis of the aldehyde(2E,4R,5S,6E)-4-isopropyl-2-[(S)-
N-methyl-S-phenyl-sulfonimidoyl)]-5-(triethylsilyloxy)octa-2,6-dienal (95) GP 5. 
 
To a solution of sulfoximine 77 (1 mmol) in THF (10 mL) was added at –78 °C BuLi (1.1 mmol, 
0.69 ml of 1.6 M in hexane) and the mixture was stirred at 0 °C for 3 h. Then a solution of the 
corresponding formylating agent in THF (3 mL) was added and the resulting mixture was stirred 
first for 2 h. Subsequently half saturated aqueous NaCl (10 mL) was added and the resulting 
mixture was extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum. 
 
4.8.2 Attempted synthesis of (2E,4R,5S,6E)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)octa-2,6-dienal (95) via reaction of 77 with DMF (96). 
 
iPr
OSiEt3
S
Ph
O NMe
O 95 
 
Following GP 5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with DMF (96, 0.46 
mmol) at –78 °C. Subsequent purification yielded unreacted 77.  
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with DMF (96, 0.46 
mmol) at 0 °C. Subsequent purification yielded unreacted 77. 
 
4.8.3 Attempted synthesis of (2E,4R,5S,6E)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)octa-2,6-dienal (95) via reaction of 77 with N-
Formylocarbazone (97). 
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Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with N-
Formylocarbazone (97, 90 mg, 0.46 mmol) at –78 °C. Subsequent purification yielded unreacted 
77.  
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with N-
Formylocarbazone (97, 90 mg, 0.46 mmol) at 0 °C. Subsequent purification yielded unreacted 77.  
 
4.8.4 Synthesis of (2E,4R,5S,6E)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5-
(triethylsilyloxy)octa-2,6-dienal (95) via reaction of 77 with N-methoxy-N-methylformamide 
(98). 
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol)) was reacted with N-methoxy-N-
methylformamide (98, 100 mg of compound contaminated with Et2O) at –78 °C. Subsequent 
purification yielded unreacted 77. 
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol)) was reacted with N-methoxy-N-
methylformamide (98, 100 mg of compound contaminated with Et2O) at 0 °C. Subsequent 
purification by a flash chromatography (EtOAc/cyclohexane 1:5) yielded aldehyde 95 (87 mg, 
84%) as viscous liquid 
 
Rf  = 0.45 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 61.8 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.51 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.81 (d, J = 6.8 Hz, 3 H, 
CH3), 0.89 (d, J = 6.8 Hz, 3 H, CH3), 0.94 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.28 (dd, J = 6.5, J = 1.5 
Hz, 3 H, CHOSi-CH=CH-CH3), 1.91 (dd, J = 7.8, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.93 (s, 3 H, N-
CH3), 3.18 (ddd, J = 11.7, J = 7.4, J = 4.4 Hz, 1 H, C=CH-CH-CHOSi), 4.23 (dd, J = 7.1, J = 4.5 Hz, 
1 H, CH-OSi), 5.09 (ddd, J = 15.3, J = 7.3, J = 1.6 Hz, 1 H, CHOSi-CH=CH-CH3), 5.26 (dq, J = 
15.3, J = 6.4 Hz, 1 H, CHOSi-CH=CH-CH3), 6.95−7.03 (m, 3 H, Ph), 7.82 (d, J = 11.6, J = 1.9 Hz, 1 
H, CH-CH=C-S), 8.03−8.07 (m, 2 H, Ph), 10.1 (d, J = 1.9 Hz, 1 H, CH=C-CHO) 
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13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.3 (d), 19.7 (d), 21.1 (d), 28.9 (d), 29.6 
(d), 51.4 (d), 74.4 (d), 126.7 (d), 127.4 (d), 128.9 (d), 129.1 (d), 133.2 (u), 140.7 (d), 141.2 (d), 
158.0 (u), 186.4 (u) 
 
IR (capillar) ν 3065 (w), 2958 (s), 2878 (s), 2805 (m), 1969 (s), 1608 (m), 1450 (m), 1414 (w), 
1378 (w), 1253 (s), 1151 (s), 1113 (s), 1082 (s), 1008 (m), 971 (m), 912 (w), 860 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 450 (2), 449 (2), 406 (15), 265 (11), 186 (16), 185 
(100), 156 (9), 124 (15), 115 (46), 87 (32)  
 
HRMS (EI) Calcd for C24H39NO3SSi:  449.241996; Found: 449.242024 
 
4.8.5 Synthesis of (2E,4R,5S,6E)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5-
(triethylsilyloxy)octa-2,6-dienal (95) via reaction of 77 with N-formylomorpholine (99). 
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with N-
formylmorpholine (99, 53 mg, 0.46 mmol) at –78 °C. Subsequent purification yielded unreacted 
77. 
 
Following GP5, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with N-
formylmorpholine (53 mg, 0.46 mmol) at 0 °C. Subsequent purification by flash chromatography 
yielded 95 (90 mg, 86%) as viscous liquid. For analytical date see Chapter 6.4 
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4.9. Synthesis of Trienes via Addition of Grignard Reagents to the α–
Sulfoximido Aldehydes 
 
 
4.9.1 General Procedure for Stereoselective Synthesis of Secondary Allylic Alcohols (GP6) 
 
To a solution of aldehyde 95 (1 mmol) in THF (30 mL) was added at –78 °C solution of 
corresponding Girgnard reagent (3 mmol) and the mixture was stirred at –78 °C for 1 h. 
Subsequently half saturated aqueous NaCl (10 mL) was added and the resulting mixture was 
extracted with EtOAc. The combined organic phases were dried (MgSO4) and concentrated in 
vacuum. 
 
4.9.2 Synthesis of (2E,4S,5E,7R,8S,9E)-7-isopropyl-5-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]8-(triethylsilyloxy)undeca-2,5,9-trien-4-ol (S-89) 
 
Following GP6, aldehyde 95 (100 mg, 0.22 mmol) was reacted with (E)-prop-1-enylmagnesium 
bromide (0.44 mmol, 0.22 mL of 2 M solution, slighly contaminated with Z-isomer). Purification 
via flash chromatography afforded alcohol S-89 (97 mg, 90 %). 
 
 
4.9.3 Synthesis of (4S,5E,7R,8S,9E)-7-isopropyl-5-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
8-(triethylsilyloxy)undeca-1,5,9-trien-4-ol (100) 
 
iPr
OSiEt3
S
Ph
O NMe
OH
100 
 
EXPERIMENTAL PART 
 
 
164
Following GP6, aldehyde 95 (100 mg, 0.27 mmol) was reacted with allylmagnesium bromide 
(0.27 mmol, 0.27 mL of 1M solution). Purification via flash chromatography afforded alcohol 
100 (111 mg, 84 %). 
 
Rf  = 0,28 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = + 14.5 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.46 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.81 (d, J = 6.9 Hz, 3 H, 
CH3), 0.88 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 0.89 (d, J = 6.9 Hz, 3 H, CH3), 1.58 (dd, J = 5.1 Hz, 3 
H, CH=CH-CH3), 1.86 (m, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.12 (ddd, J = 11.2, J = 8.6, J = 2.8 Hz, 1 
H, CH-CH=CH-S), 2.70 (s, 3 H, N-CH3), 2.88 (tddd, J = 14.2, J = 7.5, J = 5.4, J = 1.1 Hz, 1 H, 
CHOH-CHH), 3.22 (tddd, J = 14.2, J = 9.0, J = 6.7, J = 1.3 Hz, 1 H, CHOH-CHH), 4.16 (dd, J = 6.8, 
J = 2.7 Hz, 1 H, CH-OSi), 4.79 (t, J = 8.2 Hz, 1 H, CH-OH), 5.04 (ddt, J = 10.2, J = 3.3, J = 2.1 Hz, 
1 H, CH2-CH=CHH), 5.14 (dd, J = 17.1, J = 3.5 Hz, 1 H, CH2-CH=CHH), 5.18−5.34 (m, 2 H, 
CHOSi-CH=CH), 6.05 (br, 1 H, CHOH-CH2), 6.11 (ddd, J = 17.1, J = 10.3, J = 6.9 Hz, 1 H, CH2-
CH=CH2), 6.53 (d, J = 11.1 Hz, 1 H, CH-CH=C), 6.97−7.07 (m, 3 H, Ph), 7.98−8.03 (m, 2 H, Ph)
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.5 (d), 21.0 (d), 21.4 (d), 29.1 (u), 29.3 (u), 
43.3 (d), 52.6 (d), 70.7 (d), 74.4 (d), 116.9 (u), 126.7 (d), 129.1 (d), 129.6 (d), 132.1 (d), 133.9 (d), 
136.1 (d), 140.9 (u), 143.8 (d), 145.4 (u) 
 
IR (CHCl3) ν 3071 (w), 2957 (s), 2877 (s), 2805 (w), 1638 (w), 1449 (s), 1417 (w), 1378 (w), 
1238 (s), 1147 (s), 1112 (m), 1077 (s), 1008 (m), 973 (s), 915 (m), 862 (m), 812 (w), 751 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 493 (2) (M+), 492 (7), 491 (2), 463 (2), 462 (6), 450 
(8), 422 (10), 421 (32), 380 (15), 223 (9), 186 (15), 185 (100), 155 (12), 125 (17), 115 (32), 87 
(23) 
 
HRMS (EI) Calcd for C27H45NO3SSi: 491.288946; Found: 491.288781 
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4.9.4 Synthesis of (5S,6E,8R,9S,10E)-8-isopropyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
9-(triethylsilyloxy)dodeca-1,6,10-trien-5-ol (S-90) 
 
Following GP6, aldehyde 95 (200 mg, 0.44 mmol) was reacted with but-3-enylmagnesium 
bromide (0.44 mmol, 0.22 mL of 2 M solution). Purification via flash chromatography afforded 
alcohol S-90 (111 mg, 92 %). 
 
 
4.9.5 Synthesis of (6S,7E,9R,10S,11E)-9-isopropyl-7-[(S)-N-methyl-S-phenyl-sulfo-
nimidoyl)]-10-(triethylsilyloxy)trideca-1,7,11-trien-6-ol (101) 
 
iPr
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S
Ph
O NMe
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101 
 
Following GP7, aldehyde 74 (100 mg, 0.22 mmol) was reacted with but-3-enylmagnesium 
bromide (0.66 mmol, 0.66 mL of 1 M solution). Purification via flash chromatography afforded 
alcohol 80 (107 mg, 94 %). 
 
Rf  = 0,30 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = + 18.7 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.47 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.83 (d, J = 6.9 Hz, 3 H, 
CH3), 0.88 (d, J = 6.9 Hz, 3 H, CH3), 0.91 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 1.35 (dd, J = 6.4 Hz, 4 
H, CH=CH-CH3, CHOH-CH2-CH2-CHH’), 1.68−1.80 (m, 1 H, CHOH-CH2-CH2-CHH’), 1.88 (m, J 
= 6.9, 1 H, CH-(CH3)2), 1.94−2.08 (m, 3 H, CHOH-CHH’-CH2-CH2), 2.15 (m, J = 11.2, J = 8.7, J = 
2.8 Hz, 1 H, CH-CH=CH-S), 2.44 (m, J = 14.4, J = 9.8, J = 4.8 Hz, 1 H, CHOH-CHH), 2.73 (s, 3 H, 
N-CH3), 4.19 (dd, J = 7.2, J = 2.7 Hz, 1 H, CH-OSi), 4.69−4.76 (b, 1 H, CH-OH),4.97 (ddt, J = 10.2, 
J = 3.3, J = 1.2 Hz, 1 H, CH2-CH=CHH), 5.00 (dd, J = 16.9, J = 3.7 Hz, 1 H, CH2-CH=CHH), 
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5.20−5.37 (m, 2 H, CHOSi-CH=CH), 5.21−5.37 (m, 2 H, CH2-CH=CHH), 5.75 (ddd, J = 16.9,  J = 
10.2, J = 6.7 Hz, 1 H, CH2-CH=CH2), 5.90−5.96 (br, 1 H, CHOH-CH2), 6.58 (d, J = 11.1 Hz, 1 H, 
CH-CH=C), 6.99−7.08 (m, 3 H, Ph), 8.01−8.05 (m, 2 H, Ph)   
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 6.9 (d), 17.3 (d), 20.8 (d), 21.1 (d), 25.9 (u), 28.8 
(d), 29.1 (u), 33.5 (d), 37.6 (u), 52.3 (d), 69.9 (d), 74.1 (d), 114.4 (u), 126.3 (d), 128.6 (d), 129.0 
(d), 131.6 (d), 133.6 (d), 138.6 (d), 140.7 (u), 143.0 (d), 145.6 (u)  
 
IR (capillar) ν 2956 (s), 2878 (s), 1639 (w), 1449 (s), 1417 (w), 1239 (s), 1148 (m), 1112 (w), 
1079 (s), 1007 (m), 972 (w), 911 (w), 862 (m)  
 
MS (EI, 70 eV) (relative intensity, %) m/z 522 (3) (M+), 521 (2), 520 (19), 380 (14), 334 (11), 
321 (15), 270 (16), 223 (27), 186 (15), 185 (100), 156 (29), 124 (21), 115 (35), 103 (11), 87 (27) 
 
HRMS (EI) Calcd for C29H49NO3SSi: 519.320246; Found: 519.320389 
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4.10.Synthesis of the α -Sulfoximido Ketones 
 
 
4.10.1 Synthesis of the (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
6-(triethylsilyloxy)nona-3,7-dien-2-one (103) 
 
iPr
OSiEt3
S
Ph
O NMe
Me O
Me
 103 
 
4.10.2 General Procedure for the synthesis of (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-
phenyl-sulfonimidoyl)]-6-(triethylsilyloxy)nona-3,7-dien-2-one (103) (GP7) 
 
To a solution of vinylic sulfoximine 77 (100 mg, 0.23 mmol) in THF (10 mL) was added at –78 
°C BuLi (0.25 mmol, 0.16 ml of 1.6 M in hexane) and the mixture was stirred at 0 °C for 3 h. 
Then N-methoxy-N-methylacetamide (102) (60 mg, 0.46 mmol) in THF (3 mL) was added and 
the resulting mixture was stirred for 2 h. Subsequently half saturated aqueous NaCl (10 mL) was 
added and the resulting mixture was extracted with EtOAc. The combined organic phases were 
dried (MgSO4) and concentrated in vacuum. 
 
4.10.3 Synthesis of (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-6-
(triethylsilyloxy)nona-3,7-dien-2-one (103) at –78 °C. 
 
Following general procedure GP7, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with 
N-methoxy-N-methylacetamide (103) (60 mg, 0.46 mmol) (3 mL) and the resulting mixture was 
stirred for 2 h at –78 °C. Purification by flash chromatography (EtOAc/cyclohexane 1:5) gave 
enone (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-6-
(triethylsilyloxy)nona-3,7-dien-2-one (103) as viscous oil (40 mg, 40%) and vinylic sulfoximine 
E-77 (55 mg, 55%). 
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Rf = 0.42 (EtOAc/cyclohexane 1:5) 
 
[α]D = − 70.5 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.54 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.79 (d, J = 6.8 Hz, 3 H, 
CH3), 0.86 (d, J = 6.8 Hz, 3 H, CH3), 0.96 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.41 (dd, J = 6.5, J = 1.5 
Hz, 3 H, CHOSi-CH=CH-CH3), 1.88 (dd, J = 7.8, J = 6.9 Hz, 1 H, CH-(CH3)2), 1.99 (ddd, J = 11.5, 
J = 7.8, J = 3.7 Hz, 1 H, C=CH-CH-CHOSi), 2.37 (s, 3 H, CO-CH3), 3.00 (s, 3 H, N-CH3), 4.19 (td, 
J = 6.9, J = 3.7 Hz, 1 H, CH-OSi), 5.12−5.33 (m, 2 H, CHOSi-CH=CH-CH3), 6.96−7.08 (m, 3 H, 
Ph), 6.98 (d, J = 11.6 Hz, 1 H, CH-CH=C-S), 8.05−8.11 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.4 (d), 20.4 (d), 21.2 (d), 28.7 (d), 29.7 
(d), 32.8 (d), 54.2 (d), 74.5 (d), 126.7 (d), 128.9 (d), 129.2 (d), 132.3 (d), 134.0 (u), 141.3 (d), 
144.5 (d), 146.4 (u), 198.1 (u) 
 
IR (capillar) ν 2956 (s), 2877 (s), 2805 (w), 1702 (s), 1664 (m), 1449 (s), 1414 (w), 1369 (m), 
1257 (s), 1154 (s), 1076 (s), 1009 (m), 972 (m), 882 (w), 856 (m), 812 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 435 (2), 434 (5), 281 (11), 279 (11), 186 (16), 185 
(100), 115 (27), 87 (18) 
 
HRMS (EI) Calcd. for C25H41NO3SSi – C2H5: 434.218521; Found: 434.218647 
 
4.10.4. Synthesis of (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-6-
(triethylsilyloxy)nona-3,7-dien-2-one (103) at –45 °C. 
 
Following general procedure GP7, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with 
N-methoxy-N-methylacetamide (102) (60 mg, 0.46 mmol) (3 mL) and the resulting mixture was 
stirred for 2 h at –45 °C. Purification by flash chromatography gave enone 103 as viscous oil (40 
mg, 40%) and vinylic sulfoximine E-77 (55 mg, 55%). 
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4.10.5. Synthesis of (3E,5R,6S,7E)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-6-
(triethylsilyloxy)nona-3,7-dien-2-one (103) at 0 °C.  
 
Following general procedure GP7, vinylic sulfoximine 77 (100 mg, 0.23 mmol) was reacted with 
N-methoxy-N-methylacetamide (102) (60 mg, 0.46 mmol) (3 mL) and the resulting mixture was 
stirred for 2 h at 0 °C. Purification by flash chromatography gave enone 103 as viscous oil (52 
mg, 50%) and vinylic sulfoximine E-77 (40 mg, 40%).  
 
4.10.6 General Procedure for the Oxidation of the Allylic Alcohols (GP8):  
 
To a solution of the epimeric allylic alcohols (0.95 mmol) in CH2Cl2 (25 mL) Dess-Martin 
periodinane (1.425 mmmol, 4.03 g, 15 wt% solution in CH2Cl2) was added. The mixture was 
stirred at ambient temperatures for 0.5 h, after which time all of the starting material was 
consumed as indicated by TLC. Then aqueous Na2S2O3 (10 mL, 10 wt.%) and saturated NaHCO3 
were added. The resulting mixture was stirred for 1 h and than extracted with EtOAc. The 
combined organic phases were dried (Na2SO4) and concentrated in vacuum. Purification by 
chromatography gave the corresponding enones as a yellow viscous liquid. 
 
4.10.7 Synthesis of (2E,5E,7R,8S,9E)-7-isopropyl-5-[(S)-N-methyl-S-phenyl-sulfon-
imidoyl)]-8-(triethylsilyloxy)undeca-2,5,9-trien-4-one (106) 
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Following GP8, reaction of allylic alcohols R-89 and S-89 (300 mg, 0.61 mmol) with Dess-
Martin periodinane (2.6 g, 0.91 mmol) afforded after purification by flash chromatography 
(EtOAc/c-hexane 1:5) ketone 106 (285 mg, 96%) as a colorless syrup.  
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Rf  = 0.48 (EtOAc/cyclohexane 1:5) 
 
[α]D = − 53.8 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.57 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.83 (d, J = 6.8 Hz, 3 H, 
CH3), 0.88 (d, J = 6.8 Hz, 3 H, CH3), 0.98 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.38 (dd, J = 6.9, J = 1.6 
Hz, 3 H, CHOSi-CH=CH-CH3), 1.45 (d, J = 6.9 Hz, 3 H, CHOH-CH=CH-CH3), 1.92 (dd, J = 7.4, J 
= 6.9 Hz, 1 H, CH-(CH3)2), 2.08 (ddd, J = 11.5, J = 7.4, J = 4.1 Hz, 1 H, C=CH-CH-CHOSi), 3.02 (s, 
3 H, N-CH3), 4.20 (td, J = 7.4, J = 4.1 Hz, 1 H, CH-OSi), 5.19 (ddd, J = 15.2, J = 7.4, J = 1.3 Hz, 1 
H, CHOSi-CH=CH-CH3), 5.28 (dd, J = 15.2, J = 6.3 Hz, 1 H, CHOSi-CH=CH-CH3), 6.30 (d, J = 
15.4 Hz, 1 H, CHOH-CH=CH-CH3), 6.84 (dq, J = 15.4, J = 6.9 Hz, 1 H, CHOH-CH=CH-CH3), 
6.96−7.07 (m, 3 H, Ph), 7.18 (d, J = 11.5 Hz, 1 H, CH-CH=C-S), 8.11−8.17 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.5 (d), 17.9 (d), 20.4 (d), 21.4 (d), 28.9 
(d), 29.9 (d), 53.7 (d), 74.9 (d), 126.5 (u), 128.6 (d), 129.4 (d), 132.0 (d), 133.3 (d), 133.8 (u), 
141.0 (u), 144.6 (d), 145.2 (d), 146.6 (u), 190.1 (d) 
 
IR (capillar) ν 3345 (w), 2955 (s), 2808 (w), 1656 (m), 1544 (w), 1450 (s), 1381 (m), 1254 (s), 
1153 (m), 1078 (m), 1009 (w), 970 (m), 858 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 490 (3) (M+), 460 (10), 446 (11), 376 (24), 364 (14), 
261 (12), 186 (16), 185 (100), 124 (10), 115 (43), 87 (34) 
 
HRMS (EI) Calcd. for C27H43NO3SSi + H: 490.281121; Found: 490.280450 
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4.10.8 Synthesis of (6E,8R,9S,10E)-8-isopropyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-9-
(triethylsilyloxy)dodeca-1,6,10-trien-5-one (107) 
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Following GP8, reaction of a mixture of R-90 and S-90 (0.454 g, 0.9 mmol) with Dess-Martin 
periodinane (3.78 g, 1.35 mmol) afforded after purification by flash chromatography (EtOAc/c-
hexane 1:9) ketone 107 (433 mg, 96%) as a colorless syrup.  
 
Rf = 0.38 (EtOAc/cyclohexane 1:9)  
 
[α]D = + 33.4 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.55 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.80 (d, J = 6.9 Hz, 3 H, 
CH3), 0.87 (d, J = 6.8 Hz, 3 H, CH3), 0.97 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.44 (dd, J = 5.2 Hz, 3 
H, CH=CH-CH3), 1.89 (m, J = 6.7 Hz, 1 H, CH-(CH3)2), 1.98 (ddd, J = 11.6, J = 7.7, J = 3.9 Hz, 1 
H, CH-CH=C-S), 2.46 (ddd, J = 13.9, J = 7.1, J = 1.3 Hz, 2 H, CO-CH2-CH2), 2.91 (dd, J = 18.4, J = 
7.3 Hz, 1 H, CO-CHH’), 3.02 (s, 3 H, N-CH3), 3.05 (dd, J = 18.4, J = 7.3 Hz, 1 H, CO-CHH’), 4.20 
(dd, J = 6.7, J = 3.8 Hz, 1 H, CH-OSi), 4.94 (ddd, J = 10.1, J = 3.0 Hz, 1 H, CH2-CH=CHH), 5.03 
(ddd, J = 17.1, J = 1.7, J = 3.4 Hz, 1 H, CH2-CH=CHH), 5.26 (ddd, J = 15.4, J = 7.7 Hz, 1 H, 
CH=CH-CH3), 5.28 (m, J = 15.4, J = 5.2 Hz, 1 H, CHOSi-CH=CH), 5.80 (ddd, J = 17.0, J = 10.3, J 
= 6.6 Hz, 1 H, CH2-CH=CH2), 6.94–7.04 (m, 3 H, Ph), 7.01 (d, J = 11.6 Hz, 1 H, CH-CH=C), 8.08–
8.11 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.5 (d), 20.3 (d), 21.2 (d), 27.7 (u), 28.7 
(d), 29.7 (d), 44.7 (u), 54.1 (d), 74.5 (d), 115.2 (u), 126.6 (d), 128.7 (d), 129.0 (d), 132.1 (d), 
133.9 (d), 137.3 (d), 141.1 (u), 144.2 (d), 146.0 (u), 199.6 (u)  
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IR (CHCl3) ν 3073 (w), 2958 (s), 2913 (s), 2878 (s), 2807 (w), 1746 (w), 1702 (s), 1447 (m), 
1374 (w), 1257 (s), 1153 (s), 1115 (m), 1076 (s), 1006 (m), 973 (m), 915 (w), 856 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 503 (0.5) (M+), 474 (4), 434 (2), 433 (5), 321 (6), 319 
(6), 318 (8), 305 (5), 265 (5), 239 (7), 223 (2), 186 (16), 185 (100), 157 (6), 156 (3), 115 (27), 
103 (5), 87 (20), 75 (6) 
 
HRMS (EI) Calcd. for C28H45NO3SSi − C4H6O: 433.247081; Found: 433.247125 
 
4.10.9 Synthesis of (8E,10R,11S,12E)-10-isopropyl-8-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
11-(triethylsilyloxy)tetradeca-1,8,12-trien-7-one (108). 
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Following GP8, reaction of a mixture of R-91 and S-91 (0.4 g, 0.75 mmol) with Dess-Martin 
periodinane (3.18 g, 1.16 mmol) afforded after purification by flash chromatography (EtOAc/c-
hexane 1:9) ketone 108 (380 mg, 96%) as a colorless syrup. 
 
Rf = 0,33 (EtOAc/cyclohexane, 1:9) 
 
[α]D  = + 35.7 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.56 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.82 (d, J = 6.9 Hz, 3 H, 
CH3), 0.88 (d, J = 6.9 Hz, 3 H, CH3), 0.98 (t, J = 6.9 Hz, 9 H, Si-CH2-CH3), 1.32−1.40 (m, 2 H, CO-
CH2-CH2-CH2), 1.45 (d, J = 6.4 Hz, 3 H, CH=CH-CH3), 1.68−1.77 (m, 2 H, CO-CH2-CH2), 
1.85−2.08 (m, 4 H, CH-(CH3)2, CH2-CH=CH2, CH-CH=CH-S), 2.81 (td, J = 18.5, J = 7.2 Hz, 1 H, 
CO-CHH), 2.97 (td, J = 18.5, J = 7.2 Hz, 1 H, CO-CHH), 3.03 (s, 3 H, N-CH3), 4.21 (dd, J = 6.8, J = 
3.7 Hz, 1 H, CH-OSi), 4.95 (ddd, J = 10.2, 1 H, CH2-CH=CHH), 4.97 (ddd, J = 16.9 Hz, 1 H, CH2-
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CH=CHH), 5.20−5.34 (m, 2 H, CHOSi-CH=CH), 5.73 (ddd, J = 16.9,  J = 10.2, J = 6.7 Hz, 1 H, 
CH2-CH=CH2), 6.97−7.06 (m, 3 H, Ph), 7.01 (d, J = 11.7 Hz, 1 H, CH-CH=C), 8.08−8.11 (m, 2 H, 
Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  5.5 (u), 7.1 (d), 17.5 (d), 20.4 (d), 21.3 (d), 22.9 (u), 28.6 (u), 
28.8 (u), 29.7 (d), 33.9 (u), 45.3 (d), 54.2 (d), 74.5 (d), 114.6 (u), 126.6 (d), 128.7 (d), 129.0 (d), 
132.1 (d), 133.9 (d), 138.6 (d), 143.9 (u), 146.2 (d), 200.2 (u) 
 
IR (CHCl3) ν 3067 (w), 2957 (s), 2878 (s), 2807 (w), 1701 (s), 1449 (m), 1372 (w), 1256 (s), 
1152 (s), 1115 (m), 1077 (s), 1009 (w), 971 (w), 912 (w), 857 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 532 (0.5) (M+), 502 (2), 461 (1), 432 (2), 376 (8), 349 
(11), 346 (12), 333 (15), 186 (19), 185 (100), 115 (29), 87 (25) 
 
HRMS (EI) Calcd. for C30H49NO3SSi − C2H5: 502.281121; Found: 502.281508 
 
4.10.10 Synthesis of (8R,9S,E)-8-isopropyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-9-
(triethylsilyloxy)trideca-1,6,12-trien-5-one (109) 
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Following GP8, reaction of alcohols R-92 and S-92 (420 mg, 0.81 mmol) with Dess-Martin 
periodinane (3.43 g, 1.21 mmol) afforded after purification by chromatography (c-hexane/EtOAc, 
9:1) enone 109 (400 mg, 96%) as viscous liquids 
 
Rf = 0.35 (EtOAc/cyclohexane, 1:9) 
 
[α]D  = − 46.3 (c  1.00, CH2Cl2) 
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1H NMR (300 MHz, C6D6, TMS)  δ 0.54 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.83 (d, J = 6.9 Hz, 3 H, 
CH3), 0.85 (d, J = 6.9 Hz, 3 H, CH3), 0.96 (t, J = 6.9 Hz, 9 H, Si-CH2-CH3), 1.33−1.55 (m, 2 H, CH-
OSi-CHH-CHH), 1.81−1.95 (m, 2 H, CH-(CH3)2, CH-OSi-CH2-CHH), 1.96−2.11 (m, 2 H, CH-OSi-
CHH, CH-CH=CH-S), 2.44−2.55 (m, 2 H, CO-CH2-CH2), 2.85 (ddd, J = 18.4, J = 7.8, J = 6.6 Hz, 1 
H, CO-CHH), 2.92 (s, 3 H, N-CH3), 3.30 (ddd, J = 18.4, J = 7.4, J = 6.9 Hz, 1 H, CO-CHH), 4.21 
(dd, J = 7.9, J = 4.7, J = 1.9 Hz, 1 H, CH-OSi), 4.95 (ddd, 2 H, CH2-CH=CHH, CH2-CH=CHH), 
5.02 (ddd, J = 17.3, J = 3.5, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.05 (dd, J = 17.1, J = 1.7 Hz, 1 H, 
CH2-CH=CHH), 5.82 (ddd, J = 17.1,  J = 10.3, J = 6.7 Hz, 1 H, CH2-CH=CH2), 6.96−7.06 (m, 3 H, 
Ph), 7.03 (d, J = 11.6 Hz, 1 H, CH-CH=C), 8.02−8.06 (m, 2 H, Ph) 
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.7 (u), 7.2 (d), 21.3 (d), 21.5 (d), 27.9 (u), 28.8 (u), 29.7 
(d), 29.9 (u), 35.7 (u), 44.7 (u), 51.1 (d), 72.5 (d), 115.1 (u), 115.5 (u), 129.1 (d), 129.2 (d), 132.3 
(d), 137.5 (d), 138.2 (d), 141.1 (u), 145.7 (d), 146.6 (u), 199.9 (u) 
 
IR (capillar) ν 3072 (w), 2953 (s), 2811 (w), 2356 (w), 1701 (m), 1636 (w), 1454 (m), 1376 (w), 
1255 (s), 1154 (s), 1085 (s), 1004 (m), 915 (w), 858 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 517 (0.5) (M+), 489 (3), 488 (9), 462 (4), 434 (4), 433 
(10), 392 (5), 390 (6), 363 (4), 362 (4), 333 (13), 320 (10), 319 (29), 318 (92), 308 (25), 307 (41), 
279 (16), 278 (15), 277 (16), 270 (30), 265 (38), 261 (12), 249 (13), 240 (18), 239 (22), 199 (47), 
195 (11), 194 (48), 185 (19), 169 (14), 167 (100), 155 (34), 148 (15), 124 (41), 115 (69), 106 
(14), 103 (16), 87 (44) 
 
HRMS (EI)  Calcd for C29H47NO3SSi – C2H5: C27H42NO3SSi : 488,265471; Found: 488.265380 
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4.10.11. Synthesis of (3S,4E,6R,7S,8E)- and (3R,4E,6R,7S,8E)-6-isopropyl-4-[(S)-N-methyl-
S-phenyl-sulfonimidoyl)]-7-(triethylsilyloxy)deca-4,8-dien-3-ol (R-110) and (S-110). 
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Following GP4, reaction of sulfoximine 77 (400 mg, 0.95 mmol) with propanal (110 mg, 1.9 
mmol) afforded after purification by flash chromatography (c-hexane/EtOAc, 5:1) an equimolar 
mixture of alcohols R-110 and S-110 (330 mg, 72 %) as viscous liquid. The sample of 50 mg of 
the mixture was separated via flash chromatography (cyclohexane/EtOAc, 5:1) to give alcohols 
R-110 and S-110 needed for analysis (20 mg and 17 mg respectively, the remaining mixture was 
not separated).  
 
S-110:  
 
Rf = 0,30 (EtOAc/cyclohexane, 1:5) 
 
[α]D = +40.3 (c =1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.47 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.80 (d, J = 6.7 Hz, 3 H, 
CH3), 0.89 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 0.90 (d, J = 6.7 Hz, 3 H, CH3), 1.09 (t, J = 7.5 Hz, 3 H, 
CHOH-CH2-CH3), 1.60 (dd, J = 6.0, J = 1.0 Hz, 3 H, CH=CH-CH3), 1.82−1.91 (m, J = 6.7, J = 1.9 
Hz, 1 H, CH-(CH3)2), 2.04−2.15 (m, J = 11.1, J = 2.9 Hz, 2 H, CH-CH=C-S, CHOH-CHH), 
2.37−2.48 (m, J = 7.5, J = 1.8 Hz, 1 H, CHOH-CHH), 2.72 (s, 3 H, N-CH3), 4.18 (dd, J = 7.4, J = 2.8 
Hz, 1 H, CH-OSi), 4.62 (dd, J = 9.1, J = 5.2 Hz, 1 H, CH-OH), 5.21−5.29 (m, J = 15.1, J = 6.0 Hz, 1 
H, CH=CH-CH3), 5.30−5.38 (m, J = 15.1, J = 7.6, J = 2.7 Hz, 1 H, CH=CH-CH3), 5.90−6.01 (m, 1 
H, CH-OH), 6.55 (d, J = 11.1 Hz, 1 H, CH=C-S), 6.97−7.06 (m, 3 H, Ph), 8.00−8.05 (m, 2 H, Ph)
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13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 11.4 (d), 17.5 (d), 21.0 (d), 21.3 (d), 29.0 
(d), 29.3 (d), 31.5 (u), 52.5 (d), 72.0 (d), 74.4 (d), 126.5 (d), 128.8 (d), 129.3 (d), 131.9 (d), 133.8 
(d), 140.9 (u), 143.3 (d), 145.8 (d) 
 
IR (CHCl3) ν 2958 (s), 2877 (s), 1461 (m), 1378 (w), 1240 (s), 1149 (m), 1111 (w), 1078 (s), 
1012 (m), 973 (m), 858 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 451 (2) (M+– C2H5), 450 (7), 381 (2), 380 (8), 379 (2), 
324 (7), 295 (8), 294 (9), 281 (13), 270 (9), 223 (24), 186 (16), 185 (100), 155 (29), 124 (14), 115 
(21), 87 (13) 
 
HRMS (EI) Calcd for C26H45NO3SSi – C2H5: 450.249821; Found: 450.249909 
 
R-110  
 
Rf = 0.28 (EtOAc/cyclohexane, 1:5) 
 
[α]D = −13.5 (c =1.00, CH2Cl2)  
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.51 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.92 (d, J = 6.7 Hz, 3 H, 
CH3), 0.94 (d, J = 6.7 Hz, 3H, CH3), 0.95 (t, J = 7.8 Hz, 9H, Si-CH2-CH3), 0.99 (t, J = 7.5 Hz, 3 H, 
CHOH-CH2-CH3), 1.31 (dd, J = 6.6 Hz, J = 1.5 Hz, 3 H, CH=CH-CH3), 1.74−1.84 (m, J = 7.5, J = 
6.8 Hz, 1 H, CHOH-CHH), 1.81−1.91 (m, J = 11.4, J = 7.5, J = 4.0 Hz, 1 H, CH-(CH3)2), 2.00−2.10 
(m, J =18.7, J = 7.3 Hz, 1 H, CHOH-CHH), 2.37−2.44 (m, J =18.7, J = 7.5 Hz, 1 H, CH=C-S), 2.82 
(s, 3 H, N-CH3), 4.15 (dd, J = 7.9, J = 5.0 Hz, 1 H, CH-OSi), 4.72 (dd, J = 9.2, J = 4.7 Hz, 1 H, CH-
OH), 4.97−5.05 (m, J = 15.2, J = 8.0, J = 2.8 Hz, 1 H, CH=CH-CH3), 5.23−5.32 (m, J = 15.2, J = 
6.3, J = 2.4 Hz, 1 H, CH=CH-CH3), 5.90 (m, 1 H, CH-OH), 6.98−7.08 (m, 3 H, Ph), 7.23 (d, J = 11.5 
Hz, 1 H, CH=C-S), 7.97−8.00 (m, 2 H, Ph) 
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13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 11.4 (d), 17.3 (d), 19.1 (d), 21.4 (d), 28.8 
(d), 29.4 (d), 31.2 (u), 51.9 (d), 71.6 (d), 74.7 (d), 126.5 (d), 128.9 (d), 129.2 (d), 131.8 (d), 134.0 
(d), 141.9 (u), 143.0 (d), 145.4 (d) 
 
IR (CHCl3) ν 2958 (s), 2877 (s), 1461 (m), 1379 (w), 1239 (s), 1150 (m), 1109 (w), 1078 (s), 
1012 (m), 973 (m), 858 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 451 (2) (M+– C2H5), 450 (7), 381 (2), 380 (8), 379 (2), 
324 (7), 295 (8), 294 (9), 281 (13), 270 (9), 223 (24), 186 (16), 185 (100), 155 (29), 124 (14), 115 
(21), 87 (13) 
 
HRMS (EI) Calcd. for C26H45NO3SSi – C2H5: 450.249821; Found: 450.249902 
 
4.10.12. Synthesis of (4E,6R,7S,8E)-6-isopropyl-4-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-7-
(triethylsilyloxy)deca-4,8-dien-3-one (111) 
 
 
iPr
OSiEt3
S
Ph
O NMe
Et O
Me
111 
  
Following GP8, reaction of alcohols 110 and epi-110 (457 mg, 0.95 mmol) with Dess-Martin 
periodinane (4.03 g, 1.42 mmol) afforded after purification by chromatography 
(cyclohexane/EtOAc, 1:3) enone 111 (436 mg, 96%) as a viscous liquid. 
 
Rf = 0.46 (EtOAc/cyclohexane, 1:3) 
 
[α]D = + 198.2 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.55 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.79 (d, J = 6.7 Hz, 3 H, 
CH3), 0.86 (d, J = 6.7 Hz, 3H, CH3), 0.97 (t, J = 7.8 Hz, 9H, Si-CH2-CH3), 1.11 (t, J = 7.1 Hz, 3 H, 
CHOH-CH2-CH3), 1.43 (dd, J = 6.1 Hz, J = 1.1 Hz, 3 H, CH=CH-CH3), 1.84−1.92 (m, J = 7.5, J = 
6.8 Hz, 1 H, CH-(CH3)2), 1.92−1.98 (m, J = 11.4, J = 7.5, J = 4.0 Hz, 1 H, CH-CH=C-S), 2.69−2.80 
(m, J =18.7, J = 7.3 Hz, 1 H, CO-CHH), 2.87−2.97 (m, J =18.7, J = 7.5 Hz, 1 H, CO-CHH), 3.01 (s, 
3 H, N-CH3), 4.19 (dd, J = 7.0 , J = 3.7 Hz, 1 H, CH-OSi), 5.20 (m, J = 15.4, J = 7.0 Hz, 1 H, 
CH=CH-CH3), 5.28 (m, J = 15.4, J = 6.1 Hz, 1 H, CH=CH-CH3), 6.95−7.04 (m, 3 H, Ph), 6.98 (d, J 
= 11.4 Hz, 1 H, -CH=C-S), 8.06−8.11 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.4 (d), 20.4 (d), 21.2 (d), 28.7 (d), 29.7 
(d), 38.7 (u), 54.2 (d), 74.5 (d), 126.5 (d), 128.7 (d), 129.0 (d), 132.0 (d), 133.9 (d), 141.2 (u), 
144.0 (d), 146.2 (d), 200.9 (u) 
 
IR (CHCl3) ν 3019 (s), 2959 (s), 2879 (s), 2807 (w), 2362 (m), 2335 (w), 1702 (s), 1457 (s), 1414 
(w), 1374 (w), 1256 (w), 1156 (s), 1116 (w), 1077 (m), 1010 (m), 972 (m), 934 ( w), 854 (m), 
815 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 477 (0.5) (M+), 448 (2), 295 (3), 293 (13), 292 (11), 
186 (14), 185 (100), 115 (31), 87 (24) 
 
HRMS (EI) Calcd. for C26H43NO3SSi – C2H5: 448.234171; Found: 489.234275 
 
4.10.13. Synthesis of (E)-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-1-((R)-2-((S,E)-1-
(triethylsilyloxy)but-2-enyl)cyclohexylidene)hex-5-en-2-one (112) 
 
Et3SiO
S
Ph
O NMeO
112 
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Following GP8, reaction of alcohols 94 (340 mg, 0.66 mmol) with Dess-Martin periodinane (2.8 
g, 0.99 mmol) afforded after purification by chromatography (cyclohexane/EtOAc, 9:1) enone 
112 (330 mg, 96%) as a viscous liquid. 
 
Rf  = 0,36 (EtOAc/cyclohexane, 1:9) 
 
[α]D  = + 78.9 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.56 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.91-1.19 (m, 3 H, C=C-
CH2-CH2-CHH-CH2), 0.96 (t, J = 7.1 Hz, 9 H, Si-CH2-CH3), 1.23−1.58 (m, 3 H, C=C-CH2-CH2-
CHH), 1.40 (dd, J = 6.4, J = 1.4 Hz, 3 H, CH=CH-CH3), 1.81 (dt, J = 13.4, J = 4.4 Hz, 1 H, C=C-
CHH), 2.38 (bd, J = 10.2 Hz, 1 H, CH-C=C), 2.68−2.78 (m, 2 H, CO-CHH-CHH), 3.07 (s, 3 H, N-
CH3), 3.28−3.38 (m, 2 H, CO-CHH-CHH), 3.66 (m, J = 13.3 Hz, 1 H, C=C-CHH), 4.21 (t, J = 9.0 
Hz, 1 H, CH-OSi), 4.98−5.08 (m, 1 H, CHOSi-CH=CH-CH3), 5.02 (ddt, J = 10.2, J = 2.2, J = 1.2 
Hz, 1 H, CH2-CH=CHH), 5.17 (ddt, J = 17.0, J = 3.5, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.28 (dq, J = 
15.3, J = 6.4 Hz, 1 H, CHOSi-CH=CH-CH3), 6.02 (ddd, J = 17.0, J = 10.2 Hz, J = 6.6 Hz, 1 H, CH2-
CH=CH2), 6.92−7.04 (m, 3 H, Ph), 8.31−8.36 (m, 2 H, Ph)  
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.4 (d), 20.8 (d), 24.8 (u), 27.6 (u), 28.2 
(d), 29.6 (u), 29.8 (d), 45.4 (d), 48.5 (u), 74.3 (d), 115.2 (u), 128.8 (d), 128.9 (d), 132.0 (d), 133.7 
(d), 138.1 (d), 139.2 (d), 143.4 (d), 155.6 (d), 200.2 (u) 
 
IR (CHCl3) ν 3068 (w), 2937 (s), 2878 (m), 2804 (w), 1699 (s), 1615 (w), 1449 (s), 1414 (m), 
1355 (w), 1248 (s), 1149 (s), 1088 (s), 1055 (s), 1005 (m), 974 (m), 918 (w), 873 (w), 825 (w), 
751 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 516 (4) (M+), 486 (5), 360 (23), 359 (16), 332 (11), 331 
(27), 330 (19), 276 (17), 227 (15), 187 (21), 186 (21), 185 (100), 144 (11), 124 (16), 114 (41), 87 
(35) 
HRMS (EI) Calcd. for C28H42NO3SSi – CH3N: 486.262397; Found: 486.261627 
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4.11. Stereoselective Synthesis of Tertiary Allylic Alcohols. 
 
4.11.1 General Procedure for the Synthesis of Tertiary Allylic Alcohols (GP9) 
 
To a solution of ketone (1 mmol) in THF (30 mL) was added at –78 °C solution of corresponding 
Girgnard reagent (2 mmol) and the mixture was stirred at –78 °C for 1 h. Subsequently half 
saturated aqueous NaCl (10 mL) was added and the resulting mixture was extracted with EtOAc. 
The combined organic phases were dried (MgSO4) and concentrated in vacuum. 
 
4.11.2. Synthesis of (4S,5E,7R,8S,9E)-4-ethyl-7-isopropyl-5-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-8-(triethylsilyloxy)undeca-1,5,9-trien-4-ol (113). 
 
iPr
OSiEt3
S
Ph
O NMe
Et OH
Me
113 
 
Following GP9, reaction of enone 111 (90 mg, 0.19 mmol) in THF (10 mL) with CH2=CH-CH2-
MgCl (0.38 mmol, 0.19 ml of 2 M in n-hexanes) afforded after purification by flash 
chromatography (cyclohexane/EtOAc, 3:1) alcohol 113 ( 90 mg, 90%) 
 
Rf = 0.48 (EtOAc/cyclohexane, 1:3) 
 
[α]D = − 12.7 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.55 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.92 (d, J = 6.6 Hz, 3 H, 
CH3), 0.99 (t, J = 7.9 Hz, 9H, Si-CH2-CH3), 1.00 (d, J = 6.6 Hz, 3H, CH3), 1.16 (t, J = 7.3 Hz, J = 
1.09 Hz, 3 H, CHOH-CH2-CH3), 1.41 (dd, J = 3.2 Hz, J = 1.3 Hz, 3 H, CH=CH-CH3), 1.84−1.94 (m, 
J = 7.3 Hz, 2 H, CHOH-CH2-CH3), 1.94−2.09 (m, J = 6.6, J = 2.1 Hz, 1 H, CH-(CH3)2), 2.54−2.61 
(m, J = 6.9, J = 5.2 Hz, 3 H, CH-CH=C-S, CHOH-CH2-CH=CH), 2.83 (s, 3 H, N-CH3), 4.22 (dd, J = 
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5.2 , J = 4.0, J = 2.5 Hz, 1 H, CH-OSi), 4.99 (ddd, J =10.1 Hz, J = 1.5Hz, 1 H, CH2-CH=CHH), 5.08 
(d, J = 17.2 Hz, 1 H, CH2-CH=CHH), 5.24−5.28 (m, 1 H, CH=CH-CH3), 5.89−6.04 (m, J = 17.2, J = 
10.1, J = 8.6,J = 7.1 Hz, 1 H, CH2-CH=CH2), 6.99−7.10 (m, 3 H, Ph), 7.41 (d, J = 12.2 Hz, 1 H, CH-
CH=C-S), 8.11−8.21 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 9.0 (d), 17.4 (d), 20.9 (d), 21.5 (d), 29.7 
(d), 35.6 (u), 47.9 (u), 75.3 (d), 76.9 (u), 117.0 (u), 127.0 (d), 129.9 (d), 132.0 (d), 134.2 (d), 
135.5 (d), 141.8 (u), 142.5 (d), 147.0 (d) 
 
IR (CHCl3) ν 3067 (w), 2953 (s), 1454 (m), 1237 (w), 1147 (m), 1074 (s), 1006 (m), 858 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 490 (3), 479 (2), 478 (6), 449 (4), 334 (6), 270 (6), 186 
(16), 185 (100), 156 (8), 125 (12), 115 (27), 87 (21) 
 
HRMS (EI) Calcd for C29H49NO3SSi – C3H5: 478.281121; Found: 478.281121 
 
4.11.3.  Synthesis of (5S,6E,8R,9S,10E)-8-isopropyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
5-phenyl-9-(triethylsilyloxy)dodeca-1,6,10-trien-5-ol (114) 
 
iPr
OSiEt3
S
Ph
O NMe
OH
Me
Ph
114 
 
Following GP9, reaction of enone 107 (90 mg, 0.18 mmol) in THF (10 mL) with 
phenylmagnesiumbromide (0.36 mmol, 0.18 ml of 2 M in n-hexanes) afforded after purification 
by chromatography (cyclohexane/EtOAc, 5:1) alcohol 114 ( 90 mg, 86%) 
 
Rf = 0.40 (EtOAc/cyclohexane, 1:5) 
 
[α]D = − 15.4 (c = 1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.44 (d, J = 6.9 Hz, 3 H, CH3), 0.58 (q, J = 7.1 Hz, 6 H, Si-
CH2), 0.72 (d, J = 6.9 Hz, 3 H, CH3), 1.01 (t, J = 6.9 Hz, 9 H, Si-CH2-CH3), 1.51 (s, J = 5.5 Hz, 3 H, 
CH=CH-CH3), 1.68 (m, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.14−2.50 (m, 5 H, CH-CH=CH-S, CH2-CH2-
CH=CH2), 2.92 (s, 3 H, N-CH3), 4.23 (dd, J = 7.5, J = 3.2 Hz, 1 H, CH-OSi), 4.95 (d, J = 10.2, 1 H, 
CH2-CH=CHH), 5.00 (d, J = 16.4, J = 1.4 Hz, 1 H, CH2-CH=CHH), 5.27−5.44 (m, 2 H, CHOSi-
CH=CH), 5.84 (ddd, J = 16.4, J = 10.2, J = 6.2 Hz, 1 H, CH2-CH=CH2), 6.97−7.06 (m, 3 H, Ph), 
7.09−7.15 (m, 3 H, Ph), 7.35 (d, J = 12.1 Hz, 1 H, CH-CH=C), 7.70−7.74 (m, 2 H, Ph), 8.00−8.04 
(m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 17.6 (d), 20.2 (d), 20.6 (d), 28.6 (u), 29.1 
(u), 29.7 (d), 40.6 (d), 51.0 (d), 74.7 (d), 77.5 (d), 114.1 (u), 126.5 (d), 127.0 (d), 128.6 (d), 129.3 
(d), 131.8 (d), 134.3 (d), 139.2 (u), 141.6 (u), 143.6 (d), 146.7 (u), 147.1 (u) 
 
IR (CHCl3) ν 3067 (w), 2957 (s), 2880 (s), 1747 (w), 1596 (w), 1449 (m), 1242 (s), 1149 (s), 
1113 (m), 1075 (s), 1011 (m), 914 (w), 864 (w), 806 (m), 754 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 582 (12), 422 (13), 232 (24), 186 (17), 185 (100), 125 
(14), 115 (37), 107 (37), 106 (18), 105 (31), 103 (12), 87 (28) 
 
HRMS (EI) Calcd for C34H51NO3SSi + H: 582.343721; Found: 582.343445 
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4.11.4  Synthesis of (5R,6E,8R,9S,10E)- and (5S,6E,8R,9S,10E)-8-isopropyl-5-methyl-6-[(S)-N-
methyl-S-phenyl-sulfonimidoyl)]-9-(triethylsilyloxy)dodeca-1,6,10-trien-5-ol (S-115) and (R-
115) 
 
iPr
OSiEt3
S
Ph
O NMe
OH
Me
Me
S-115
iPr
OSiEt3
S
Ph
O NMe
OH
Me
Me
R-115 
 
Following GP7, reaction of enone 107 (80 mg, 0.16 mmol) in THF (10 mL) with 
methylmagnesiumbromide (0.32 mmol, 0.16 ml of 2 M in n-hexanes) afforded after purification 
by chromatography (cyclohexane/EtOAc, 5:1) alcohols R-115 (50 mg, 60%) and S-115 (12 mg, 
15%) 
 
R-115: 
 
Rf = 0,42 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = + 44.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.49 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.95 (d, J = 6.9 Hz, 3 H, 
CH3), 0.97 (d, J = 6.9 Hz, 3 H, CH3), 0.98 (t, J = 6.9 Hz, 9 H, Si-CH2-CH3), 1.32 (d, J = 5.9 Hz, 3 H, 
CH=CH-CH3), 1.49 (s, 3 H, CH=C-C(OH)CH3), 1.92−2.04 (m, 2 H, CH-(CH3)2, CHH-CH2-
CH=CH2), 2.17 (td, J = 13.3, J = 5.2 Hz, 1 H, CHH-CH2-CH=CH2), 2.44 (ddd, J = 12.2, J = 4.7, J = 
4.1 Hz, 1 H, CH-CH=CH-S), 2.97 (td, J = 12.7, J = 6.1 Hz, 2 H, CH2-CH2-CH=CHH), 2.78 (s, 3 H, 
N-CH3), 4.16 (dd, J = 7.8, J = 4.1 Hz, 1 H, CH-OSi), 4.99 (ddd, J = 10.3 Hz, 1 H, CH2-CH=CHH), 
5.11 (d, J = 16.9 Hz, 1 H, CH2-CH=CHH), 5.08−5.23 (m, 2 H, CHOSi-CH=CH), 5.90 (ddd, J = 17.1,  
J = 10.3, J = 6.8 Hz, 1 H, CH2-CH=CH2), 6.96−7.11 (m, 3 H, Ph), 7.37 (d, J = 12.2 Hz, 1 H, CH-
CH=C), 8.23−8.27 (m, 2 H, Ph)  
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13C NMR (100 MHz, C6D6, TMS)  δ 5.4 (u), 7.1 (d), 17.3 (d), 20.6 (d), 21.3 (d), 29.0 (u), 29.4 
(u), 29.5 (d), 30.7 (u), 44.9 (d), 52.6 (d), 74.9 (d), 114.3 (u), 126.4 (d), 128.7 (d), 129.4 (d), 131.7 
(d), 134.2 (d), 139.0 (d), 142.4 (u), 147.8 (d) 
 
IR (CHCl3) ν 3069 (w), 2958 (s), 2878 (s), 2804 (w), 1448 (m), 1379 (w), 1238 (s), 1155 (s), 
1108 (m), 1075 (s), 1008 (m), 972 (m), 910 (w), 866 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 520 (3) (M+), 519 (4), 490 (3), 464 (11), 334 (13), 187 
(16), 185 (100), 156 (22), 125 (14), 115 (30), 87 (24) 
 
HRMS (EI) Calcd for C29H49NO3SSi: 519.320246; Found: 519.320468 
 
S-115 : 
 
Rf  = 0,38 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 16.2 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.56 (q, J = 7.1 Hz, 6 H, Si-CH2), 0.89 (d, J = 6.9 Hz, 3 H, 
CH3), 0.94 (d, J = 6.9 Hz, 3 H, CH3), 0.98 (t, J = 6.9 Hz, 9 H, Si-CH2-CH3), 1.43 (d, J = 5.4 Hz, 3 H, 
CH=CH-CH3), 1.71 (s, 3 H, CH=C-C(OH)CH3), 1.89−2.03 (m, 3 H, CH-(CH3)2, CH2-CH2-
CH=CH2), 2.20 (td, J = 15.3, J = 7.6 Hz, 2 H, CH2-CH2-CH=CH2), 2.55 (ddd, J = 11.6, J = 6.7, J = 
4.6 Hz, 1 H, CH-CH=CH-S), 2.87 (s, 3 H, N-CH3), 4.18 (dd, J = 7.3, J = 4.5 Hz, 1 H, CH-OSi), 4.93 
(ddd, J = 10.2 Hz, 1 H, CH2-CH=CHH), 4.99 (d, J = 16.8 Hz, 1 H, CH2-CH=CHH), 5.20−5.35 (m, 2 
H, CHOSi-CH=CH), 5.79 (ddd, J = 16.8, J = 10.2, J = 6.5 Hz, 1 H, CH2-CH=CH2), 6.96−7.08 (m, 3 
H, Ph), 7.28 (d, J = 12.0 Hz, 1 H, CH-CH=C), 8.10−8.14 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.6 (d), 20.3 (d), 21.6 (d), 28.4 (u), 29.3 
(u), 29.6 (d), 31.9 (u), 42.8 (d), 52.0 (d), 74.1 (d), 74.9 (d), 114.0 (u), 126.9 (d), 128.6 (d), 129.3 
(d), 131.7 (d), 133.8 (d), 139.3 (d), 141.6 (u), 142.1 (u), 148.7 (d) 
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IR (CHCl3) ν 2958 (s), 2878 (s), 1451 (m), 1237 (s), 1147 (s), 1111 (m), 1074 (s), 1006 (m), 972 
(m), 909 (w), 865 (m), 752 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 520 (2) (M+), 519 (5), 490(3), 464 (4), 334 (6), 186 
(16), 185 (100), 156 (19), 125 (11), 115 (28), 87 (20) 
 
HRMS (EI) Calcd for C29H49NO3SSi: 519.320246; Found: 519.320088 
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4.12. Synthesis of Sulfoximine Substituted Carbocycles
 
 
4.12.1. General Procedure for the RCM Reaction of Trienes 84 and 85 (GP10).  
 
To a solution of the ruthenium complex 30 (0.024 mmol) in toluene or CH2Cl2 (5 mL) a solution of 
triene 84 or 85 (0.49 mmol) in toluene or CH2Cl2 (98 mL) was added. The reaction mixture was 
stirred at reflux for 16 h, after which time all of the starting material was consumed as indicated by 
TLC. The mixture was cooled and filtered through a short pad of silica gel, and the solvent was 
removed in vacuum. Purification by flash chromatography (EtOAc/cyclohexane, 1:3) afforded the 
corresponding carbocycle as slightly yellow syrup. 
 
4.12.2 Synthesis of triethyl((1S,2Z,5E,7R)-7-isopropyl-5-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-cyclohepta-2,5-dienyloxy)silane (131).  
 
iPr
Et3SiO
S
Ph
O NMe
131 
 
Following GP10, reaction of triene 84 (100 mg, 0.22 mmol) in CH2Cl2 (44 mL) with complex 30 (9 
mg, 0.011 mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane, 1:3) 
carbocycle 131 (37 mg, 40%) as a viscous liquid and 84 (50 mg, 50%). 
 
Rf = 0.28 (EtOAc/cyclohexane, 1:3) 
 
[α]D = − 66.9 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.48 (q, J = 7.4 Hz, 6 H, Si-CH2), 0.90 (t, J = 7.4 Hz, 9 H, Si-
CH2-CH3), 0.92 (d, J = 6.4 Hz, 3 H, CH3), 0.95 (dd, J = 6.4 Hz, 3 H, CH3), 1.98−2.10 (m, J = 12.6, J 
= 6.4 Hz, 1 H, CH-(CH3)2), 2.20−2.28 (m, J = 12.6, J = 6.4, J = 2.5 Hz, 1 H, CH=CH-CH), 2.97 (s, 3 
H, N-CH3), 3.12 (m, J = 19.7, J = 7.2 Hz, 1 H, CHH-CH=CH), 3.18 (m, J = 19.7, J = 3.5, J = 1.9 Hz, 
1 H, CHH-CH=CH), 4.44 (m, J = 2.5 Hz, 1 H, CH-OSi), 5.19−5.28 (ddd, J = 11.5, J = 7.2, J = 3.5 
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Hz, 1 H, CHOSi-CH=CH), 5.51−5.59 (m, J = 11.5, J = 5.3, J = 2.3 Hz, 1 H, CHOSi-CH=CH), 
7.00−7.08 (m, 3 H, Ph), 7.36 (dd, J = 6.5, J = 1.9 Hz, 1 H, CH-CH=C), 8.01−8.06 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.2 (u), 6.9 (d), 21.2 (d), 21.3 (d), 27.3 (u), 29.1 (d), 29.4 
(d), 50.9 (d), 68.5 (d), 125.1 (d), 128.5 (d), 128.6 (d), 131.6 (d), 134.5 (d), 139.6 (u), 139.9 (u), 
143.2 (d) 
 
IR (capillar) ν 3062 (w), 2956 (s), 2876 (s), 2802 (m), 1462 (m), 1414 (m), 1246 (s), 1153 (s), 
1084 (s), 1010 (s), 976 (w), 867 (s), 830 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 421 (14), 420 (35), 419 (100) (M+), 391 (10), 390 (34), 
376 (18), 270 (31), 264 (22), 249 (29), 221 (14), 198 (19), 139 (11), 132 (14), 117 (32), 115 (34), 
110 (11), 106 (13), 103 (29), 91 (14), 87 (43) 
 
HRMS (EI) Calcd. for C23H37NO2SSi: 419.231431. Found: 419.231443 
 
Following GP10, reaction of triene 84 (226 mg, 0.49 mmol) in toluene (98 mL) with complex 30 
(20.8 mg, 0.024 mmol) afforded after purification by chromatography (EtOAc/cyclohexane, 1:3) 
carbocycle 131 (197 mg, 96%) as a viscous liquid. 
 
4.12.3 Synthesis of ((1S,2R,3E,6Z)-2-isopropyl-4-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]cyclonona-3,6-dienyloxy)triethylsilane (133).  
 
iPr
Et3SiO
S
Ph
O NMe
133 
 
Following GP10, reaction of triene 84 (167 mg, 0.35 mmol) in toluene with complex 30 (15 mg, 
0.018 mmol) afforded carbocycle 133 (141 mg, 90%) as a viscous liquid.  
 
Rf = 0.22 (EtOAc/cyclohexane, 1:3) 
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[α]D = − 41.5 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.53 (q, J = 7.6 Hz, 6 H, Si-CH2),  0.79 (d, J = 6.8 Hz, 3 H, 
CH3) , 0.92 (d, J = 6.8 Hz, 3 H, CH3) , 0.97 (t, J = 7.6 Hz, 9 H, Si-CH2-CH3), 1.17−1.25 (m, J = 11.0, 
J = 5.0, J = 2.8 Hz, 1 H, CH-CH=CH), 1.58−1.65 (m, J = 5.0, J = 2.8 Hz, 1 H,CHOH-CHH), 
1.68−1.79 (m, 2 H,CH-CH=CH, CHOH-CHH), 2.00−2.10 (m, J = 13.4, J = 6.8 Hz, 1 H, CH-(CH3)2), 
2.39−2.47 (m, J = 10.9, J = 9.7, J = 2.5 Hz, 1 H, CH-CH=CH), 2.99 (s, 3 H, N-CH3), 3.13 (d, J = 7.1 
Hz, 1 H,CH-CH=CH2), 3.92−3.98 (ddd, J =10.7, J = 4.6, J = 2.3 Hz, 1 H, CH-OH), 5.50−5.57 (m, J 
= 10.6, J = 7.5 Hz, 1 H, CH=CH), 5.58−5.64 (m, J = 10.6, J = 7.1 Hz, 1 H, CH=CH), 6.91 (d, J = 
10.9 Hz, 1 H, CH-CH=C), 7.02−7.08 (m, 3 H, Ph), 8.01−8.05 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.6 (u), 7.2 (d), 19.8 (u), 20.6 (d), 22.1 (d), 25.9 (u), 28.8 
(d), 29.6(d), 36.5 (u), 49.1 (d), 73.7 (d), 128.1 (d), 128.5 (d), 129.0 (d), 131.7 (d), 132.9 (d), 141.4 
(u), 142.4 (d)  
 
IR (capillar) ν 3063 (w), 3026 (m), 2957 (s), 2803 (m), 1463 (s), 1418 (w), 1363 (w), 1244 (s), 
1144 (s), 1102 (s), 1074 (s), 1012 (m), 970 (w), 945 (w), 863 (s), 813 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 447 (5) (M+), 418 (30), 323 (24), 322 (100), 316 (18), 
280 (15), 270 (21), 249 (34), 240 (14), 227 (44), 194 (12), 191 (11), 190 (60), 173 (13), 171 (23), 
164 (14), 161 (26), 160 (22), 156 (41), 149 (24), 145 (27), 139 (34), 134 (15), 133 (19), 125 (39) 
 
HRMS (EI) Calcd. for C25H41NO2SSi: C, 447.262731; Found: 447.262836 
 
4.12.4. General Procedure for the RCM Reaction of Allylic Alcohols R-90, S-90, R-92, S-92 and 
113 (GP11).  
 
To a solution of the ruthenium complex 30 (0.024 mmol) in CH2Cl2 (98 mL) a solution of the allylic 
alcohol ( 0.49 mmol) in CH2Cl2 (8 mL) was added. The reaction mixture was stirred at ambient 
temperature for 16 h and subsequently 4 h at reflux temperature, after which time all of the starting 
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material was consumed as indicated by TLC. The mixture was cooled and filtered through a short 
pad of silica gel, and the solvent was removed in vacuum.  
 
4.12.5 Attempted synthesis of (1R,2E,4R,5S,6Z)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)cyclonona-2,6-dienol (R-134)  
 
iPr
Et3SiO
S
OH
Ph
O NMe
 R-134 
 
Following GP11, reaction of the allylic alcohol R-90 (50 mg, 0.1 mmol) with the ruthenium complex 
30 (4 mg, 0.005 mol) gave mixture of undefined decomposition products. 
 
4.12.6 Attempted synthesis of (1S,2E,4R,5S,6Z)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)cyclonona-2,6-dienol (S-134) 
 
iPr
Et3SiO
S
OH
Ph
O NMe
 S-134 
 
Following GP11, reaction of allylic alcohol S-69 (50 mg, 0.1 mmol) with ruthenium complex 30 (4 
mg, 0.005 mol) gave mixture of undefined decomposition products. 
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4.12.7 Attempted synthesis of (1R,2E,4R,5S,8Z)-4-isopropyl-2-(N-methylphenylsulfonimidoyl)-
5-(triethylsilyloxy)cycloundeca-2,8-dienol (S-135) 
 
iPr
Et3SiO
OH
S
Ph
O NMe
 S-135 
 
Following GP11, reaction of allylic alcohol S-92 (50 mg, 0.1 mmol) with ruthenium complex 30 (4 
mg, 0.005 mol) gave mixture of undefined decomposition products. 
 
4.12.8 Attempted synthesis of (1S,2E,4R,5S,8Z)-4-isopropyl-2-(N-methylphenylsulfonimidoyl)-
5-(triethylsilyloxy)cycloundeca-2,8-dienol (R-135) 
 
iPr
Et3SiO
OH
S
Ph
O NMe
 R-135 
 
Following GP11, reaction of allylic alcohol R-92 (50 mg, 0.1 mmol) with ruthenium complex 30 (4 
mg, 0.005 mol) gave mixture of undefined decomposition products. 
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4.12.9 Synthesis of (1S,2E,4R,5S,6Z)-1-ethyl-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)cycloocta-2,6-dienol (136).  
 
Following GP11, reaction of triene 113 (73 mg, 0.14 mmol) with ruthenium complex 30 (6 mg, 
0.007 mmol) afforded after purification by flash chromatography (cyclohexane/EtOAc, 1:5) 
carbocycle 136 (60 mg, 90%).  
 
S
OH Me
iPr
Et3SiO Ph
O NMe
136 
 
Rf = 0.46 (cyclohexane/EtOAc, 1:5) 
 
[α]D = − 60.2 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.42 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.82 (d, J = 6.6 Hz, 3 H, 
CH3), 0.83 (t, J = 7.9 Hz, 9H, Si-CH2-CH3), 0.89 (d, J = 6.6 Hz, 3H, CH3), 1.08 (t, J = 7.5 Hz, 3 H, 
CHOH-CH2-CH3), 1.93−2.03 (m, J = 6.7, J = 3.2 Hz, 1 H, CH-(CH3)2), 2.09−2.19 (m, J = 13.8, J = 
7.5 Hz, 1 H, COH-CHH-CH3), 2.26−2.32 (m, J = 13.8, J = 7.5 Hz, 1 H, COH-CHH-CH3), 2.33−2.40 
(m, J = 15.4, J = 6.2 Hz, 1 H, CHOH-CHH), 2.40−2.47 (m, J = 10.2, J = 3.1 Hz, 1 H, CH-CH=C-S), 
2.57−2.65 (m, J = 15.4, J = 9.1 Hz, 1 H, CHOH-CHH-CH=CH), 2.70 (s, 3 H, N-CH3), 4.51 (dd, J = 
2.3, J=1.7 Hz, 1 H, CH-OSi), 5.26 (ddd, J =11.6, J = 1.7Hz, 1 H, CH2-CH=CH), 5.69 (ddd, J = 11.6, 
J = 8.8, J = 2.3 Hz, 1 H, CH2-CH=CH), 6.93 (d, J = 10.2 Hz, 1 H, CH=C-S), 6.97−7.08 (m, 3 H, Ph), 
7.49 (m, 1 H, COH-CH2), 8.07−8.11 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 8.8 (d), 20.3 (d), 22.3 (d), 29.3 (d), 29.7 (d), 
37.8 (u), 39.3 (u), 52.8 (u), 72.8 (d), 80.5 (u), 124.9 (d), 128.5 (d), 128.9 (d), 131.3 (d), 135.3 (d), 
142.2 (u), 146.1 (d), 147.6 (d) 
 
IR (CHCl3) ν 3235 (w), 2956 (s), 1458 (m), 1234 (s), 1081 (s), 1008 (s), 851 (m) 
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MS (EI, 70 eV) (relative intensity, %) m/z 477 (3) (M+), 449 (16), 448 (47), 322 (20), 307 (28), 
304 (16), 294 (21), 293 (93), 279 (15), 278 (8), 270 (19), 265 (17), 264 (14), 263 (12), 261 (13), 
251 (20), 250 (100), 247 (15), 223 (9), 219 (15), 185 (14), 161 (17), 156 (34), 147 (11), 139 (16), 
124 (50), 122 (10), 119 (11), 115 (19), 107 (16), 104 (10), 103 (15), 87 (22) 
 
HRMS (EI) Calcd. for C26H43NO3SSi: 477.273296; Found: 477.273389 
 
4.12.10. General procedure for the Synthesis of the Silyl Ethers R-137, S-137 and R-138, S-138 
(GP12).  
 
To a solution of the allylic alcohol R-90, S-90 or R-92, S-92 (1 mmol) in DMF (5 mL) was added at 
0 °C first imidazole (273 mg, 4 mmol) and then after 1 h ClSitBuMe2 (4 mmol). After the reaction 
mixture was stirred for 20 h at ambient temperature, half saturated aqueous NaHCO3 was added and 
the resulting mixture was extracted with ether. The combined organic phases were dried (Na2SO4) 
and concentrated in vacuum. The purification by chromatography gave the silyl ether R-137, S-137, 
R-138 and S-138. 
 
4.12.11. Synthesis of (5R,8R,9S,E)-5-(But-3-enyl)-11,11-diethyl-8-isopropyl-2,2,3,3-tetramethyl-
6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-9-((E)-prop-1-enyl)-4,10-dioxa-3,11-disilatridec-6-
ene (R-110).  
 
Following GP12, reaction of alcohol R-90 (260 mg, 0.51 mmol) afforded the silyl ether R-137 (305 
mg, 96 %) as a viscous liquid.  
 
iPr
OSiEt3
S
Ph
O NMe
OSitBuMe2
Me
 R-137 
 
Rf = 0,28 (cyclohexane/EtOAc, 1:15) 
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[α]D = + 20.7 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ −0.29 (s, 3 H, Si-CH3), 0.08 (s, 3 H, Si-CH3), 0.65 (q, J = 7.9 
Hz, 6 H, Si-CH2), 0.91 (d, J = 6.8 Hz, 3 H, CH3), 0.92 (s, 9 H, Si-C(CH3)3), 1.03 (d, J = 6.8 Hz, 3 H, 
CH3), 1.04 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.53 (dd, J = 5.7, J = 1.0 Hz, 3 H, CH3), 2.02−2.12 (m, 
J = 6.8, J = 6.8 Hz, 1 H, CH-(CH3)2), 2.14−2.30 (m, 4 H, CHOOSi(CH3)2C(CH3)3-CHH’-CHH), 
2.66−2.77 (m, 1 H, CH-CH=C-S), 2.96 (s, 3 H, N-CH3), 4.37 (dd, J = 7.7, J = 3.7 Hz, 1 H, CH-OSi), 
4.92 (dd, J = 5.2, J = 2.0 Hz, 1 H, CH-OSi(CH3)2C(CH3)3), 4.99 (dd, J = 10.9, J = 2.0 Hz, 1 H, CH2-
CH=CHH), 5.11 (d, J = 17.1 Hz, 1 H, CH2-CH=CHH), 5.36−5.51 (ddd, J = 15.1, J = 12.2, J = 6.6 
Hz, 2 H, CH=CH-CH3), 5.87 (m, J = 17.1, J = 10.3, J = 6.1, J = 2.9 Hz, 1 H, CH2-CH=CH2), 
6.99−7.09 (m, 3 H, Ph), 7.28 (d, J = 11.3 Hz, 1 H, CH-CH=C), 8.00−8.05 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ −4.7 (d), −4.0 (d), 5.7 (u), 7.2 (d), 17.7 (d), 18.5 (u), 21.2 
(d), 21.5 (d), 26.4 (d), 29.8 (d), 30.0 (d), 31.3 (u), 38.8 (u), 50.9 (d), 70.7 (d), 75.3 (d), 114.9 (u), 
1272 (d), 128.7 (d), 129.3 (d), 131.6 (d), 134.2 (d), 138.6 (d), 142.5 (u), 144.1 (d), 144.4 (u) 
 
IR (CHCl3) ν 3069 (w), 2951 (s), 2807 (w), 2358 (w), 1459 (m), 1382 (w), 1248 (s), 1151 (m), 
1079 (s), 971 (w), 843 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 619 (1) (M+), 590 (5), 564 (6), 563 (11), 562 (25), 423 
(12), 422 (9), 421 (23), 367 (9), 353 (8), 319 (13), 270 (9), 186 (16), 185 (100), 115 (32), 87 (23) 
 
HRMS (EI) Calcd. for C34H61NO3SSi2-C4H9: 562.320650 Found: 562.320615 
 
4.12.12. Synthesis of (5S,8R,9S,E)-5-(But-3-enyl)-11,11-diethyl-8-isopropyl-2,2,3,3-
tetramethyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-9-((E)-prop-1-enyl)-4,10-dioxa-3,11-
disilatridec-6-ene (S-137). 
 
Following GP12, reaction of alcohol S-90 (238 mg, 0.47 mmol) afforded the silyl ether S-137 
(280 mg, 96 %) as a viscous liquid. 
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iPr
OSiEt3
S
Ph
O NMe
OSitBuMe2
S-137 
 
Rf = 0,36 (cyclohexane/EtOAc, 1:15) 
 
[α]D = −4.3 (c = 1.00, CH2Cl2) 
 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.13 (s, 3 H, Si-CH3), 0.28 (s, 3 H, Si-CH3), 0.74 (q, J = 7.9 Hz, 
6 H, Si-CH2), 1.08 (s, 9 H, Si-C(CH3)3), 1.14 (d, J = 6.7 Hz, 3 H, CH3), 1.16 (t, J = 7.9 Hz, 9 H, Si-
CH2-CH3), 1.27 (d, J = 6.7 Hz, 3 H, CH3), 1.59 (dd, J = 5.02 Hz, 3 H, CH3-CH=CH), 1.88−1.96 (m, 
J = 5.7, J = 3.5 Hz, 1 H, CHOH-CHH’-CHH), 2.12−2.22 (m, 1 H, CHOOSi(CH3)2C(CH3)3-CHH’-
CHH’), 2.22−2.32 (m, 2 H, CH-(CH3)2, CHOOSi(CH3)2C(CH3)3-CHH’-CHH’), 2.52−2.62 (m, 1 H, 
CHOH-CHH’-CHH’), 3.09 (s, 3 H, N-CH3), 3. 06−3.12 (m, J = 11.8, J = 7.3, J = 3.3 Hz, 1 H, CH-
CH=C-S), 4.49 (dd, J = 7.4, J = 3.5 Hz, 1 H, CH-OSi), 5.13 (ddd, J = 10.2, J = 2.1, J = 1.2 Hz, 1 H, 
CH2-CH=CHH), 5.23 (dd, J = 8.5, J = 3.1 Hz, 1 H, CH-OSi(CH3)2C(CH3)3), 5.24 (dd, J = 17.2, J = 
3.7, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.41−5.55 (m, J = 15.6, J = 11.6, J = 5.8 Hz, 2 H, CH=CH-
CH3), 5.98 (m, J = 17.2, J = 10.3, J = 6.5 Hz, 1 H, CH2-CH=CH2), 7.14−7.21 (m, 3 H, Ph), 7.40 (d, J 
= 11.8 Hz, 1 H, CH-CH=C), 8.07−8.11 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ - 4.9 (d), -3.7 (d), 5.6 (u), 7.2 (d), 17.6 (d), 18.5 (u), 21.1 
(d), 21.6 (d), 26.4 (d), 27.2 (u), 29.7 (d), 29.8 (d), 31.7 (u), 40.1 (u), 51.1 (d), 69.7 (d), 74.9 (d), 
114.8 (u), 126.2 (d), 128.9 (d), 129.3 (d), 129.2 (d), 131.8 (d), 134.5 (d), 138.4 (d), 141.0 (u), 
144.2 (d), 144.7 (u) 
 
IR (CHCl3) ν 2949 (s), 2354 (w), 1457 (m), 1248 (s), 1148 (m), 1076 (s), 1013 (m), 969 (m), 839 
(s) 
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MS (EI, 70 eV) (relative intensity, %) m/z 619 (3) (M,+), 590 (5), 564 (7), 563 (13), 562 (31), 
464 (12), 423 (15), 422 (11), 421 (30), 407 (8), 367 (7), 353 (7), 319 (18), 270 (8), 186 (17), 185 
(100), 115 (29), 87 (21) 
 
HRMS (EI) Calcd. for C34H61NO3SSi2-C4H9: 562.320650 Found: 562.320714 
 
4.12.13 Synthesis of (5R,8R,9S,E)-5,9-Di(but-3-enyl)-11,11-diethyl-8-isopropyl-2,2,3,3-
tetramethyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-4,10-dioxa-3,11-disilatridec-6-ene (R-
138).  
 
iPr
OSiEt3
S
Ph
O NMe
OSitBuMe2
R-138 
 
Following GP12, reaction of alcohol R-92 (180 mg, 0.35 mmol) afforded the silyl ether R-138 
(210 mg, 96%) as a viscous liquid.  
 
Rf = 0.30 (cyclohexane/EtOAc, 10:1)  
 
[α]D = −1.0 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.15 (s, 3 H, Si-CH3), 0.29 (s, 3 H, Si-CH3), 0.80 (q, J = 7.9 Hz, 
6 H, Si-CH2), 1.10 (s, 9 H, Si-C-(CH3)3), 1.11 (d, J = 6.4 Hz, 3 H, CH3), 1.18 (t, J = 7.9 Hz, 9 H, Si-
CH2-CH3), 1.25 (d, J = 6.4 Hz, 3 H, CH3), 1.72−1.81 (m, 2 H, CHOSi-CH2-CH2-CH=CH2), 
2.00−2.40 (m, 6 H, CHOSi-CH2-CH2-CH=CH2, CHOSi(CH2CH3)3-CH2-CHH-CH=CH2, CH-
(CH3)2), 2.51−2.65 (m, J = 4.6, J = 1.5 Hz, 1 H, CHOSi(CH2CH3)3-CH2-CHH-CH=CH2,), 3.10 (s, 3 
H, N-CH3), 3.15−3.24 (m, J = 11.6, J = 7.2, J = 3.1 Hz, 1 H, CH-CH=C-S), 4.10 (ddd, J = 5.9, J = 
3.0 Hz, 1 H, CH-OSi), 5.08−5.12 (ddd, J = 10.1 Hz, 1 H, CH-OSi(CH3)2C(CH3)3), 5.13−5.19 (dd, J = 
10.2, J = 3.3, J = 1.9 Hz, 2 H, CHOSi-CH2-CH2-CH=CHH, CHOSi(CH2CH3)3-CH2-CH2-CH=CHH), 
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5.20−5.30 (ddd, J = 17.2, J = 3.4, J = 1.6 Hz, 2 H, CHOSi-CH2-CH2-CH=CHH, CHOSi(CH2CH3)3-
CH2-CH2-CH=CHH), 5.82−6.06 (m, J = 17.2, J = 10.2, J = 6.4 Hz, 2 H, CHOSi(CH2CH3)3-CH2-
CH2-CH=CH2 , CHOSi-CH2-CH2-CH=CH2), 7.12−7.23 (m, 3 H, Ph), 7.40 (d, J = 11.6 Hz, 1 H, 
CH=C-S), 8.09−8.13 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ -4.9 (d), -3.7 (d), 5.8 (u), 7.3 (d), 18.4 (u), 21.6 (d), 21.7 (d), 
26.4 (d), 29.7 (d), 29.8 (d), 30.6 (u), 31.5 (u), 35.2 (u), 40.0 (u), 48.7 (d), 69.9 (d), 73.2 (d), 115.0 
(u), 115.1 (u), 129.1 (d), 129.4 (d), 132.0 (d), 138.3 (d), 141.2 (u), 144.4 (d), 144.9 (u) 
 
IR (capillar) ν 3072 (w), 2953 (s), 2807 (w), 1640 (w), 1463 (m), 1415 (w), 1385 (w), 1249 (s), 
1150 (s), 1081 (s), 1006 (w), 913 (s), 840 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 634 (6), 633 (13) (M+), 604 (17), 578 (23), 577 (43), 
576 (100), 479 (12), 478 (34), 437 (23), 436 (35), 435 (96), 425 (10), 424 (28), 423 (42), 381 
(20), 280 (39), 279 (25), 270 (32), 239 (14), 223 (22), 221 (14), 212 (13), 211 (13), 200 (17), 199 
(97), 181 (14), 178 (16), 169 (11), 168 (12), 161 (10), 156 (18), 143 (11), 135 (13), 133 (12), 124 
(16), 116 (12), 115 (91), 108 (10), 103 (16), 87 (64) 
 
HRMS (EI) Calcd. for C35H63NO3SSi2-C4H9: 576.336300. Found: 576.336351 
 
4.12.14 Synthesis of (5S,8R,9S,E)-5,9-Di(but-3-enyl)-11,11-diethyl-8-isopropyl-2,2,3,3-
tetramethyl-6-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-4,10-dioxa-3,11-disilatridec-6-ene (S-
138).  
 
iPr
OSiEt3
S
Ph
O NMe
OSitBuMe2
S-138 
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Following GP12, reaction of alcohol S-92 (190 mg, 0.37 mmol) afforded the silyl ether S-138 
(222 mg, 96%) as a viscous liquid.  
 
Rf = 0,28 (cyclohexane/EtOAc, 10:1) 
 
[α]D = +8.4 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.13 (s, 3 H, Si-CH3), 0.31 (s, 3 H, Si-CH3), 0.77 (q, J = 7.9 Hz, 
6 H, Si-CH2), 0.99 (d, J = 6.8 Hz, 3 H, CH3), 1.08 (s, 9 H, Si-C-(CH3)3), 1.09 (d, J = 6.8 Hz, 3 H, 
CH3), 1.16 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.61−1.73 (m, 1 H, CHOSi-CHH), 1.74−1.86 (m, 1 H, 
CHOSi-CHH), 2.03−2.23 (m, 4 H, CHOSi(CH2CH3)3-CHH-CHH-CH=CH2, CHOSi-CH2-CHH-
CH=CH2, CH-(CH3)2), 2.24−2.48 (m, 3 H, CHOSi(CH2CH3)3-CHH-CHH, CHOSi-CH2-CHH), 
2.67−2.76 (m, J = 11.1, J = 6.8 Hz, 1 H, CH-CH=C-S), 3.08 (s, 3 H, N-CH3), 4.10 (ddd, J = 7.4, J = 
4.6, J = 2.3 Hz, 1 H, CH-OSi), 5.07−5.11 (dd, J = 10.2, J = 6.9 Hz, 2 H, CHOSi-CH2-CH2-
CH=CHH, CHOSi(CH2CH3)3-CH2-CH2-CH=CHH), 5.12−5.15 (dd, J = 6.8, J = 1.1 Hz, 1 H, CH-
OSi(CH3)2C(CH3)3), 5.15−5.24 (ddd, J = 17.1, J = 3.3, J = 1.7 Hz, 2 H, -CHOSi-CH2-CH2-
CH=CHH, CHOSi(CH2CH3)3-CH2-CH2-CH=CHH), 5.84−5.99 (m, J = 17.1 , J = 10.2, J = 6.5 Hz, 2 
H, CHOSi(CH2CH3)3-CH2-CH2-CH=CH2, CHOSi-CH2-CH2-CH=CH2), 7.12−7.22 (m, 3 H, Ph), 7.39 
(d, J = 11.1 Hz, 1 H, CH=C-S), 8.11−8.18 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ -4.7 (d), -3.6 (d), 5.9 (u), 7.3 (d), 18.6 (u), 21.6 (d), 21.7 (d), 
26.6 (d), 29.6 (d), 29.7 (d), 31.2 (u), 31.3 (u), 36.6 (u), 39.1 (u), 50.6 (d), 70.0 (d), 73.1 (d), 114.9 
(u), 115.2 (u), 128.8 (d), 129.2 (d), 131.8 (d), 138.3 (d), 138.4 (d), 142.1 (u), 144.5 (d), 144.9 (u) 
 
IR (capillar) ν 2954 (s), 2806 (w), 1640 (w), 1463 (m), 1379 (w), 1249 (s), 1150 (s), 1080 (s), 
1005 (w), 912 (w), 842 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 634 (3), 633 (6) (M+), 604 (16), 578 (21), 577 (38), 
576 (85), 479 (12), 478 (31), 437 (18), 436 (27), 435 (67), 424 (26), 423 (32), 381 (18), 304 (11), 
280 (32), 279 (21), 270 (31), 223 (16), 221 (15), 211 (15), 200 (17), 199 (100), 181 (13), 178 
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(17), 169 (10), 168 (15), 161 (11), 156 (15), 143 (11), 135 (12), 133 (13), 125 (16), 116 (11), 115 
(86), 108 (10), 103 (14), 87 (61) 
 
HRMS (EI) Calcd. for C35H63NO3SSi2-C4H9: 576.336300. Found: 576.336341 
 
4.12.15 General Procedure for the RCM Reaction of Trienes R-137, S-137, R-138 and S-138 
(GP13). 
 
To a solution of the ruthenium complex 30 (0.024 mmol) in CH2Cl2 (90 mL) was added a 
solution of the corresponding triene (0.49 mmol) in CH2Cl2 (8 mL). The mixture was stirred at 
reflux for 16 h, after which time all of the starting material was consumed as indicated by TLC. 
Then the mixture was cooled and filtered through a short pad of silica gel, and the solvent was 
removed in vacuum. Purifcation by flash chromatograph and subsequently by HPLC (if 
necessary) gave carbocycles. 
 
4.12.16 Synthesis of tert-Butyl((1R,2E,4S,5S,6Z)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethyl-ilyloxy)cyclonona-2,6-dienyloxy)dimethylsilane (R-139).  
 
iPr
Et3SiO
S
Ph
O NMe
OSitBuMe2  R-139 
 
Following GP13, reaction of triene R-137 (100 mg, 0.16 mmol) afforded after purifcation by flash 
chromatography carbocycle R-139 (84 mg, 90%) as a viscous liquid.  
 
Rf = 0,28 (cyclohexane/EtOAc, 10:1) 
 
[α]D = + 22.3 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ −0.11 (s, 3 H, Si-CH3), 0.13 (s, 3 H, Si-CH3) 0.73 (q, J = 7.9 
Hz, 6 H, Si-CH2), 0.94 (s, 9 H, Si-C(CH3)3), 1.02 (d, J = 6.6 Hz, 3H, CH3), 1.07 (d, J = 6.6 Hz, 3 H, 
CH3), 1.13 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.83−1.93 (m, J = 12.9, J = 4.0, J = 2.7 Hz , 1 H, CH-
OSi(CH3)2C(CH3)3-CHH’-CHH), 1.94−1.97 (m, J = 7.0, J = 6.6 Hz, 1 H, CH-(CH3)2), 1.98−2.02 (m, 
J = 7.0 Hz, 1 H, CH-OSi(CH3)2C(CH3)3-CHH’-CHH’), 2.18−2.26 (m, J = 9.2, J = 3.0, J = 1.6 Hz, 1 
H, CH-CH=C-S), 2.97−3.13 (m, J = 12.9, J = 4.0, J = 2.7 Hz, 1 H,CH-OSi(CH3)2C(CH3)3-CH2’-
CHH’), 3.30 (s, 3 H, N-CH3), 3.32−3.48 (m, J = 12.9, J = 2.7 Hz, 1 H, CH-OSi(CH3)2C(CH3)3-
CHH’-CHH’), 4.57 (dd, J = 6.3, J = 1.6 Hz, 1 H, CH-OSi(CH2CH3)3), 5.07 (dd, J = 11.6, J = 5.0 Hz, 
1 H, CH-OSi(CH3)2C(CH3)3), 5.58−5.62 (ddd, J = 11.6, J = 11.3, J = 5.6 Hz, 1 H, CHOSi-CH=CH), 
5.63−5.66 (m, J = 11.6, J = 6.3 Hz, 1 H, CHOSi-CH=CH), 7.10−7.20 (m, 3 H, Ph), 7.24 (d, J =9.2 
Hz, 1 H, CH=CH), 8.26−8.36 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ –4.9 (d), –4.5 (d), 5.2 (u), 7.2 (d), 18.7 (u), 20.7 (d), 21.5 
(d), 25.9 (u), 26.23 (d), 30.0 (d), 52.4 (d), 70.7 (d), 73.7 (d), 128.1 (d), 128.5 (d), 131.2 (d), 133.3 
(d), 133.4 (d), 141.3 (u), 143.7 (u), 145.2 (d) 
 
IR (capillar) ν 2950 (s), 1459 (m), 1242 (s), 1147 (w), 1073 (s), 984 (w), 860 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 578 (0.5) (M+), 548 (3), 452 (3), 434 (12), 432 (16), 
422 (17), 395 (6), 380 (17), 379 (25), 309 (12), 308 (38), 298 (16), 293 (15), 292 (16), 291 (44), 
290 (24), 280 (12), 279 (34), 278 (11), 275 (17), 271 (12), 270 (52), 267 (14), 266 (66), 265 
(100), 264 (15), 263 (24), 251 (10), 247 (30), 239 (30), 238 (10), 237 (41), 235 (18), 234 (22), 
223 (10), 222 (26), 221 (27), 212 (22), 211 (16), 209 (17), 205 (16), 197 (18), 176 (39), 161 (18), 
159 (11), 158 (11), 157 (11), 155 (56), 148 (50), 147 (12), 138 (15), 132 (26), 124 (62), 117 (12), 
116 (11), 115 (45), 106 (24), 104 (11), 102 (21), 91 (14), 87 (50) 
 
HRMS (EI) Calcd for C31H55NO3SSi2-C4H9: 520.27370. Found: 520.27384 
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1H {1H }-NOE-Experiment (500 MHz, C6D6) of R-139 
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4.12.17 Synthesis of tert-Butyl((1S,2E,4S,5S,6Z)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5-(triethylsilyloxy)cyclonona-2,6-dienyloxy)dimethylsilane (S-139).  
 
iPr
Et3SiO
S
OSitBuMe2
Ph
O NMe
 S-139 
 
Following GP13, reaction of triene S-137 (156 mg, 0.25 mmol) afforded after purifcation by flash 
chromatography carbocycle S-139 (116 mg, 80%) as a viscous liquid.  
 
Rf  = 0,30 (cyclohexane/EtOAc, 1:10) 
 
[α]D = − 46.3 (c = 1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ −0.22 (s, 3 H, Si-CH3), 0.10 (s, 3 H, Si-CH3), 0.73 (q, J = 7.9 
Hz, 6 H, Si-CH2), 0.95 (s, 9 H, Si-C(CH3)3), 1.11 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.13 (d, J = 6.0 
Hz, 3 H, CH3),1.18 (d, J = 6.0 Hz, 3 H, CH3), 1.76−1.88 (m, 2 H, CH-OSi(CH3)2C(CH3)3-CHH’-
CHH’), 1.89−2.02 (m, J = 3.3 Hz, 1 H, CH-OSi(CH3)2C(CH3)3-CHH’-CHH’), 2.36−2.49 (m, J = 
11.9 Hz, J = 6.0 Hz, 1 H, CH-(CH3)2), 2.56−2.70 (m, J = 11.5 Hz, J = 6.5 Hz, 1 H, CH-
OSi(CH3)2C(CH3)3-CHH’-CHH’), 3.12 (s, 3 H, N-CH3), 3.57 (m, J = 12.1, J = 4.3 Hz, 1 H, CH-
CH=CH-S), 4.90 (dd, J = 4.3, J = 2.4 Hz, 1 H, CHOSi(CH2CH3)3), 5.17 (dd, J = 3.3 Hz, 1 H, CH-
OSi(CH3)2C(CH3)3), 5.35−5.45 (ddd, J = 11.9, J = 11.5, J = 6.0 Hz, 1 H, CHOSi(CH2CH3)3-
CH=CH), 5.46−5.52 (m, J = 11.9, J = 2.4 Hz, 1 H, CHOSi(CH2CH3)3-CH=CH), 7.06−7.13 (m, 3 H, 
Ph), 7.22 (d, J = 12.1 Hz, 1 H, CH-CH=C), 8.06−8.13 (m, 2 H, Ph) 
  
13C NMR (75 MHz, C6D6, TMS)  δ −5.7 (d), −4.0 (d), 5.6 (u), 7.3 (d), 18.3 (u), 21.0 (d), 21.0 
(d), 22.3 (u), 26.2 (d), 28.5 (d), 29.8 (d), 34.1 (u), 51.3 (d), 69.0 (d), 71.7 (d), 128.8 (d), 129.0 (d), 
129.4 (d), 131.9 (d), 135.2 (d), 141.2 (u), 141.4 (u), 146.0 (d) 
 
IR (CHCl3) ν 2951 (s), 1461 (m), 1244 (s), 1148 (w), 1072 (s), 998 (w), 839 (m) 
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MS (EI, 70 eV) (relative intensity, %) m/z 578 (0.5) (M+), 548 (6), 452 (9), 424 (12), 423 (38), 
422 (100), 395 (14), 381 (10), 380 (29), 379 (55), 320 (9), 298 (22), 292 (11), 291 (39), 279 (7), 
277 (9), 275 (9), 270 (14), 265 (19), 264 (42), 247 (30), 212 (16), 124 (12), 115 (16), 87 (19) 
 
HRMS (EI) Calcd. for C31H55NO3SSi2-CH3N: 548.317576. Found: 548.317247 
 
1H {1H }-NOESY-Experiment (400 MHz, C6D6) of S-139 
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4.12.18 Synthesis of 8.17 Synthesis of tert-Butyl((1R,2E,4S,5S,8Z) and tert-
butyl((1R,2E,4S,5S,8E)-4-isopropyl-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5-(triethyl-
silyloxy)cycloundeca-2,8-dienyloxy)dimethylsilane (R,Z-140) and (R,E-140).  
 
Following GP13, reaction of triene R-138 (100 mg, 0.16 mmol) afforded after purification by flash 
chromatography (cyclohexane/EtOAc, 1:5) and subsequently HPLC (Chromasil Si 100, 30 mm, 
cyclohexane/EtOAc, 93:7) carbocycles R,Z-140 (67 mg, 70 %) and R,E-140 (4 mg, 4 %) as viscous 
liquids. 
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iPr
Et3SiO
OSitBuMe2
S
Ph
O NMe
 R,Z-140, 
iPr
Et3SiO
OSitBuMe2
S
Ph
O NMe
 R,E-140 
 
R,Z-140 
 
Rf  = 0.46 (cyclohexane/EtOAc, 1:5) 
 
[α]D = + 39.9 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ −0.38 (s, 3 H, Si-Me), 0.06 (s, 3 H, Si-Me), 0.68 (q, J = 7.97 
Hz, 6 H, Si-CH2), 0.85 (d, J = 6.4 Hz, 3 H, CH3), 0.89 (s, 9 H, Si-C(CH3)3), 0.94 (d, J = 6.4 Hz, 3 H, 
CH3), 1.08 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.37−1.46 (m, J = 4.6 Hz, 1 H, CHOSi(CH2CH3)3-
CHH), 1.70−1.86 (m, 3 H, CHOSi(CH2CH3)3-CH2-CHH, CH-OSi(CH3)2C(CH3)3-CHH, CH-(CH3)2), 
1.91−2.01 (m, 1 H, CHOSi(CH2CH3)3-CHH-CH2), 2.10−2.20 (m, J = 8.0, J = 3.4 Hz, 1 H, 
CHOSi(CH2CH3)3-CH2-CHH, CH-OSi(CH3)2C(CH3)3-CH2-CHH), 2.76–2.84 (m, J = 11.5, J = 3.3, J 
= 1.5 Hz, 1 H, CH-CH=CH-S), 3.08 (s, 3 H, N-CH3), 3.29 (m, J = 11.9, J = 2.8 Hz, 1 H CH-
OSi(CH3)2C(CH3)3-CHH-CH2), 3.98 (ddd, J = 7.9, J = 2.8, J = 1.3 Hz, 1 H, CHOSi(CH2CH3)3), 4.81 
(dd, J = 11.5, J = 3.9 Hz, 1 H, CH-OSi(CH3)2C(CH3)3), 5.36 (dd, J = 10.7, J = 7.6, J = 1.1 Hz 1 H, 
CHOSi(CH2CH3)3-CH=CH), 5.44 (m, J = 10.7, J = 6.4 Hz, 1 H, CHOSi(CH2CH3)3-CH=CH), 
6.95−7.07 (m, 3 H, Ph), 7.50 (dd, J = 11.5 Hz, 1 H, CH=CH-S), 8.14−8.18 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ −4.8 (d), −4.0 (d), 5.7 (u), 7.3 (d), 18.4 (u), 20.9 (d), 21.1 
(d), 22.6 (u), 24.0 (u), 26.4 (d), 30.0 (d), 31.1 (d), 35.4 (u), 37.5 (u), 49.6 (d), 71.0 (d), 73.0 (d), 
127.8 (d), 130.1 (d), 133.6 (d), 141.8 (d), 144.2 (u), 146.7 (d) 
 
IR (capillar) ν 3317 (w), 2950 (s), 2359 (w), 1642 (w), 1459 (s), 1378 (w), 1245 (s), 1148 (m), 
1081 (s), 1014 (m), 850 (s) 
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MS (EI, 70 eV) (relative intensity, %) m/z 605 (5) (M+), 576 (19), 550 (12), 549 (26), 548 (60), 
519 (12), 480 (11), 450 (12), 407 (21), 393 (20), 365 (14), 319 (25), 318 (38), 304 (12), 303 (12), 
275 (31), 271 (17), 270 (82), 261 (19), 251 (11), 240 (10), 235 (14), 226 (10), 225 (11), 223 (12), 
214 (40), 213 (10), 212 (25), 211 (14), 210 (13), 199 (18), 197 (11), 187 (20), 186 (25), 185 (22), 
184 (12), 171 (41), 161 (16), 160 (13), 157 (15), 156 (71), 145 (14), 143 (23), 138 (11), 135 (29), 
133 (16), 131 (18), 128 (12), 125 (43), 119 (15), 117 (24), 116 (13), 115 (66), 109 (18), 108 (14), 
107 (21), 105 (21), 104 (11), 103 (33), 97 (13), 93 (15), 91 (21), 88 (11), 87 (100), 81 (11) 
 
HRMS (EI) Calcd. for C33H59NO3SSi2: 605.375452. Found: 605.375549 
 
1H {1H }-NOE-Experiment (500 MHz, C6D6) of R,Z-140 
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SiCH2CH3 w m w
SiCH3 m w w m m w
SiCH3 w m m m w
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R,E-140: 
 
Rf  = 0.43 (cyclohexane/EtOAc, 1:5) 
 
[α]D = +6.9 (c  0.25, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ −0.23 (s, 3 H, Si-Me), 0.11 (s, 3 H, Si-Me), 0.64 (q, J = 7.9 Hz, 
6 H, Si-CH2), 0.80 (d, J = 6.9 Hz, 3 H, CH3), 0.87 (s, 3 H, Si-C(CH3)3), 0.97 (d, J = 6.9 Hz, 3 H, 
CH3), 1.07 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.51−1.61 (m, 1 H, CHOSi(CH2CH3)3-CH2-CHH), 
1.63−1.76 (m, 2 H, CHOSi(CH2CH3)3-CH2-CH2), 1.80−1.90 (m, J = 6.9 Hz, 1 H, CH-(CH3)2), 
2.01−2.19 (m, 3 H, CHOSi(CH2CH3)3-CH2-CHH, CH-OSi(CH3)2C(CH3)3-CHH-CHH), 2.32−2.40 
(m, 1 H, CH-OSi(CH3)2C(CH3)3-CH2-CHH), 2.44 (m, J = 10.6, J=7.8, J = 2.3 Hz, 1 H, CH-CH=CH-
S), 3.09 (s, 3 H, N-CH3), 3.14−3.26 (m, 1 H, CH-OSi(CH3)2C(CH3)3-CHH-CH2), 3.94 (m, J = 9.8, J 
= 4.1, J = 2.2 Hz, 1 H, CH-OSi(CH2CH3)3), 4.65 (m, J = 7.7, J = 2.5 Hz, 1 H, CH-
OSi(CH3)2C(CH3)3), 5.32−5.40 (dd, J = 15.6, J = 8.0, J = 4.2, J = 0.9 Hz 1 H, CHOSi(CH2CH3)3 –
CH2-CH2-CH=CH), 5.41−5.50 (m, J = 15.6, J = 7.7, J = 4.8, J = 1.1 Hz, 1 H, CHOSi(CH2CH3)3 –
CH2-CH2-CH=CH), 6.95−7.07 (m, 3 H, Ph), 7.23 (d, J = 10.6 Hz, 1 H, CH-CH=C-S), 8.20−8.24 (m, 
2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ −4.1 (d), −4.0 (d), 5.9 (u), 7.3 (d), 18.4 (u), 21.2 (d), 21.8 
(d), 26.3 (d), 26.3 (u), 29.8 (d), 30.0 (d), 30.8 (u), 37.0 (u), 37.6 (u), 49.8 (d), 72.3 (d), 74.0 (d), 
128.4 (d), 128.8 (d), 130.8 (d), 131.1 (d), 132.2 (d), 143.4 (d), 143.9 (u) 
 
IR (capillar) ν 3316 (w), 2949 (s), 2359 (w), 1641 (w), 1459 (s), 1378 (w), 1245 (s), 1148 (m), 
1081 (s), 1014 (m), 850 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 605 (6) (M+), 576 (10), 550 (6), 549 (15), 548 (38), 
519 (5), 462 (15), 450 (7), 407 (15), 393 (12), 365 (4), 319 (15), 318 (31), 304 (20), 303 (12), 276 
(12), 275 (33), 271 (12), 270 (68), 265 (12), 262 (12), 261 (18), 250 (18), 239 (12), 236 (12), 235 
(11), 225 (9), 224 (10), 223 (8), 213 (12), 212 (6), 211 (28), 203 (12), 199 (26), 196 (12), 188 
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(10), 187 (15), 186 (23), 185 (17), 184 (8), 171 (39), 168 (11), 166 (10), 161 (18), 160 (18), 159 
(11), 158 (11), 157 (22), 155 (79), 147 (12), 146 (10), 145 (27), 144 (11), 142 (31), 139 (11), 137 
(11), 134 (24), 132 (18), 131 (24), 130 (16), 128 (23), 124 (64), 119 (13), 118 (16), 117 (16), 116 
(27), 115 (68), 108 (29), 107 (22), 106 (21), 105 (26), 104 (18), 103 (45), 96 (15), 94 (13), 93 
(14), 92 (12), 91 (36), 88 (11), 87 (100), 81 (16) 
 
4.12.19. Synthesis of ((1S,4E,8S,9R,10E,12S,15E,19S,20E,22R)-12,19-Bis(tert-
butyldimethylsilyloxy)-9,22-diisopropyl-11,20-bis-(S)-N-methyl-S-phenyl-sulfonimi 
doyl)-cyclodocosa-4,10,15,20-tetraene-1,8-diyl)bis(oxy)bis(triethylsilane) and ((1S,2R 
,3E,5S,8E,12S,13R,14E,16S,19E)-5-(tert-Butyldimethylsilyloxy)-2,13-diisopropyl-4,15-bis-
(S)-N-methyl-S-phenyl-sulfonimidoyl)-16-((2,3,3-trimethylbutan-2-yl)silyloxy)cyclodocosa-
3,8,14,19-tetraene-1,12-diyl)bis(oxy)bis(triethylsilane) (S-141) and (S-142). 
 
 
Following GP13, reaction of triene S-111 (110 mg, 0.17 mmol) afforded after separation by flash 
chromatography (cyclohexane/EtOAc, 1:5) carbocycles S-141 (36 mg, 34%) and S-142 (38 mg, 
36%) as viscous liquids. 
 
SMe2BuSitO
S
Et3SiO
iPriPr
Et3SiO
OSitBuMe2
Ph
O NMe
Ph
OMeN
SEt3SiO
Et3SiO
iPr
OSitBuMe2
Ph
O NMe
Pri
S
Ph
O NMe
OSitBuMe2
 
 
((1S,4E,8S,9R,10E,12S,15E,19S,20E,22R)-12,19-Bis(tert-butyldimethylsilyloxy)-9,22-
diisopropyl-11,20-bis-(S)-N-methyl-S-phenyl-sulfonimidoyl)-cyclodocosa-4,10,15,20-tetraene-
1,8-diyl)bis(oxy)bis(triethylsilane) (S-141).  
 
Rf = 0.38 (cyclohexane/EtOAc, 1:5) 
 
[α]D = +22.8 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.16 (s, 3 H, Si-CH3); 0.32 (s, 3 H, Si-CH3); 0.82 (q, J = 7.9 
Hz, 6 H, Si-CH2), 1.13 (s, 9 H, Si-C-(CH3)3), 1.20 (d, J = 6.6 Hz, 3 H, CH3), 1.22 (t, J = 7.9 Hz, 9 H, 
Si-CH2-CH3), 1.28 (d, J = 6.6 Hz, 3 H, CH3), 1.66−1.76 (m, 1 H, CHOSi(CH2CH3)3-CHH-CH2-
CH=CH2), 1.78−1.88 (m, 1 H, CHOSi(CH2CH3)3-CHH-CH2-CH=CH2), 2.12−2.26 (m, 2 H, 
CHOSi(CH3)2C(CH3)3-CHH-CHH-CH=CH2), 2.27−2.36 (m, 1 H, CHOSi(CH2CH3)3-CH2-CHH-
CH=CH2, CH-(CH3)2), 2.63−2.73 (m, 1 H, CHOSi(CH3)2C(CH3)3-CH2-CHH-CH=CH2), 3.05 (dd, J 
= 11.4, J = 7.0 Hz, 1 H, CH-CH=C-S), 3.18 (s, 3 H, N-CH3), 4.17 (ddd, J = 7.5, J = 4.9, J = 1.0 Hz, 1 
H, -CHOSi(CH2CH3)3), 5.31 (m, J = 7.8, J = 5.0 Hz, 1 H, CHOSi(CH3)2C(CH3)3), 5.60 (m, J = 3.5 
Hz, 1 H, CHOSi(CH2CH3)3-CH2-CH2-CH=CH), 5.63 (m, J = 3.4 Hz, 1 H, CHOSi(CH2CH3)3-CH2-
CH2-CH=CH), 7.14−7.21 (m, 3 H, Ph), 7.61 (d, J = 11.1 Hz, 1 H, CH=C-S), 8.16−8.28 (m, 2 H, Ph)  
  
13C NMR (100 MHz, C6D6, TMS)  δ −4.9 (d), −3.8 (d), 5.9 (u), 7.3 (d), 18.4 (u), 20.2 (d), 21.9 
(d), 26.4 (d), 29.7 (d), 30.1 (u), 30.5 (d), 31.0 (u), 37.8 (u), 39.9 (u), 48.3 (d), 70.6 (d), 72.8 (d), 
127.6 (d), 127.8 (d), 128.1 (d), 129.6 (d), 129.8 (d), 131.7 (d), 141.1 (u), 143.9 (d), 144.5 (u) 
 
IR (capillar) ν 2946 (s), 2354 (w), 1459 (m), 1381 (w), 1247 (s), 1145 (m), 1080 (s), 963 (w), 
843 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z  1154 (1) (M+), 999 (1), 857 (1), 478 (1), 380 (1), 369 
(2), 339 (1), 305 (1), 301 (1), 270 (9), 265 (7), 240 (4), 212 (8), 211 (11), 171 (14), 155 (16), 125 
(62), 115 (25), 107 (100), 97 (27), 87 (20) 
 
((1S,2R,3E,5S,8E,12S,13R,14E,16S,19E)-5-(tert-Butyldimethylsilyloxy)-2,13-diiso 
propyl-4,15-bis-(S)-N-methyl-S-phenyl-sulfonimidoyl)-16-((2,3,3-trimethylbutan-2-
yl)silyloxy)cyclodocosa-3,8,14,19-tetraene-1,12-diyl)bis(oxy)bis(triethylsilane) (S-142). 
 
Rf = 0.36 (cyclohexane/EtOAc, 1:5) 
 
[α]D = +32.0 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.13 (s, 3 H, Si-CH3)-CHOSi(CH2CH3)3-CH2-CH2-CH=CH2), 
0.30 (s, 3 H, Si-CH3), 0.79 (q, J = 7.9 Hz, 6 H, Si-CH2), 1.09 (s, 9 H, Si-C-(CH3)3), 1.13 (d, J = 6.2 
Hz, 3 H, CH3), 1.18 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.21 (d, J = 6.2 Hz, 3 H, CH3), 1.62−1.81 (m, 2 
H, -CHOSi(CH2CH3)3-CH2-CH2-CH=CH2), 1.96−2.06 (m, 2 H, -CHOSi(CH3)2C(CH3)3-CH2-CH2-
CH=CH2), 2.07−2.22 (m, 2 H, CHOSi(CH2CH3)3-CH2-CH2-CH=CH2), 2.23−2.32 (m, 2 H, 
CHOSi(CH3)2C(CH3)3-CH2-CHH-CH=CH2, CH-(CH3)2), 2.62−2.73 (m, 1 H, CHOSi(CH3)2C(CH3)3-
CH2-CHH-CH=CH2), 2.97 (dd, J = 11.5, J = 7.3 Hz, 1 H, CH-CH=C-S), 3.13 (s, 3 H, N-CH3), 4.11 
(ddd, J = 6.1, J = 1.0 Hz, 1 H, -CHOSi(CH2CH3)3), 5.31 (m, J = 8.2, J = 4.3 Hz, 1 H, 
CHOSi(CH3)2C(CH3)3), 5.49−5.63 (m, J = 5.3 Hz, 2 H, CHOSi(CH2CH3)3-CH2-CH2-CH=CH), 
7.20−7.29 (m, 3 H, Ph), 7.58 (d, J = 11.5 Hz, 1 H, CH-CH=C-S), 8.10−8.15 (m, 2 H, Ph) 
  
13C NMR (100 MHz, C6D6, TMS)  δ −4.9 (d), −3.7 (d), 6.0 (u), 7.4 (d), 18.5 (u), 20.3 (d), 22.0 
(d), 26.4 (d), 29.7 (u), 29.8 (d), 30.5 (d), 31.3 (u), 37.5 (u), 40.0 (u), 48.7 (d), 70.6 (d), 72.8 (d), 
127.6 (d), 127.8 (d), 128.1 (d), 129.5 (d), 129.7 (d), 131.9 (d), 141.1 (u), 144.3 (d), 144.4 (u) 
 
IR (capillar) ν 2949 (s), 1458 (m), 1332 (s), 1242 (s), 1145 (m), 1080 (s), 1009 (w), 970 (w), 845 
(m), 748 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z  1184 (1) (M+), 1183 (1), 999 (1), 858 (1), 857 (1), 451 
(1), 369 (1), 339 (1), 319 (1), 291 (1), 279 (1), 277 (1), 240 (2), 212 (4), 211 (3), 171 (4), 155 
(16), 125 (60), 115 (1), 107 (100), 95 (25), 87 (10) 
 
 
4.12.20. Synthesis of (5R,6R,7E,12E,17E,19R,20S)-3,3,22,22-tetraethyl-6,19-diisopropyl-
8,17-bis-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5,20-di((E)-prop-1-enyl)-4,21-dioxa-3,22-
disilatetracosa-7,12,17-triene-9,16-dione (147) 
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iPr
S
Et3SiO
Ph
O NMe
O O
S
iPr
Et3SiO
Ph
OMeN 147 
 
Following GP13, reaction of triene 107 (100 mg, 0.2 mmol) afforded after purification by flash 
chromatography (cyclohexane/EtOAc, 1:9) pentaen 147 (82 mg, 84%) as viscous liquid. 
 
Rf = 0.32 (EtOAc/cyclohexane 1:9)  
 
[α]D = + 19.4 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.57 (q, J = 7.9 Hz, 12 H, Si-CH2), 0.82 (d, J = 6.9 Hz, 6 H, 
CH3), 0.90 (d, J = 6.8 Hz, 6 H, CH3), 0.99 (t, J = 7.9 Hz, 18 H, Si-CH2-CH3), 1.50(dd, J = 5.7 Hz, 6 
H, CH=CH-CH3), 1.91 (m, J = 6.7, J = 3.7 Hz, 2 H, CH-(CH3)2), 2.00 (ddd, J = 11.6, J = 7.8, J = 3.7 
Hz, 2 H, CH-CH=C-S), 2.45 (ddd, J = 13.9, J = 7.1, J = 1.3 Hz, 4 H, CO-CH2-CH2), 2.91 (dd, J = 
18.4, J = 7.6 Hz, 2 H, CO-CHH’), 3.02 (s, 3 H, N-CH3), 3.05 (dd, J = 18.4, J = 7.3 Hz, 2 H, CO-
CHH’), 4.24 (dd, J = 7.2, J = 3.6 Hz, 2 H, CH-OSi), 5.30 (m, 4 H, CH=CH-CH3), 5.49 (dd, J = 4.0, J 
= 3.6 Hz, 2 H, CH2-CH=CH), 6.98–7.08 (m, 6 H, Ph), 7.01 (d, J = 11.7 Hz, 2 H, CH-CH=C), 8.10–
8.13 (m, 4 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.5 (d), 20.4 (d), 21.2 (d), 26.7 (u), 28.8 
(d), 29.7 (d), 45.3 (u), 54.1 (d), 74.4 (d), 126.6 (d), 128.7 (d), 129.0 (d), 132.1 (d), 133.9 (d), 
134.0 (d), 141.1 (u), 144.2 (d), 146.0 (u), 199.8 (u)  
 
IR (CHCl3) ν  2956 (s), 2808 (w), 1701 (s), 1451 (s), 1377 (m), 1254 (s), 1151 (s), 1076 (s), 1010 
(s), 972 (s), 858 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 950 (0.5) (M+-C2H5), 420 (5), 295 (3), 265 (3), 240 
(4), 223 (2), 186 (17), 185 (100), 157 (5), 156 (3), 115 (44), 103 (19), 87 (29), 75 (19) 
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4.13. Transformations of Sulfoximine-Substituted Carbocycles 
 
4.13.1. Synthesis of (1R,2E,4S,5S,8Z)-4-Isopropyl-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5-
(triethylsilyloxy)cycloundeca-2,8-dienol (150).  
 
iPr
Et3SiO
OH
S
Ph
O NMe
150 
 
To a solution of the bissilyl ether R,Z-140 (60 mg, 0.10 mmol) in THF (3 mL) mixture of THF (2 
mL), H2O (2 mL) and AcOH (1 mL) was added. The mixture was stirred at ambient temperatures for 
3 h, after which time all of the starting material was consumed as indicated by TLC. Then the 
mixture was added slowly to half saturated aqueous NaHCO3. The resulting mixture was extracted 
with EtOAc. The combined organic phases were dried (Na2SO4) and concentrated in vacuum. Dienol 
150 (47 mg, 96 %) was obtained as a colorless oil.  
 
Rf = 0.28 (cyclohexane/EtOAc, 5:1) 
 
[α]D = + 24.0 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.59 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.93 (d, J = 6.8 Hz, 3 H, 
CH3), 0.98 (d, J = 6.8 Hz, 3 H, CH3), 1.01 (t, 9 H, Si-CH2-CH3), 1.17−1.24 (m, J = 11.2, J = 7.0, J = 
2.7 Hz, 1 H, CHOSi-CHH), 1.45−1.56 (m, 1 H, CHOSi-CHH), 1.56−1.65 (m, 1 H, CHOSi-CH2-
CHH), 1.65−1.75 (m, 2 H, CH-(CH3)2, CHOSi-CH2-CHH), 1.96−2.04 (m, 2 H, CHOH-CH2-CH2), 
2.04−2.14 (m, 1 H, CHOH-CHH), 2.39 (m, J = 12.1, J = 3.7 Hz, 1 H, CHOH-CHH), 2.66−2.72 (m, J 
= 11.2, J = 7.2, J = 3.0 Hz, 1 H, CH-CH=C-S), 2.81 (s, 3 H, N-CH3), 3.89 (m, J = 7.1, J = 3.9, J = 
2.1 Hz, 1 H, CH-OSi), 4.77 (m, J = 12.1, J = 4.1 Hz, 1 H, CH-OH), 5.12 (dd, J = 10.9, J = 7.6 Hz, 1 
H, CHOSi-CH2-CH2-CH=CH), 5.22 (dd, J = 10.9, J = 7.1, J=5.6 Hz, 1 H, CHOSi-CH2-CH2-
CH=CH), 7.00−7.10 (m, 3 H, Ph), 7.47 (d, J = 11.2 Hz, 1 H, CH=C-S), 7.92−7.96 (m, 2 H, Ph)  
 
EXPERIMENTAL PART 
 
 
215
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 20.1 (d), 20.9 (d), 21.6 (u), 23.5 (u), 29.4 
(d), 31.2 (d), 36.0 (u), 36.5 (u), 48.9 (d), 69.3 (d), 73.5 (d), 128.4 (d), 128.9 (d), 128.9 (d), 130.3 
(d), 131.8 (d), 131.8 (d), 141.6 (u), 142.7 (u), 146.7 (d) 
 
IR (capillar) ν 3292 (m), 3065 (w), 2956 (s), 2808 (w), 2358 (w), 1739 (m), 1447 (s), 1416 (w), 
1376 (m), 1243 (s), 1153 (s), 1082 (s), 1016 (s), 859 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 494 (14), 493 (35), 492 (100) (M++1), 491 (10), 490 
(23), 476 (5), 462 (22), 366 (6), 318 (4), 270 (11), 213 (5), 203 (5), 186 (4), 170 (4), 155 (19), 
124 (12), 106 (5), 87 (4) 
 
HRMS (EI) Calcd for C27H45NO3SSi: 491.288946. Found: 491.288989 
 
4.13.2 Synthesis of (2E,4S,5S,8Z)-4-Isopropyl-2-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-5-
(triethylsilyloxy)-cycloundeca-2,8-dienone (151).  
 
iPr
Et3SiO
O
S
Ph
O NMe
151 
 
Following GP8, reaction of alcohol 150 (40 mg, 0.08 mmol) with Dess-Martin periodinane (0.12 
mmol, 339 mg, 15 wt% solution in CH2Cl2) afforded enone 151 (37 mg, 96%) as viscous liquids.  
 
Rf = 0.35 (cyclohexane/EtOAc, 1:7) 
 
[α]D = + 198.2 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.55 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.87 (d, J = 6.8 Hz, 3 H, 
CH3), 0.89 (d, J = 6.8 Hz, 3 H, CH3), 0.98 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.33−1.43 (m, J = 9.3, J 
= 5.6 Hz, 1 H, CHOSi-CHH-CH2-CH=CH), 1.44−1.55 (m, J = 7.3, J = 2.9 Hz, 1 H, CHOSi-CHH-
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CH2-CH=CH), 1.68−1.83 (m, J = 7.4, J = 3.2 Hz, 2 H, CHOSi-CH2-CH2), 1.84−1.94 (m, J = 6.8, J = 
1.4 Hz, 1 H, CH-(CH3)2), 2.11−2.21 (m, J = 8.9, J = 2.4 Hz, 1 H, CO-CH2-CHH), 2.44−2.53 (m, J = 
6.8 Hz, 1 H, CO-CH2-CHH), 2.64−2.71 (m, J = 8.5, J = 2.9 Hz, 1 H, CO-CHH), 2.72−2.78 (m, J = 
11.6, J = 3.2 Hz, 1 H, CH-CH=C-S), 3.02−3.09 (m, J = 7.1, J = 2.6 Hz, 1 H, CO-CHH), 3.10 (s, 3 H, 
N-CH3), 3.81 (m, J = 9.6, J = 3.0 Hz, 1 H, CH-OSi), 5.28 (ddd, J = 10.7, J = 6.9, J = 1.4 Hz, 1 H, 
CHOSi-CH2-CH2-CH=CH), 5.40 (ddd, J = 10.7, J = 9.1, J = 6.6 Hz, 1 H, CHOSi-CH2-CH2-
CH=CH), 6.89−6.99 (m, 3 H, Ph), 7.07 (d, J = 11.6 Hz, 1 H, CH=C-S), 8.06−8.09 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 20.8 (d), 21.1 (d), 21.6 (u), 23.2 (u), 29.4 
(d), 29.6 (d), 36.2 (u), 44.4 (u), 49.1 (d), 72.4 (d), 128.3 (d), 128.7 (d), 130.1 (d), 130.8 (d), 132.0 
(d), 141.8 (u), 146.9 (u), 148.9 (d), 201.6 (u) 
 
IR (CHCl3) ν 3471 (w), 2954 (s), 2809 (w), 2359 (w), 1691 (s), 1458 (m), 1256 (s), 1154 (s), 
1087 (s), 1007 (m), 859 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 491 (5), 490 (15), 489 (41) (M+), 460 (30), 446 (16), 
422 (13), 365 (18), 364 (61), 335 (19), 334 (41), 319 (15), 307 (15), 306 (29), 305 (89), 296 (13), 
295 (56), 292 (21), 291 (79), 279 (10), 278 (17), 277 (14), 272 (10), 271 (19), 270 (100), 265 
(10), 264 (13), 263 (13), 262 (10), 251 (13), 250 (20), 249 (65), 240 (19), 239 (14), 238 (12), 237 
(12), 236 (15), 235 (19), 233 (10), 232 (38), 225 (14), 223 (17), 215 (10), 214 (39), 211 (10), 210 
(14), 209 (22), 203 (10), 202 (19), 201 (15), 200 (12), 199 (27), 194 (11), 187 (15), 185 (19), 184 
(25), 175 (13), 174 (13), 171 (39), 162 (17), 161 (15), 160 (12), 159 (27), 156 (19), 155 (46), 147 
(16), 145 (11), 144 (13), 134 (12), 132 (14), 130 (13), 129 (10), 124 (54), 117 (13), 116 (12), 115 
(53), 109 (10), 107 (31), 106 (19), 105 (18), 102 (28), 96 (10), 90 (16), 87 (64) 
 
HRMS (EI) Calcd. for C27H43NO2SSi: 489.273296. Found: 489.273241 
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4.14. Replacement of Sulfoximine Moiety 
 
 
4.14.1. Attempted synthesis of ((1S,2Z,5Z,7R)-7-Isopropyl-5-methylcyclohepta-2,5-
dienyloxy)triethylsilane (167).  
 
iPr
Et3SiO
Me
167 
 
To a slurry of CuI (131 mg, 0.42 mmol) in Et2O (10 mL) was added at −78 0C MeLi (0.7 mmol, 
0.43 ml of 1.6 M in Et2O) and the reaction mixture was stirred at 0 0C for 1 h. Then a solution of 
carbocycle 131 (60 mg, 0.14 mmol) in Et2O (3 mL) was added and the resulting mixture was 
stirred first at −78 0C for 2 h and then at ambient temperature for 16 h. Then solution of saturated 
NH4Cl and concentrated NH3 was added and the resulting mixture was stirred at ambient 
temperature for 1 h. Then the mixture was extracted with Et2O and the combined organic phases 
were dried (Na2SO4) and concentrated in vacuum to give unreacted carbocycle 131 
quantitatively. 
 
4.14.2. Synthesis of ((1S,2Z,5Z,7R)-7-Isopropyl-5-methylcyclohepta-2,5-
dienyloxy)triethylsilane (167).  
 
To a slurry of CuI (131 mg, 0.69 mmol) in Et2O (10 mL) was added at −78 0C MeLi (1.14 mmol, 
0.71 ml of 1.6 M in Et2O) and the reaction mixture was stirred at 0 0C for 1 h. Subsequently 
ClSi(CH3)3 (1.14 mmol, 120 mg) was addded by −78 0C and the resulting mixture was stirred for 
1 h. Then solution of carbocycle 131 (96 mg, 0.23 mmol) in Et2O (3 mL) was added and the 
resulting mixture was stirred first at −78 0C for 2 h and then at ambient temperature for 16 h. 
Then solution of saturated NH4Cl and concentrated NH3 was added and the resulting mixture was 
stirred at ambient temperature for 1 h. Then the mixture was extracted with Et2O and the 
combined organic phases were dried (Na2SO4) and concentrated in vacuum. Separation by flash 
chromatography afforded alkene 167 (40 mg, 60 %) and sulfoximine 131 (34 mg, 35 %)  
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Rf = 0.75 (cyclohexane/EtOAc, 10:1)  
 
[α]D = − 2.4 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.63 (q, J = 7.6 Hz, 6H, Si-CH2), 1.04 (t, J = 7.6 Hz, 9 H, Si-
CH2-CH3), 1.05 (d, J = 6.4 Hz, 3 H, CH3), 1.13 (d, J = 6.4 Hz, 3 H, CH3), 1.63 (s, J = 0.9 Hz, 3 H, 
CH=C-CH3), 2.11−2.16 (m, J = 6.4, J = 1.6 Hz, 1 H, CH-(CH3)2), 2.17−2.20 (m, J = 6.9, J = 1.7 Hz 
1 H, CH-CH=CH), 2.26 (dd, J = 19.6, J = 7.2 Hz, 1 H, CHH-CH=CH), 2.83 (m, J = 19.6 Hz, 1 H, 
CHH-CH=CH), 5.47−5.51 (m, J = 11.5, J = 7.1, J = 3.2 Hz, 1 H, CH-OSi), 5.51−5.54 (ddd, J = 6.9, J 
= 1.5 Hz, 1 H, CH=C-CH3), 5.80 (ddd, J = 11.5, J = 4.6, J = 2.8 Hz, 1 H, CHOSi-CH=CH)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.70 (u), 7.2 (d), 22.0 (d), 22.2 (d), 26.4 (d), 29.8 (d), 34.2 
(u), 51.7 (d), 70.5 (d), 126.1 (d), 127.1 (d), 134.9 (d); 135.5 (u)  
 
IR (CHCl3) ν 3400 (w), 2958 (s), 2402 (w), 2279 (w), 1457 (w), 1261 (s), 1088 (s), 805 (s).  
 
MS (EI, 70 eV) (relative intensity, %) m/z 279 (37) (M+-1), 167 (45), 150 (11), 149 (100), 113 
(8), 104 (4), 71 (10), 57 (11) 
 
HRMS (EI) Calcd. for C17H32OSi-H: 279.214420; Found: 279.214445 
 
 
To a slurry of CuI (137 mg, 0.72 mmol) in Et2O (10 mL) was added at −78 0C MeLi (1.20 mmol, 
0.75 ml of 1.6 M in Et2O) and the reaction mixture was stirred at 0 0C for 1 h. Subsequently 
ClSi(CH3)3 (1.2 mmol, 130 mg) was addded by −78 0C and the resulting mixture was stirred for 1 h. 
Then a solution of carbocycle 131 (50 mg, 0.12 mmol in 3 mL Et2O) was added and the resulting 
mixture was stirred first at −78 0C for 2 h and then at ambient temperature for 16 h. Then solution of 
saturated NH4Cl and concentrated NH3 was added and the resulting mixture was stirred at ambient 
temperature for 1 h. Then the mixture was extracted with Et2O and the combined organic phases 
were dried (Na2SO4) and concentrated in vacuum. Separation by flash chromatography afforded 
alkene 167 (20 mg, 60%) and starting material 131 (17 mg, 35%). 
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4.14.3. Synthesis of triethyl((1S,2R,3Z,6Z)-2-isopropylcyclonona-3,6-dienyloxy)silane (174) 
and (1E,3R,4S,7Z)-3-isopropyl-N-methyl-4-(triethylsilyloxy)cyclonona-1,7-diene-1-
sulfinamide (175) 
 
iPr
Et3SiO
H
174
iPr
Et3SiO
S
O
NHMe
175 
 
4.14.3.1 General procedure for the reduction of sulfoximine moiety (GP14). 
To a solution of carbocycle 133 in wet THF (2 mL), small pieces of aluminum amalgam (which 
was prepared as follows: small pieces of aluminum foil (500 mg) were added to 2% solution of 
HgCl2 (500 mg) and stirred for 30 second, washed with water and THF) was added. In the primal 
stage the reaction proceeded vigourously and evolution of gas was observed. Subsequently, the 
mixture was stirred at room temperature until all of the starting material was consumed as 
indicated by TLC. The mixture was filtered through a short pad of celite, than CH2Cl2 (20 mL) 
was added to the filtrate. The filtrate was subsequently washed with water, dried (MgSO4) and 
concentrated in vacuum. Purification by flash chromatography on silica gel gave carbocycle 174 
as an oil. 
 
4.14.3.2. Synthesis of triethyl((1S,2R,3Z,6Z)-2-isopropylcyclonona-3,6-dienyloxy)silane (174) 
and (1E,3R,4S,7Z)-3-isopropyl-N-methyl-4-(triethylsilyloxy)cyclonona-1,7-diene-1-
sulfinamide (175) (5 h reaction time). 
Following GP14, reaction of carbocylce 133 (80 mg, 0.18 mmol) afforded after stirring for 5 h 
cyclonanotriene 174 (27 mg, 50%) and sulfinamide 175 (20 mg, 30%) as viscous liquids. 
Sulfinamide 165 was detected in the crude mixture but its isolation failed. 
 
174: 
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Rf = (cyclohexane/EtOAc, 10:1) 
 
[α]D = + 49.5 (c 1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.59 (q, J = 7.8 Hz, 6 H, Si-CH2), 1.00 (d, J = 6.9 Hz, 3 H, 
CH3), 1.01 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 1.05 (d, J = 6.9 Hz, 3 H, CH3), 1.60−1.76 (m, 2 H, 
CHH-CHH-CHOSi), 1.87 (ddd, J = 12.4, J = 7.7, J = 4.9 Hz, 1H, CH-CH=CH-CH2), 1.96−2.07 (m, 
2 H, CHH-CH2-CH-OSi, CH-(CH3)2), 2.22 (dd, J = 13.3, J = 6.7 Hz, 1 H, CH=CH-CHH-CH=CH-
CH2), 2.59 (ddd, J = 10.7, J = 10.1, J = 2.4 Hz, 1H, CH-CH=CH-CH2), 3.17 (dd, J = 13.6, J = 9.6 
Hz, 1 H, CH=CH-CHH-CH=CH-CH2), 4.06 (dd, J = 11.0, J = 4.9, J = 2.8 Hz ,1 H, CH-OSi), 5.45 (t, 
J = 10.7 Hz, 1 H, CH=CH-CH2-CH=CH-CH2), 5.54-5.56 (m, 2 H, CH=CH-CH2-CH=CH), 5.78 
(ddd, J = 10.3, J = 1.7 Hz, 1 H, CH=CH-CH2-CH=CH-CH2)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.9 (u), 7.3, 20.1 (u), 20.9 (u), 22.5 (u), 26.6 (u), 28.6 (d), 
36.4(u), 46.8 (d), 74.8 (u), 127.9 (d), 128.6 (d), 130.4 (d), 133.0 (u) 
 
IR (CHCl3) ν 3015 (m), 2953 (s), 2877 (s), 1463 (m), 1239 (w), 1143 (w), 1073 (s), 1010 (m), 
967 (w), 892 (w), 824 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 295 (4), 294 (16, M+), 266 (11), 265 (53), 200 (33), 
184 (13), 183 (24), 171 (11), 162 (47), 161 (30), 147 (15), 129 (26), 119 (76), 115 (34), 106 (11), 
105 (15), 104 (14), 103 (100), 101 (11), 95 (20), 92 (16), 91 (25), 87 (44) 
 
HRMS (EI) Calcd for C18H34NO2Si: 294.237895; Found: 294.238520 
 
175: 
 
Rf = (cyclohexane/EtOAc, 10:1) 
 
[α]D = + 70.7 (c, 1.00, CH2Cl2) 
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1H NMR (300 MHz, C6D6, TMS)  0.54 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.88 (d, J = 6.9 Hz, 3 H, CH3), 
0.98 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 1.00 (d, J = 6.8 Hz, 3 H, CH3), 1.38−1.48 (m, 1 H, CH2-CHH-
CH-OSi), 1.64−1.94 (m, 3 H, CH2-CHH-CH-OSi), 2.09−2.16 (m, 1 H, CH-(CH3)2), 2.18 (d, J = 5.4 
Hz , 1 H, CH=CSNHCH3), 2.53 (ddd, J = 10.3, J = 9.8, J = 2.4 Hz, 1 H, CH-CH=CS), 2.72 (dd, J = 
13.9, J = 7.5 Hz, 1 H, CH=CS-CHH-CH=CH), 3.08 (q, J = 5.4 Hz , 1 H, CH=C-SNHCH3), 3.18 (dd, 
J = 13.9, J = 7.1 Hz , 1 H, CH=CS-CHH-CH=CH), 4.04 (ddd, J = 10.7, J = 4.1, J = 2.7 Hz, 1 H, CH-
OSi), 5.71 (m, 2 H, CH=CH-CH2), 6.57 (d, J = 10.9 Hz, 1 H, CH=CS)  
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.8 (u), 7.3 (d), 20.2 (u), 20.8 (u), 22.5 (u), 24.5 (u), 25.0 
(d), 28.6 (u), 36.4 (d), 48.9 (d), 74.1 (u), 126.8 (d), 134.6 (d), 144.5 (d) 
 
IR (CHCl3) ν 3241 (w), 2954 (s), 2878 (s), 1463 (m), 1240 (w), 1071 (s), 1013 (s), 973 (w), 811 
(w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 372 (10), 371 (10), 370 (44), 342 (32), 321 (14), 320 
(11), 290 (13), 250 (11), 249 (57), 242 (13), 239 (12), 214 (22), 196 (25), 118 (18), 117 (16), 116 
(59), 114 (53), 106 (11), 104 (17), 102 (24), 90 (24), 87 (45) 
 
 
HRMS (EI) Calcd for C19H37NO2SSi: 371.234431; Found: 371.231562 
 
4.14.3.3. Synthesis of triethyl((1S,2R,3Z,6Z)-2-isopropylcyclonona-3,6-dienyloxy)silane (174) 
and (1E,3R,4S,7Z)-3-isopropyl-N-methyl-4-(triethylsilyloxy)cyclonona-1,7-diene-1-
sulfinamide (175) (12 h reaction time). 
 
 
Following GP14, reaction of carbocylce 133 (100 mg, 0.22 mmol) afforded after stirring for 12 h 
cyclonanotriene 174 (50 mg, 76%) and sulfinamide 165 (14 mg, 42 %) as viscous liquids. 
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4.15. Synthesis of Starting Materials for Synthesis of Sulfoximine-Substituted 
Pyran Derivatives. 
 
 
4.15.1. Synhesis of allylic alcohols (6SR,9R,10S,E)- and (6R,9R,10S,E)-9-isopropyl-11-
methyl-7-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-10-(triethylsilyloxy)dodeca-1,7-dien-6-ol 
(220) and (epi-220) 
 
iPr
iPr
OSiEt3
S
Ph
O NMe
OH
220  
iPr
iPr
OSiEt3
S
Ph
O NMe
OH
epi-220 
 
Following GP4, reaction of sulfoximine 219 (890 mg, 2.1mmol) with hex-5-enal (300 mg, 3.15 
mmol) afforded a 1:1 diastreomeric mixture (as revealed by ratio of the NMe signals in 1H NMR 
spectrum of the crude mixture) of alcohols 220 and epi-220 (1.00 g, 92%). One isomer was 
purified by flash chromatography (EtOAc/cyclohexane 1:9) and the remaining mixture was 
purified by HPLC (EtOAc/cyclohexane 5:95).  
 
epi-220 
 
Rf = 0.28 (EtOAc/cyclohexane 1:9)  
 
[α]D = − 42.9 (c  1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.47 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.81 (d, J = 6.9 Hz, 3 H, 
CH3), 0.82 (d, J = 6.9 Hz, 3 H, CH3), 0.84 (d, J = 6.9 Hz, 3 H, CH3), 0.85 (d, J = 6.9 Hz, 3 H, CH3), 
0.87 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 1.52 (m, J = 6.8 Hz, 1 H, CHOSi-CH-(CH3)2), 1.64–1.79 (m, J 
= 6.8, J = 6.7 Hz, 2 H, CHOH-CH2-CHH, C=CH-CH-CH-(CH3)2), 1.85–2.00 (m, 1 H, CHOH-CH2-
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CHH), 2.02–2.18 (m, 3 H, COH-CHH, CH2-CH=CH), 2.27 (ddd, J = 10.4 Hz, 1 H, C=CH-CH), 2.69 
(m, 1 H,
 
COH-CHH), 3.51 (m, J = 7.3, J = 4.85 Hz, 1 H, CH-OSi), 4.81 (m, J = 9.9, J = 3.8 Hz, 1 H, 
CH-OH), 4.97 (dd, J = 10.1 Hz, 1 H, CH2-CH=CHH), 5.04 (dd, J = 17.1, J = 3.3, J = 1.6 Hz, 1 H, 
CH2-CH=CHH), 5.81 (ddd, J = 17.1, 10.3, J = 6.7 Hz, 1 H, CH2-CH=CH2), 6.45 (d, J = 11.1 Hz, 1 
H, CH=C-S), 7.03–7.06 (m, 3 H, Ph), 7.95−7.98 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.4 (u), 7.0 (d), 18.3 (d), 19.5 (d), 21.0 (d), 21.5 (d), 26.1 
(u), 28.9 (d), 29.2 (d), 33.4 (d), 36.8 (u), 47.4 (d), 70.2 (d), 78.1 (d), 114.4 (u), 128.7 (d), 129.5 
(d), 131.9 (d), 138.7 (d), 142.7 (u), 144.7 (u) 
 
IR (CHCl3) ν 3291 (bm), 2957 (s), 2878 (s), 1638 (w), 1464 (m), 1416 (w), 1237 (s), 1144 (s), 
1081 (s), 1008 (s), 1008 (m), 910 (w), 862 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 524 (0.5), 523 (5), 522 (14), 521 (3) (M+), 492 (8), 452 
(20), 366 (19), 335 (18), 334 (37), 323 (16), 293 (14), 270 (49), 267 (12), 266 (27), 187 (54), 159 
(29), 157 (12), 155 (100), 124 (32), 115 (24), 107 (34), 102 (15) 
 
HRMS (EI) Calcd. for C29H51NO3SSi: 521.335896; Found: 521.336023 
 
220  
 
Rf = 0.21 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 61.8 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.60 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.68 (d, J = 6.8 Hz, 3 H, 
CH3), 0.74 (d, J = 6.8 Hz, 3 H, CH3), 0.91 (d, J = 6.8 Hz, 3 H, CH3), 0.99 (d, J = 6.8 Hz, 3 H, CH3), 
1.02 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.31–1.42 (m, 2 H, C=CH-CH-CHOSi-CH-(CH3)2, COH-
CH2-CHH), 1.51 (dddd, J = 13.3, J = 9.7, J = 5.9, J = 3.9 Hz, 1 H, CHOH-CHH), 1.80 (m, J = 6.9 
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Hz, 1 H, C=CH-CH-CH-(CH3)2), 1.81–1.85 (m, 1 H, COH-CH2-CHH), 2.00 (ddd, J = 6.9, J = 1.3 
Hz, 2 H, CH2-CH=CH), 2.15 (ddd, J = 13.4, J = 9.9, J = 4.5 Hz, 1 H, CHOH-CHH), 2.37 (ddd, J = 
11.1, J = 8.2, J = 2.2 Hz, 1 H, C=CH-CH), 2.80 (s, 3 H, N-CH3), 3.62 (dd, J = 6.4, J = 2.0 Hz, 1 H, 
CH-OSi), 4.80 (m, J = 9.9, J = 3.7 Hz, 1 H, CH-OH), 4.94 (dd, J = 10.3 Hz, 1 H, CH2-CH=CHH), 
4.97 (dd, J = 17.1, J = 1.4 Hz, 1 H, CH2-CH=CHH), 5.72 (ddd, J = 17.1, J = 10.3, J = 6.7 Hz, 1 H, 
CH2-CH=CH2), 6.96–7.08 (m, 3 H, Ph), 7.32 (d, J = 11.1 Hz, 1 H, CH-CH=C-S), 7.93–7.97 (m, 2 H, 
Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.0 (d), 18.6 (d), 18.7 (d), 20.3 (d), 21.2 (d), 26.1 
(u), 29.1 (d), 29.3 (d), 33.3 (d), 33.6 (u), 36.9 (u), 47.6 (d), 69.8 (d), 77.9 (d), 114.4 (u), 128.6 (d), 
129.0 (d), 131.6 (d), 138.5 (d), 141.9 (u), 143.3 (u), 143.9 (d) 
 
IR (CHCl3) ν 3279 (bm), 2957 (s), 1463 (m), 1416 (w), 1384 (w), 1243 (s), 1149 (m), 1081 (s), 
1007 (m), 861 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 524 (4), 523 (10), 522 (26), 521 (3) (M+), 492 (11), 
452 (16), 367 (10), 366 (34), 335 (15), 334 (22), 323 (15), 293 (19), 270 (36), 266 (27), 191 (11), 
188 (10), 187 (63), 159 (31), 157 (14), 155 (100), 124 (38), 15 (53), 107 (14), 102 (26) 
 
HRMS (EI) Calcd for C29H51NO3SSi: 521.335896; Found: 521.335895 
 
4.15.2. Synthesis of enone (9R,10S,E)-9-isopropyl-11-methyl-7-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-10-(triethylsilyloxy)dodeca-1,7-dien-6-one (221) 
 
 
iPr
iPr
OSiEt3
S
Ph
O NMe
O
221 
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Following GP8, reaction of a mixture of allylic alcohols 220 and epi-220 (0.31 g, 0.6 mmol) with 
Dess-Martin periodinane (2.7 mL, 0.9 mmol) afforded after purification by flash chromatography 
(EtOAc/cyclohexane 1:9) enone 221 (0.3 g, 96%) as colorless syrup  
 
Rf = 0.33 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 79.2 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.59 (q, J = 7.6 Hz, 6 H, Si-CH2), 0.77 (d, J = 6.9 Hz, 3 H, 
CH3), 0.80 (d, J = 6.9 Hz, 3 H, CH3), 0.84 (d, J = 6.9 Hz, 3 H, CH3), 0.85 (d, J = 6.9 Hz, 3 H, CH3), 
0.99 (t, J = 7.6 Hz, 9 H, Si-CH2-CH3), 1.59 (m, J = 6.9 Hz 1 H, CHOSi-CH-(CH3)2), 1.79 (m, J = 6.9 
Hz, 1 H, C=CH-CH-CH-(CH3)2), 1.85–1.91 (q, J = 7.1, J = 1.8 Hz, 2 H, CO-CH2-CH2), 2.02 (dddd, 
J = 13.9, J = 6.6, J = 3.7, J = 1.6 Hz, 2 H, CH2-CH=CH), 2.26 (ddd, J = 11.7, J = 8.7, J = 1.6 Hz, 1 
H, C=CH-CH), 2.79 (dt, J = 18.3, J = 7.1, J = 2.9 Hz, 1 H, CO-CHH), 2.93 (s, 3 H, N-CH3), 3.17 (dt, 
J = 18.4, J = 7.1 Hz, 1 H, CO-CHH), 3.58 (m, J = 6.6, J = 1.7 Hz, 1 H, CH-OSi), 4.95 (dd, J = 10.1, 
J = 3.3 Hz, 1 H, CH2-CH=CHH), 5.00 (dd, J = 17.1, J = 3.6, J = 1.8 Hz, 1 H, CH2-CH=CHH), 5.70 
(ddd, J = 17.3, J = 10.1, J = 6.7 Hz, 1 H, CH2-CH=CH2), 6.97−7.05 (m, 3 H, Ph), 7.12 (d, J = 12.5 
Hz, 1 H, CH-CH=C-S), 8.02−8.05 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.9 (u), 7.3 (d), 18.7 (d), 19.0 (d), 21.2 (d), 21.5 (d), 22.9 
(u), 29.6 (d), 29.7 (d), 33.2 (u), 33.7 (d), 44.5 (u), 49.1 (d), 78.3 (d), 115.1 (u), 128.8 (d), 129.2 
(d), 132.1 (d), 138.2 (d), 140.6 (u), 144.9 (u), 146.6 (d), 200.3 (u) 
 
IR (CHCl3) ν 3072 (w), 2958 (s), 2879 (s), 2807 (m), 1742 (s), 1670 (s), 1639 (w), 1463 (s), 1414 
(m), 1373 (m), 1254 (s), 1153 (s), 1081 (s), 1005 (m), 913 (m), 858 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 519 (0.5) (M+), 491 (3), 490 (3), 478 (13), 476 (10), 
365 (14), 364 (39), 335 (14), 333 (26), 332 (100), 322 (11), 321 (38), 308 (10), 293 (10), 292 
(20), 279 (33), 270 (25), 237 (11), 188 (11), 187 (64), 178 (22), 167 (13), 163 (11), 159 (44), 156 
(33), 135 (34), 124 (34), 116 (10), 115 (72), 107 (17), 103 (23) 
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HRMS (EI) Calcd for C29H49NO3SSi: 519.320246; Found: 519.320269 
 
4.15.3. Synhesis of allylic alcohol (2R,E)-1-(2-((S)-2-methyl-1-(triethylsilyloxy)-propyl)-
cyclohexylidene)-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-hept-6-en-2-ol (223).  
 
iPr
Et3SiO
S
Ph
O NMeHO
223 
 
Following GP4, reaction of sulfoximine 222 (800 mg, 1.84 mmol) with hex-5-enal (270 mg, 2.76 
mmol) afforded in the ratio of 9:1 a diastreomeric mixture (as determined by ratio of the NMe signals 
in 1H NMR spectrum of the crude mixture) of alcohol 223 (740 mg, 76%) as colorless syrup. The 
isolation of the minor epimer failed.  
 
Rf  = 0.18 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 52.1 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.35 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.78 (t, J = 7.8 Hz, 9 H, Si-
CH2-CH3), 0.85 (d, J = 6.9 Hz, 3 H, CH3), 0.92 (d, J = 6.9 Hz, 3 H, CH3), 0.93-1.04 (m, 1 H, C=C-
CH2-CHH-CH2), 1.30–1.47 (m, 4 H, C=C-CH2-CHH-CH2-CHH, CHOH-CH2-CH2), 1.60–1.79 (m, 6 
H, C=C-CH2-CH2-CH2-CHH, CHOH-CHH), 1.83 (m, J = 6.9 Hz, 1 H, C=C-CH-CHOSi-CH-
(CH3)2), 1.97–2.08 (m, 3 H, COH-CHH-CH2-CH2), 2.64 (s, 3 H, N-CH3), 3.26 (bd, J = 9.6 Hz, 1 H, 
C=C-CH-CHOSi), 3.42 (bd, J = 13.2 Hz, 1 H, C=C-CHH-CH2-CH2-CH2), 3.94 (m, J = 9.9 Hz, 1 H, 
CHOSi), 4.82 (d, J = 9.3 Hz, 1 H, CHOH), 4.88 (dd, J = 10.2 Hz, 1 H, CH2-CH=CHH), 4.96 (dd, J = 
17.1, 1 H, CH2-CH=CHH), 5.78 (ddd, J = 17.1, 10.2, J = 6.7 Hz, 1 H, CH2-CH=CH2), 7.41–7.48 (m, 
3 H, Ph), 7.89–7.96 (m, 2 H, Ph)  
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13C NMR (100 MHz, C6D6, TMS)  δ 5.3 (u), 7.1 (d), 16.7 (d), 19.0 (d), 20.8 (u), 26.3 (u), 27.6 
(u), 29.3 (d), 29.8 (u), 30.5 (u), 32.4 (d), 33.7 (u), 37.8 (u), 44.0 (d), 70.5 (d), 75.7 (d), 114.1 (u), 
128.6 (d), 128.7 (d), 131.8 (d), 138.8 (d), 139.0 (d), 141.6 (u), 157.8 (u)  
 
IR (CHCl3) ν 3461 (m), 3070 (w), 2953 (s), 2877 (s), 2802 (w), 1640 (w), 1593 (m), 1459 (s), 
1416 (w), 1364 (w), 1236 (s), 1142 (s), 1110 (s), 1073 (s), 1008 (s), 1008 (m), 909 (m), 864 (m), 
805 (w), 752 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 504 (3), 490 (2), 464 (6), 378 (2), 347 (3), 335 (4), 293 
(2), 279 (10), 270 (22), 246 (8), 203 (12), 192 (40), 188 (10), 187 (52), 159 (26), 157 (14), 156 
(100), 149 (16), 148 (22), 133 (10), 125 (29), 115 (50), 103 (21), 91 (11), 87 (50), 75 (23) 
 
HRMS (EI) Calcd for C30H51NO3SSi – C5H9 = C25H42NO3SSi : 464.265471; Found: 464.265445 
 
4.15.4. Synthesis of enone (E)-1-((R)-2-((S)-2-methyl-1-(triethylsilyloxy)propyl)-cyclo-
hexylidene)-1-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-hept-6-en-2-one (224) 
 
iPr
Et3SiO
S
Ph
O NMeO
224 
 
Following GP8, reaction of a 183 (0.48 g, 0.9 mmol) with Dess-Martin periodinane (3.80 g, 1.35 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) ketone 184 
(468 mg, 98%) as colorless syrup.  
 
Rf = 0.3 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 17.9 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.51 (q, J = 7.8 Hz, 6 H, Si-CH2), 0.79 (d, J = 6.9 Hz, 3 H, 
CH3), 0.91 (d, J = 6.9 Hz, 3 H, CH3), 0.92 (t, J = 7.8 Hz, 9 H, Si-CH2-CH3), 0.93–1.07 (m, 1 H, 
C=C-CH2-CHH), 1.32–1.48 (m, 3 H, C=C-CHH-CH2), 1.71–1.94 (m, 7 H, CO-CH2-CH2, C=C-
CHH-CH2-CH2-CHH, CHOSi-CH-(CH3)2), 2.08 (ddd, J = 7.4, J = 6.7, J = 1.8 Hz, 2 H, CO-CH2-
CH2-CH2), 2.36 (d, J = 9.8 Hz, 1 H, C=C-CH-CHOSi), 2.66–2.83 (m, 1 H, CO-CHH), 2.83 (s, 3 H, 
N-CH3), 2.83−2.95 (m, 1 H, CO-CHH), 3.46 (dd, J = 13.2, J = 3.3 Hz, 1 H, CH-OSi-CH-CHH), 4.02 
(dd, J = 9.8, J = 1.7 Hz, 1 H, CH-OSi), 4.95 (dd, J = 10.3, J = 2.3 Hz, 1 H, CH2-CH=CHH), 5.03 (dd, 
J = 17.1, J = 3.6, J = 1.6 Hz, 1 H, CH2-CH=CHH), 5.80 (ddd, J = 17.1, 10.3, J = 6.6 Hz, 1 H, CH2-
CH=CH2), 7.46–7.55 (m, 3 H, Ph), 8.02–8.06 (m, 2 H, Ph)  
 
13C NMR (75 MHz, C6D6, TMS)  δ 5.5 (u), 7.2 (d), 16.0 (d), 19.3 (d), 20.7 (u), 22.4 (u), 25.3 
(u), 27.9 (u), 29.6 (d), 30.9(u), 31.6 (d), 32.9 (u), 45.1 (u), 45.9 (d), 75.3 (d), 114.8 (u), 128.8 (d), 
128.9 (d), 132.4 (d), 137.8 (u), 138.4 (d), 141.5 (u), 157.5 (u), 202.4 (u) 
 
IR (CHCl3) ν 3069 (w), 2951 (s), 2877 (s), 1699 (s), 1611 (w), 1456 (m), 1416 (w), 1362 (w), 
1249 (s), 1148 (s), 1109 (s), 1055 (s), 1009 (s), 912 (m), 854 (m), 748 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 531 (3) (M+), 502 (8), 488 (4), 377 (10), 376 (28), 347 
(14), 345 (15), 344 (11), 334 (18), 333 (63), 307 (6), 305 (7), 292 (6), 291 (24), 279 (17), 271 
(11), 270 (50), 249 (13), 201 (10), 191 (18), 190 (86), 189 (14), 188 (14), 187 (63), 175 (13), 173 
(16), 161 (11), 159 (39), 157 (11), 156 (30), 149 (9), 148 (18), 147 (40), 136 (10), 131 (10), 125 
(25), 117 (10), 116 (13), 115 (89), 107 (13), 105 (12), 103 (27), 97 (13), 91 (15), 87 (100), 81 
(18), 79 (10), 77 (13), 75 (32) 
 
HRMS (EI) Calcd. for C30H49NO3SSi − C2H5: 502.281121; Found: 502.281146 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
 
229
4.16. Synthesis of Sulfoximine-Substituted Pyrans 
 
4.16.1. General Procedure for the Synthesis of Sulfoximine-Substituted Pyrans under 
Acidic Conditions (GP15). 
To a solution of enone (0.9 mmol) in THF (3 mL) a mixture of CHCOOH:THF:H2O:HCl in the 
ratio of 8:8:1:0.2 (5 mL) was added. The mixture was stirred at ambient temperature for 3 h, after 
which time all of the starting material was consumed as indicated by TLC. Then mixture was 
treated with halfsaturated solution of NaHCO3 (30 mL). The resulting mixture was stirred for 30 
min and than extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum. Flash chromatography afforded corresponding hemiacetal as a colorless 
oil. 
 
4.16.2. General Procedure for the Synthesis of Sulfoximine-Substituted Pyrans with (n-
Bu)4NF (GP16). 
 
To a solution of enone (0.9 mmol) in THF (10 mL) the solution of (n-Bu)4NF (420 mg, 1.35 
mmol) in THF (4 mL) was added. The mixture was stirred at ambient temperature for 1 h, after 
which time all of the starting material was consumed as indicated by TLC. Then mixture was 
treated with of H2O (5 mL). The resulting mixture was stirred for 30 min and than extracted with 
EtOAc. The combined organic phases were dried (MgSO4) and concentrated in vacuum. Flash 
chromatography afforded the corresponding hemiacetal as a colorless oil. 
 
4.16.3. Synthesis of (2R,5R,6S)-2,6-di(but-3-enyl)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5,6-dihydro-2H-pyran-2-ol (225) and optimization of Reaction Conditions 
 
O
SiPr
Ph
O NMe
OH
 225 
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4.16.3.1 Synthesis of 225 with (n-Bu)4NF at ambient temperature 
 
Following GP16, reaction of enone 109 (80 mg, 0.15 mmol) with (n-Bu)4NF (70 mg, 0.22 mmol) 
at ambient temperature afforded after purification by flash chromatography (EtOAc/cyclohexane 
1:9) hemiacetal 225 (40 mg, 65%) as a colorless oil. 
 
Rf = 0.3 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 11.7 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.35 (d, J = 6.9 Hz, 3 H, CH3), 0.42 (d, J = 6.9 Hz, 3 H, CH3), 
1.38−1.54 (m, 2 H, CH-OSi-CHH-CH2-CH=CH2, CH-(CH3)2), 1.63 (ddd, J = 14.2, J = 7.3, J = 2.5 
Hz, 1 H, CHO-CHH-CH2-CH=CH2), 1.83 (ddd, J = 9.9, J = 3.0, J = 1.9 Hz, 1 H, CH-CH=C-S), 
2.33−2.47 (m, 2 H, CHO-CH2-CH2-CH=CH2), 2.57 (s, 3 H, N-CH3), 2.58−2.83 (m, J = 18.4, 4 H, 
COH-CH2-CH2), 4.07 (dd, J = 9.5, J = 2.5 Hz, 1 H, CH-OSi), 4.98 (dd, J = 10.3, J = 2.3, J = 1.2 Hz, 
1 H, CH2-CH=CHH), 5.05 (ddt, J = 10.1, J = 2.2, J = 1.3 Hz, 1 H, CH2-CH=CHH), 5.17 (ddd, J = 
17.3, J = 3.5, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.20 (dd, J = 17.1, J = 3.5 Hz, 1 H, CH2-CH=CHH), 
5.90 (ddd, J = 17.1, J = 10.3, J = 6.7 Hz, 1 H, CH2-CH=CH2), 5.92 (d, J = 1.6 Hz, 1 H, CH-CH=C), 
6.02 (ddd, J = 17.2,  J = 10.1, J = 6.8 Hz, 1 H, CH2-CH=CH2), 6.92−6.97 (m, 3 H, Ph), 7.72−7.77 
(m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 16.8 (u), 20.4 (d), 26.5 (d), 28.9 (d), 29.0 (u), 29.7 (d), 31.6 
(u), 41.0 (u), 46.0 (u), 68.7 (d), 96.6 (d), 114.3 (u), 114.9 (u), 129.0 (d), 130.3 (d), 132.7 (d), 
137.3 (d), 137.9 (d), 138.5 (u), 139.0 (d), 144.8 (u), 186.8 (u) 
 
IR (CHCl3) ν 3259 (w), 3073 (m), 2960 (s), 2875 (s), 2808 (m), 1725 (s), 1640 (m), 1446 (s), 
1242 (s), 1155 (s), 1109 (m), 1078 (s), 996 (w), 913 (s), 853 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 386 (4) (M+), 350 (5), 349 (14), 348 (65), 342 (22), 
318 (10), 262 (14), 194 (16), 167 (31), 166 (11), 156 (33), 153 (22), 149 (29), 126 (11), 124 
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(100), 123 (11), 109 (17), 107 (40), 106 (16), 105 (18), 97 (17), 95 (14), 83 (16), 81 (21), 79 (17), 
78 (15), 77 (22), 71 (12) 
 
HRMS (EI) Calcd for C23H33NO3S – C4H7: 348.163341; Found: 348.163316 
 
4.16.3.2. Synthesis of 225 with (n-Bu4)NF at 0 oC.  
 
Following GP16, reaction of enone 109 (80 mg, 0.15 mmol) with (n-Bu)4NF (70 mg, 0.22 mmol) 
at 0 oC afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 
225 (42 mg, 70%) as a colorless oil. 
 
4.16.3.3. Attempted synthesis of 225 by the use of AcOH 
 
Enone 109 (80 mg, 0.15 mmol) was dissolved in AcOH (5 mL) and the resulting mixture was 
stirred at ambient temperature for 3 h, after which time it was treated with halfsaturated solution 
of NaHCO3 (30 mL). The obtained mixture was stirred for 30 min and than extracted with 
EtOAc. The combined organic phases were dried (MgSO4) and concentrated in vacuum to give 
unreacte 109 quantitatively.. 
 
4.16.3.4 Attempted synthesis of 225 via methanolysis with PPTS 
 
Solution of enone 109 (80 mg, 0.15 mmol) in MeOH (5 mL) was treated with PPTS (65 mg, 0.3 
mmol) and the resulting mixture was stirred at ambient temperature for 3 h, after which time it 
was treated with halfsaturated solution of NaHCO3 (30 mL). The obtained mixture was stirred for 
30 min and than extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum to give unreacted 109 quantitatively. 
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4.16.3.5 Attempted synthesis of 225 via methanolysis with p-TosOH 
 
Solution of enone 109 (80 mg, 0.15 mmol) in CH2Cl2 (5 mL) was treated with pTosOH (50 mg, 
0.3 mmol) and the resulting mixture was stirred at ambient temperature for 3 h, after which time 
it was treated with halfsaturated solution of NaHCO3 (30 mL). The obtained mixture was stirred 
for 30 min and than extracted with EtOAc. The combined organic phases were dried (MgSO4) 
and concentrated in vacuum to give unreacted 109 quantitatively. 
 
4.16.3.6 Synthesis of 225 by the use of the mixture of acids 
 
Following GP15, reaction of enone 109 (300 mg, 0.58 mmol) afforded after purification by flash 
chromatography (EtOAc/cyclohexane 1:9) hemiacetal 225 (210 mg, 90%) as a colorless oil. 
 
4.16.4. Attempted synthesis of (2R,5R,6S)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-2,6-di((E)-prop-1-enyl)-5,6-dihydro-2H-pyran-2-ol (226) 
 
O
SiPr
Ph
O NMe
OH
226 
 
Following GP15, reaction of enone 106 (200 mg, 0.4 mmol) with the mixture of acids afforded 
mixture of undefined decomposition products. 
 
Following GP16, reaction of enone 106 (100 mg, 0.2 mmol) with (n-Bu)4NF afforded mixture of 
undefined decomposition products. 
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4.16.5. Synthesis of  (2R,5R,6S,E)-2-(but-3-enyl)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-6-(prop-1-enyl)-5,6-dihydro-2H-pyran-2-ol (227)  
 
O
SiPr
Ph
O NMe
OH
227 
 
Following GP15, reaction of enone 107 (0.20 g, 0.4 mmol) with the mixture of the acids (5 mL) 
afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 227 
(0.14 g, 92%) as a colorless oil. 
 
Rf = 0.22 (EtOAc/cyclohexane 1:9) 
 
[α]D = + 0.6 (c = 1.00, CH2Cl2) 
 
1H NMR (300 MHz, C6D6, TMS)  δ 0.41 (d, J = 6.9 Hz, 3 H, CH3), 0.46 (d, J = 6.8 Hz, 3 H, CH3), 
1.52 (dd, J = 6.6 Hz 3 H, CH=CH-CH3), 1.64 (m, J = 6.7, J = 6.9 Hz, 1 H, CH-(CH3)2), 1.92 (ddd, J 
= 10.1, J = 2.9, J = 1.9 Hz, 1 H, CH-CH=C-S), 2.58 (s, 3 H, N-CH3), 2.60–2.85 (m, 4 H, CHOH-
CH2-CH2), 4.52 (dd, J = 9.9, J = 7.8 Hz, 1 H, CH-CH=CH-CH3), 4.97 (ddd, J = 10.1, J = 2.1 Hz, 1 
H, CH2-CH=CHH), 5.17 (ddd, J = 17.1, J = 3.6 Hz, 1 H, CH2-CH=CHH), 5.40 (ddd, J = 15.4, J = 
7.9 Hz, 1 H, CH=CH-CH3), 5.67 (m, J = 15.4, J = 6.6 Hz, 1 H, CHOSi-CH=CH), 5.97 (d, J = 1.9 Hz, 
1 H, CH=C-S), 6.00 (ddd, J = 17.2, J = 10.3, J = 6.3 Hz, 1 H, CH2-CH=CH2), 6.99–7.02 (m, 3 H, 
Ph), 7.77–7.81 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 16.9 (d), 17.9 (d), 20.4 (d), 26.4 (u), 29.0 (d), 29.1 (u), 41.0 
(u), 46.4 (d), 71.3 (d), 96.8 (u), 114.3 (u), 129.1 (d), 129.6 (d), 130.1 (d), 130.3 (d), 132.8 (d), 
137.3 (d), 137.9 (u), 138.9 (d), 144.5 (u) 
 
IR (CHCl3) ν 2959 (s), 2876 (s), 2807 (w), 1729 (w), 1638 (w), 1447 (m), 1373 (w), 1241 (s), 
1151 (s), 1079 (m), 1037 (w), 968 (w), 912 (w), 852 (m) 
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MS (EI, 70 eV) (relative intensity, %) m/z 389 (0.5) (M+), 372 (4), 356 (2), 334 (43), 292 (17), 
194 (23), 168 (29), 156 (46), 154 (20), 151 (10), 149 (18), 126 (11), 125 (100), 121 (11), 110 
(11), 109 (15), 107 (29), 106 (12), 105 (14), 95 (15) 
 
HRMS (EI) Calcd for C22H31NO3S − H2O: 372.199711; Found: 372.199727 
 
4.16.6. Synthesis of (2R,5R,6S)-2-(hex-5-enyl)-5-isopropyl-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-6-((E)-prop-1-enyl)-5,6-dihydro-2H-pyran-2-ol (228)  
 
O
SiPr
Ph
O NMe
OH
Me
228 
 
Following GP15, reaction of enone 108 (250 mg, 0.47 mmol) with mixture of acids (5 mL) 
afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 228 
(165 mg, 84%) as a colorless oil. 
 
Rf = 0.24 (EtOAc/cyclohexane 1:9)  
 
[α]D = − 15.4 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ  0.42 (d, J = 6.9 Hz, 3 H, CH3), 0.45 (d, J = 6.9 Hz, 3 H, CH3), 
1.32−1.40 (m, 2 H, CO-CH2-CH2-CH2), 1.46−1.56 (m, 2 H, COH-CH2-CHH-CHH), 1.51 (d, J = 6.4 
Hz, 3 H, CH=CH-CH3), 1.61−1.69 (m, 1 H, CH-(CH3)2), 1.86−1.98 (m, 2 H, CH-CH=C-S, COH-
CH2-CHH), 1.74−1.84 (m, 1 H, COH-CH2-CH2-CHH), 1.86−1.98 (m, 2 H, CH-CH=C, COH-CH2-
CHH), 2.09 (dd, J = 14.0, J = 6.6 Hz, 1 H, COH-CH2-CH2-CH2-CH2), 2.57 (ddd, J = 13.2, J = 11.9, J 
= 4.8 Hz, 1 H, COH-CHH), 2.62 (s, 3 H, N-CH3), 2.71 (ddd, J = 13.2, J = 11.6, J = 4.7 Hz, 1 H, 
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COH-CHH), 4.57 (dd, J = 8.6 Hz, 1 H, CH-OSi), 4.96 (ddd, J = 10.2, 1 H, CH2-CH=CHH), 5.02 
(ddd, J = 17.1, J = 3.5, J = 1.7 Hz, 1 H, CH2-CH=CHH), 5.42 (dq, J = 15.2, J = 7.8, J = 1.7 Hz, 1 H, 
CHOSi-CH=CH), 5.69 (dq, J = 15.2, J = 6.4 Hz, 1 H, CHOSi-CH=CH), 5.81 (ddt, J = 16.9, J = 10.2, 
J = 6.7 Hz, 1 H, CH2-CH=CH2), 5.98 (d, J = 1.7 Hz, 1 H, CH-CH=C), 6.63 (bs, 1 H, CHOH), 
6.94−6.98 (m, 3 H, Ph), 7.78−7.82 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 16.9 (d), 17.9 (d), 20.4 (d), 24.1 (d), 26.4 (u), 29.0 (u), 29.6 
(u), 34.3 (d), 41.8 (u), 46.4 (d), 71.2 (d), 97.2 (u), 114.2 (u), 129.0 (d), 129.2 (d), 129.7 (d), 130.0 
(d), 130.3 (d), 132.7 (d), 137.5 (u), 137.8 (u), 139.2 (d), 144.9 (u) 
 
IR (CHCl3) ν 3381 (w), 3275 (w), 3069 (m), 2958 (s), 2809 (w), 1705 (m), 1637 (m), 1446 (s), 
1242 (s), 1149 (s), 1081 (m), 1036 (s), 967 (m), 913 (m), 852 (m), 756 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 418 (5) (M+), 417 (4), 399 (9), 355 (13), 345 (12), 335 
(13), 333 (81), 303 (24), 291 (28), 289 (10), 261 (11), 244 (15), 218 (17), 191 (17), 178 (12), 155 
(72), 153 (23), 148 (14), 138 (11), 136 (11), 134 (11), 125 (18), 124 (100), 121 (10), 110 (11), 
109 (20), 108 (22), 107 (32), 106 (20), 104 (16), 96 (14), 94 (19), 91 (14) 
 
HRMS (EI) Calcd for C24H35NO3S − H2O: 399.223202; Found: 399.223502 
 
4.16.7. Synthesis of (2R,5R,6S)-2-ethyl-5-isopropyl-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-6-((E)-prop-1-enyl)-5,6-dihydro-2H-pyran-2-ol (229)  
 
O
SiPr
Me
Ph
O NMe
OH
Me 229 
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Following GP15, reaction of enone 111 (300 mg, 0.63 mmol) with the acids mixture (5 mL) 
afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 229 
(205 mg, 90 %) as a colorless oil. 
 
Rf = 0.28 (EtOAc/cyclohexane 1:9) 
 
[α]D = − 9.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.40 (d, J = 6.9 Hz, 3 H, CH3), 0.44 (d, J = 6.9 Hz, 3 H, CH3), 
1.33 (t, J = 7.2 Hz, 3 H, COH-CH2-CH3), 1.51 (d, J = 6.4, J = 1.6 Hz, 3 H, CH=CH-CH3), 1.63 (m, J 
= 6.9, J = 3.9Hz, 1 H, CH-(CH3)2), 1.92 (ddd, J = 9.8, J = 2.9, J = 1.8 Hz, 1 H, CH-CH=CH-S), 2.60 
(dd, J = 13.7, J = 7.4 Hz, 1 H, COH-CHH-CH3), 2.61 (s, 3 H, N-CH3), 2.76 (dd, J = 13.7, J = 7.6 Hz, 
1 H, COH-CHH-CH3), 4.54 (dd, J = 9.8, J = 7.9 Hz, 1 H, CH-OSi), 5.41 (ddd, J = 15.3, J = 7.9, J = 
1.6 Hz, 1 H, CHOSi-CH=CH-CH3), 5.67 (dq, J = 15.3, J = 6.6 Hz, 1 H, CHOSi-CH=CH-CH3), 5.96 
(d, J = 1.8 Hz, 1 H, CH=C), 6.96−7.00 (m, 3 H, Ph), 7.82−7.96 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ  8.7 (d), 16.9 (d), 17.9 (d), 20.4 (d), 26.5 (d), 29.0 (d), 34.8 
(u), 46.5 (d), 71.3 (d), 97.8 (u), 129.2 (d), 129.9 (d), 130.2 (d), 130.6 (d), 132.9 (d), 137.7 (u), 
138.2 (d), 145.0 (u) 
 
IR (capillar) ν 3251 (w), 3225 (w), 3063 (w), 2961 (s), 2877 (s), 2805 (w), 1730 (w), 1704 (w), 
1633 (w), 1447 (m), 1410 (m), 1374 (m), 1241 (s), 1152 (s), 1110 (m), 1082 (s), 1035 (m), 969 
(m), 853 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 364 (2) (M+), 363 (5), 346 (5), 335 (10), 334 (40), 293 
(16), 292 (19), 276 (22), 250 (35), 208 (16), 179 (9), 165 (19), 156 (81), 154 (14), 148 (9), 139 
(14), 138 (11), 126 (11), 125 (100), 123 (12), 110 (11), 109 (16), 107 (33), 106 (12), 105 (14), 97 
(11), 95 (16), 78 (12), 77 (16), 71 (10) 
 
HRMS (EI) Calcd for C20H29NO3S: 363.186816; Found: 363.186908 
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1H {1H }-NOE-Experiment (500 MHz, C6D6) of R-229 
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4.16.8 Attempted synthesis of (1S,3R,8aR)-3-(but-3-enyl)-4-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-1-((E)-prop-1-enyl)-3,5,6,7,8,8a-hexahydro-1H-isochromen-3-ol (230)  
 
O
S
Ph
O NMe
OH
Me
 230 
Following GP15, reaction of enone 112 (150 mg, 0.35 mmol) with a mixture of the acids (5 mL) 
gave mixture of undefined decomposition products. 
 
Following GP16, reaction of enone 112 (100 mg, 0.24 mmol) with (n-Bu)4NF gave mixture of 
undefined decomposition products. 
 
4.16.9. Synthesis of (2R,5R,6S)-5,6-diisopropyl-2-(pent-4-enyl)-3-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-5,6-dihydro-2H-pyran-2-ol (231).  
 
O
SiPr
iPr
Ph
O NMe
OH
231 
 
Following GP3, reaction of enone 221 (0.20 g, 0.38 mmol) with a mixture of the acids (5 mL) 
afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 231 
(0.12 g, 80%) colorless oil.  
 
Rf = 0.12 (EtOAc/cyclohexane 1:9) 
 
[α]D  = − 11.8 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  δ 0.51 (d, J = 6.8 Hz, 3 H, CH3), 0.75 (d, J = 6.8 Hz, 3 H, 
CH3), 0.83 (d, J = 6.8 Hz, 3 H, CH3), 1.06 (d, J = 6.9 Hz, 3 H, CH3), 1.19–1.31 (m, 1 H, CHH-
CH=CH2), 1.39–1.52 (m, 1 H, CHH-CH=CH2), 1.80–2.10 (m, 6 H, (CH3)2-CH-CHO-CH-CH-
(CH3)2, COH-CH2-CH2-CH2), 2.14 (ddd, J = 10.0, J = 2.9, J = 1.8 Hz, 1 H, CH-CH=C-S), 2.67 
(s, 3 H, N-CH3), 3.67 (dd, J = 10.3, J = 4.0 Hz, 1 H, CH-OH), 4.90 (dd, J = 10.3 Hz, 1 H, CH2-
CH=CHH), 4.96 (dd, J = 17.2 Hz, 1 H, CH2-CH=CHH), 5.76 (ddd, J = 17.2,  J = 10.3, J = 6.9 
Hz, 1 H, CH2-CH=CH2), 6.03 (bs, 1 H, COH), 6.17 (d, J = 1.6 Hz, 1 H, CH-CH=C-S), 7.55–7.66 
(m, 3 H, Ph), 7.88–7.92 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 14.6 (d), 16.7 (d), 20.0 (d), 20.7 (d), 23.1 (u), 25.8 (d), 27.4 
(d), 29.1 (d), 33.7 (d), 40.4 (u), 43.3 (d), 72.7 (d), 96.1 (u), 114.0 (d), 129.1 (d), 129.6 (d), 132.9 
(d), 138.9 (u), 140.2 (d), 141.6 (u) 
 
IR (CHCl3) ν 3069 (w), 2962 (s), 2877 (s), 2806 (w), 1731 (w), 1638 (w), 1465 (m), 1387 (w), 
1371 (w), 1242 (s), 1159 (m), 1080 (m), 1030 (s), 912 (m), 854 (s), 757 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 405(1) (M+), 387 (13), 346 (32), 345 (25), 344 (100), 
337 (16), 336 (80), 293 (11), 276 (12), 223 (23), 168 (11), 155 (34), 124 (70), 108 (13), 107 (26), 
97 (13), 95 (10), 78 (10) 
 
HRMS (EI) Calcd. for C23H35NO3S – H2O: 387.223202; Found: 387.223148 
 
4.16.10. Synthesis of (1S,3R,8aR)-1-isopropyl-3-(pent-4-enyl)-4-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-3,5,6,7,8,8a-hexahydro-1H-isochromen-3-ol (232).  
 
O
S
iPr
Ph
O NMe
OH
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4.16.10.1. Synthesis of (1S,3R,8aR)-1-isopropyl-3-(pent-4-enyl)-4-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-3,5,6,7,8,8a-hexahydro-1H-isochromen-3-ol (232) according to GP16 
 
Following GP16, reaction of enone 224 (0.21 g, 0.4 mmol) with (n-Bu)4NF (0.19 g, 0.6 mmol) 
afforded after purification by flash chromatography (EtOAc/cyclohexane 1:9) hemiacetal 232 
(0.15 g, 90%) as a pale yellow oil.  
 
Rf = 0.25 (EtOAc/cyclohexane 1:9)  
 
[α]D  = + 80.8 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ −0.20 (m, J = 12.9, J = 3.8 Hz, 1 H, C=C-CH2-CHH), 0.74 (dd, 
J = 13.1, J = 3.7 Hz, 1 H, C=C-CH2-CH2-CH2-CHH), 0.92 (d, J = 6.9 Hz, 3 H, CH3), 1.14 (d, J = 6.9 
Hz, 3 H, CH3), 1.18–1.37 (m, 2 H, C=C-CH2-CHH-CHH), 1.47–1.61 (m, 3 H, COH-CH2-CH2, C=C-
CH2-CH2-CHH), 1.67–1.96 (m, 3 H, C=C-CHH-CH2-CH2-CHH, CHO-CH-(CH3)2), 2.08–2.24 (m, 4 
H, COH-CHH-CH2-CH2, C=C-CH-CHO), 2.44 (ddd, J = 9.6, J = 6.7, J = 5.2 Hz, 1 H, COH-CHH), 
2.59 (s, 3 H, N-CH3), 3.14 (d, J = 15.1 Hz, 1 H, C=C-CHH), 3.50 (dd, J = 9.6, J = 2.0 Hz, 1 H, 
CHO), 4.98 (dd, J = 10.3, J = 2.3 Hz, 1 H, CH2-CH=CHH), 5.07 (ddd, J = 17.2, J = 3.8, J = 1.6 Hz, 1 
H, CH2-CH=CHH), 5.88 (ddd, J = 17.2, 10.3, J = 6.6 Hz, 1 H, CH2-CH=CH2), 7.00 (bs, 1 H, COH-
CH2), 7.54–7.59 (m, 3 H, Ph), 7.88–7.93 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ  14.7 (d), 20.1 (d), 23.5 (u), 23.7 (u), 24.1 (u), 27.4 (d), 
28.3 (d), 29.2 (u), 31.4 (d), 33.7 (u), 41.8 (u), 41.9 (u), 75.4 (d), 97.3 (u), 114.0 (u), 128.5 (d), 
128.7 (d), 131.7 (d), 136.3 (u), 139.1 (d), 141.5 (u), 155.1 (u) 
 
IR (CHCl3) ν 3063 (w), 2934 (s), 1705 (w), 1604 (m), 1447 (s), 1232 (s), 1147 (s), 1106 (m), 
1075 (s), 911 (m), 855 (m), 755 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 417 (0.5), 400 (6), 399 (17), 358 (37), 356 (19), 349 
(23), 348 (100), 328 (16), 320 (10), 268 (9), 244 (13), 206 (16), 155 (15), 124 (45), 107 (14), 105 
(12), 91 (18), 81 (12), 79 (14), 77 (14) 
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HRMS (EI) Calcd for C24H35NO3S − H2O: 399.223202; Found: 399.223358 
 
4.16.10.2. Synthesis of (1S,3R,8aR)-1-isopropyl-3-(pent-4-enyl)-4-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-3,5,6,7,8,8a-hexahydro-1H-isochromen-3-ol (232) according to GP15 
 
Following GP15, reaction of enone 224 (80 mg, 0.15 mmol) with a mixture of the acids (5 mL) 
gave mixture of undefined decomposition products. 
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4.17. Synthesis of Sulfoximine-Substituted Oxabicycles 
 
4.17.1. General Procedure for the Synthesis of Sulfoximine Substituted Oxabicycles (GP17). 
 
To a solution of the ruthenium catalyst 30 (0.049 mmol) in CH2Cl2 or toluene (90 mL) a solution 
of the α,α’-diene (0.49 mmol) in CH2Cl2 (8 mL) was added. The mixture was stirred at room 
temperature for 16 h and at reflux temperature for 4 h, after which time all of the starting material 
was consumed as indicated by TLC. The mixture was filtered through a short pad of silica gel, 
and the solvent was removed in vacuum. Purification by flash chromatography on silica gave the 
corresponding compound
 
as pale yellow syrup.
 
 
4.17.2. General Procedure for the Synthesis of Ethyl Ester (GP18) 
 
To a solution of hemiacetal (0.16 mmol) in CH2Cl2 (6 mL) at – 78 oC were added TiCl4 (0.32 
mmol, solution in CH2Cl2 (2 mL)) and (1-ethoxyvinyloxy)trimethylsilane (0.32 mmol, solution in 
CH2Cl2 (2 mL)). After 20 min were added TiCl4 (0.32 mmol, solution in CH2Cl2 (2 mL)) and (1-
ethoxyvinyloxy)trimethylsilane (0.32 mmol, solution in CH2Cl2 (2 mL)). After another 20 min 
were added TiCl4 (0.32 mmol, solution in CH2Cl2 (2 mL)) and (1-ethoxyvinyloxy)trimethylsilane 
(0.32 mmol, solution in CH2Cl2 (2 mL)). After stirring by –78 oC for additional 2 h the mixture 
was treated with saturated (NH4)2CO3 solution and allowed to warm to ambient temperature. 
Subsequently water was added and the mixture was extracted with CH2Cl2, dried (MgSO4) and 
concentrated in vacuum. 
 
4.17.3. Synthesis of (1R,6S,7R,Z)-7-isopropyl-9-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-10-
oxabicyclo[4.3.1]deca-4,8-dien-1-ol (233). 
 
O
iPr S Ph
O NMe
OH
233 
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Following GP17, reaction of hemiacetal 227 (120 mg, 0.31 mmol) with ruthenium complex 30 
(26 mg, 0.031 mmol) in CH2Cl2 (62 mL) afforded after purification by flash chromatography on 
silica (EtOAc/cyclohexane, 1:5) bicycle 233 (100 mg, 90%) as a pale yellow oil.  
 
Rf = 0.1 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 13.1 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  0.58 (d, J = 6.9 Hz, 3 H, CH3), 0.60 (d, J = 6.8 Hz, 3 H, CH3), 
1.45 (dd, J = 6.2 Hz, 1 H, CH-CH=C-S), 1.59 (m, J = 6.9 Hz, 1 H, CH-(CH3)2), 2.16 (dd, J = 18.0, J 
= 6.9, J = 3.6 Hz, 1 H, COH-CH2-CHH), 2.53 (dd, J = 13.0, J = 4.1 Hz, 1 H, COH-CHH), 2.57 (s, 3 
H, N-CH3), 2.61 (dd, J = 18.0, J = 4.7 Hz, 1 H, COH-CH2-CHH), 3.06 (dd, J = 13.0, J = 3.2 Hz, 1 H, 
COH-CHH), 4.39 (dd, J = 5.3 Hz, 1 H, CHO), 5.26 (ddd, J = 12.5, J = 2.9 Hz, 1 H, CHO-CH=CH), 
5.54 (m, J = 12.5, J = 6.9 Hz, 1 H, CHO-CH=CH), 6.17 (d, J = 5.8 Hz, 1 H, CH-CH=C-S), 
6.92−6.96 (m, 3 H, Ph), 7.83−7.86 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 19.8 (d), 20.8 (d), 25.1 (u), 29.0 (d), 32.4 (d), 42.3 (u), 46.2 
(d), 72.4 (d), 98.3 (u), 129.0 (d), 129.1 (d), 129.0 (d), 130.0 (d), 132.5 (d), 132.7 (d), 138.4 (u), 
140.6 (d), 143.0 (u) 
 
IR (CHCl3) ν 3062 (w), 3012 (s), 2960 (s), 2926 (s), 2875 (s), 2806 (w), 1732 (w), 1634 (w), 
1445 (s), 1370 (m), 1240 (s), 1151 (s), 1085 (m), 933 (w), 857 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 348 (6), 347 (10) (M+), 321 (3), 305 (9), 304 (50), 276 
(11), 192 (28), 177 (9), 163 (7), 156 (58), 149 (14), 147 (10), 138 (13), 131 (10), 125 (100), 121 
(12), 109 (13), 108 (10), 107 (37), 106 (12), 105 (21), 97 (12) 
 
HRMS (EI) Calcd. for C19H25NO3S: 347.155516; Found: 347.155573 
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4.17.4. Attempted synthesis of (1R,8S,9R,Z)-9-isopropyl-11-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-12-oxabicyclo[6.3.1]dodeca-4,10-dien-1-ol (234) 
 
O
SiPr
Ph
O NMe
OH
234 
 
Following GP17, reaction of hemiacetal 225 (60 mg, 0.15 mmol) with ruthenium complex 30 (13 
mg, 0.015 mmol) in CH2Cl2 (30 mL) gave unreacted 225. 
 
Following GP17, reaction of hemiacetal 225 (50 mg, 0.12 mmol) with ruthenium complex 30 (10 
mg, 0.012 mmol) in toluene (24 mL) gave mixture of undefined products. 
 
4.17.5. Attempted synthesis of (1R,8S,9R,Z)-9-isopropyl-11-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-12-oxabicyclo[6.3.1]dodeca-6,10-dien-1-ol (235). 
 
O
SiPr
Ph
O NMe
OH
235 
 
Following GP17, reaction of hemiacetal 228 (50 mg, 0.12 mmol) with ruthenium complex 30 (10 
mg, 0.012 mmol) in CH2Cl2 (24 mL) gave unreacted 228. 
 
Following GP17, reaction of hemiacetal 228 (50 mg, 0.12 mmol) with ruthenium complex 30 (10 
mg, 0.012 mmol) in toluene (24 mL) gave mixture of undefined products. 
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4.17.6. Attempted synthesis of ethyl 2-((1S,6S,7R,Z)-7-isopropyl-9-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-10-oxabicyclo[4.3.1]deca-4,8-dien-1-yl)acetate (237) via Sakurai reaction of 
233 
 
O
iPr S Ph
O NMe
CO2Et
237 
 
Following GP18, reaction of oxabicycle 233 (50 mg, 0.14 mmol) with TiCl4 (a portion of 53 mg 
(0.28 mmol) was added tree times) and with (1-ethoxyvinyloxy)trimethylsilane 236 (a portion of 
45 mg (0.28 mmol, admixed with equimolar amount of the corresponding ethyl acetate 236b) 
was added tree times) gave unreacted 233. 
 
4.17.7. Synthesis of ethyl 2-((2S,5R,6S)-2-(but-3-enyl)-5-isopropyl-3-[(S)-N-methyl-S-
phenyl-sulfonimidoyl)]-6-((E)-prop-1-enyl)-5,6-dihydro-2H-pyran-2-yl)acetate (238). 
 
O
SiPr
Me
Ph
O NMe
CO2Et
238 
 
Following GP18, pyran 227 (50 mg, 0.14 mmol) was reacted with TiCl4 (a portion of 53 mg 
(0.28 mmol) was added tree times) and with (1-ethoxyvinyloxy)trimethylsilane 236 (a portion of 
45 mg (0.28 mmol) admixed with equimolar amount of the corresponding ethyl acetate 236b). 
The residue obtained after water work-up was purified by flash chromatography on silica 
(EtOAc/cyclohexane, 1:9) to give ethyl ester 238 as a colorless gum 
 
Rf = 0.16 (EtoAc/cyclohexane, 1:9) 
 
[α]D = − 32.8 (c  1.00, CH2Cl2) 
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1H NMR (400 MHz, C6D6, TMS)  0.71 (d, J = 6.8 Hz, 3 H, CH3), 0.80 (d, J = 6.8 Hz, 3 H, CH3), 
1.01 (t, J = 7.3 Hz, CO-CH2-CH3), 1.58 (dd, J = 6.6, J = 1.6 Hz 3 H, CH=CH-CH3), 1.59–1.62 (m, 1 
H, CHOH-CH2-CHH), 1.76 (dq, J = 9.7, J = 6.8, J = 2.9 Hz, 1 H, CH-(CH3)2), 1.98 (ddd, J = 9.7, J = 
2.7, J = 1.9 Hz, 1 H, CH-CH=C-S), 2.29−2.39 (m, 1 H, CO-CH2-CHH), 2.48−2.61 (m, , J = 10.9, J = 
6.2 Hz, 2 H, CO-CH2-CH2), 2.90 (s, 3 H, N-CH3), 3.40 (d, J = 14.1 Hz, 1 H, CHH-CO), 3.64 (m, J = 
14.1 Hz, 1 H, CHH-CO), 4.00 (dq, J = 7.3, J = 2.5 Hz, 2 H, CO-CH2-CH3), 4.30 (dd, J = 9.6, J = 7.8 
Hz, 1 H, CHO), 4.80−4.86 (m, 2 H, CH2-CH=CH2), 5.33 (ddd, J = 15.2, J = 7.6, J = 1.7 Hz, 1 H, 
CH=CH-CH3), 5.57 (m, J = 15.2, J = 6.6 Hz, 1 H, CHOSi-CH=CH), 5.77 (m J = 17.9, J = 10.3, J = 
6.5 Hz, 1 H, CH2-CH=CH2), 6.93−6.99 (m, 3 H, Ph), 7.03 (d, J = 1.9 Hz, 1 H, CH-CH=C), 
7.92−7.95 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 14.3 (d), 17.3 (d), 17.8 (d), 20.8 (d), 26.9 (d), 28.5 (u), 29.9 
(d), 36.7 (u), 45.3 (d), 47.2 (d), 60.2 (u), 71.9 (d), 78.3 (u), 114.1 (u), 128.8 (d), 128.9 (d), 129.6 
(d), 130.5 (d), 131.9 (d), 138.7 (d), 141.4 (d), 141.5 (d), 145.5 (u), 169.7 (u) 
 
IR (CHCl3) ν 3068 (w), 2960 (s), 2806 (w), 1732 (w), 1636 (w), 1449 (s), 1372 (w), 1249 (s), 
1150 (s), 1081 (m), 1039 (m), 967 (w), 914 (w), 851 (m); 756 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 462 (6), 461 (19), 460 (61), 459 (11) (M+), 416 (15), 
415 (13), 414 (49), 409 (24), 404 (10), 372 (24), 368 (19), 363 (22), 362 (100), 348 (3), 335 (10), 
334 (32), 316 (19), 273 (12), 264 (28), 263 (15), 262 (10), 261 (38), 250 (13), 235 (12), 217 (15), 
209 (17), 207 (12), 189 (12), 179 (14), 175 (14), 173 (17), 168 (28), 163 (18), 162 (11), 160 (26), 
159 (11), 157 (13), 156 (68), 147 (32), 145 (19), 139 (12), 135 (13), 133 (19), 131 (15), 126 (13), 
125 (93), 121 (13), 120 (11), 119 (30), 117 (14), 109 (14), 107 (34), 106 (18), 105 (40), 97 (15), 
95 (22), 93 (13), 91 (38), 81 (14) 
 
HRMS (EI) Calcd for C26H37NO4S: 459.244331; Found: 459.244364 
 
 
 
 
EXPERIMENTAL PART 
 
 
247
1H {1H }-NOE-Experiment (500 MHz, C6D6) of 238 
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4.17.8. Synthesis of ethyl 2-((1S,6S,7R,Z)-7-isopropyl-9-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-10-oxabicyclo[4.3.1]deca-4,8-dien-1-yl)acetate (237).  
 
O
iPr S Ph
O NMe
CO2Et
237 
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Following GP17, reaction of ethyl acetate 238 (69 mg, 0.15 mmol) with ruthenium complex 30 
(13 mg, 0.015 mmol) afforded after purification by flash chromatography on silica 
(EtOAc/cyclohexane, 1:5) oxabicycle 237 (56 mg, 90%) as a pale yellow oil. 
 
Rf = 0.16 (EtOAc/cyclohexane, 1:5)  
 
[α]D  = − 26.5 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.74 (d, J = 6.8 Hz, 3 H, CH3), 0.75 (d, J = 6.8 Hz, 3 H, CH3), 
0.97 (t, J = 7.1 Hz, CH2-CO-CH2-CH3), 1.52 (ddd, J = 8.4, J = 6.3 Hz, 1 H, CH-CH=C-S), 1.80−1.92 
(m,  J = 6.7, J = 3.4 Hz, 1 H, CH-(CH3)2), 1.90–2.02 (m, 1 H, CHH-CH=CH), 2.10–2.31 (m, 2 H, 
CHH-CHH-CH=CH), 2.70 (ddd, J = 13.4, J = 4.5 Hz, 1 H, CHH-CH2-CH=CH), 2.93 (s, 3 H, N-
CH3), 3.25 (d, J = 14.3 Hz, 1 H, CHH-CO), 3.96 (dq, J = 7.3, J = 2.5 Hz, 1 H, CH2-CO-CHH), 3.98 
(dq, J = 7.3, J = 2.5 Hz, 1 H, CH2-CO-CHH), 4.06 (m, J = 14.3 Hz, 1 H, CHH-CO), 4.40 (dd, J = 5.2 
Hz, 1 H, CHO), 5.20 (ddd, J = 12.4, J = 5.2, J = 2.7 Hz, 1 H, CH=CH-CH2), 5.39 (ddd, J = 12.4, J = 
6.9, J = 2.7 Hz, 1 H, CH=CH-CH2), 6.95 (d, J = 6.3 Hz, 1 H, CH-CH=C), 6.93−7.05 (m, 3 H, Ph), 
8.04−8.08 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 13.9 (d), 20.1 (d), 21.2 (d), 25.9 (u), 29.6 (d), 31.8 (d), 38.8 
(u), 45.8 (u), 47.5 (d), 59.4 (u), 72.1 (d), 78.6 (u), 128.4 (d), 128.5 (d), 129.2 (d), 131.6 (d), 132.8 
(d), 141.3 (u), 142.5 (d), 143.4 (u), 169.9 (u) 
 
IR (CHCl3) ν 3071 (w), 2960 (s), 2874 (m), 1732 (s), 1639 (w), 1447 (s), 1370 (m), 1248 (s), 
1150 (s), 1082 (w), 1037 (m), 967 (w), 912 (m), 851 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 419 (9), 418 (33), 417 (50) (M+), 375 (24), 374 (100), 
373 (11), 372 (52), 328 (32), 302 (29), 263 (12), 262 (22), 244 (17), 219 (31), 215 (11), 214 (49), 
175 (24), 174 (19), 173 (15), 159 (12), 156 (48), 148 (22), 147 (26), 145 (19), 138 (11), 133 (31), 
132 (26), 131 (38), 124 (58), 117 (16), 107 (20), 106 (11), 105 (26), 97 (12), 91 (26), 81 (12) 
 
HRMS (EI) Calcd. for C23H31NO4S: 417.197381; Found: 417.197416 
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4.17.9. Synthesis of (1R,6S,7R,Z)-7-isopropyl-10-oxabicyclo[4.3.1]deca-4,8-dien-1-ol (239).  
 
O
iPr
OH
239 
 
Following GP9, reaction of 233 (38 mg, 0.11 mmol) with aluminum amalgaman (prepared from 
500 mg of aluminum foil) gave after purification by flash chromatography the oxabicycle 239 (16 
mg, 78% (EtOAc/cyclohexane, 1:9)) as oil and sulfinamide 165 (10 mg, 59% 
(EtOAc/cyclohexane, 4:1), 77% in regard to the formation of 239)) as an oil. 
 
Rf = 0.13 (EtOAc/cyclohexane, 1:9) 
 
[α]D = − 36.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  0.99 (d, J = 6.8 Hz, 3 H, CH3), 1.00 (d, J = 6.8 Hz, 3 H, CH3), 
1.71 (dd, J = 5.7 Hz, 1 H, CH-CH=C-S), 1.80 (m, J = 6.8 Hz, 1 H, CH-(CH3)2), 2.06 (m, J = 17.3, J 
= 8.9, J = 3.2 Hz, 2 H, CH=CH-CH2-CH2), 2.19 (m, J = 7.6, J = 3.6 Hz, 2 H, CH=CH-CH2), 2.37 (m, 
1 H, CH=CH-CH2-CH2-COH), 4.53 (dd, J = 4.4 Hz, 1 H, CHO-CH=CH), 5.57 (m, 2 H, CHO-
CH=CH), 5.77 (dd, J = 10.5, J = 1.0 Hz, 1 H, CH(CH-(CH3)2)-CH=CH), 5.97 (dd, J = 10.5, J = 5.7 
Hz, 1 H, CH(CH-(CH3)2)-CH=CH) 
  
13C NMR (100 MHz, C6D6, TMS)  δ 20.1 (d), 20.8 (d), 23.7 (u), 32.1 (d), 38.5 (u), 43.2 (d), 73.8 
(d), 96.1 (u), 127.3 (d), 129.6 (d), 130.3 (d), 133.7 (d) 
 
IR (CHCl3) ν 3402 (m), 2959 (s), 2873 (s), 1729 (s), 1464 (m), 1373 (w), 1242 (w), 1071 (m), 
920 (w), 883 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 195 (5), 194 (45) (M+), 179 (14), 152 (11), 151 (65), 
149 (54), 148 (14), 139 (21), 134 (15), 133 (100), 125 (19), 124 (40), 123 (17), 122 (11), 121 
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(16), 119 (16), 111 (27), 110 (16), 109 (62), 108 (20), 107 (67), 106 (12), 105 (100), 103 (11), 97 
(17), 96 (16), 95 (83), 93 (43), 92 (15), 91 (58) 
 
HRMS (EI) Calcd for C19H25NO3S: 194.130680; Found: 194.130628 
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4.18. Synthesis of Sulfoximine-Substituted Spiroethers via Prins Reaction 
 
4.18.1. General Procedure for the Prins Reaction (GP19). 
 
To a solution of hemiacetal (0.3 mmol) in CH2Cl2 (5 mL) at –78 oC was slowly added a solution 
of TiCl4 (0.1 mL, 0.9 mmol) in CH2Cl2 (5 mL). The mixture was stirred at this temperature for 2 
h. Subsequently saturated (NH4)2CO3 was added and the mixture was warmed to ambient 
temperature. Water was added and the mixture was extracted with CH2Cl2, dried (MgSO4) and 
concentrated under vacuum. Purification by flash chromatography on silica gave chlorides as 
colorless oils 
 
4.18.2. Synthesis of (2S,3R,6S,8S)-8-chloro-2,3-diisopropyl-5-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-(phenylsulfonyl)-1-oxaspiro[5.5]undec-4-ene (246) and (2S,3R,6r,9S)-9-
chloro-2,3-diisopropyl-5-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-1-oxaspiro[5.5]undec-4-
ene (247).  
 
Following GP19, reaction of hemiacetal 231 (0.15 g, 0.37 mmol) with TiCl4 (1.1 mmol) afforded 
a 8:1 mixture (as revealed by the signals of NMe in 1H NMR of the crude mixture) of chlorides 
(129 mg, 82%) 246 ( 110 mg, 70%) and 247 (11 mg, 7%), which were purified by flash 
chromatography (EtOAc/cyclohexane 1:9) and subsequently by HPLC (EtOAc/cyclohexane 
5:95)  
 
246: 
 
Rf = 0.12 (EtOAc/cyclohexane 1:9)  
 
[α]D = + 9.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.82 (d, J = 6.8 Hz, 3 H, CH3), 0.84 (d, J = 6.8 Hz, 3 H, CH3), 
1.06 (d, J = 6.8 Hz, 3 H, CH3), 1.08 (d, J = 6.8 Hz, 3 H, CH3), 1.09 (m, 1 H, CHH-CH2-CHCl), 1.52 
(m, J = 12.4, J = 3.4 Hz, 1 H, CHH-CH2-CH2-CHCl), 1.60 (m, J = 11.4, J = 3.1 Hz, 1 H, CHH-
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CHCl), 1.71 (ddt, J = 12.9, J = 3.5 Hz, 1 H, CHH-CH2-CH2-CHCl), 1.93 (m, J = 6.9, J = 2.4 Hz, 2 H, 
CHO-CH-(CH3)2, C=CH-CH-CH(CH3)2, 2.07 (ddd, J = 12.7, J = 4.2 Hz, 1 H, CHH-CH2-CHCl), 
2.14 (m, J = 4.2 Hz, 1 H, CHH-CHCl), 2.28 (ddd, J = 9.7, J = 2.6 Hz, 1 H, C=CH-CH), 2.43 (m, J = 
13.8, J = 4.4, J = 2.2 Hz, 1 H, CHCl-CHH), 2.57 (m, J = 13.7, J = 12.1, J = 1.7 Hz, 1 H, CHCl-
CHH), 2.79 (s, 3 H, N-CH3), 3.45 (dd, J = 9.8, J = 2.3 Hz, 1 H, CHO-CH-(CH3)2), 4.08 (ddt, J = 7.5, 
J = 4.6, J = 1.9 Hz, 1 H, CHCl), 6.91 (d, J = 2.4 Hz, 1 H, CH=C-S), 7.47–7.57 (m, 3 H, Ph), 7.83–
7.86 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ  14.5 (d), 17.5 (d), 20.9 (u), 21.2 (d), 21.4 (d), 26.7 (d), 
28.6 (d), 30.0 (d), 33.5 (u), 35.9 (u), 42.1 (u), 44.2 (d), 55.8 (d), 71.6 (d), 76.5 (u), 127.4 (d), 
128.8 (d), 132.1 (d), 141.3 (u), 141.8 (d), 144.5 (u) 
 
IR (CHCl3) ν 2960 (s), 2874 (s), 2803 (w), 1449 (s), 1386 (m), 1370 (m), 1110 (w), 1082 (w), 
1037 (s), 952 (m), 852 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 426 (2), 425 (4), 424 (5), 423 (10) (M+), 389 (26), 388 
(100), 225 (13), 155 (14), 138 (9), 124 (9) 
 
HRMS (EI) Calcd for C23H34NO2SCl: 423.199880; Found: 423.199856 
 
1H {1H }-NOE-Experiment (500 MHz, C6D6) of 246: 
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247: 
 
Rf = 0.10 (EtOAc/cyclohexane 1:9)  
 
[α]D =.− 40.5 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.84 (d, J = 6.9 Hz, 3 H, CH3), 0.85 (d, J = 6.9 Hz, 3 H, 
CH3), 1.04 (d, J = 6.9 Hz, 3 H, CH3), 1.10 (d, J = 6.9 Hz, 3 H, CH3), 1.63-1.77 (m, 3 H, CH(CH-
(CH3)2)-COH-CH-(CH3)2, CHH-CHCl), 1.87-1.96 (m, 2 H, CH2-CH2-CHCl-CHH), 2.04 (tt, J = 
14.1, J = 3.2 Hz, 1 H, CHH-CHCl), 2.15 (tt, J = 13.1, J = 3.2 Hz, 1 H, CHCl-CHH), 2.30 (m, J = 
9.7, J = 2.6 Hz, 1 H, C=CH-CH), 2.60 (m, J = 14.1, J = 4.0 Hz, 2 H, CHH-CH2-CHCl-CH2-
CHH), 2.81 (s, 3 H, N-CH3), 3.38 (dd, J = 9.7, J = 2.3 Hz, 1 H, C=CH-CH-CHO), 4.42 (dt, J = 
2.9 Hz, 1 H, CHCl), 6.96 (d, J = 2.4 Hz, 1 H, CH=C-S), 7.46–7.55 (m, 3 H, Ph), 7.88–7.92 (m, 2 
H, Ph)  
 
13C NMR (75 MHz, CDCl3): δ  14.6 (d), 17.5 (d), 21.3 (d), 21.5 (d), 26.3 (d), 26.9 (d), 28.9 (u), 
29.0 (d), 29.1 (d), 30.0 (u), 44.4 (d), 58.8 (d), 71.6 (d), 74.4 (u), 127.8 (d), 128.9 (d), 132.2 (d), 
141.4 (u), 141.5 (d), 145.8 (u) 
  
IR (CHCl3) ν 2960 (s), 2877 (s), 2804 (w), 1447 (s), 1384 (w), 1246 (s), 1151 (s), 1110 (w), 1083 
(w), 1030 (m), 1003 (m), 950 (w), 921 (w), 852 (m) 
  
MS (EI, 70 eV) (relative intensity, %) m/z 426 (4) , 425 (12), 424 (11), 423 (30) (M+), 389 (10), 
388 (40), 382 (19), 381 (14), 380 (49), 354 (9), 353 (16), 352 (26), 351 (30), 227 (29), 226 (14), 
225 (85), 161 (11), 157 (11), 156 (100), 147 (15), 145 (10), 140 (22), 139 (68), 125 (72), 119 
(18), 117 (11), 107 (18), 106 (15), 105 (27), 97 (19), 93 (11), 91 (27), 81 (26), 79 (25), 78 (13), 
77 (27) 
 
HRMS (EI) Calcd for C23H34NO2SCl: 423.199880; Found: 423.199667 
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1H {1H }-NOE-Experiment (500 MHz, C6D6) of 247 
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4.18.3. Synthesis of (1S,1'S,3S,8a'R)-3-chloro-1'-isopropyl-4'-[(S)-N-methyl-S-phenyl-sulfo-
nimidoyl)]-1',5',6',7',8',8a'-hexahydrospiro[cyclohexane-1,3'-isochromene] and (1r,1'S,4S,8a'R) 
-4-chloro-1'-isopropyl-4'-[(S)-N-methyl-S-phenyl-sulfo-nimidoyl)]-1',5',6',7',8',8a'-
hexahydrospiro[cyclohexane-1,3'-isochromene] (270) and (271). 
 
Following GP19, reaction of hemiacetal 232 (60 mg, 0.143 mmol) with TiCl4 (0.43 mmol) 
afforded a 8:1 mixture (as determined by ratio of the NMe group signals in 1H NMR of the crude 
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mixture) of chlorides (51 mg, 82%) 270 (42 mg, 68%) and 271 (3 mg, 5%) . The major 
regioisomer was purified by flash chromatography (EtOAc/cyclohexane 1:9) the second one was 
isolated only in traces. 
 
270: 
 
Rf = 0.20 (EtOAc/cyclohexane 1:9) 
 
[α]D = + 119.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.84-0.91 (m, 1 H, CH2-CClH-CH2-CHH), 0.90 (d, J = 6.9 Hz, 
3 H, CH3), 0.92–1.04 (m, 1 H, C=C-CH2-CHH), 1.09 (d, J = 6.9 Hz, 3 H, CH3), 1.33 (dt, J = 13.2, J 
= 3.8 Hz, 1 H, CClH-CH2-CH2-CHH), 1.42 (dd, 1 H, CClH-CH2-CHH), 1.46–1.54 (m, 1 H, C=C-
CH2-CHH), 1.56–1.72 (m, 4 H, CH2-CClH-CHH-CH2-CHH, C=C-CHH-CH2-CHH), 1.77–1.95 (m, 
2 H, CH-(CH3)2, C=C-CH2-CH2-CHH), 2.08–2.20 (m, 3 H, CH-CHO-CH, C=C-CH2-CHH-CH2-
CHH, CClH-CHH), 2.60 (ddd, J = 13.5, J = 4.1, J = 2.1Hz, 1 H, CHH-CClH), 2.76 (s, 3 H, N-CH3), 
2.89–2.99 (m, 2 H, CHH-CClH, C=C-CH2-CH2-CH2-CHH), 3.23 (dd, J = 9.3, J = 2.5 Hz, 1 H, 
CHO), 3.60 (dd, J = 13.9, J = 1.2 Hz, 1 H, C=C-CHH-CH2), 4.14 (tt, J = 11.8, J = 4.2 Hz, 1 H, 
CClH), 7.46−7.52 (m, 3 H, Ph), 7.84−7.90 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ  15.3 (d), 21.6 (d), 21.9 (u), 25.1 (u), 26.5 (u), 29.4 (d), 29.9 
(d), 31.9 (u), 32.0 (u), 34.5 (u), 36.1 (u), 41.3 (u), 43.1 (d), 56.7 (d), 74.6 (d), 78.0 (u), 126.7 (d), 
128.8 (d), 131.8 (d) 
IR (CHCl3) ν 3012 (w), 2936 (s), 2868 (s), 2800 (w), 1590 (m), 1449 (s), 1385 (w), 1236 (s), 
1146 (s), 1108 (s), 1079 (s), 1049 (s), 963 (w), 860 (s), 756 (s)  
 
MS (EI, 70 eV) (relative intensity, %) m/z 438 (3), 437 (7), 436 (9), 435 (15) (M+), 401 (27), 349 
(23), 400 (100), 382 (11), 358 (21), 357 (21), 356 (49), 321 (22), 301 (14), 299 (14), 286 (14), 
285 (27), 284 (29), 283 (15), 265 (16), 255 (10), 250 (22), 249 (14), 245 (14), 237 (36), 201 (12), 
185 (16), 181 (12), 173 (17), 169 (11), 156 (13), 147 (12), 145 (13), 143 (13), 139 (14), 131 (23), 
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129 (12), 125 (36), 117 (19), 115 (11), 109 (14), 107 (18), 105 (26), 95 (16), 93 (16), 91 (42), 81 
(26) 
 
HRMS (EI) Calcd for C24H34NO2SCl: 435.199880 Found: 435.200198 
 
1H {1H }-NOE-Experiment (500 MHz, C6D6) of 270 
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271: 
 
Rf = 0.19 (EtOAc/cyclohexane 1:9) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.92 (d, J = 6.9 Hz, 3 H, CH3), 1.07 (d, J = 6.9 Hz, 3 H, CH3), 
0.97−1.09 (m, 1 H), 1.30−1.57 (m, 4 H), 1.68 (t, 2 H, J = 13.6 Hz), 1.76−1.96 (m, 7 H), 2.04-2.24 
(m, 3 H), 2.29 (tt, J = 13.8, J = 3.6 Hz, 1H), 2.81 (s, 3 H, N-CH3), 3.04 (dd, J = 12.9 Hz, 1 H), 3.19 
(dd, J = 9.3, J = 2.0 Hz, 1 H), 3.42 (t, J = 10.8 Hz, 1 H), 3.62 (d, J = 14.2 Hz, 1 H), 4.48 (t, J = 2.5 
Hz, 1 H, CHCl), 7.47−7.56 (m, 3 H, Ph), 7.89−7.94 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)   
 
IR (CHCl3) ν 2933 (s), 2870 (s), 2800 (w), 1726 (w), 1590 (w), 1446 (s), 1384 (w), 1266 (m), 
1239 (s), 1147 (m), 1106 (m), 1078 (m), 1047 (m), 921 (w), 863 (m), 755 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 437 (6), 436 (6), 435 (14), 406 (12), 405 (11), 404 
(20), 400 (28), 389 (12), 387 (15), 359 (12), 358 (41), 357 (41), 356 (100), 355 (23), 339 (11), 
332 (11), 320 (10), 301 (18), 299 (24), 287 (15), 286 (31), 285 (53), 284 (70), 283 (33), 282 (13), 
281 (20), 280 (16), 279 (14), 265 (12), 255 (23), 249 (14), 239 (15), 237 (44), 223 (10), 209 (11), 
208 (10), 201 (10), 181 (15), 173 (15), 169 (15), 168 (10), 167 (10), 156 (18), 155 (10), 149 (10), 
147 (16), 145 (21), 143 (12), 142 (12), 141 (11), 139 (33), 135 (11), 133 (12), 131 (30), 129 (17), 
125 (56), 119 (14), 117 (26), 115 (14), 109 (19), 107 (25), 106 (12), 105 (36), 97 (18), 95 (19) 
 
HRMS (EI) Calcd. for C24H34NO2SCl: 435.1998; Found: 435.2019 
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4.18.4 Attempted selective synthesis of (1S,1'S,3S,8a'R)-3-chloro-1'-isopropyl-4'-[(S)-N-
methyl-S-phenyl-sulfo-nimidoyl)]-1',5',6',7',8',8a'-hexahydrospiro[cyclohexane-1,3'-
isochromene] (270) 
 
To a solution of hemiacetal 232 (50 mg, 0.12 mmol) in CH2Cl2 (5 mL) at –90 oC was slowly 
added TiCl4 (137 mg, 0.72 mmol). The mixture was stirred at this temperature for 2 h. 
Subsequently saturated (NH4)2CO3 was added and the mixture was warmed to ambient 
temperature. Water was added and the mixture was extracted with CH2Cl2, dried (MgSO4) and 
concentrated under vacuum to give Purification by flash chromatography on silica gave chlorides 
270 and 271 (40 mg, 76%) in a ratio of 8:1 (as depicted by NMe signal ratio in 1H NMR of the 
crude mixture) as colorless oil. 
 
To a solution of hemiacetal 232 (50 mg, 0.12 mmol) in CH2Cl2 (5 mL) at –78 oC was slowly 
added a solution of SnCl4 (94 mg, 0.36 mmol) in CH2Cl2 (5 mL). The mixture was stirred at this 
temperature for 2 h. Subsequently saturated (NH4)2CO3 was added and the mixture was warmed 
to ambient temperature. Water was added and the mixture was extracted with CH2Cl2, dried 
(MgSO4) and concentrated under vacuum to give mixture of undefined products. 
 
 
To a solution of hemiacetal
 232 (50 mg, 0.12 mmol) in ClCH2CH2Cl (5 mL) at –35 oC was 
slowly added a solution TiCl4 (68 mg, 0.36 mmol) in ClCH2CH2Cl (5 mL). The mixture was 
stirred at this temperature for 2 h. Subsequently saturated (NH4)2CO3 was added and the mixture 
was warmed to ambient temperature. Water was added and the mixture was extracted with 
CH2Cl2, dried (MgSO4) and concentrated under vacuum to give Purification by flash 
chromatography on silica gave chlorides 270 and 271 (35 mg, 67%) in the ratio of 3:2 (as 
depicted by NMe signal ratio in 1H NMR of the crude mixture) as colorless oils. 
 
To a solution of hemiacetal 232 (50 mg, 0.12 mmol) in CHCl3 (5 mL) at –60 oC was slowly 
added a solution TiCl4 (68 mg, 0.36 mmol) in CHCl3 (5 mL). The mixture was stirred at this 
temperature for 2 h. Subsequently saturated (NH4)2CO3 was added and the mixture was warmed 
to ambient temperature. Water was added and the mixture was extracted with CH2Cl2, dried 
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(MgSO4) and concentrated under vacuum to give Purification by flash chromatography on silica 
gave chlorides 270 and 271 (40 mg, 76%) in the ratio of 6:1 (as depicted by NMe signal ratio in 
1H NMR of the crude mixture) as colorless oils. 
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4.19. Synthesis of Sulfoximine-Substituted Spiroketals 
 
4.19.1 General Procedure for the synthesis of keto diols (GP20) 
 
To a solution of ether 77 (0.7 mmol) in THF (25 ml) was added at –78 0C nBuLi (0.9 mmol, 
0.57ml of 1.6 M solution in hexane) and the mixture was stirred at 0 0C for 3 h. Then a solution 
of γ-valerolactone (1.4 mmol) in THF (5 mL ) was added at –78 0C and the resulting mixture was 
stirred for 2 h. Subsequently half saturated aqueous NaCl (20 mL) was added and the resulting 
mixture was extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum. Purification by flash chromatography gave hydroxy ketone as a 
colorless gum. 
 
4.19.2 Synthesis of (8R,9S,E)-1-hydroxy-8-isopropyl-10-methyl-6-(phenylsulfonyl)-9-
(triethylsilyloxy)undec-6-en-5-one (278).  
 
iPr
iPr
OSiEt3
S
Ph
O NMe
O OH4 278 
 
Following GP20, reaction of vinylic sulfoximine 219 (0.3 g, 0.71 mmol) with δ-valero lactone 
(140 mg, 1.4 mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane, 
1:2) the hydroxy ketone 278 (0.35 g, 94%)  
 
Rf = 0.16 (EtOAc/cyclohexane, 1:2) 
 
[α]D = − 72.7 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.60 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.69 (d, J = 6.8 Hz, 3 H, 
CH3), 0.75 (d, J = 6.8 Hz, 3 H, CH3), 0.78 (d, J = 6.8 Hz, 3 H, CH3), 0.90 (d, J = 6.8 Hz, 3 H, CH3), 
0.97 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.50 (sept, J = 6.8 Hz, 1 H, C=CH-CH-CH-(CH3)2), 1.55−1.76 
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(m, 5 H, CO-CH2-CH2-CH2, CHOSi-CH-(CH3)2), 2.11 (ddd, J = 11.2, J = 8.6, J = 1.4 Hz, 1 H, 
C=CH-CH), 2.65 (td, J = 18.6, J = 6.8 Hz, 1 H, CO-CHH), 2.80 (s, 3 H, N-CH3), 2.90 (td, J = 18.6, J 
= 7.0 Hz, 1 H, CO-CHH), 3.60 (dd, J = 6.7, J = 1.4 Hz, 1 H, CH-OSi), 3.64 (t, J = 6.7 Hz, 2 H, CH2-
OH), 6.86 (d, J = 11.2 Hz, 1 H, CH=C-S), 7.44−7.59 (m, 3 H, Ph), 7.83−7.88 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 18.4 (d), 18.9 (d), 19.4 (u), 21.1 (d), 21.4 
(d), 29.3 (d), 29.6 (d), 31.7 (u), 33.5 (d), 44.1 (u), 48.8 (d), 62.3 (u), 77.9 (d), 128.4 (d), 128.8 (d), 
132.5 (d), 139.4 (u), 143.1 (u), 148.1 (d), 200.6 (u) 
 
IR (CHCl3) ν 3408 (m), 2958 (s), 2808 (m), 1698 (s), 1616 (w), 1465 (s), 1411 (w), 1249 (s), 
1375 (m), 1253 (s), 1152 (s), 1081 (s), 1011 (m), 858 (w), 800 (w) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 524 (6) (M+), 523 (3), 494 (5), 480 (5), 368 (8), 339 
(7), 338 (13), 337 (48), 336 (100), 322 (19), 294 (21), 283 (14), 270 (18), 267 (10), 187 (40), 159 
(31), 156 (24), 125 (27), 115 (57), 111 (10), 107 (17), 103 (21), 87 (55)  
 
HRMS (EI) Calcd for C28H49NO4SSi: 523.315161; Found: 523.315147 
 
 
4.19.3 Synthesis of (6E,8R,9S,10E)-1-hydroxy-8-isopropyl-6-[(S)-N-methyl-S-phenyl-
sulfonimidoyl)]-9-(triethylsilyloxy)dodeca-6,10-dien-5-one (277).  
 
iPr
OSiEt3
S
Ph
O NMe
O OH4
Me
277 
 
Following GP9, reaction of ether 77 (56 mg, 0.72 mmol) with δ-valero lactone (140 mg, 1.4 
mmol) afforded after purification by flash chromatography (EtOAc/cyclohexane, 1:2) the 
hydroxy ketone 277 (350 mg, 96%).  
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Rf = 0.18 (EtOAc/cyclohexane, 1:2) 
 
[α]D  = − 64.8 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.57 (q, J = 7.9 Hz, 6 H, Si-CH2), 0.82 (d, J = 6.8 Hz, 3 H, 
CH3), 0.89 (d, J = 6.8 Hz, 3 H, CH3), 0.98 (t, J = 7.9 Hz, 9 H, Si-CH2-CH3), 1.36−1.48 (m, 5 H, 
CH=CH-CH3, CH2-CH2-OH), 1.77 (m, 2 H, CO-CH2-CH2), 1.84−2.03 (m, 2 H, C=CH-CH-CH-
(CH3)2), 2.83 (td, J = 18.4, J = 7.0 Hz, 1 H, CO-CHH), 2.98 (td, J = 18.4, J = 7.1 Hz, 1 H, CO-CHH), 
3.02 (s, 3 H, N-CH3), 3.39 (t, J = 6.3 Hz, 2 H, CH2-OH), 4.21 (dd, J = 7.0, J = 3.8 Hz, 1 H, CH-OSi), 
5.19−5.34 (m, 2 H, CHOSi-CH=CH-CH3), 6.95−7.06 (m, 3 H, Ph), 7.02 (d, J = 11.2 Hz, 1 H, CH-
CH=C-S), 8.08−8.11 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 5.5 (u), 7.1 (d), 17.4 (d), 19.9 (d), 20.4 (u), 21.2 (d), 28.8 
(d), 29.7 (d), 32.2 (d), 45.1 (u), 54.2 (d), 62.2 (u), 74.5 (d), 126.6 (d), 127.3 (d), 128.8 (d), 129.0 
(u), 132.1 (u), 133.9 (d), 141.1 (u), 144.2 (d), 146.0 (u), 200.5 (u) 
 
IR (CHCl3) ν 3503 (m), 3387 (m), 3213 (w), 3062 (w), 2877 (s), 2807 (m), 1701 (s), 1627 (s), 
1450 (m), 1373 (w), 1252 (s), 1153 (m), 1075 (m), 1008 (w), 971 (m), 857 (m), 748 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 492 (2) (M+), 408 (2), 336 (14), 207 (11), 186 (16), 
185 (100), 115 (28), 87 (23) 
 
HRMS (EI) Calcd for C28H47NO4SSi-CH3N: 492.272961; Found: 492.272873 
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4.19.4. Synthesis of (2S,3R,6R)-3-isopropyl-5-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-2-
((E)-prop-1-enyl)-1,7-dioxaspiro[5.5]undec-4-ene (280). 
 
O
iPr S Ph
O NMe
O
 
 
A solution of the hydroxy ketone 277 (62 mg, 0.12 mmol) in CH2Cl2 (5 mL) was treated with 
pTsOH (62 mg, 0.36 mmol,) and stirred at ambient temperature for 3 h. Then half saturated 
aqueous NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The 
combined organic phases were dried (MgSO4) and concentrated in vacuum. The crude mixture 
was purified by flash chromatography (EtOAc/cyclohexane, 1:5) to give spiroketals 280 and epi-
280 (37 mg, 80 %, combined yield). Separation of 280 and epi-280 by both flash chromatography 
and HPLC failed. 
 
To a solution of hydroxy ketone 277 (62 mg, 0.12 mmol) in THF (3 mL) a mixture of 
CHCOOH:THF:H2O:HCl in the ratio of 8:8:1:0.2 (5 mL) was added. The mixture was stirred at 
ambient temperature for 3 h, after which time all of the starting material was consumed as 
indicated by TLC. Then mixture was treated with halfsaturated solution of NaHCO3 (30 mL). The 
resulting mixture was stirred for 30 min and than extracted with EtOAc. The combined organic 
phases were dried (MgSO4) and concentrated in vacuum. Flash chromatography 
(EtOAc/cyclohexane, 1:5) afforded spiroketals 280 and epi-280 (23 mg, 50 % combined yield). 
Separation of 280 and epi-280 by both flash chromatography and HPLC failed. 
 
A solution of the hydroxy ketone 277 (62 mg, 0.12 mmol) in THF (5 mL) was treated with 1N 
HCl (0.36 ml, 0.36 mmol). The mixture was stirred at ambient temperature for 3 h, after which 
time all of the starting material was consumed as indicated by TLC. Then mixture was treated 
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with halfsaturated solution of NaHCO3 (30 mL). The resulting mixture was stirred for 30 min and 
than extracted with EtOAc. The combined organic phases were dried (MgSO4) and concentrated 
in vacuum. Flash chromatography afforded spiroketals 280 and epi-280 (20 mg, 46 % combined 
yield). Separation of 280 and epi-280 by both flash chromatography and HPLC failed. 
 
A solution of thrhydroxy ketone 277 (62 mg, 0.12 mmol) in CH2Cl2 (5 mL) was treated with 
PPTS (90 mg, 0.36 mmol) and stirred at ambient temperature for 3 h. Then half saturated 
aqueous NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The 
combined organic phases were dried (MgSO4) and concentrated in vacuum. The crude mixture 
was purified by flash chromatography to give spiroketal 280 and epi-280 (33 mg, 70 % combined 
yield). Separation of 280 and epi-280 by both flash chromatography and HPLC failed. 
 
A solution of the hydroxy ketone 277 (62 mg, 0.12 mmol) in CH2Cl2 (5 mL) was treated with 
(+)-CAS (0.36 mmol) and stirred at ambient temperature for 3 h. Then half saturated aqueous 
NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The combined 
organic phases were dried (MgSO4) and concentrated in vacuum. The crude mixture was purified 
by flash chromatography to give spiroketal 280 and epi-280 (35 mg, 75% combined yield). 
Separation of 280 and epi-280 by both flash chromatography and HPLC failed. 
 
A solution of the hydroxy ketone 277 (62 mg, 0.12 mmol) in CH2Cl2 (5 mL) was treated with (-)-
CAS (0.36 mmol) and stirred at ambient temperature for 3 h. Then half saturated aqueous 
NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The combined 
organic phases were dried (MgSO4) and concentrated in vacuum. The crude mixture was purified 
by flash chromatography to give spiroketal 280 and epi-280 (40 mg, 85% combined yield). 
Separation of 280 and epi-280 by both flash chromatography and HPLC failed. 
 
A solution of the hydroxy ketone 277 (90 mg, 0.17 mmol) in CF3CHOHCF3 (5 mL) was treated 
with p-TsOH (89 mg, 0.51 mmol) and stirred at ambient temperature for 3 h. Then half saturated 
aqueous NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The 
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combined organic phases were dried (MgSO4) and concentrated in vacuum. Purification by flash 
chromatography gave spiroketal 280 (57 mg, 86% yield). 
 
Rf = 0.30 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 115.1 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)   δ 0.73 (d, J = 6.8 Hz, 3 H, CH3), 0.85 (d, J = 6.8 Hz, 3 H, 
CH3), 1.04−1.10 (m, 1 H, CO-CH2-CHH), 1.35−1.48 (m, 2 H, CO-CH2-CHH-CHH), 1.51 (d, J = 
6.4, J = 1.5 Hz, 3 H, -CH=CH-CH3), 1.68−1.78 (m, 2 H, CO-CHH-CH2, CH-(CH3)2), 1.95 (dt, J 
= 13.1, J = 3.8 Hz, 1 H, CO-CH2-CH2-CHH), 2.12 (dd, J = 10.1, J = 2.7 Hz, 1 H, C=CH-CH), 
3.05 (s, 3 H, N-CH3), 3.22 (dt, J = 13.3, J = 4.6 Hz, 1 H, CO-CH2-CH2-CH2-CHH), 3.22 (dd, J = 
10.9, J = 4.5 Hz, 1 H, CO-CHH), 3.64 (ddd, J = 13.1, J = 10.9, J = 2.5 Hz, 1 H, CO-CHH), 4.11 
(dd, J = 10.1, J = 7.9 Hz, 1 H, CH-O), 5.45 (dq, J = 15.0, J = 7.8, J = 1.5 Hz, 1 H, CHOSi-
CH=CH-CH3), 5.59 (dq, J = 15.0, J = 6.4 Hz, 1 H, CHOSi-CH=CH-CH3), 6.99−7.07 (m, 3 H, 
Ph), 7.47 (d, J = 2.0 Hz, 1 H, CH-CH=C-S), 8.14−8.18 (m, 2 H, Ph) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 17.3 (d), 17.9 (d), 18.7 (u), 20.8 (d), 24.8 (u), 26.9 (d), 29.9 
(d), 31.7 (u), 47.4 (d), 61.2 (u), 69.8 (d), 95.7 (d), 128.6 (d), 129.2 (d), 129.4 (d), 130.5 (d), 131.5 
(d), 142.0 (u), 143.0 (d), 143.5 (u) 
 
IR (capillar) ν 3063 (w), 2957 (s), 2874 (s), 2806 (m), 1737 (w), 1627 (w), 1447 (s), 1373 (m), 
1249 (s), 1152 (s), 1073 (m), 1046 (w), 1004 (s), 965 (m), 911 (m), 888 (w), 855 (m), 755 (s) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 391 (6) (M+), 390 (19), 389 (34), 375 (10), 374 (39), 
347 (15), 346 (66), 319 (17), 318 (16), 305 (27), 304 (14), 292 (14), 256 (11), 243 (10), 235 (54), 
234 (61), 225 (20), 219 (18), 206 (35), 205 (46), 192 (17), 191 (66), 177 (18), 167 (11), 165 (12), 
164 (20), 163 (32), 156 (39), 151 (58), 150 (73), 149 (74), 148 (17), 147 (12), 139 (32), 137 (16), 
136 (12), 135 (31), 133 (11), 131 (22), 126 (12), 125 (100), 123 (14), 122 (12), 121 (24), 119 
(15), 111 (11) 
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HRMS (EI) Calcd for C22H31NO3S: 389.202466; Found: 389.202521 
 
1H {1H }-NOE-Experiment (500 MHz, C6D6) of 280 
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o-Ph H-13 H-12 H-2 H-3 H-4 H-11ax H-10ax H-9eq H-8ax H-8eq H-16 H-17 N-Me
o-Ph w m w w
H-14 m w
H-13 s s
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H-2 m m w w m s
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H-10ax m m
H-10eq m vs
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H-9eq m m m
H-8ax m m s vs
H-8eq m vs
H-15 w m m w m s s
H-16 w m m w
H-17 w m w w w w
N-Me w w w w w
 
 
4.19.5. Synthesis of (2S,3R,6R)-2,3-diisopropyl-5-[(S)-N-methyl-S-phenyl-sulfonimidoyl)]-
1,7-dioxaspiro[5.5]undec-4-ene (282).  
 
O
iPr
iPr
S Ph
O NMe
O
282 
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Solution of hydroxy ketone 278 (80 mg, 0.15 mmol) in HFIP (5 mL) was treated with p-TsOH 
(79 mg, 0.45 mmol) and stirred at ambient temperature for 3 h. Then half saturated aqueous 
NaHCO3 (10 mL) was added and the resulting mixture was extracted with EtOAc. The combined 
organic phases were dried (MgSO4) and concentrated in vacuum. The crude mixture was purified 
by flash chromatography (EtOAc/cyclohexane, 1:5) to give spiroketal 282 (48 mg, 82%). 
 
Rf = 0.26 (EtOAc/cyclohexane, 1:5) 
 
[α]D  = − 91.6 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.68 (d, J = 6.8 Hz, 3 H, CH3), 0.85 (d, J = 6.8 Hz, 3 H, CH3), 
0.87 (d, J = 6.8 Hz, 3 H, CH3), 1.03 (d, J = 6.8 Hz, 3 H, CH3), 1.05−1.14 (m, 1 H, CO-CH2-CHH), 
1.38 (ddd, J = 13.1, J = 4.8, J = 4.0 Hz, 1 H, CO-CH2-CHH), 1.42−1.73 (m, 4 H, CO-CH2, CHO-
CH-(CH3)2), 1.87 (dt, J = 13.0, J = 3.8 Hz, 1 H, CO-CH2-CH2-CHH), 2.11 (ddd, J = 7.0, J = 3.8, J = 
2.4 Hz, 1 H, C=CH-CH), 2.93 (s, 3 H, N-CH3), 3.06−3.21 (m, 2 H, CO-CHH-CH2-CHH), 3.58 (dd, J 
= 10.3, J = 2.3 Hz, 1 H, CH-O), 3.64 (ddd, J = 13.3, J = 10.8, J = 2.6 Hz, 1 H, CO-CHH), 6.98−7.07 
(m, 3 H, Ph), 7.46 (d, J = 2.1 Hz, 1 H, CH-CH=C-S), 8.12−8.28 (m, 2 H, Ph)  
 
13C NMR (100 MHz, C6D6, TMS)  δ 15.0 (d), 17.1 (d), 19.0 (u), 20.9 (d), 21.5 (d), 25.0 (u), 26.9 
(d), 28.6 (d), 30.0 (d), 32.0 (u), 44.1 (d), 61.4 (u), 71.4 (d), 95.3 (d), 128.4 (d), 129.5 (d), 131.6 
(d), 142.2 (u), 143.4 (u), 143.7 (d) 
 
IR (CHCl3) ν 2959 (s), 2876 (s), 2805 (w), 1734 (w), 1629 (w), 1449 (m), 1373 (m), 1250 (s), 
1151 (s), 1109 (w), 1078 (m), 1047 (w), 1006 (s), 907 (w), 858 (m) 
 
MS (EI, 70 eV) (relative intensity, %) m/z 393 (3) (M+), 392 (8), 391 (32), 349 (22), 348 (7), 320 
(23), 125 (14) 
 
HRMS (EI) Calcd. for C22H33NO3S: 391.218116; Found: 391.217754 
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4.20. Removal of sulfoximine moiety 
 
 
4.20.1 Attempted synthesis of (2S,3R,6R)-3-isopropyl-5-methyl-2-((E)-prop-1-enyl)-1,7-
dioxaspiro[5.5]undec-4-ene (283) 
 
O
O
iPr Me
283 
 
To a slurry of CuI (86 mg, 0.45 mmol) in Et2O (10 mL) was added at −78 0C MeLi (0.75 
mmol, 0.47 ml of 1.6 M in Et2O) and the reaction mixture was stirred at 0 0C for 1 h. Then 
solution of spiroketal 280 (60 mg, 0.15 mmol in 3 mL Et2O) was added and the resulting mixture 
was stirred first at −78 0C for 2 h and then at ambient temperature for 16 h. Then solution of 
saturated NH4Cl and concentrated NH3 was added and the resulting mixture was stirred at 
ambient temperature for 1 h. Then the mixture was extracted with Et2O and the combined organic 
phases were dried (Na2SO4) and concentrated in vacuum to give unreacted 280 quantitatively. 
 
To a slurry of CuI (86 mg, 0.45 mmol) in Et2O (10 mL) was added at −78 0C MeLi (0.75 
mmol, 0.47 ml of 1.6 M in Et2O) and the reaction mixture was stirred at 0 0C for 1 h. 
Subsequently ClSi(CH3)3 (82 mg, 0.75 mmol) was addded at −78 0C and the resulting mixture 
was stirred for 1 h. Then solution of spiroketal 280 (60 mg, 0.15 mmol in 3 mL Et2O) was added 
and the resulting mixture was stirred first at −78 0C for 2 h and then at ambient temperature for 
16 h. Then solution of saturated NH4Cl and concentrated NH3 was added and the resulting 
mixture was stirred at ambient temperature for 1 h. Then the mixture was extracted with Et2O and 
the combined organic phases were dried (Na2SO4) and concentrated in vacuum to give unreacted 
280 quantitatively. 
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4.20.2. Attempts to synthesis of (2S,3R,6R)-3-isopropyl-5-phenyl-2-((E)-prop-1-enyl)-1,7-
dioxaspiro[5.5]undec-4-ene (284) 
 
O
O
iPr Ph
284 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(dppp) (8 mg, 0.013 mmol) in Et2O 
(10 mL) was added PhMgBr (0.52 ml of 1.0 M in n-hexanes, 0.52 mmol) and the mixture was 
stirred at ambient temperature for 24 h. Subsequently, half saturated aqueous NaCl (10 mL) was 
added and the mixture was extracted with EtOAc. The combined organic phases were dried 
(MgSO4) and concentrated in vacuum. Subsequent purification by flash chromatography gave 
280 (32 mg, 63% Yield). The desired spiroketal 284 was not observed. 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(dppp) (8 mg, 0.013 mmol) in THF 
(10 mL) was added PhMgBr (0.52 ml of 1.0 M in n-hexanes, 0.52 mmol) and the mixture was 
stirred at 0 oC for 48 h. Subsequently, half saturated aqueous NaCl (10 mL) was added and the 
mixture was extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum. Subsequent purification by flash chromatography gave 280 (25 mg, 50% 
Yield). The desired spiroketal 284 was not observed. 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(dppp) (8 mg, 0.013 mmol) in Et2O 
(10 mL) was added Ph2Zn (produced from PhLi (0.52 mmol) and ZnCl2 (35 mg, 0.26 mmol)) and 
the mixture was stirred at ambient temperature for 72 h. Subsequently, half saturated aqueous 
NaCl (10 mL) was added and the mixture was extracted with EtOAc. The combined organic 
phases were dried (MgSO4) and concentrated in vacuum. Subsequent purification by flash 
chromatography gave 280 (20 mg, 40% Yield). The desired spiroketal 284 was not observed. 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(PPh3)2 (9 mg, 0.013 mmol) in 
Et2O (10 mL) was added Ph2Zn (produced from PhLi (0.52 mmol) and ZnCl2 (35 mg, 0.26 
mmol)) and the mixture was stirred at ambient temperature for 72 h. Subsequently, half saturated 
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aqueous NaCl (10 mL) was added and the mixture was extracted with EtOAc. The combined 
organic phases were dried (MgSO4) and concentrated in vacuum. Subsequent purification by 
flash chromatography gave 280 (30 mg, 60% Yield). The desired spiroketal 284 was not 
observed. 
 
4.20.3. Attempted synthesis of (2S,3R,6R)-5-ethyl-3-isopropyl-2-((E)-prop-1-enyl)-1,7-
dioxaspiro[5.5]undec-4-ene (285) 
 
O
O
iPr Et
285 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(dppp) (8 mg, 0.013 mmol) in Et2O 
(10 mL) was added Et2Zn (0.52 mL of 1.0 M solution, 0.52 mmol) and the mixture was stirred at 
ambient temperature for 72 h. Subsequently, half saturated aqueous NaCl (10 mL) was added and 
the mixture was extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated in vacuum to give unreacted 280 quantitatively. The desired spiroketal 285 was not 
observed. 
 
To a solution of spiroketal 280 (50 mg, 0.13 mmol) and NiCl2(PPh3)2 (9 mg, 0.013 mmol) in 
Et2O (10 mL) was added Et2Zn (0.52 mL of 1.0 M solution, 0.52 mmol) and the mixture was 
stirred at ambient temperature for 72 h. Subsequently, half saturated aqueous NaCl (10 mL) was 
added and the mixture was extracted with EtOAc. The combined organic phases were dried 
(MgSO4) and concentrated in vacuum to give unreacted 280 quantitatively. The desired spiroketal 
285 was not observed. 
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4.20.4. Synthesis of (2S,3R,6R)-3-Isopropyl-2-((E)-prop-1-enyl)-1,7-dioxaspiro-[5.5]undec-4-
ene (286) 
  
O
O
iPr
286 
 
Following GP14, reaction of 280 (40 mg, 0.10 mmol)  with aluminum amalgam (produced from 
500 mg of aluminum foil) gave after purification by flash chromatography on silica the bicyclic 
spiroketal 286 (18 mg, 74% (EtOAc/cyclohexane, 1:40) as oil and sulfinamide 165 (8 mg, 50% 
(EtOAc/cyclohexane, 4:1) (67% in regard to formation of 286)) as an oil.  
 
Rf = 0.12 (EtOAc/cyclohexane, 1:40) 
 
[α]D = − 165.3 (c  1.00, CH2Cl2) 
 
1H NMR (400 MHz, C6D6, TMS)  δ 0.79 (d, J = 6.8 Hz, 3 H, CH3), 0.86 (d, J = 6.8 Hz, 3 H, 
CH3), 1.24 (m, 1 H, CO-CH2-CHH), 1.39−1.62 (m, 3 H, ,CO-CH2-CH2-CH2-CH2, CH-(CH3)2), 
1.58 (dd, J = 6.3, J = 1.0 Hz, 1 H, CH=CH-CH3), 1.77−1.85 (m, H, CH-(CH3)2), CO-CH2-CH2-
CHH), 2.06 (dd, J = 12.7, J = 3.4 Hz, 2 H, CH-CH=CH, CO-CH2-CH2-CHH), 3.63 (ddd, J = 
10.8, J = 4.6 Hz, 1 H, CO-CHH), 3.99 (ddd, J = 10.1, J = 7.6 Hz, 1 H, CO-CHH), 4.36 (dd, J = 
10.1, J = 7.7 Hz, 1 H, CH-O), 5.62 (dq, J = 15.3, J = 7.7, J = 1.4 Hz, 1 H, CHOSi-CH=CH-CH3), 
5.71 (dd, J = 10.2 Hz, 1 H, CH-CH=CH), 5.73 (dq, J = 15.3, J = 6.4 Hz, 1 H, CHOSi-CH=CH-
CH3), 5.81 (dd, J = 10.2, J = 2.6 Hz, 1 H, CH-CH=CH) 
 
13C NMR (100 MHz, C6D6, TMS)  δ 17.3 (d), 16.8 (d), 17.9 (u), 18.9 (d), 21.1 (u), 25.6 (d), 26.6 
(d), 35.4 (u), 45.5 (d), 60.7 (u), 71.6 (d), 93.7 (d), 127.9 (d), 128.4 (d), 131.7 (d), 132.2 (u) 
 
IR (capillar) ν 3035 (w), 2952 (s), 2872 (s), 1457 (m), 1381 (w), 1269 (w), 1201 (w), 1181 (w), 
1120 (w), 1074 (w), 1049 (w), 1002 (s), 968 (w), 898 (w), 808 (w) 
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MS (EI, 70 eV) (relative intensity, %) m/z 236 (0.5) (M+), 219 (0.5), 193 (2), 167 (11), 166 (100), 
98 (30), 95 (20), 93 (12) 
 
HRMS (EI) Calcd for C15H24O2 − C4H6O: 166.135765; Found: 166.135765 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
278
5. References 
 
[1] (a) Reggelin, M.; Zur, C. Synthesis 2000, 1. b) Okamura, H.; Bolm, C. Chem. Lett. 2004, 33, 
482 (c) Gais, H.-J. Het. Chem. 2007, 18, 472. (d) Pyne, S. Sulfur Reports 1992, 12, 57. 
[2] Moncada, S., Gryglewski, R.; Bunting, S.; Vane, J. R. Nature 1976, 1, 263. 
[3] Bund, J.; Gais, H.-J.; Schmitz, E.; Erdelmeier, I.; Raabe, G. Eur. J. Org. Chem. 1998, 1319. 
[4] (a) Kotera, M. Bull. Soc. Chim. Fr. 1989, 370. (b) Jilal-Miah, M. A.; Hudlicky, T.; Redd, J. 
W. In The Alkaloids; Vol. 51, p. 199, Academic: San Diego, CA, 1998 (c) Weinreb, S. M. Chem. 
Rev. 2006, 106, 2531. (d) Clive, D.; Yu, M.; Wang, J.; Yeh, V. S. C.; Kang, S. Chem. Rev. 2005, 
105, 4483. 
[5] Adrien, A.; Gais, H.-J.; Köhler, F.; Runsink, J.; Raabe, G.; Org. Lett. 2007, 9, 2155.  
[6] (a) Trabocchi, A.; Guarna, F.; Guarna, A. Curr. Org. Chem. 2005, 9, 1127. (b) Zhenliang, C.; 
Zhiyong, C.; Yaozhong, J.; Wenhao, H. Tetrahedron 2005, 61, 1579. (c) Rilatt, I.; Caggiano, L.; 
Jackson, R. F. W. Synlett 2005, 18, 2701. (d) Takigawa, Y.; Ito, H.; Omodera, K.; Koura, M.; 
Kai, Y.; Yoshida, E.; Taguchi, T. Synthesis 2005, 2046. (e) Moutevelis-Minakakis, P.; 
Sinanoglou, C.; Loukas, V.; Kokotos, G. Synthesis 2005, 933. (f) Ordóñez, M.; Cativiela, C. 
Tetrahedron: Asymmetry 2007, 18, 3. 
[7] Köhler, F.; Gais, H.-J.; Raabe, G. Org. Lett., 2007, 9, 1231. 
[8] (a) Devon, T. K.; Scott, A. I. In Handbook of Naturally Occurring Compounds; Vol.II. 
Academic Press: New York and London, 1972 (b) Faulkner, D. J. Nat. Prod. Rep. 1984, 1, 251 
(c) Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199. (d) Fuerstner, A.; Radkowski, K.; 
Wirtz, C.; Goodard, R.; Lehmann, C. W.; Mynott, R. J. Am. Chem. Soc. 2002, 124, 7061. (e) 
Crimmins, M. T.; Brown, B. H. J. Am. Chem. Soc. 2004, 126, 10264. (f) Nicolaou, K. C.; 
Vourloumis, D.; Baran, P. Angew. Chem., Int. Ed. 2000, 39, 44. 
[9] (a) Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. 
Ed. 2002, 41, 1668. (b) Mohammad, M., Angew. Chem. Int. Ed. 2002, 46, 565. 
[10] Illuminati, G.; Mandolini, L. Acc. Chem. Res. 1981, 14, 95. 
[11] (a) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413. (b) Conrad, J. C.; Fogg, D. E. 
Curr. Org. Chem. 2006, 10, 185. (c) Grubbs, R. H. Tetrahedron 2004, 60, 7117. (d) Hoveyda, A. 
H.; Schrock, R. R. Compr. Asym. Catal. 2004, 1, 207. 
[12] Hoveyda, A. H. Nature, 2007, 450, 243. 
REFERENCES 
 
279
[13] (a) Schuster, M.; Blechert, S. Angew. Chem., Int. Ed. Engl. 1997, 36, 2036. (b) Schrock, R. 
R.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2003, 42, 4592. 
[14] Schrock, R. R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O’Reagen, M. J. Am. 
Chem. Soc. 1990, 112, 3875. 
[15] (a) Nguyen, S. T.; Johnson, L. K.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1992, 114, 
3974. (b) Nguyen, S. T.; Grubbs, R.H.; Ziller, J. W. J. Am. Chem. Soc. 1993, 115, 9858. 
[16] (a) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Ang. Chem., Int. Ed. 2005, 44, 4490. (b) 
Mulzer, J.; Oehler, E. Topics in Org. Chem. 2004, 13, 269. 
[17] Martin, S. F.; Liao, Y.; Wong, Y.; Rein, T. Tetrahedron Lett. 1994, 35, 691. 
[18] White, J. D.; Hrnciar, P.; Yokochi, A. F. T. J. Am. Chem. Soc. 1998, 120, 7359. 
[19] Birman, V. B.; Rawal, V. H. J. Org. Chem. 1998, 63, 9146. 
[20]. Boehrsch, V.; Blechert, S. Chem. Com. 2006, 18, 1968. 
[21] Schmidt, B. Eur. J. Org. Chem. , 2004, 9, 1865. 
[22] (a) Diver, S. T.; Giessert, A. J. Chem. Rev. 2004, 104, 1317. (b) Kim, S.-H.; Bowden, N.; 
Grubbs, R. H. J. Am. Chem. Soc., 1994, 116, 10801. (c) Villar, H.; Frings, M.; Bolm, C. Chem. 
Soc. Rev. 2007, 36, 55. 
[23] Movassaghi, M.; Piizzi, G.; Siegel, D. S.; Piersanti, G., Ang. Chem., Int. Ed., 2006, 45, 5859. 
[24] Fuerstner, A.; Turet, L. Angew. Chem. 2005, 117, 3528. 
[25] (a) Fuerstner, A.; Seidel, G. Angew. Chem., Int. Ed. 1998, 37, 1734. (b) Fuerstner, A.; Guth, 
O.; Rumbo, A.; Seidel, G. J. Am. Chem. Soc. 1999, 121, 11108. (c) Fuerstner, A.; Mathes, C.; 
Lehmann, C. W. J. Am. Chem. Soc. 1999, 121, 9453. (d) Fuerstner, A.; Mathes, C.; Lehmann, C. 
W. Chem. Eur. J., 2001, 7, 5299. (e) Evano, G.; Schaus, J. V.; Panek, J. S., Org. Lett. 2004, 6, 
525. (f) Wang, X.; Porco, J. A., Jr., J. Am. Chem. Soc. 2003, 125, 6040. (g) Lacombe, F., 
Radkowski, K., Seidel, G., Fuerstner, A., Tetrahedron, 2004, 7315. 
[26] Deng, L.; Giessert, A. J.; Gerlitz, O. O.; Dai, X.; Diver, S. T.; Davies, H. M. L. J. Am. Chem. 
Soc. 2005, 127, 1342. 
[27] Denmark, S. E.; Yang, S.-M. Tetrahedron, 2004, 60, 9695. 
[28] Rigby, J. H. In Studies in Natural Products Synthesis; Vol. 12, p. 233, Elsevier: Amsterdam, 
The Netherlands, 1993. 
[29] Petasis, N. A.; Patane, M. A. Tetrahedron 1992, 48, 5757. 
[30] (a) Rowinsky, E. K.; Oneto, N.;Canetta, R. M.; Arbuck, S. G. Semin. Oncol. 1992, 19, 646. 
(b) Kingston, D. G. I.; Molinero, A. A.; Rimoldo, J. M. Prog. Chem. Org. Nat. Prod. 1993, 61, 1. 
REFERENCES 
 
280
(c) Nicolaou, K. C.; Dai, W.-M.; Guy, R. K. Angew. Chem., Int. Ed. Engl. 1994, 33, 15. (d) 
Nicolaou, K. C.; Guy, R. K. Angew. Chem., Int. Ed. Engl. 1995, 34, 2079. (e) Kingston, D. G. I., 
Chem. Com., 2001, 10, 867. 
[31] (a) Gais, H.-J.; Müller, H.; Bund, J.; Scommoda, M.; Brandt, J.; Raabe, G. J. Am. Chem. 
Soc. 1995, 117, 2453. (b) Johnson, C. R.; Zeller, J. R. Tetrahedron 1984, 40, 1225. (c) Bailey, P. 
L.; Clegg, W.; Jackson, R. F. W.; Meth-Cohn, 0. J. Chem. Soc. Perkin Trans. 1 1993, 343. (d) 
Bailey, P. L.; Clegg, W.; Jackson, R. F. W.; Meth-Cohn, O. J. Chem. Soc., Perkin Trans. 1 1990, 
200. (e) Johnson, C. R.; Lockard, J. P.; Kennedy, E. R. J. Org. Chem. 1980, 45, 264. (f) 
Erdelmeier, I.; Gais, H.-J.; Lindner, H. J. Angew. Chem., Int. Ed. Engl. 1986, 25, 935. (g) Pyne, 
S. G. J. Org. Chem. 1986, 51, 81. (h) Hwang, K.-J.; Logusch, E. W. Tetrahedron Lett. 1987, 28, 
4149. (i) Craig, D.; Geach, N. J. Synlett 1993, 481. 
[32] Brandt, J.; Gais, H.-J. Tetrahedron: Asymmetry 1997, 8, 909. 
[33] (a) Gais, H.-J.; Hainz, R.; Muller, H.; Bruns, P. R.; Giesen, N.; Raabe, G.; Runsink, J.; 
Nienstedt, S.; Decker, J.; Schleusner, M.; Hachtel, J.; Loo, R.; Woo, C.-W.; Das, P. Eur. J. Org. 
Chem. 2000, 3973. (b) Reddy, L. R.; Gais, H.-J.; Woo, C.-W.; Raabe, G. J. Am. Chem. Soc. 2002, 
124, 10427. 
[34] Mahrwald, R. In. Modern Aldol Reactions, Volumes 1 and 2. Wiley-VCH Verlag GmbH & 
Co. KGaA, Weinheim, Germany, 2004. 
[35] (a) Greene, T. W.; Wutsin, M. In Protective Groups in Organic Synthesis 3rd Edition, John 
Wiley & Sons, Inc. 1999. (b) Kocienski, P. J. In Protecting Groups 3rd Edition, Georg Thieme 
Verlag, Stuttgart, New York, 2005. 
[36] (a) R.Loo, Ph. D. Thesis RWTH Aachen 1999. (b) Wang-Woo, Ch. Ph. D. Thesis RWTH 
Aachen 2000. 
[37] Hachtel, J., Ph. D. Thesis RWTH Aachen 1998. 
[38] Gais, H.-J.; Müller, H.; Bund, J.; Scommoda, M.; Brandt, J.; Raabe, G. J. Am. Chem. Soc. 
1995, 117, 2453.  
[39] Olah, G. A.; Ohanessian, L.; Arvanaghi M., Chem. Rev. 1987, 87, 671. 
[40] Journet, M.; Dongwei C.; DiMichele L. M.; Larsen R. D. Tetrahedron Letters 1998, 39, 
6427. 
[41] Dixon, D. J.; Lucas, A. C., Synlett, 2004, 6, 1092. 
[42] Lipshutz, B. H.; Pfeiffer, S. S.; Chrisman, W. Tetrahedron Letters 1999, 40, 7889. 
[43] Olah, G. A.; Ohanessian, L.; Arvanaghi M. J. Org. Chem. 1984, 49, 3856. 
REFERENCES 
 
281
[44] Cotton, F. A.; Wilkinson, G. In Advanced Inorganic Chemistry, John Wiley and Sons: New 
York, 1988. 
[45] Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, P.; Dolling, U.-H.; Grabowski, 
E.J.J. Tetrahedron Letters 1995, 36, 5461. 
 
[46] Gais, H.-J.; Loo, R.; Roder, D.; Das, P.; Raabe, G. Eur. J. Org. Chem. 2003, 1500. 
[47] C. Bolm, H. Villar, Synthesis , 2005,1421. 
[48] Günter, M., Ph. D. Thesis RWTH Aachen 2002. 
[49] Lindenmeier, A., Ph. D. Thesis RWTH Aachen 2006. 
[50] Michrowska, A.; Bieniek, M.; Kim, M.; Klajn, R.; Grela, K., Tetrahedron, 2003, 59, 4525. 
[51] Schmidt, B.; Nave, S., Chem. Commun. 2006, 2489. 
[52] (a) Smith, A. B., III; Adams, Ch. M.; Kozmin, S. A.; Paone, D., V. J. Am. Chem. Soc. 2001, 
123, 5925. (b) Smith, A., B., III; Adams, Ch. M.; Kozmin, S., A. J. Am. Chem. Soc. 2001, 123, 
990. 
[53] H.-J. Gais, G. S. Babu, M. Günter, P. Das, Eur. J. Org. Chem. 2004, 1463. 
[54] (a) Gais, H.-J.; Loo, R.; Roder, D.; Das, P.; Raabe, G. Eur. J. Org. Chem. 2003, 1500. (b) 
Tiwari, S. K.; Gais, H.-J.; Lindenmaier, A.; Babu, G. S.; Raabe, G.; Reddy, L. R.; Köhler, F.; 
Günter, M.; Koep, S.; Iska, V. B. R. J. Am. Chem. Soc. 2006, 128, 7360. 
[55] Erdelmeier, I.; Gais, H.- J. J. Am. Chem. Soc., 1989, 111, 1125. 
[56] H.-J. Gais, C. V. Rao, R. Loo, Chem. Eur. J. 
[57] Bulow, G. Ph. D. Thesis RWTH Aachen 1995. 
[58] Rappoport, Z.; Marek, I. In The Chemistry of Organozinc Compounds, John Wiley & Sons: 
Chichester, UK, 2006. 
[59] Voswinkel, D., Ph. D. Thesis RWTH Aachen 1997. 
[60] (a) Pyne, S. G. Sulfur Rep. 1999, 21, 281. (b) Johnson, C. R.; Jonsson, E. U.; Wambsgans, 
A. J. Org. Chem. 1979, 44, 2061. 
[61] Schmidbaur, H.; Kammel, G. Chem. Ber. 1971, 104, 3234. 
[62] (a) Ley, S. V.; Milroy, L.-G.; Myers, R. M. Sci. Synth. 2007, 29, 613. (b) Mead, K. T.; 
Brewer, B. N. Curr. Org. Chem. 2003, 7, 227. (b) Brimble, M. A.; Farès, F. A. Tetrahedron 
1999, 55, 7661. 
REFERENCES 
 
282
[63] (a) La Cruz, T. E.; Rychnovsky, S. D. J. Org. Chem. 2007, 72, 2602. (b) de Greef, M.; Zard, 
S. Z. Org. Lett. 2007, 9, 1773. 
[64] (a) Zinzalla, G.; Milroy, L.-G.; Ley, S. V. Org. Biomol. Chem. 2006, 4, 1977. (b) Lindsey, 
C. C.; Wu, K. L.; Pettus, T. R. R. Org. Lett. 2006, 8, 2365. (c) Waters, S. P.; Fennie, W.; 
Kozlowski, M. C. Org. Lett. 2006, 8, 3243. (d) Sorgel, S.; Azap, Reissig, H.-U. Org. Lett. 2006, 
8, 4875. (e) Zanatta, S. D.; White, J. M.; Rizzacasa, M. A. Org. Lett. 2004, 6, 1041. (f) Enders, 
D.; Lenzen, A., Synlett 2003, 2185. (g) Panek, J. S.; Jain, N. F. J. Org. Chem. 2001, 66, 2747. (h) 
Brown, H. C.; Kulkarni, S. V.; Racherla, U. S.; Dhokte, U. P. J. Org. Chem. 1998, 63, 7030. (i) 
Barrett, A. G. M.; Edmunds, J. J.; Horita, K.; Parkinson, C. J. J. Chem. Soc. Chem. Commun. 
1992, 1236. 
[65] (a) Perron, F.; Albizati, K. F. Chem.Rev. 1989, 89, 1617. (b) Francke, W.; Kitching, W. 
Curr. Org. Chem. 2001, 5, 233. (c) Aho, J. E.; Pihko, P. M.; Rissa, T. K. Chem. Rev. 2005, 105, 
4406. 
[66] (a) Mead, K. T.; Brewer, B. N. Curr. Org. Chem. 2003, 7, 227 (b) Boivin, T. L. B. 
Tetrahedron, 1987, 43, 3309. 
[67] Castagnolo, D.; Breuer, I., Pihko, P. M. J. Org. Chem. 2007, 72, 10081. 
[68] Lowe, J. T.; Wrona, I. E.; Panek, J. S., Org. Lett. 2007, 2, 327. 
[69] (a) Osada, H.; Koshino, H.; Isono, K.; Takahashi, H.; Kawanishi, G. J. Antibiot. 1991, 44, 
259. (b) Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, 
M.; Isono, K. J. Antibiot. 1992, 45, 1409. (c) Takahashi, T.; Osada, H.; Koshino, H.; Sasaki, M.; 
Onose, R.; Nakakoshi, M.; Yoshihama, M.; Isono, K. J. Antibiot. 1992, 45, 1414. (d) Koshino, 
H.; Takahashi, H.; Osada, H.; Isono, K. J. Antibiot. 1992, 45, 1420. 
[70] El Sous, M.; Ganame, D.; Tregloan, P. A.; Rizzacasa, M. A. Organic Letters 2004, 17, 3001. 
[71] Shimizu, T.; Masuda, T.; Hiramoto, K.; Nakata, T., Org. Lett. 2000, 14, 2153. 
[72] (a) Tachibana, K; J. Am. Chem. Soc. 1981, 103, 2469. (b) Isobe, M; Tetrahedron Lett 1986, 
27, 963. 
[73] (a) Dounay, A. B.; Urbanek, R A.; Frydrychowski, V. A.; Forsyth, C. J., J. Org. Chem.  
2001, 3, 925. (b) Dounay, A. B.; Urbanek, R. A.; Sabes, S. F.; Forsyth, C. J., Angew. Chem. Int. 
Ed. Engl. 1999, 15, 2258. (c) Dounay, A. B.; Forsyth, C. J., Org. Lett. 1999, 3, 451. (d) Urbanek, 
R. A.; Sabes, S. F.; Forsyth, C. J. J. Am. Chem. Soc. 1998, 11, 2523. (e) Sabes, Steven F.; 
Urbanek, R. A.; Forsyth, C. J., J. Am. Chem. Soc. 1998, 11, 2534. (f) Forsyth, C. J.; Sabes, S. F.; 
Urbanek, R. A., J. Am. Chem. Soc. 1997, 35, 8381. (g) Dounay A B; Forsyth C J. Curr. Med. 
REFERENCES 
 
283
Chem. 2002, 9, 1939. (h) Dounay A B; Urbanek R A; Frydrychowski V A; Forsyth C J. J. Org. 
Chem. 2001, 66, 925. (i) Dounay A B; Forsyth C J. Org. Lett. 1999, 3, 451. 
[74] (a) Mishima, H.; Kurabayashi, M.; Tamura, C.; Sato, S.; Kuwano, H.; Saito, A. Tetrahedron 
Lett. 1975, 16, 711. (b) Takiguchi, Y.; Ono, M.; Muramatsu, S.; Ide, J.; Mishima, H.; Terao, M. 
J. Antibiot. 1983, 36, 502. (c) Takiguchi, Y.; Mishima, H.; Okuda, M.; Terao, M.; Aoki, A.; 
Fukuda, R. J. Antibiot. 1980, 33, 1120. 
[75] Li, M.; O'Doherty, G. A., Org. Lett. 2006, 18, 3987. 
[76] Figueroa, R.; Hsung, R. P.; Guevarra, C. C. Org. Lett. 2007, 9, 4857. 
[77] Liu, J.; Hsung, R. P. Org. Lett. 2005, 7, 2273. 
[78] (a) M. Entzeroth, A.J.; Blackman, J.S.; Mynderse, R.E. Moore J. Org. Chem. 1985, 50, 
1255. (b) Moore, R.E.; Blackman, A.J.; Cheuk, C.J.; Mynderse, J.S.; Matsumoto, G.K.; Clardy, 
R.; Woodard, R.W.; Craig, J.C. J. Org. Chem. 1984, 49, 2484. (c) Moore, R.E. Pure & Appl. 
Chem. 1982, 54, 1919. 
[79] Toshima, H.; Goto, T.; Ichihara, A., Tetr. Lett. 1994, 25, 4361. 
[80] a) Hartung, I. V.; Hoffmann, H. M. R. Angew. Chem., Int. Ed. 2004, 43, 1934. 
[81] Delgado, A., Castedo, L., Mascarenas, J. L., Org. Lett. 2002, 30, 913. 
[82] (a) Bernardelli, P.; Paquette, L. A. Hetereocycles 1998, 49, 531 (b) Chiu, P.; Lautens, M. 
Top. Curr. Chem. 1997, 190, 1. 
[83] (a) Tius, M. A., Chem. Rev. 1988, 5, 719. (b) Petasis, N. A.; Bzowej, E. I., Tetr. Lett. 1993, 
11, 1721.  
[84] (a) Sato, B.; Muramatsu, H. Miyauchi, M.; Hori,Y.; Takase, S.; Hino, M.; Hashimoto, S.; 
Terano, H. J. Antibiot. 2000, 53, 123. (b) Sato, B.; Nakajima, H.; Hori, Y.; Hino, M.; Hashimoto, 
S.; Terano, H. J. Antibiot. 2000, 53, 204.  
[85] (a) Clarke, P. A.; Grist, Matthew; E. M.; Wilson, C.; Blake, A. J., Tetrahedron  2005, 2, 353 
(b) Clarke, P. A.; Grist, M.; Ebden, M., Tetr. Lett. 2004, 5, 927. (c) Clarke, P. A.; Grist, M.; 
Ebden, M.; Wilson, Chem. Com., 2003, 13, 1560. 
[86] Takao, K.; Yasui, H.; Yamamoto, S.; Sasaki, D.; Kawasaki, S.; Watanabe, G.; Tadano, K. J. 
Org. Chem. 2004, 69, 8789. 
[87] Lejkowski, M.; Gais, H.-J.; Banerjee, P.; Vermeeren, C. J. Am. Chem. Soc. 2006, 128, 
15378. 
[88] (a) Juaristi, E.; Cuevas, G, Tetrahedron, 48, 1992, 5019. (b) Box, V. G. S. Heterocycles 
1998, 48, 2389. 
REFERENCES 
 
284
[89] Jung, M. E.; Pontillo, J., Tetrahedron, 2003, 59, 2729. 
[90] (a) Hosomi, A.; Sakurai, H. Tetrahedron Lett., 1976, 1295. (b) Hosomi, A. et al. Chem. 
Letters 1976, 941. (c) Hosomi, A. et al. J. Am. Chem. Soc. 1977, 99, 1673. (d) Hosomi, A. Acc. 
Chem. Res. 1988, 21, 200. (e) Fleming, I. et al. Org. React. 1989, 37, 57. (f) Fleming, I. Comp. 
Org. Syn. 1991, 2, 563.  
[91] Oisaki, K.; Suto, Y.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 5644. 
[92] Lida, A.; Osada, J.; Nagase, R.; Misaki, T.; Tanabe, Y. Org. Lett. 2007, 10, 1859. 
[93] Fawcett, J., Griffith, G. A., Percy, J. M., Uneyama, E., Org. Lett., 2004, 6, 1277. 
[94] (a) Ferrier, R. J. Top. Curr. Chem. 2001, 215, 153. (b) Yadav, J. S.; Reddy, B. V. S.; Raju, 
A. K.; Rao, C. V. Tetrahedron Lett. 2002, 43, 5437. 
[95] Lejkowski, M.; Banerjee, P.; Gais, H.-J.; Runsink, J. Org. Lett. 10, 2713.  
[96] a) Arundale, E.; L. A. Mikeska, Chem. Rev., 1952, 51; 505. (b) Miles, R. B.; Davis, C. E.; 
Coates, R. M.; J. Org. Chem., 2006, 71, 1493. (c) Overman, L. E., Velthuisen, E. J. J. Org. 
Chem., 2006, 71, 1581. (d) Kwon, M. S.; Woo, S. K.; Na S. W.; Lee, E.; Angew. Chem. Int. Ed., 
2008, 47, 1733. 
[97] (a) Rychnovsky, S.D, Thomas, C.R. Org. Lett. 2000, 2, 1217. (b) Rychnovsky, S.D.; Yang, 
G.; Hu, Y.; Khire, U.R. J. Org. Chem. 1997, 62, 3022. 
[98] (a) Barry, C.St.J.; Crosby, S.R.; Harding, J.R.; Hughes, R.A.; King, C.D.; Parker, G.D.; 
Willis, C.L.; Org. Lett., 2003, 5, 2429. (b) Yang, X.-F.; Mague; J.T.; Li, C.-J. J. Org. Chem. 
2001, 66, 739. 
[99] (a) Zhang, W.-C.; Viswanathan G.S.; Li, C.J. Chem. Commun. 1999, 291. (b) C. Semeyn, 
C.; Blaauw; R.H.; Speckamp, W.N. J. Org. Chem. 1997, 62, 3426. (c)Loh, T.-P.; Hu, Q.-Y. Ma, 
L.-T. J. Am. Chem. Soc., 2001, 123, 2450. (d) Hu, Y. Skalitzky; D.J.; Rychnovsky, S.D. 
Tetrahedron Lett. 1996, 28, 8679. 
[100] (a):Dahanukar; V.H.; Rychnovsky, S.D. J. Org. Chem. 1996, 61, 8317. (b) Kopecky; D.J. 
Rychnovsky, S.D. J. Org. Chem. 2000, 65, 191. 
[101] Cloninger, M. J.; Overman, L. E. J. Am. Chem. Soc. 1999, 121, 1092. 
[102] a) Searle, P. A.; Molinski, T. F. J. Am. Chem. Soc. 1995, 117, 8126. b) Searle, P. A.; 
Molinski, T. F.; Brzezinski, L. J.; Leahy, J. W. J. Am. Chem. Soc. 1996, 118, 9422. c) Molinski, 
T. F. Tetrahedron.Lett. 1996, 37, 7879. 
[103] Rychnovsky, S. D.; Thomas, Ch. R. Org. Lett. 2000, 9, 1217. 
REFERENCES 
 
285
[104] Marumoto, S.; Jaber, J. J.; Vitale, J. P.; Rychnovsky, S. D. Org. Lett. 2002, 22, 3919. 
[105] (a) Paquette, L. A.; Tae, J. J. Org. Chem. 1996, 61, 7860. (b) Marko, I. E.; Mekhalfia, A.; 
Bayston, D. J.; Adams, H. J. Org. Chem. 1992, 57, 2211. 
[106] Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
[107] Nunez, A.; Cuadro, A. M.; Alvarez-Builla, J.; Vaquero, J. J. Org. Lett. 2004, 6, 4125. 
[108] Paczkowski, R.; Maichle-Moessmer, C.; Maier, M. E. Org. Lett. 2000, 2, 3967. 
[109] (a) Runge M; Haufe G. J. Org. Chem. 2000, 65, 8737. (b) Taylor, R. E.; Galvin, G. M.; 
Hilfiker, K. A.; Chen, Y. J. Org. Chem. 1998, 63, 9580. 
 
 
 
 
 
  
CURRICULUM VITAE 
 
 
                                    Personal Informations 
Name                          Michal Lejkowski 
Date of Birth               03 January 1981 
Place of Birth              Lodz (Pl) 
Nationality                   Polish 
Marital Status              Married 
                                    Education 
1988-1996                   Primary school, Lodz (Pl) 
1996-2000                   Secondary school, Lodz (Pl) 
2000–2005       M.Sc., Organic Chemistry, Chemistry of bioactive compounds, 
Technical University of Lodz (Poland), January 2005 (grade: 
excellent),  
Msc. Thesis: The novel enantiopure pinane derivatives – 
potential ligands of chiral catalystsTechnical  
2005–2008                  PhD in research group of Prof. H.-J. Gais in Institut of Organic 
Chemistry at RWTH Aachen  
PhD. Thesis: Asymmetric Synthesis of Medium-Sized 
Carbocycles, Spirocycles and Oxabicycles via Ring-Closing 
Metathesis of Sulfoximine-Substituted Trienes and 
Dihydropyran Derivatives 
 
 
